公开/公告号CN101845438A
专利类型发明专利
公开/公告日2010-09-29
原文格式PDF
申请/专利权人 北京锐健特生物技术有限公司;
申请/专利号CN200910119655.X
发明设计人 段陵浔;
申请日2009-03-25
分类号C12N15/12(20060101);C07K14/435(20060101);C12N15/63(20060101);C12N1/21(20060101);C12N5/08(20060101);C07K16/18(20060101);A61K48/00(20060101);A61K39/385(20060101);A61P35/00(20060101);C12Q1/68(20060101);G01N33/574(20060101);C12Q1/04(20060101);C12R1/19(20060101);
代理机构
代理人
地址 100085 北京市海淀区上地信息路26号中关村创业大厦1004
入库时间 2023-12-18 00:52:30
法律状态公告日
法律状态信息
法律状态
2015-07-01
未缴年费专利权终止 IPC(主分类):C12N15/12 授权公告日:20130807 终止日期:20140325 申请日:20090325
专利权的终止
2015-02-04
文件的公告送达 IPC(主分类):C12N15/12 收件人:北京锐健特生物技术有限公司 文件名称:专利权终止通知书 申请日:20090325
文件的公告送达
2014-07-02
文件的公告送达 IPC(主分类):C12N15/12 收件人:北京锐健特生物技术有限公司 文件名称:缴费通知书 申请日:20090325
文件的公告送达
2013-08-07
授权
授权
2013-05-01
文件的公告送达 IPC(主分类):C12N15/12 收件人:北京锐健特生物技术有限公司 文件名称:办理登记手续通知书 申请日:20090325
文件的公告送达
2010-12-15
实质审查的生效 IPC(主分类):C12N15/12 申请日:20090325
实质审查的生效
2010-09-29
公开
公开
查看全部
技术领域
本发明主要围绕在人肿瘤新型诊断与治疗。以新的肿瘤诊断之特异靶基因,靶蛋白的发现,以及其在新型肿瘤诊断中之用途和用法,与靶蛋白在肿瘤疫苗中的应用为核心。
背景技术
癌症,为全人类共患之疾,目前,仅有放疗,化疗等非特异肿瘤治疗手段为目前临床诊治的主要方法,其5年成活率在大部分肿瘤患者中还很低.而特异的肿瘤诊断还局限于甲胎球蛋白在肝癌中或PSA在前列腺癌等少数肿瘤类型之应用.新的肿瘤靶抗原的发现在过去的20年中进展缓慢,因为目前常用技术在新的肿瘤诊断的特异靶基因,靶蛋白的发现过程中困难重重.而癌症的临床诊治应用中有急需新技术,新的肿瘤诊断的特异靶基因为治疗提供新手段.
癌症,目前仍然为仅次于心肌梗塞致死的第二位临床疾病致死的杀手.全球每年死于癌症的患者依然以数百万记.在中国,每年常见肿瘤的发病人数在120万以上,死于癌症的患者也有50万人之多.各国常见肿瘤类型大体说来基本相同,以肺癌,乳腺癌,胃癌,肝癌,前列腺,结直肠癌,脑肿瘤,胰腺癌,卵巢癌等为多发病例.死亡率也大致相当.而且一旦肿瘤转移,其临床预后极差.目前,仅有放疗,化疗等非特异肿瘤治疗手段,而且其副作用也很大.
目前,早期的特异的肿瘤诊断还仅仅局限于肝癌中甲胎球蛋白(AFP)或PSA在前列腺癌等少数肿瘤中.大部分临床常见肿瘤仍无好的诊断方法.现在临床中使用的X光,直肠镜,等不但费用高,病人也极受操作的痛苦.往往是因患者有临床症状而入院时则已为晚期.而治疗中因缺少特异的肿瘤诊断指标,往往治疗效果也有盲目性.故癌症的临床诊治中,目前急需新技术,新的肿瘤诊断的特异靶基因的发现与发展.而本技术发明正是为此而创新.
发明内容
本发明提供了分离的多核苷酸,其选自:(1)序列为SEQ ID NO:1-20之一的多核苷酸;(2)序列为SEQID NO:1-20之一的多核苷酸的互补序列;(3)序列为SEQ ID NO:1-20之一的多核苷酸的反义序列。
本发明提供了所述多核苷酸编码的多肽。在优选的技术方案中,多肽的氨基酸序列为SEQ ID NO:21-40之一。
本发明提供了携带有所述分离的多核苷酸的表达载体。
本发明还提供了宿主细胞,其转化或转染了所述分离的多核苷酸或者所述表达载体。本发明提供了特异性结合所述多肽的抗体或其片段。
本发明提供了所述分离的多核苷酸或多肽在制备制剂中的用途,该制剂用于刺激或扩增能特异性识别肿瘤蛋白的T细胞。
本发明提供了用于刺激或扩增能特异性识别肿瘤蛋白的T细胞的制剂,其含有所述分离的多核苷酸或所述多肽;以及所述制剂制备的T细胞群。
本发明还提供了所述分离的多核苷酸、所述多肽或所述T细胞群在制备预防和/或治疗肿瘤和/或癌症的疫苗中的用途。
本发明还提供了预防和/或治疗肿瘤和/或癌症的疫苗,其含有所述分离的多核苷酸、多肽或T细胞群以及药学上可接受的佐剂。
本发明还提供了所述分离的多核苷酸、多肽或T细胞群在制备诊断肿瘤和/或癌症的试剂盒中的用途。
本发明还提供了诊断肿瘤和/或癌症的试剂盒,其含有所述分离的多核苷酸、多肽或T细胞群。
本发明的肿瘤疫苗的技术方案中,我们提供如何使用靶蛋白抗体,或靶蛋白抗原本身结合载体蛋白的技术方法.进一步来说,在本发明的肿瘤疫苗的技术方案中,我们详细描述有:1)如何将靶蛋白表达为免疫细胞表面作为靶蛋白抗原来刺激患者免疫系统,所描述的免疫细胞包括:树突状细胞,T和B淋巴细胞等.2)作为佐剂载体蛋白发展的技术内容.这类技术包含有融合蛋白技术,其中涵盖有如何通过融合蛋白中载体蛋白部分来刺激患者免疫系统,如何选用高免疫原性之蛋白为载体蛋白.如何借用载体蛋白部分的特点来简化重组蛋白的纯化工艺等.
在临床肿瘤的早期诊断应用方面,本发明提供具体如何使用靶蛋白及多肽结合抗体技术开发各类常规临床检验技术:抗体酶联法,组织染色法,分析质谱多肽鉴定法等技术应用细节.同时本发明也提供具体如何使用靶基因特异D N A 序列而开展的以D N A 杂交为核心而检验的技术系统:如P C R技术和GeXP技术系统等.
最后,在临床应用的总体诊断,治疗方面,本发明提供具体案例:1)如何从患者肿瘤组织中检测2
0种靶基因的表达谱,2)依据患者肿瘤组织中检测出的20种靶基因的表达谱,利用高表达靶基因来指导临床医生即时选用预先生产好的20种靶基因所制造出的重组蛋白作为患者特异功能肿瘤疫苗而对病人进行治疗来杀灭肿瘤细胞和预防术后肿瘤复发的具体治疗方案.
附图说明
图1为人脑源DNA CHIP_DSL人基因启动子DNA甲基化实验结果扫描图.本图为MA校正后的结果展示图,F532坐标为对数值.读数为2时其靶基因的荧光信号实际增强了4倍.
图2为DNALI1靶基因在GNF芯片库中mRNA在各种人体组织中特异性表达图.本结果源于用美国Affymetrix公司U133A DNA芯片杂技61种正常人体组织,16种细胞系及一种肿瘤样品后综合分析后结果之展示.图上方读数代表其相对基因表达之水平.DNALI1在人睾丸生殖细胞表达水平为其他组织的3500倍.同时可见这一靶基因在其他正常体组织中几乎不表达.
图3为20种靶基因的名称与基因序列号
图4为14种靶基因的多肽合成序列
图5为20种靶基因的名称与基因序列号和其对应的全长cDNA克隆号
图6为在大肠杆菌中表达6种靶基因的DNA引物合成序列。为克隆6个靶基因以便在大肠杆菌中表达而获得全长重组蛋白,靶基因特异性DNA引物合成如下:5’端引物加有EcoRI酶切点,3’端引物加有XhoI酶切点.
图7为二种靶蛋白SSCPDH和GSTM3表达菌在2mM IPTG诱导后靶基因在大肠杆菌中表达SDS-PAGE图.
图8为靶蛋白特异抗体进行免疫蛋白印迹(Western Blot)筛选各种肿瘤细胞及正常人组织裂解液结果图.
图9为REALTIME-PCR鉴定用靶基因DNA引物合成序列
图10为人结肠癌样本REALTIME-PCR结果分析图。分析人结肠肿瘤组织的CSNK2A2靶基因表达表达水平是用购置于美国Origene公司,(产品目录号#H C R T 101&H C R T 501),其包含有5例正常人结肠组织(C1至C5)和19例人结肠肿瘤组织的cDNA样品.靶基因D NA引物经美国I D T公司合成,其序列见图9:实时PCR反应用美国Bio-Rad iQ5探测器检测,同时使用iQ SYBR Green Supermix(产品目录号:170-8884)进行样品反应.CSNK2A2靶基因表达表达水平用倍数之质而标记而小结于图10.
图11为GEXP系统鉴定用靶基因DNA引物合成序列,列出了GeXP实验中全部靶基因和4种House-Keeping基因所用的DNA引物.
图12为GeXP结果之小结。因为本组靶基因分别表达在不同种类的肿瘤中,为测试GeXP结果,我们用数种肿瘤混合的高质量RNA起始测试.美国Stratagene公司Universal human Reference RNA(产品目录号740000),为人腺癌,肝癌,宫颈癌,睾丸肿瘤,脑胶质瘤,黑色素瘤,脂肪瘤,白血病细胞等组织纯化的RNA混合物.本次实验中,20种靶基因于于2种看家基因(TBP,ATP50,ACTB和GAPDH)被清晰的在肿瘤样品中检测出.C17ORF39和CPD靶基因表达水平明显增加.
图13为靶蛋白C17ORF39特异性抗体在人肾肿瘤组织组织化学染色(IHC)中的应用.蛋白A柱纯化的抗C17ORF39重组蛋白特异抗体的免疫组化使用浓度为1ug/ml。组织标本固定在福尔马林溶液中先固定,然后石蜡包埋,然后切成4(μm)厚度的片子。按常规组织片微波加热处理法对组织标本片处理后用美国Ventana公司自动免疫组织化学染色仪进行组织化学染色.染色使用AEC检测合(美国Covance公司产品).C17ORF39的免疫组化结果见下图.在部分的人肾肿瘤组织中可见高表达的细胞核染色.而对照的正常人肾组织中几乎检测不到任何染色信号.
本发明中涉及的序列说明如下:
序列号为1(SEQ ID NO:1)的靶基因在N C B I基因库中为基因序列号为NM_001464的,名称为ADAM2的基因.
序列号为2(SEQ ID NO:2)的靶基因在N C B I基因库中为基因序列号为NM_024052的,名称为C17ORF39的基因.
序列号为3(SEQ ID NO:3)的靶基因在N C B I基因库中为基因序列号为NM_145036的,名称为CCDC46的基因.
序列号为4(SEQ ID NO:4)的靶基因在N C B I基因库中为基因序列号为NM_001304的,名称为C P D的基因.
序列号为5(SEQ ID NO:5)的靶基因在N C B I基因库中为基因序列号为NM_144782的,名称为CRAT的基因.
序列号为6(SEQ ID NO:6)的靶基因在N C B I基因库中为基因序列号为NM_001896的,名称为CSNK2A的基因.
序列号为7(SEQ ID NO:7)的靶基因在N C B I基因库中为基因序列号为NM_003462的,名称为DNALI1的基因.
序列号为8(SEQ ID NO:8)的靶基因在N C B I基因库中为基因序列号为NM_033214的,名称为G K 2的基因.
序列号为9(SEQ ID NO:9)的靶基因在N C B I基因库中为基因序列号为NM_153823的,名称为GSG1的基因.
序列号为10(SEQ ID NO:10)的靶基因在N C B I基因库中为基因序列号为NM_000849的,名称为GSTM3的基因.
序列号为11(SEQ ID NO:11)的靶基因在N C B I基因库中为基因序列号为NM_000640的,名称为IL13RA2的基因.
序列号为12(SEQ ID NO:12)的靶基因在N C B I基因库中为基因序列号为NM_016368的,名称为ISYNA1的基因.
序列号为13(SEQ ID NO:13)的靶基因在N C B I基因库中为基因序列号为NM_004923的,名称为MTL5的基因.
序列号为14(SEQ ID NO:14)的靶基因在N C B I基因库中为基因序列号为NM_153485的,名称为NUP155的基因
序列号为15(SEQ ID NO:15)的靶基因在N C B I基因库中为基因序列号为NM_015589的,名称为SAMD4A的基因
序列号为16(SEQ ID NO:16)的靶基因在N C B I基因库中为基因序列号为NM_016002的,名称为SCCPDH的基因
序列号为17(SEQ ID NO:17)的靶基因在N C B I基因库中为基因序列号为NM_019073的,名称为SPATA6的基因
序列号为18(SEQ ID NO:18)的靶基因在N C B I基因库中为基因序列号为NM_003284的,名称为TNP1的基因
序列号为19(SEQ ID NO:19)的靶基因在N C B I基因库中为基因序列号为NM_021733的,名称为TSKS的基因
序列号为20(SEQ ID NO:20)的靶基因在N C B I基因库中为基因序列号为NM_017481的,名称为UBQLN3的基因
序列号为21(SEQ ID NO:21)的靶蛋白在N C B I基因库中为蛋白序列号为NP_001455的,名称为ADAM2的蛋白.
序列号为22(SEQ ID NO:22)的靶蛋白在N C B I基因库中为蛋白序列号为NP 076957的,名称为C17ORF39的蛋白
序列号为23(SEQ ID NO:23)的靶蛋白在N C B I基因库中为蛋白序列号为NP_659473的,名称为CCDC46的蛋白.
序列号为24(SEQ ID NO:24)的靶蛋白在N C B I基因库中为蛋白序列号为NP_001295的,名称为CPD的蛋白.
序列号为25(SEQ ID NO:25)的靶蛋白在N C B I基因库中为蛋白序列号为NP_000746的,名称为CRAT的蛋白.
序列号为26(SEQ ID NO:26)的靶蛋白在N C B I基因库中为蛋白序列号为NP_001887的,名称为CSNK2A2的蛋白.
序列号为27(SEQ ID NO:27)的靶蛋白在N C B I基因库中为蛋白序列号为NP_003453的,名称为DNALI1的蛋白.
序列号为28(SEQ ID NO:28)的靶蛋白在N C B I基因库中为蛋白序列号为NP_149991的,名称为G K 2的蛋白.
序列号为29(SEQ ID NO:29)的靶蛋白在N C B I基因库中为蛋白序列号为NP_722545的,名称为GSG1的蛋白.
序列号为30(SEQ ID NO:30)的靶蛋白在N C B I基因库中为蛋白序列号为NP_000840的,名称为GSTM3的蛋白
序列号为31(SEQ ID NO:31)的靶蛋白在N C B I基因库中为蛋白序列号为NP_000631的,名称为IL13RA2的蛋白
序列号为32(SEQ ID NO:32)的靶蛋白在N C B I基因库中为蛋白序列号为NP_057452的,名称为ISYNA1的蛋白
序列号为33(SEQ ID NO:33)的靶蛋白在N C B I基因库中为蛋白序列号为NP_004914的,名称为MTL5的蛋白
序列号为34(SEQ ID NO:34)的靶蛋白在N C B I基因库中为蛋白序列号为NP_004289的,名称为NUP155的蛋白
序列号为35(SEQ ID NO:35)的靶蛋白在N C B I基因库中为蛋白序列号为NP_056404的,名称为SAMD4A的蛋白
序列号为36(SEQ ID NO:36)的靶蛋白在N C B I基因库中为蛋白序列号为NP_057086的,名称为SCCPDH的蛋白
序列号为37(SEQ ID NO:37)的靶蛋白在N C B I基因库中为蛋白序列号为NP_061946的,名称为SPATA6的蛋白
序列号为38(SEQ ID NO:38)的靶蛋白在N C B I基因库中为蛋白序列号为NP_003275的,名称为TNP1的蛋白
序列号为39(SEQ ID NO:39)的靶蛋白在N C B I基因库中为蛋白序列号为NP_068379的,名称为TSKS的蛋白
序列号为40(SEQ ID NO:40)的靶蛋白在N C B I基因库中为蛋白序列号为NP_059509的,名称为UBQLN3的蛋白
具体实施方式
任何引用的参考资料如专利,发表的文献等均作为文献应用.
本发明的核心之处在于发现新的多种肿瘤中特异表达的靶基因与其编码的蛋白.同时提供详细的技术步骤说明与实验案例来指导如何应用这组肿瘤中特异表达的靶基因与其编码的蛋白在临床诊断和重组蛋白在肿瘤疫苗发展中的应用.
在本发明的详细说明之中,会引用出许多常见的病毒学,免疫学,微生物学,分子生物学,DNA重组技术的常规技术与学术用语,在以下书籍中可查询引用:Sambrook,et al.Molecular Cloning:A LaboratoryManual(2nd Edition,1989);Maniatis et al.Molecular Cloning:A Laboratory Manual(1982);Oligonucleotide Synthesis(N.Gait,ed.,1984);Nucleic Acid Hybridization(B.Hames&S.Higgins,eds.,1985);Transcription and Translation(B.Hames&S.Higgins,eds.,1984);Animal CellCulture(R.Freshney,ed.,1986);Perbal,A Practical Guide to Molecular Cloning(1984).
本发明中从人肿瘤组织中分离鉴定出来的20种特指肿瘤相关抗原(TAA)的技术路线为新型技术思路,其首先利用商业化的技术如CHIP-DSL系统寻找出正常组织中高度DNA甲基化的基因启动子靶基因,然后从DNA芯片的阵列中很容易的查到其对应的靶基因而同时获得靶基因的基因序列号.以此基因序列号而很快得到靶基因序列与靶蛋白序列.同时,依据基因序列号,从NCBI库中可上网查寻完全同源的全长cDNA克隆(IMAGE克隆号),次开发而从ATCC或OPEN BIOSYSTEMS公司购买靶基因全长cDNA克隆.这一技术路线避免了传统的肿瘤组织cDNA库构建,基因杂交筛选,全长cDNA克隆,序列测定时耗时的工艺.
在获得20种特指肿瘤相关抗原(TAA)后,利用其靶基因来开发有关DNA序列依赖性诊断,重组蛋白表达的基因克隆,多肽或重组蛋白在特异抗体中的应用,以及抗体在肿瘤早期诊断中应用等为常规发展技术路线.最后本发明还重点描述这组肿瘤相关抗原在肿瘤疫苗发展中的使用.
本文中的蛋白多肽包括靶蛋白的任何连续在8个氨基酸以上的多肽序列.同时也包括常见的多种修饰性氨基酸而组成的多肽序列:如糖基化,乙酰化,磷酸化,甲基化等.同时本专利因涉及临床诊断和重组蛋白在肿瘤疫苗发展中的应用,如一些常用免疫概念:蛋白多肽的免疫原性,多肽表位等更是本专利的描述重点.本文中的靶蛋白有时会被称之为肿瘤相关抗原(TAA,Tumor associated Antigen),因其有特异的在肿瘤组织中高表达的特点.
在发现新的多种肿瘤中特异表达的这组靶基因与其编码的蛋白后,许多常规的免疫学方法自然而然的可据此组靶基因与其编码的蛋白而发展出各种临床诊断系统:如选用靶蛋白多肽而制备特异抗体,然后建立起ELISA,胶体金,放射免疫等传统诊断试剂合.或用这组靶基因DNA序列而发展出以PCR,DNA芯片等诊断试剂盒.这类常规技术系统在以下文献中有详细指导说明:Harlow and Lane,Antibodies:A LaboratoryManual,Cold Spring Harbor Laboratory,1988.Fundamental Immunology,3rd ed.,243-247(RavenPress,1993).
虽然有时蛋白多肽的免疫原性不容易掌握,本发明的详细说明中有涵盖使用靶蛋白全长序列来制备重组蛋白之技术路线.如果是细胞中穿膜蛋白在大肠杆菌中表达,我们还阐明有如何祛除蛋白N端的信号肽与穿膜蛋白功能域等技术路线来保障重组蛋白之高表达.此外,现今的DNA合成技术已使用的大肠杆菌蛋白合成优先码(codon optimization)成为常规技术,更进一步确保重组蛋白在大肠杆菌中高表达的技术路线之成功率.至于重组蛋白在其他哺乳类细胞中高表达的技术路线包括使用表达载体,用较强的启动子,载体携带筛选标记基因等都在下例案例中有具体例案。
在多肽化学合成的技术路线中,利用相似氨基酸来部分置换靶蛋白序列中的部分氨基酸而生产出功能类似、但序列不同的多肽其实是非常成熟的技术:如Kyte和Doolittle,1982)即在其文献出终结出氨基酸的亲水,疏水之分而给各中氨基酸相关值来考虑氨基酸置换:如:Isoleucine(+4.5);valine(+4.2);leucine(+3.8);phenylalanine(+2.8);cysteine/cystine(+2.5);methionine(+1.9);alanine(+1.8);glycine(-0.4);threonine(-0.7);serine(-0.8);tryptophan(-0.9);tyrosine(-1.3);proline(-1.6);histidine(-3.2);glutamate(-3.5);glutamine(-3.5);aspartate(-3.5);asparagine(-3.5);lysine(-3.9);and arginine(-4.5).在U.S.Pat.No.4,554,101专利中也有具体说明.
在选用靶蛋白序列中多肽来作为肿瘤疫苗发展时,其多肽序列的独特性的选择也是治疗成功的关键因素之一.选择序列独特的多肽,可降低与其它体内蛋白的同源性而产生交叉反应的副作用,从而使肿瘤疫苗治疗效果更特异.利用美国NCBI蛋白库中BLAST功能来开展这一工作很方便.具体操作方法在Altschulet al.(1977)Nucl.Acids Res.25:3389-3402and Altschul et al.(1990)J.Mol.Biol.215:403-410,文献中有详细说明.而下面的文献对多肽序列的独特性的选择提供了多方面,、更详细的说明(DNASTAR,Inc.,Dayhoff,M.O.(1978)A model of evolutionary change in proteins--Matrices for detectingdistant relationships.In Dayhoff,M.O.(ed.)Atlas of Protein Sequence and Structure,NationalBiomedical Research Foundation,Washington D.C.Vol.5,Suppl.3,pp.345-358;Hein J.(1990)Unified Approach to Alignment and Phylogenes pp.626-645Methods in Enzymology vol.183,AcademicPress,Inc.,San Diego,Calif.;Higgins,D.G.and Sharp,P.M.(1989)CABIOS 5:151-153;Myers,E.W.and Muller W.(1988)CABIOS 4:11-17;Robinson,E.D.(1971)Comb.Theor 11:105;Santou,N.Nes,M.(1987)Mol.Biol.Evol.4:406-425;Sneath,P.H.A.and Sokal,R.R.(1973)NumericalTaxonomy--the Principles and Practice of Numerical Taxonomy,Freeman Press,San Francisco,Calif.;Wilbur,W.J.and Lipman,D.J.(1983)Proc.Natl.Acad.,Sci.USA 80:726-730.
有时,当多肽序列的独特性的选择已挑选出某些区域而需要经一步细化时,下列文献中给出许多具体指导:Smith and Waterman(1981)Add.APL.Math 2:482.Needleman and Wunsch(1970)J.Mol.Biol.48:443.Pearson and Lipman(1988)Proc.Natl.Acad.Sci.USA 85:2444.
利用融合蛋白技术来增加靶蛋白序列中多肽的生产,方便纯化,提高靶蛋白多肽的免疫原性等可按部分以下文献中的方法来操作.如His-Tag,HA-Tag,GST融和载体等蛋白可经特殊的蛋白酶切点肽段如TEV等而融合,在经亲和柱纯化后用TEV蛋白酶切除融合载体蛋白部分来获得靶蛋白多肽纯品.(Lucast et al.Biotechniques 30:544-550,2001)其他常用的融合载体蛋白还包括抗体中的FC段和人白蛋白等.这在以下文献中也有详细说明(WO/2003/035105).
利用融合蛋白技术来提高靶蛋白多肽的免疫原性往往以选择那些对人T细胞、树突状细胞等有较强刺激性的载体蛋白为首选.有些亚类的IgG Fc端因能特异结合免疫细胞表面受体而具有较强的刺激性,这在文献Stoute et al.New Engl.J.Med.,336:86-91,1997中有详细描述.
在融合蛋白技术中有时载体蛋白与免疫靶蛋白多肽的三维结构也至关重要,需在二者结合处放置连接域小肽,如GGGGS和(GGGGS)3等免疫原性低,而结构灵活的连接域小肽.这类技术在以下文献中有详细描述:Maratea et al.,Gene 40:39-46,1985;Murphy et al.,Proc.Natl.Acad.Sci.USA 83:8258-8262,1986;U.S.Pat.No.4,935,233and U.S.Pat.No.4,751,180.
并且,融合蛋白技术中还包括新近发展出的DNA-蛋白融合技术.目前,免疫细胞表面受体中有一类RNA,DNA结合受体如TLR3,TLR9当其被激活时能极大调动免疫反应.故TLR9结合非甲基化的DNA可化学合成并绞连上靶蛋白免疫多肽而增强其肿瘤疫苗之疗效.以下文献对这类DNA-蛋白融合技术有较详细的描述(Stefan et al Vaccine.2003,vol.21, pp.990-995).
多肽在血中的生物半衰期也至关重要.而在多肽化学合成的技术路线中,使用非天然氨基酸、应用修饰性氨基酸等来增加多肽稳定性也在下述文献中有详细描述(FH Arnold.The FASEB Journal,Vol 7,744-749,1993.).至于经化学合成方法来同时稳定DNA核苷酸链的技术则更为成熟.如使用phosphorothioate or 2’O-methyl rather than phosphodiesterase linkages,用非天然碱基如:inosine,queosine and wybutosine,和acetyl-,methyl-,thio-等修饰adenine,cytidine,guanine,thymineand uridine等技术都能增加DNA核苷酸链在血中的生物半衰期.
正如专利中U.S.Patent Application 7270821描述的一样,乙肝病毒的核心蛋白(HBcAg)为病毒之结构蛋白之一,分子量仅18KD左右.但往往以病毒核心体形式出现.每一个核心体以180个左右的单体聚合物组成直径为27nm,具有极强的免疫原性.同时,在过去多年的研究发现,这种病毒核心体具有特殊的密度浮力,经简单的蔗糖密度梯度离心即可纯化出.把免疫靶蛋白多肽融合在HBcAg蛋白的C末端,然后在大肠杆菌中高表达重组蛋白,经破菌,离心等步骤即可获得免疫原性极高的融合重组蛋白.这一技术在下例文献中有详细的描述(WO/9940934).
因16型,18型等亚型的人乳头瘤病毒的感染能诱发妇女宫颈癌而在科研领域对其有较深入的研究.过去的数年中,利用人乳头瘤病毒的重组膜蛋白L1而发展出的人乳头瘤病毒的疫苗已被美国FDA批准而在临床广泛应用.重组膜蛋白L1有极高的免疫原性,同时其生产、纯化工艺成熟((US patent 6908613).甚至HPV18型的L1蛋白的多肽53之194本身已具极高的免疫原性.
其它常用的,高免疫原性的载体蛋白还包括肺炎链球菌(Streptococcus pneumoniae)的LYTA蛋白.其功能是负责合成N-acetyl-L-alanine amidase.这在Gene 43:265-292,1986文献中有详细的说明.LYTA蛋白对磷酸胆碱和DEAE都有较高的亲和力.所以其重组之融合蛋白可用DEAE柱来纯化.(Biotechnology10:795-798,1992).当LYTA蛋白的C末端,从178个氨基酸以后,(用188-305区可能更好)片段为载体蛋白与免疫靶蛋白多肽融合即可获得重组蛋白而用于肿瘤疫苗的发展.
在载体蛋白与免疫靶蛋白多肽融合时,有功能性的肽段如:增加蛋白进入细胞溶酶体,或增加融合肽在免疫靶细胞上结合MHC class II展示等均可考虑加入融合蛋白之中.具体的技术细节在专利中U.S.Pat.No.5,633,234.有较详细的说明.
本发明中靶蛋白多肽生产技术是极为成熟的技术之一,既有多肽合成仪可买也有商业公司提供优质的多肽合成服务.文献中如Merrifield,J.Am.Chem.Soc.85:2149-2146,1963对多肽合成原理有详细的说明,而多肽合成仪可购买美国Perkin Elmer/Applied BioSystems Division(Foster City,Calif.),或ACT公司等产品.中国上海吉尔生化有限公司等提供多肽合成服务.本发明中所指靶蛋白多肽是指我们从人肿瘤组织中分离鉴定出来的20种特指肿瘤相关抗原(TAA).
至于本发明中分离鉴定出来一组肿瘤诊治相关的命名为序号为1至20的靶基因,在此可指与这组基因相关的,基因片段,DNA探针,反义基因序列,RNAi等.同时也包括其表达载体,质粒等.当然,这组基因也包含那些经DNA合成,编码已经优化但仍然产生同类蛋白的DNA产物.在了解这一组肿瘤诊治相关靶基因特定序列后,以此而衍生出的突变体,同源序列等是本领域的常规技术.如DNA产物与本发明中序号为1至20的靶基因有任何75%以上的同源序列性均视为类似基因.而DNA片段之长度达15bp之长时以上时还与靶基因有任何75%以上的同源序列性也视为为类似基因.这类常规基因工程实验操作可在以下这类文献中有较详细的说明.Maloy et al.,1994;Segal,1976;Prokop and Bajpai,1991;Kuby,1994;and Maniatis et al.,1982.U.S.Pat.No.4,683,202.
依据序号为1至20的靶基因而衍生出反义基因序列,RNAi在抑制靶基因的表达中的应用是显而易见的技术,这在专利文件如U.S.Pat.No.5,739,119和U.S.Pat.No.5,759,829中有详细的说明.用肿瘤靶基因如的反义基因序列来抑制肿瘤细胞生长在U.S.Pat.No.5,747,470;和U.S.Pat.No.5,591,317以及U.S.Pat.No.5,783,683等专利中均有技术方案之介绍.故此,在本发明中所分离鉴定出来的这一组肿瘤诊治相关靶基因的应用中,以靶基因而衍生出其反义基因序列,RNAi来治疗肿瘤就成为治疗应用之一.更多的相关技术文献见下:Int.Pat.Appl.Publ.No.WO 93/23569和Int.Pat.Appl.Publ.No.WO 94/02595.至于稳定小片段DNA分子的技术可从下面参考资料中获得:Int.Pat.Appl.Publ.No.WO 92/07065;Iht.Pat.Appl.Publ.No.WO 93/15187;Int.Pat.Appl.Publ.No.WO 91/03162;Eur.Pat.Appl.Publ.No.92110298.4;U.S.Pat.No.5,334,711;and Iht.Pat.Appl.Publ.No.WO 94/13688.有关DNA-多肽杂合技术如PNA(peptide nucleic acids)也在文献Good and Nielsen,Antisense Nucleic Acid Drug Dev.19977(4)431-37中有详细的说明.这一技术的具体应用在下面的技术综述文献中有更进一步的描述:Corey et al (Trends Biotechnol 1997 June;15(6):224-9).
依据本发明中序号为1至20的靶基因而衍生出的DNA依赖性临床诊断中多聚核苷酸片段将成为重要的施加部分.其纯度鉴定,质量检验,表达水平等均为重要的技术成分.故将简要在此进行描述:
其一,多聚核苷酸片段的纯度鉴定,质量检验,表达水平测定等均为常规分子生物学技术,在Sambrooket al.,Molecular Cloning:A Laboratory Manual,Cold Spring Harbor Laboratories,Cold SpringHarbor,N.Y.,1989,书中有详细描述.同时,目前商用的DNA合成服务公司如美国IDT公司对其DNA引物合成有严格的质量检验.各种PCR引物之设计,PCR操作,实施PCR的使用等均有厂家提供标准试剂,和操作说明书.如DNA连接技术衍生的Ligation PCR见文献:Eur.Pat.Appl.Publ.No.320,308和U.S.Pat.No.4,883,750.独特的Qbeta Replicase酶的应用见PCT Intl.Pat.Appl.Publ.No.PCT/US87/00880专利.链置换型DNA扩增技术(Strand Displacement Amplification)见Great Britain Pat.Appl.No.2202328,和PCT Intl.Pat.Appl.Publ.No.PCT/US89/01025.其它技术如转录依赖型DNA扩增技术(transcription-based amplification systems(TAS)见文献PCT Intl.Pat.Appl.Publ.No.WO88/10315等.在文献中也见报道的还有:cyclically synthesizing single-stranded RNA(″ssRNA″),ssDNA,and double-stranded DNA(dsDNA).技术,见PCT Intl.Pat.Appl.Publ.No.WO 89/06700.在1990年Frohman报导的″RACE″技术等.
至于靶基因的基因工程中,使用各种表达载体,菌株或细胞系也为常规分子生物学技术,其表达系统可在大肠杆菌,酵母,蚕螽病毒,哺乳细胞系统,转基因动,植物等系统中进行.常用的表达启动子包括CMV,T7等强启动子系统来获得高表达.为获得稳定的哺乳细胞表达株,包括各种筛选基因的使用,增强子(enhancer)的应用等均有商用系统:如美国EMD公司的pET载体系统,美国Invitrogen公司的pSPORT1载体系统等.
至于靶基因在大肠杆菌系统的表达,美国EMD公司的pET载体系统就可作为首选系统.这一表达系统以噬菌体T7的启动子为核心,配备各种筛选基因如青酶素,卡那酶素等.同时还是IPTG诱导表达故表达水平高.同时,pET载体系统还配有各种融合蛋白如GST,HIS多肽等,使表达的重组蛋白纯化变的相对简单.如果结合TEV等蛋白酶切位点,重组蛋白的纯品可很容易的控制在融合重组蛋白或非融合重组蛋白状态.其他表达系统,如pIN载体系统,常在文献Van Heeke,G.and S.M.Schuster(1989)J.Biol.Chem.264:5503-5509)中有详细说明.美国Promega公司的pGEX载体系统也是可选系统之一.
如果使用酵母系统,啤酒酵母系统中与甲醇酵母表达系统均有商用系统.美国Invitrogen公司的甲醇酵母表达系统配件与工业放大技术完善,而啤酒酵母系统在文献Ausubel et al.(supra)and Grant et al.(1987)Methods Enzymol.153:516-544中有详细说明.
有的靶蛋白的表达量达到公斤级时,为减少长期生产成本也许选用转基因植物系统来表达靶蛋白.这一系统中常用的启动子为CaMV的35S和19S基因启动子.同时配备烟草花叶病毒(TMV)omega的分泌信号肽.这一技术系统在文献Takamatsu,N.(1987)EMBO J.6:307-311中有详细说明.其它启动子系统,如RUBISCO启动子,热休克蛋白启动子等在文献Coruzzi,G.et al.(1984)EMBO J.3:1671-1680;Broglie,R.et al.(1984)Science 224:838-843;and Winter,J.et al.(1991)Results Probl.Cell Differ.17:85-105)中有详细说明.而具体的蛋白表达之操作规程在Hobbs,S.or Murry,L.E.in McGraw HillYearbook of Science and Technology(1992)McGraw Hill,New York,N.Y.;pp.191-196文献中有详细说明.
蚕螽病毒(baculovirus)蛋白表达系统也为教常用的工程菌系统之一.其表达载体,细胞株均可从美国Invitrogen公司购置.
至于哺乳细胞蛋白表达系统,其技术成熟同时有许多商用系统可选择使用.如常用的启动子有CMV,B-ACTIN等,常用的有筛选基因有G418,ZEOSIN等,常用的载体有SV40,腺病毒载体,逆转录病毒载体等.这类系统在重组蛋白表达中的应用在文献Dachs et al.Oncology Research,Vol.9,pp:313-325,1997中有详细说明.
不管在哪种系统表达,常用的基因工程重组技术中的有关技术细节是需要注意的:如靶基因的转译码ATG上游的Kozak序列有助于基因在细胞中的高表达,有些蛋白在分泌表达时选用抗体蛋白IgG的分泌信号肽有助于获得高产量.在表达载体中使用合适的增强子有能有效提高重组蛋白表达量.这类技术在文献Scharf,D.et al.(1994)Results Probl.Cell Differ.20:125-162中有详细说明.
而表达细胞系的选择目前有许多文献有这方面的专门报导.如常用的细胞系CHO,COS,HeLa,MDCK,HEK293,and W138,列等有成熟的商用系统,其覆盖从细胞培养液的选择,稳定克隆之筛选.细胞发酵罐技术等都有专著.当然,由于靶蛋白的糖基化修饰往往影响其免疫原性,在表达宿主细胞选择时,其糖基化能力为考虑因素之一.因本专利所选用的靶蛋白为肿瘤疫苗发展之用,选用强免疫原性蛋白形式为重要的选择因素之一.
稳定的高表达克隆之转染,筛选技术在下列文献中有专门报道:如TK基因的使用:Wigler,M.et al.(1977)Cell 11:223-32.如adenine phosphoribosyltransferase基因的选用(Lowy,I.et al.(1990)Cell 22:817-23).常用的筛选基因DHFR的使用常规:Wigler,M.et al.(1980)Proc.Natl.Acad.Sci.77:3567-70);新霉素和G-418的选用:(Colbere-Garapin,F.et al(1981)J.Mol.Biol.150:1-14)等.同时使用标记基因共转染也为常见技术之一,如beta-glucuronidase和luciferase等在Rhodes,C.A.et al.(1995)Methods Mol.Biol.55:121-131.文献中有详细说明.稳定的高表达克隆之转染技术可使用美国INVITROGEN公司的lipofectamin,(Cat#18324-111)和Promega公司的磷酸钙沉淀法试剂盒(Mammalian Transfection System,Cat#E1200)
有关稳定的高表达克隆之鉴定技术也更为成熟.通常可用靶基因的探针来测定高表达克隆中表达载体插入染色体的基因数目,也可直接测定细胞上清中靶蛋白质的量.这类测定可用靶蛋白特异的抗体构建的免疫酶联法enzyme-linked immunosorbent assay(ELISA),发射免发radioimmunoassay(RIA),和荧光标记法fluorescence activated cell sorting(FACS)等.这类常规技术在以下文献中有详细说明.Hampton,R.et al.(1990;Serological Methods,a Laboratory Manual,APS Press,St Paul.Minn.)和Maddox,D.E.et al.(1983;J.Exp.Med.158:1211-1216).
本发明的第三部分重点阐述依据靶蛋白而生产的特异抗体的技术路线和应用.本发明中有的涉及专业词汇如“结合蛋白体,抗体,结合物”等专指能特异结合靶蛋白的特异结合蛋白,或蛋白多肽片段等.这种结合均指非共价的高亲和性结合,多以“结合常数,分离常数”等来描述(Davies et al.(1990)Ann.Rev.Biochem.59:439-473).这类技术也在Davies et al.(1990)Annual Rev.Biochem.59:439-473等文献中有详细说明.抗体的抗原结合部常指抗体中Fab部分,有轻,重链之分.而我们描述的这类“结合蛋白体,抗体,结合物”专指功能上能检测出肿瘤相关抗原的结合物,其临床的使用中至少能在某种类型的肿瘤中检测出>20%以上的患者,其在正常人群中的假阳性率在10%以下才具一定的使用价值.而其待检样品可以是血液样品,尿液,肿瘤组织等.最近的文献中,RNA分子也能发展成蛋白结合物,基本的抗体有关用法的知识在Harlow and Lane,Antibodies:A Laboratory Manual,Cold Spring HarborLaboratory,1988中有详细描述.
至于靶蛋白特异性的抗体生产其技术路线有多种,如兔的多肽免疫产生的多克隆抗体,鼠和兔的单克隆抗体技术,噬菌体抗体展示技术等.鼠的单克隆抗体技术
早在1976被Kohler and Milstein,Eur.J.Immunol.6:511-519,1976发表.兔的单克隆抗体技术在近几年才逐步发展起来,美国Epitomic公司提供客户技术服务.鼠的单克隆抗体技术在以下文献中有更一步的报道:Inbar et al.(1972)Proc.Nat.Acad.Sci.USA 69:2659-2662;Hochman et al.(1976)Biochem 15:2706-2710;and Ehrlich et al.(1980)Biochem 19:4091-4096.
有关在获得特异靶蛋白的稳定的鼠单克隆抗体细胞株,或从噬菌体抗体展示技术中克隆到抗体基因,都可用单链抗体技术制成单链抗体产品(single chain Fv:″sFv″),其连接抗体轻,重链的常用绞连多肽在文献Huston et al.(1988)Proc.Nat.Acad.Sci.USA 85(16):5879-5883中有详细描述.而如何提高单链抗体对靶抗原的亲和性技术路线在U.S.Pat.Nos.5,091,513和5,132,405,以及U.S.Pat.No.4,946,778,等专利文献中有详细指导.
在获得特异的抗体基因后,如需要在临床上使用,其可经鼠单克隆抗体人源化技术来降低其免疫原性(Kettleborough1 et al.Protein Engineering vol.4 no.7pp.773-783,1991).这一技术中重要的抗体蛋白氨基酸Kabat资料库在Kabat et al.,in Sequences of Proteins of Immunological Interest,4th ed.,(U.S.Dept.of Health and Human Services,U.S.Government Printing Office,1987)文献中有详细描述.
如靶蛋白为肿瘤细胞表面的膜蛋白,其特异性高亲和抗体就有可能开发成治疗性抗体.因此,治疗性抗体蛋白可标记上放射性同位素如:90I,123I,125I,131I,186Re,188Re,211At,and 212Bi,或各类毒性蛋白而达到其治疗肿瘤之疗效(U.S.Pat.No.4,735,792.和U.S.Pat.No.4,673,562).常见的毒素蛋白亚基包括:ricin,abrin,diptheria toxin,cholera toxin,gelonin,Pseudomonas exotoxin,Shigellatoxin,and pokeweed antiviral protein.小分子的抗肿瘤药物也可挂在抗体上而增家抗肿瘤抗体杀瘤之疗效.如Rodwell得专利中有实验步骤之描述U.S.Pat.No.4,671,958.以下参考专利更进一步阐明新的抗体与其他分子绞联的技术:U.S.Pat.No.4,489,710,to Spitler.U.S.Pat.No.4,625,014,to Senter et al.U.S.Pat.No.4,638,045,to Kohn et al..U.S.Pat.No.4,671,958,to Rodwellet al..U.S.Pat.No.4,569,789,to Blattler et al.
在抗肿瘤的免疫治疗中,激活T细胞是其中的重要一个环节.这类步骤既可是体内也可是体外的免疫激活.T细胞可从骨髓中,外周血中获得.许多商用系统如美国加洲Nexell Therapeutics公司的Isolex.TM.系统.其它实验相关技术细节在U.S.Pat.No.5,240,856;U.S.Pat.No.5,215,926;WO89/06280;WO 91/16116and WO 92/07243等专利中也有说明.新的iPS干细胞技术也为诱导分化获得T细胞开辟了新的技术路线(Ariff et al.Journal of Cellular Biochemistry.Jan 2009,Vol.105,No.6:1352-1360).
本组肿瘤相关性靶抗原对免疫细胞的激活可从几类技术方案中进行:1)用全长的靶抗原或其多肽直接激活T细胞.也可用表达质粒携带靶抗原cDNA转化入抗原展示细胞(antigen presenting cell:APC),树突状细胞(dentritic Cells)肌细胞中来表达靶抗原而激活T细胞.这类基因介导的免疫技术为临床试验中较为成熟的技术(Diebold et al,Human Gene Therapy.March 20,1999,10(5):775-786.).当然,用全长的靶抗原或其多肽直接激活T细胞时还可使用微粒载体等来加强其免疫活性.
在测定免疫细胞是否为靶抗原或其多肽直接激活时,可用许多方法来测定T细胞所分泌的细胞介素水平来判断其功能.如裂解靶细胞来测定细胞chromium release assay或细胞增值法(proliferation assay)以对照细胞为基值来判断.此类技术在文献Chen et al.,Cancer Res.54:1065-1070,1994中有详细描述.用放射标记的H3-thymidine掺入法在靶抗原或其多肽直接激活时测定T细胞的细胞增殖也是常用的技术Coligan et al.,Current Protocols in Immunology,vol.1,Wiley Interscience(1998).这类T细胞既可是CD4也可是CD8细胞.
临床应用时,免疫细胞在靶抗原或其多肽直接激活后,(往往也加入细胞介素如IL2,GMCSF,IL12等)会有体内或体外增殖的过程,然后给肿瘤患者使用.
T细胞重要的受体(TCR)大致分二类:alpha和beta链,经二硫键而共价相连.其结构在文献Janeway,Travers,Walport.Immunobiology.Fourth Ed.,148-159.Elsevier ScienceLtd/Garland Publishing.1999.中有详细描述.Alpha和beta链一起与CD3蛋白形成复合物来特异识别结合于MHC上的靶抗原多肽.T细胞受体在免疫分子的刺激下经类似抗体基因一样的基因重组而形成众多分子类型而展显出对靶抗原多肽不同的亲和性.这类基础知识在文献Janeway,Travers,Walport.Immunobiology.Fourth Ed.,98and 150.Elsevier Science Ltd/Garland Publishing.1999中有详细描述.利用本组肿瘤相关抗原刺激T细胞后,可筛选,克隆而获得高亲和性的TCR基因.然后可以V-J orV-D-J等基因重组形式而转入肿瘤患者的T细胞中.在组肿瘤相关抗原刺激后,这类T细胞会高效结合MHC而产生很强的免疫激活性.有报道表明利用TCR的类似物也能产生相同之效果(A Sette et al.AnnualReview of Immunology.Vol.12:413-431.1994).在靶基因的细胞转入中,表达载体可采取许多形式:TAA蛋白基因与特异TCR直接融合表达或二基因之间加入IRES(internal ribosome entry site)序列来分开表达等.Rolland,Crit.Rev.Therap.Drug Carrier Systems 15:143-198,1998.有关表达载体系统有:裸DNA直接注射,基因枪注射,腺病毒载体,逆转录病毒,腺病毒相关病毒载体AAV(adeno-associated virus),牛豆病毒,禽痘病毒等衍生的表达载体.各系统之特点在以下文献中有详细说明:Ulmer et al.,Science 259:1745-1749,1993.(Rich et al.(1993)Human Gene Therapy4:461-476).和Carter,B.J.(1992)Current Opinion in Biotechnology 3:533-539.Elroy-Stein andMoss,Proc.Natl.Acad.Sci.USA(1990)87:6743-6747;Fuerst et al.Proc.Natl.Acad.Sci.USA(1986)83:8122-8126.U.S.Pat.Nos.5,843,723;6,015,686;6,008,035和6,015,694.U.S.Pat.Nos.5,846,796;6,010,478;5,865,796;5,584,807;和EP Patent No.0500799.
综上所述,用本发明中发现的肿瘤相关蛋白来发展“特异肿瘤疫苗”已在上述各小结中予以阐述.经基因克隆,基因导入,T细胞刺激,激活细胞之扩增,TCR的使用等技术路线的说明,已使具常规医学,生物学之人士能开发,使用本技术.有关更详细的肿瘤疫苗的具体技术操作,基因转导在肿瘤疫苗中应用等总结文献见:M.F.Powell and M.J.Newman,eds.,″Vaccine Design(the subunit and adjuvantapproach),″Plenum Press(NY,1995).U.S.Pat.No.5,219,740;Miller and Rosman(1989)BioTechniques 7:980-990.
佐剂的使用在肿瘤疫苗发展中至关重要,也为本发明详细描述重点之一.而免疫增强剂是泛指所有能增加免疫反应的任何试剂.许多佐剂的功能是让抗原分子缓释如氢氧化铝aluminum hydroxide和矿物油(mineral oil),或非特异的增加免疫刺激,如磷脂A(lipid A),鲍特杆菌蛋白(Bortadella pertussis)和结核杆菌蛋白(Mycobacterium tuberculosis derived proteins).许多生产厂家有医用佐剂供应:如美国Difco Laboratories公司的Freund’s Incomplete Adjuvant and Complete Adjuvant(DifcoLaboratories,Detroit,Mich.);美国Merck公司的Adjuvant 65.美国SmithKline Beecham公司的AS-2.其他产品如:氢氧化铝胶(aluminum hydroxide gel)(alum)or磷酸铝(aluminum phosphate);钙盐(salts of calcium),铁或锌(iron or zinc);不溶的乙酰化的酪胺酸(an insoluble suspension ofacylated tyrosine);乙酰化糖(acylated sugars);阳离子化或阴离子化的多糖(cationically oranionically derivatized polysaccharides);聚磷腈(polyphosphazenes);生物降解性微粒(biodegradable microspheres);单磷酸类脂A(monophosphoryl lipid A)and quil A也为常用免疫增强剂.细胞介素,如GM-CSF,白介素2,白介素7,白介素12,等也在临床使用.
因本发明重点在使用肿瘤相关抗原刺激患者自身免疫系统来达到预防与治疗效果,我们选用免疫刺激时优先激活Th1细胞反应.高水平的Th1细胞反应将产生细胞介素如干扰素gamma.,肿瘤坏死因子alpha(TNF.alpha).,白介素2,白介素12,其有增强体液介导性免疫反应.当然,在肿瘤相关抗原刺激为肿瘤疫苗治疗的过程中,Th1和Th2细胞反应都会增强.有关细胞介素的使用请阅读文献:Mosmann and Coffman,Ann.Rev.Immunol.7:145-173,1989.
有的佐剂是优选刺激Th1细胞反应的,如佐剂加有单磷酸类脂A与aluminum salt混用.在文献U.S.Pat.Nos.4,436,727;4,877,611;4,866,034和4,912,094中有详细说明.非甲基化CpG多核苷酸作为佐剂使用也是优选刺激Th1细胞反应.这在专利文献中如WO 96/02555,WO 99/33488and U.S.Pat.Nos.6,008,200and 5,856,462中也有详细阐述.美国Aquila Biopharmaceuticals公司出售的Quil A衍生物QS21and QS7也有刺激Th1细胞反应的效果.在佐剂混合物中加入各种微粒如壳聚糖,刺蒺藜总皂苷和其它多聚体,聚阳离子型高分子材料polylactide and polylactide-co-glycolide particles,poly-N-acetyl glucosamine-based polymer matrix,particles composed of polysaccharides orchemically modified polysaccharides,liposomes and lipid-based particles,particles composedof glycerol monoesters,等.刺蒺藜总皂苷(saponins)也可和脂质体如ISCOMs混合使用.还可加入Carbopol.RTM来增加佐剂的粘连度(viscosity).故本专利的肿瘤疫苗的首选佐剂仿是:单磷酸类脂A,刺蒺藜总皂苷类的QS21和3D-MPL.RTM混合物为核心试剂.这与文献WO 94/00153中的方法大同小异.
更多的佐剂试剂呈例在这可供选择:法国Seppic公司Montanide ISA 720产品.美国Chiron公司的SAF,ISCOMS,MF-59等产品,美国SmithKline Beecham公司的SBAS-2or SBAS-4等产品.美国Corixa公司的RC-529产品.在专利文献中还有更多的有关新型佐剂试剂的阐述:U.S.patent application Ser.Nos.08/853,826and 09/074,720,和WO 99/52549A1.
本发明的特异肿瘤疫苗发展中细胞类型的选用以抗原递呈细胞(antigen presenting cells(APCs)的刺激为优先,这包括:树突状细胞(dendritic cells),巨噬细胞,B细胞,单核细胞等.其他类型的细胞也有可能经处理而具备抗原递呈能力,如导入TCR基因,让HLA配型合适等技术都可用于抗原递呈细胞的生产.至于抗原递呈细胞的来源,即可是自体,也可用异体材料.取材途径包括各种体液,器官组织等.
在各类可选用的抗原递呈细胞中,树突状细胞是最理想的细胞类型.这在文献(Banchereau andSteinman,Nature 392:245-251,1998)中有较为详细的阐述.而且配合以上所选用的TH1佐剂配方有很好的免疫刺激效果.(Timmerman and Levy,Ann.Rev.Med.50:507-529,1999).一般来说,树突状细胞可从形态学上来鉴定,也可以其对颗粒物的吞噬(take up)能力来分离.其功能往往以对特异的T细胞群的刺激能力来计量.利用转基因TCR等技术来使肿瘤患者树突状细胞具备对特异肿瘤抗原的刺激反应能力也是本专利指出的技术路线之一.这类技术的细节在Zitvogel et al.,Nature Med.4:594-600,1998文章中有更为详细的阐述.
树突状细胞的来源可取之外周血,骨髓,入侵肿瘤组织的免疫细胞,肿瘤外周组织中的免疫细胞,淋巴结,脾.皮肤组织,或脐带血等.从外周血中分离的单核细胞在体外细胞培养体系中经细胞介素GM-CSF,IL-4,IL-13或TNF.alpha处理即可诱导分化成树突状细胞.而从脐带血,骨髓中分离的CD34阳性细胞也可经GM-CSF,IL-3,TNF.alpha.,CD40l igand,LPS,flt3底物(ligand)而体外处理来诱导分化成树突状细胞.一般来说,树突状细胞被粗分成“成熟型和非成熟型”二种:非成熟型往往指其细胞仍有很强的吞噬(take up)能力,而且在细胞膜上仍有较高的Fc.gamma受体表达.而成熟型树突状细胞是指MHC I和II型分子表达高的CD54,CD11和CD40,CD80,CD86及4-1BB受体蛋白都较高表达的细胞群.
在分离,纯化出树突状细胞后,应用常规分子生物技术将本专利中所描述的20种肿瘤相关基因导入树突状细胞便为可行.这类技术在以下文献中有较为详细的阐述:专利WO 97/24447.Mahvi et al.,Immunology and cell Biology 75:456-460,1997.常用的技术是脂质体(Liposomes)转化技术.脂质体用与T细胞,肝细胞,细胞株PC 12中的具体应用在Renneisen et al.,J Biol.Chem.1990Sep.25;265(27):16337-42;Muller et al.,DNA Cell Biol.1990 April;9(3):221-9)等文章中有更为详细的阐述.
至于免疫激活后的树突状细胞治疗使用途经,既可肌肉注射,静脉注射,也可皮内,皮下,大网内等途经用药.这类技术在以下文献中有较为详细的阐述:U.S.Pat.No.5,543,158;U.S.Pat.No.5,641,515and U.S.Pat.No.5,399,363
用药制剂中的部分免疫刺激微粒成份往往是生物降解类物质.这类组分在免疫类药物中有常规制剂:如microparticles of poly(lactide-co-glycolide),polyacrylate,latex,starch,cellulose,dextran等.这类制剂的使用在专利文献中如:U.S.Pat.Nos.4,897,268;5,075,109;5,928,647;5,811,128;5,820,883;5,853,763;5,814,344,5,407,609和5,942,252中又细述.有时为达到缓释效果还在制剂中加入超大分子物如绞联的多糖物,或使用不同磷脂类物质(phospholipid).以下文献对这类技术有详细阐述U.S.Pat.No.5,151,254 and PCT applications WO 94/20078,WO/94/23701 and WO 96/06638).有关肿瘤疫苗制剂中的或使用不同磷脂类物质的使用也是常规知识,这类技术系统在以下文献中有详细报道:Lasic,Trends Biotechnol 1998 July;16(7):307-21.Takakura,Nippon Rinsho 1998March;56(3):691-5;Chandran et al.,Indian J Exp Biol.1997 August;35(8):801-9;Margalit,Crit RevTher Drug Carrier Syst.1995;12(2-3):233-61;U.S.Pat.No.5,567,434;U.S.Pat.No.5,552,157;U.S.Pat.No.5,565,213;U.S.Pat.No.5,738,868and U.S.Pat.No.5,795,587.
有关肿瘤疫苗制剂中的其它成分如各类缓冲液等,既可用生理盐水,也可用PBS(phosphate bufferedsaline)液.常用的添加剂如葡萄糖,甘露糖,蔗糖,葡聚糖,甘露醇,甘氨酸,抗氧化剂(antioxidants),抑菌剂(bacteriostats),螯合剂(chelating agents)EDTA或谷胱甘肽(glutathione)等.制剂类型既可是水溶液也可是冻干制剂.包装大小可控制在一瓶一次注射剂量或一瓶中含多次注射剂量.
肿瘤的生长往往是患者体内的免疫监视功能不足所致,而肿瘤的免疫治疗是基于调动患者体内自有的免疫功能来识别肿瘤细胞上的靶抗原而抑制其生长.这类基础知识在Jager,et al.,Oncology 2001;60(1):1-7;Renner,et al.,Ann Hematol 2000December;79(12):651-9等文献中有详细报道.目前已知体内至少有四类功能细胞与人体抗肿瘤活动有关:1)B淋巴细胞,分泌抗体来特异识别肿瘤细胞.2)单核细胞,产生补体等直接杀死靶细胞.3)中性粒细胞(natural killer lymphocytes),可利用特异抗体结合肿瘤细胞后来攻击靶细胞或释放致死因子直接产生补体等直接杀死靶细胞(natural killing),4)T细胞,处理肿瘤特异抗原而后递呈给其它免疫攻击细胞来杀伤瘤细胞,或结合那些表面带有补体的瘤细胞.(Schreiber,H.,1989,in Fundamental Immunology(ed).W.E.Paul,pp.923-955).虽然体液免疫和细胞介导的免疫都对肿瘤抑制至关重要,但实验结果表明CD4T细胞的激活对诱导机体产生高特异抗肿瘤的抗体有关键的调节作用.而蛋白类肿瘤相关抗原是极理想的肿瘤靶抗原而用于治疗.所以本专利中所描述的20种肿瘤特异相关蛋白(TAA)为肿瘤治疗提供了具体内容.本组TAA主要使用在人的肿瘤治疗中使用,它即提供了预防性治疗的可能,也为肿瘤切除术后作为肿瘤疫苗使用来阻止肿瘤复发而提供手段.而TAA的使用,既可是蛋白形式作为抗原,也可以DNA形式来经基因转导而起肿瘤疫苗之用.在治疗时,疗程往往是数周8数月如每月一针肿瘤疫苗,连续6针为一疗程.而较为理想的治疗方案是同类肿瘤患者中有大于10%的病人有良好的抗肿瘤反应,能达50%以上为理想系统.重组靶蛋白的免疫使用剂量可从病人每公斤体重注射25毫微克(25ug)至5微克((5mg)蛋白不等.而制剂体积也从0.1毫升到5毫升不等.
以获得的TAA来刺激患者自身免疫系统的方法已在例五至例七部分有叙述.作为被动免疫的技术之一如抗肿瘤独特型抗体(anti-idiotypic antibodies)的使用在专利文献U.S.Pat.No.4,918,164)有详细报道.用抗肿瘤特异性抗体来进行肿瘤诊断,治疗的成功经验在文献中比比皆是,U.S.Pat.Nos.6,090,365;6,015,542;5,843,398;5,595,721;and 4,708,930.抗肿瘤抗体或是标记有杀伤性同位素,或是融合表达有毒性蛋白部分.以下专利文献的解释既围绕这一部分:Ong etal,Cancer Immunol Immunother.Nov;39(5):325-31,1994.Kreitman R.J.Immunotoxins.ExpertOpinion on Pharmacotherapy,Vol 1,Num 6,,pp.1117-1129.2000.
在肿瘤患者中查出肿瘤抗原是典型的肿瘤早期诊断方法之一,如肝癌中的AFP蛋白和前列腺癌中的PSA等均为蛋白抗原.这类肿瘤蛋白抗原可从血液,尿液,肿瘤组织样品中测出.故定量分析某些TAA为早期诊断肿瘤提供了技术可能性.
测定靶基因的mRNA水平:大部分临床试验中的TAA因其在正常与肿瘤组织中的表达量不一样而成为所谓的肿瘤抗原,所以定量过程中以肿瘤组织中表达高于2倍于对照组织而成为“高表达”.本专利中有所发现的肿瘤抗原是依据其仅在早期胚胎组织中表达而获得,其在正常组织中一般完全不表达,为测定靶基因的mRNA水平提供了准确性.
近期文献中报导在肿瘤患者的外周血中有循环的肿瘤细胞存在.单用形态学指标往往很难发现于定量这类循环肿瘤细胞.而本组肿瘤特异性基因和蛋白的发现为定量,定性这类循环肿瘤细胞提供了可能.(Muller et al.Breast Cancer Res.8(5):110.2006.)用PCR技术对待测的靶基因的mRNA水平定量,用ELISA方法对肿瘤抗原测定等已在本文中有描述.而本文试验案例中对PCR使用的DNA引物的序列,制备特异抗体而使用的靶蛋白多肽序列等均有详细描述.而Sackett et al.,Clinical Epidemiology:ABasic Science for Clinical Medicine,Little Brown and Co.,1985,p.106-107,等专著对监测结果之分析也有阐述.
实时PCR(real-time PCR)也是临床试验中常用的监测靶基因的mRNA水平的技术系统之一,在本文的试验案例中提供有所有20种靶基因的实时PCR使用的DNA引物的序列与在人结直肠癌肿瘤样品定量分析之结果.(图11).实时PCR技术结合抗体-磁珠抓获靶细胞技术为许多血液肿瘤提供了方便快捷的方法.这类磁珠抓获靶细胞技术在以下几个公司中可买到:Dynal磁珠,美国Dynal Biotech公司,StemSep磁珠.(加拿大StemCell Technologies,公司),和RosetteSep磁珠(美国StemCell Technologies公司).这类靶抗体-磁珠系统常常挂有CD抗体,如下例抗体都有商用产品:CD2,CD3,CD4,CD5,CD8,CD10,CD11b,CD14,CD15,CD16,CD19,CD20,CD24,CD25,CD29,CD33,CD34,CD36,CD38,CD41,CD45,CD45RA,CD45RO,CD56,CD66B,CD66e,HLA-DR,IgE,and TCR.alpha..beta..从靶细胞抓获,细胞裂解,RNA快纯化,RT反应及PCR都可从QIAGEN公司购买带商用试剂盒.这类试剂也已批准在临床试验中应用.(QIAamp DNABlood Maxi Kit 50,Cat#51194).
虽然实时PCR(real-time PCR)能准确测定靶基因表达水平,但因操作是一种基因一个PCR样品来进行,有时有样品之间的读数误差.为克服这一难题,本专利更进一步展示出新技术GeXP定量测定技术.在这一技术系统中,20种靶基因的DNA特异引物与4种看家(Housekeeping)基因在单一PCR试管中进行反应,使定量测定靶基因在正常于肿瘤组织中表达水平更准确.为指导下一步的肿瘤疫苗提供正确信息.这一GeXP定量测定技术的具体应用在试验实例(六)中有详细说明.
本试验实例部分的叙述仅为提供部分试验手段作为应用样板,依据常规的基因工程,细胞学,免疫学,肿瘤学等技术方法可经不同技术系统而取得同类试验结果.故本发明中20种人肿瘤特异性相关抗原在肿瘤诊断,治疗的应用不局限于本试验的实例中.
实施例1、鉴定人正常组织中基因启动子DNA甲基化之靶基因:
人基因组中基因启动子DNA甲基化是组织分化过程中重要的基因表达调控步骤之一,在肿瘤发病早期,许多重要的组织分化相关的基因,因肿瘤细胞的甲基化调控失调,而由原静默状态而成为活跃表达,人AFP(肝中甲胎球蛋白)就是很好的例子.本实验旨在获得那些人基因组中基因启动子其在正常情况被高度甲基化,而在肿瘤细胞中有可能是去甲基化状态.这一信息为寻找肿瘤细胞中基因去甲基化提供了基础.本实验使用美国AVIVA SYSTEMS BIOLOGY(ASB)公司CHIP_DSL技术系统.本技术系统已在2006年PNAS中发表(March 20,Vol.104.2007,PNAS pp:4852-4857),可用购买的ASB公司商用试剂盒进行.
本实验结合特异抗胞嘧啶甲基化单克隆抗体进行人组长的,纯化后染色体DNA抗体免疫沉淀技术与基因启动子芯片技术相结合而进行.
1A:染色体DNA抗体免疫沉淀(ChIP Assays)与DNA产物扩增准备:
以下实验以美国ASB公司CHIP_DSL技术系统操作说明书为基本实验步骤之指导.
试剂:特异抗胞嘧啶甲基化单克隆抗体(5-Methylcytosine Antibody)为Eurogentec公司产品,(目录号:BI-MECY-0100).20K人基因启动子芯片为AVIVA产品(目录号:AK0504).正常多种人体组织基因组DNA来源于脑,肝,肾,胎盘,肺,胃,小肠,直肠结肠,胰腺,胎儿胸腺,肌肉,单个核细胞,将这些组织均匀研磨后放入消化缓冲液(100mM氯化钠,10mM TrisCl,pH值为8.0,25mM四乙酸,pH值8.0,0.5%SDS)和0.1毫克/毫升蛋白酶K中,50℃放置12-18小时,乙醇-异丙醇法提纯。提取的DNA经超声裂解后成为长度为500-800bp的片断.10微克基因组DNA先在95℃变性10分钟,迅速在冰上冷却,然后加入1ug单克隆抗体IgG并同时加入20微升蛋白A-磁珠和50微升PBS溶液后在37℃保温60分钟.最后用1毫升PBS溶液经离心法洗4次.重悬磁珠样品于50微升TE溶液中.经抗体沉淀的样品甲基化DNA样品在95℃变性3分钟,经离心去除磁珠,保留上清中DNA样品.
沉淀的DNA样品(约200-300ng DNA)按CHIP_DSL试剂盒中引物指导的DNA连接反应完成DSL反应,最后一步用荧光标记的T7引物(Cy3和Cy5)标记扩增,经QIAquick PCR扩增纯化试剂盒(Qiagen公司产品)纯化出的DNA样品溶解在50μL的水中。经95℃变性5分钟后加入至20K人启动子芯片(见详细的制备说明书)于50℃保温过夜。杂交后的芯片按制备说明书经离心洗片后再经离心干燥,用GenePix 4000B扫描仪(Axon设备)扫描。用Axon提取软件从寡核苷酸阵列扫描图象中得到荧光强度数值,对于每个位置上的数组,Cy5标记试验样品的log2比率和Cy3标记的参考样品进行比较,然后,log2比率减去各点,而进行每个通道正常化矫正。Cy5标记的芯片样品为抗体沉淀的样品甲基化DNA,而Cy3标记是来源于未经抗体处理的对照基因组DNA.
1B:数据分析
使用GenePix 5000扫描仪与GenePixPro 5.1软件分析Cy5和Cy3荧光强度。分析中去掉标记的异常点(例如,那些污染散斑,碎片或杂交中产生的杂带)
本实验使用常用的芯片结果分析软件包R.(http://www.R-project.org)为基础以Erroe模型进行分析.本方法发表在(Nature,2005.Aug 11;436(7052):876-80.Epub 2005Jun 29.).Erroe模型分析可简述如下:对所有的扫描数据。根据P值的检测结果,先将结果正常化.(以阴性对照的计算得出的结果为参量)。检测P值计算公式为1的R/n,其中R是指基因信号与阴性对照的相对值,N是阴性对照的数量。检测P值可以解释为在没有特异性目标探针杂交时检测到的一定的信号水平。低表达的信号(LEGs)我们设定了P值的阈值有几挡:0.05(0.05≤P值<1),中等表达(MEGs)我们设定P值阈值是大于0,但“小于0.05(0<P值<0.05)高表达(HEGs)的P值等于0。图1为人脑源DNA CHIP_DSL实验结果扫描图.
AVIVA人20K的启动子芯片阵列中使用了每一个基因启动子区以单一DNA引物来代表的阵列设计.其包含在美国NCBI RefSeq数据库中的全部18560特异性基因,其中2912个基因因其具备双启动子区而选定设计有2个启动子DNA引物。每个芯片点阵的确切的设计详见ASB芯片制备说明书。芯片结果分析数据按点回归至每一基因的启动子区,而得知其甲基化程度.本实验一共获得常见的在多种正常组织中其基因的启动子区高甲基化的靶基因约721个.
实施例2、鉴定肿瘤特异性表达基因之实验。
因本发明志在获得肿瘤特异性靶基因,故实验的第二步集中在寻找在正常组织中基本不表达而在肿瘤组织中高表达的基因.
据实验方案一中介绍,在许多肿瘤组织细胞中因其甲基化调控有失调的现象,许多早期胚胎阶段特异基因却在成人肿瘤组织细胞中异常高表达.这类基因往往在正常组织中关闭良好而一点也不表达.据此理论,实验的第二步集中于胚胎早期特异表达基因的鉴定.因人体中生殖细胞最接近胚胎早期状态,故使用多种人组织与人生殖细胞的mRNA的特异性表达的芯片测定库结果开展对比来分析研究.
本实验方法是以721个在实验方案一中所发现的基因启动子区高甲基化的靶基因为起点,把每一基因放入GNF symAtlas多组织mRNA的特异性表达的芯片测定库中(http://symatlas.gnf.org/SymAtlas/),寻求只在人睾丸生殖细胞表达之基因.以此获的172个目标基因.此组基因仅在人睾丸生殖细胞表达,在正常组织中其mRNA表达几乎测不出.为证明是这172个靶基因可能是肿瘤相关抗原,我们进一步通过symAtlas数据库继续鉴定NCI 60种肿瘤细胞中这172个目标基因之表达情况.经此步筛选,这172个目标基因在多种肿瘤细胞中均有不同程度的表达.图2为DNALI1靶基因在GNF芯片库中mRNA的特异性表达代表性图.
实施例3、肿瘤特异性表达基因蛋白靶抗体之生产:
为进一步证明肿瘤细胞中这172个目标基因确实在不同的肿瘤细胞中有相关的蛋白之表达,我们进一步选出20种目标基因蛋白进行兔多克隆抗体生产.(图3中列有20种目标基因名称和NCBI基因库基因序列号).其中14个靶蛋白以多肽合成获得其特异多肽抗原,每一靶蛋白设计有二个特异多肽抗原.另6个靶蛋白以全长基因重组获得蛋白抗原而进行靶蛋白特异抗体的生产.
3A:靶蛋白的多肽合成:
14个靶蛋白的多肽合成在ACT公司Apex多肽合仪中ACT公司提供的操之指导手册常规进行:以Wang树脂为固相载体,改进Fmoc(芴甲氧羰基)/tBu法进行.Fmoc经HPTU激活。特定多肽序列按序列以Wang树脂为固相载体开始反应,整个反应在一个固定的表面进行。从固定的支持物上剪切的全长多肽经:三氟乙酸∶无水乙醇∶茴香硫醚∶水∶苯酚(40∶1∶2∶2∶3)。裂解后2小时后,最后多肽沉淀在冷的甲基叔丁基醚中。肽颗粒溶解含0.1%三氟乙酸的水中,用C18柱反相高效液相色谱法纯化并冻干。14个靶蛋白多肽氨基酸序列见图4(每一靶蛋白设计有二个特异多肽抗原).
3B:KLH载体蛋白之绞连:
匙孔戚血藍蛋白(KLH)为美国EMD公司产品(产品目录号#374805),sulfo-SMCC为美国SOLTEVentures公司产品(产品目录号#C L 207).
本项目合成的多肽均在其C末端加有cys将提供出S H基团,在水溶性S M C C的作用在与K L H蛋白表面的N H 2基团经maleimide反应而产生共价绞连.具体反应操作如下:取等量(3mg)K L H和待绞连的靶基因蛋白多肽(3mg),加入50毫升烧杯中,然后缓慢加入经水溶解好的sulfo-SMCC约(1.8mg).室温搅拌30分钟而完成绞连反应.绞连蛋白经Sephadex G25柱分离收集.测定蛋白浓度以备动物免疫之用.
3C:抗血清生产过程:
对于图4这14个TAA蛋白,从每一靶抗原独特的区域中选定了两个多肽进行合成,在连接到KLH后,冻存,直到免疫接种需要时使用。
多克隆抗血清生产过程:用400微克靶抗原多肽-KLH结合物(0.5毫生),加上等量的完全弗氏佐剂(CFA)的混合,皮下注射((S.C.)成兔。4周后,400微克抗原多肽-KLH结合物与等量的不完全弗氏佐剂(IFA)的混合皮下注射兔2次,每次间隔4周。最后一次兔静脉注射100微克纯抗原KLH结合物。最后一次免疫7天后取兔血,将血放置4度孵育12-24小时,离心后得到血清。经蛋白A柱纯化而获得兔IgG抗体.
特异抗体效价之测定:在96孔板中以50ul多肽包被4度过夜.多肽浓度通常是1ug/50ul.封闭非特异性反映是在每孔加入250ul BSA室温下孵育2小时.多克隆抗血清50ul(通常是2ug/ul)经倍比稀释之1∶20万(用PBS/0.1%Tween/0.1%牛血清白蛋白稀释兔抗体),加入孔中与抗原特异性结合,4度条件下用在96孔板孵育2小时。板洗按以下条件进行:含0.1%吐温的PBS洗涤6次。然后每孔加入50ul 1∶10,000稀释的山羊抗兔辣根过氧化物酶(HRP)室温孵育30分钟而显色。加入100ul的1N的H.sub.2SO.sub.4终止反应,并立即在450nm左右波长下读数。各抗体的效价多在>1∶10000以上.
3D:靶基因全长cDNA克隆制备:
在CHIP_DSL芯片结果分析后,数据按芯片上的点阵回归至每一基因的启动子区而获得靶基因的基因库代号(accession#).然后依据靶基因的基因库代号而经美国NCBI国立生物技术信息中心数据库数据库进行搜索而获得靶基因全长cDNA序列.依此靶基因全长cDNA序列,经一步搜索美国M G C数据库数据库而获得靶基因的IMAGE克隆,以100%的同源性为准.然后从美国Open Biosystems公司购买目标特异性IMAGE克隆,根据不同的载体,用不同的D N A引物在ABI的D N A测序仪对每个克隆在纯化进一步验证其D N A序列之正确性.对应的靶基因IMAGE克隆小结在图5中.
3E:重组靶蛋白在大肠杆菌中的表达
本实验选用6个靶蛋白:C17ORF39,CSNK2A2,DNALI1,GSG1,GSTM3,IL13RA2.进行其重组蛋白的表达和纯化,用于抗体生产:
6个靶蛋白基因经P C R按常规技术进行全长编码基因人的扩增,具体D N A引物见图6.靶蛋白基因的IMAGE克隆均从美国Open Biosystems公司购买经质粒载体DNA纯化后为PCR反应之底物DNA,PC R片段经胶纯化后用内切酶NdeI-XhoI双酶切后插入pET41a改造的表达载体中,在pET41载体重组表达系统T7启动子下端有MASMTGGQQMGRHHHHHH融合在靶蛋白质的N-末端.
在大肠杆菌高表达用BL21star细菌(Invitrogen公司产品)转化表达载体,加入LB液并以kanamycin抗生素为筛选在37度摇床过夜生长。第二天早上,10毫升过夜培养的细菌液加入到500ml LB培养液中,kanamycin抗生素。摇菌至培养的光密度在560纳米达到0.4-0.6时,加入IPTG(1mM)诱导四个小时,最后离心收获重组菌。菌体经PBS液离心洗涤细胞。丢弃上清。加入10ml裂解液并震荡重悬(含溶菌酶)。大肠杆菌细胞在16,000psi压力下裂解,重新离心细胞,离心管底为大肠杆菌重组包涵体蛋白.
将包涵体蛋白重悬在10mM Tris pH 8.0,1%CHAPS液中重新离心洗涤包涵体。重复这个过程2次。然后在样品蛋白液中慢慢加入终浓度8M固体尿素,经搅拌至包涵体完全溶解。可溶性蛋白样品经5毫升镍螯合树脂(Qiagen公司His Tag column)中孵育45分钟至1小时,室温连续搅拌。将树脂和蛋白质混合物通过一次性浇柱收集。用12-20倍体积的缓冲溶液洗涤柱子(2M尿素P B S液).经10mM的Tris pH值8.0和300mM咪唑收集3毫升组分。跑SDS-PAGE凝胶,以确定纯化蛋白之纯度。如蛋白不够纯化,最后的纯化步骤,用阴离子交换树脂,Hi-Prep Q(Biorad),与缓冲液和混合液一起装入柱子中。利用增长的盐浓度洗脱每种抗原。收集各组分,跑SDS-PAGE凝胶,以确定各组分而获得纯化重组蛋白。重组蛋白组分用10mM Tris pH 8.0重新透析。最后用0.22微米的过滤器过滤蛋白装入安剖瓶中免疫接种或直接把抗原冻存备用。
实施例4、用免疫印迹(Western blot)检测癌症样本。
试剂:各肿瘤细胞株均购置于美国ATCC,并按其细胞株培养条件进行细胞培养.人肝癌细胞株HepG2,(产品目录号:HB-8065),人T细胞肿瘤株Jurkat,(产品目录号:TIB-152).人乳腺癌细胞株MCF7:(产品目录号:HTB-22):人B细胞株721B,为美国THOMAS JEFFERSON医学院Feitelson教授之赠品.人畸胎瘤细胞NTERA2,(产品目录号CRL-1973),人宫颈癌细胞株Hela,(产品目录号:CCL-2).人的正常组织如:脑,心,肺,肝,横纹肌与胎盘组织均提取于22周水囊引产的胎儿样品.
蛋白样品制备:5×107培养细胞或0.4克的组织匀浆重悬与1毫升新鲜配置的裂解液中(150mMNaCl,50mM Tris-HCl,pH7.4,1mM EDTA,1%NP-40,0.5%脱氧胆酸,0.1%SDS,1mM PMSF,1ug/ml Leupeptin,Aprotinin,Pepstatin).混匀后加入等体积2X的S D S-P A G E上样液(2×SDS Loading Buffer:0.2M DTT,4%SDS,0.2%Bromophenol blue,20%Sucrose or glycerol,0.1M Tris-HCl,pH6.8).进一步混匀后放至95C水浴中处理5分钟.经离心后取30ul样品上样进行蛋白电泳.
蛋白电泳在8%聚丙烯酰胺电泳中按常规进行,分离蛋白后用Bio-RAd公司电转移系统将蛋白转移到PVDF杂交膜上,经1%干奶粉/P B S液4℃封闭过夜后,然后通过一抗(1∶4000稀释(终浓度为1ug/ml),保温37℃,2小时.经0.1%NP-40/P B S液洗膜5次,然后加入1∶50,00稀释的H R P标记的羊抗兔二抗抗体,保温37℃,1小时,经0.1%NP-40/P B S液洗膜5次后将膜经E C L溶液(PIERCE公司产品,产品目录号#32160)处理后夹入X光片中经显影,定影完成免疫印迹的检测.图8为靶蛋白UBQLN3和DNALI1在肿瘤及正常组织中表达的情况.
实施例5、实时PCR法分析特异性靶基因在多种肿瘤中的表达。
实时PCR(Real-time PCR)分析肿瘤样本:用实时PCR检测前列腺癌和乳腺肿瘤样本在各种肿瘤和正常组织中的表达技术为一般常规技术。简言之,用PCR扩增几个周期后的DNA高于背景的对数值来定量。利用连续荧光监测,每个PCR反应很容易确定循环次数下的DNA扩增倍数的阈值。目前,一些商业荧光检测系统可供选择。一个是基于双链DNA的特异性结合荧光染料染色。另外使用含有荧光定量探针染料标记在5’端(FAM)同时Quencher染料在标记3’端(TAMRA)(Perkin Elmer/应用生物系统公司,福斯特城,加利福尼亚州)。目标的PCR扩增产物从含有的核酸探针AmpliTaq Gold.TM.(Perkin Elmer/应用生物系统公司,福斯特城,加利福尼亚州)的Quencher染料裂解和释放。因此,从释放的标记染料比例确定PCR产物产生的荧光信号。这两种检测方法,发现了相同的结果。要比较多种组织样品中基因表达的相对水平,采用组织的RNA经逆转录生成cDNA,然后用靶基因特异性引物对每个相同的cDNA量进行实时PCR。每个基因样本通常是在重复进行。最后每个基因的实时PCR结果一般是平均拷贝数的基因值。实时PCR反应的定量结果可在用SYBR Green I染色的GeneAmp 5700检测或用TaqMan探针(Perkin Elmer//应用生物系统公司司,福斯特城,加利福尼亚州)的ABI PRISM公司7700探测器检测。
试剂:人结肠肿瘤组织的cDNA样品均购置于美国Origene公司,(产品目录号#H C R T 101&HC R T 501,其包含有5例正常人结肠组织和19例人结肠肿瘤组织的cDNA样品.靶基因D N A引物经美国I D T公司合成,其序列见图9:实时PCR反应用美国Bio-Rad iQ5探测器检测,同时使用iQ SYBRGreen Supermix(产品目录号:170-8884)进行样品反应.
实时PCR分析人结肠肿瘤组织的CSNK2A2靶基因表达水平在0.2ml离心管中按下列操作程序进行:0.2ml离心管中加入:12.5ul iQ SYBR Green Supermix液,2ul人结肠肿瘤组织cDNA样品,2ul(20pM/ul)有义引物和2ul(20pM/ul)反义引物,6.5ul去离子水.振荡样品管,然后短暂离心。将管放到预热的Bio-Rad iQ5探测器检测上开始P C R反应.按下列程序开始循环:预变性94℃4分钟1次,变性94℃1分钟,退火55℃1分钟,延伸72℃1分钟,循环38次.本反应使用看家基因(house-keeping geneas control)GAPDH(甘油醛脱氢酶)转录水平来校正待测靶基因表达水平.CSNK2A靶基因在实时PCR获得在各人结肠肿瘤组织中的相对表达水平,结果总结于图10。
实施例6、使用GeXP系统检测人类癌症组织。
GeXP是一种新的,改良的多种靶D N A样品在同一试管中进行RT-PCR法(逆转录聚合酶链式反应)的反应与定量分析.它可以用通用引物转换多种RT-PCR的两个引物,最终产物能够通过现有的BeckmanCoulter公司的GenomeLab GeXP遗传分析系统进行检测。这一检测方法消除连单个靶基因在单管中进行实时PCR法时的样品人为操作误差.为临床检测多种靶基因表达水平的定量测定提供了可能.本实验意在证明使用GeXP技术结合20种新型肿瘤靶基因之监测效果.
试剂:人多肿瘤组织的mRNA样品分别均购置于美国strategene公司,(产品目录号740000,其包含有数种肿瘤细胞提取的mRNA样品.靶基因D N A引物经美国Allele Bioscience公司合成,其序列见图11:实时PCR反应用美国ABI公司Verit 96孔板P C R机进行.反应样品反应用Beckman Coulter公司的GenomeLabGeXP遗传分析系统进行检测.(http://www.beckman.com/products/instrument/geneticanalysis/gexp instdcr.asp)
根据GenomeLab GeXP分析系统使用说明书,20种靶基因的引物与4种看家基因为参照基因而结合设计.如T B P(TATA盒结合蛋白),ATP50(ATP合成酶,H+的转运,线粒体的F1复合体,O亚基),ACTB(beta Actin),GAPD(甘油三磷酸脱氢酶)。基因的引物设计原理在GenomeLab GeXP分析系统使用说明书中有详细介绍,同时Beckman Coulter公司还为客户提供基因的引物设计服务.
GeXP样品制备与检测均按GenomeLab GeXP分析系统使用说明书进行:简言之,纯化的肿瘤组织mRNA(美国stratagene公司产品),第一轮将mRNA反转录成cDNA的特异性靶基因采用反向引物见表X,其中逆转录酶及试剂盒购自Invitrogen公司。根据使用说明书,前3个循环采用通用型/基因特异的引物进行PCR反应,混合后加入F和R PCR引物扩增30个循环。5’端(The forward)引物标记了D4染料,其来源于GenomeLab GeXP制备试剂盒中。GenomeLab GeXP系统借助于合成的靶基因因每一基因P C R产品长度之间有2-5bp之差别用毛细吸管凝胶电涌读取P C R产物的荧光X度而定性定量.根据GeXP系统分析获得一定数量的前列腺癌和乳腺肿瘤样本的结果,见图12。
实施例7、靶基因C17ORF39的免疫组织化学对人类癌症组织分析
靶基因C17ORF39为全新尚无任何文献报道之基因.依据前期实时PCR(Real-time PCR)分析肿瘤样本时发现C17ORF39在部分人肿瘤样品中高表达现象,本实验在制备其特异抗体后对临床获得的肿瘤样品开展初级免疫组织化学筛选.
经实验方法三中步骤对包涵体蛋白纯化,复性后获得纯化重组蛋白和纯化抗体。为了确定C17ORF39蛋白在各种正常和各种癌组织的表达,用亲和纯化的C17ORF多克隆抗体进行免疫组织化学分析。具体地说,组织标本固定在福尔马林溶液中12-24小时,石蜡包埋,然后切成4(μm)厚度的片子。按常规组织片微波加热处理法对组织标本片处理后用美国Ventana公司自动免疫组织化学染色仪(型号Ventana320-202)进行组织化学染色.染色使用AEC检测盒(美国Covance公司产品),C17ORF多克隆抗体使用浓度为(1ug/ml).C17ORF39的免疫组化结果见图13.在部分的人肾肿瘤组织中可见高表达的细胞核染色.而对照的正常人肾组织中几乎检测不到任何染色信号.
SEQUENCE LISTING1
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_001464
<160>1
<170>PatentIn version 3.5
<210>1
<211>2657
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(130)
<220>
<221>exon
<222>(131)..(207)
<220>
<221>exon
<222>(208)..(263)
<220>
<221>exon
<222>(264)..(342)
<220>
<221>exon
<222>(343)..(419)
<220>
<221>exon
<222>(420)..(588)
<220>
<221>exon
<222>(589)..(645)
<220>
<221>exon
<222>(646)..(717)
<220>
<221>exon
<222>(718)..(884)
<220>
<221>exon
<222>(885)..(966)
<220>
<221>exon
<222>(967)..(1103)
<220>
<221>exon
<222>(1104)..(1287)
<220>
<221>exon
<222>(1288)..(1386)
<220>
<221>exon
<222>(1387)..(1582)
<220>
<221>exon
<222>(1583)..(1688)
<220>
<221>exon
<222>(1689)..(1872)
<220>
<221>exon
<222>(1873)..(1950)
<220>
<221>exon
<222>(1951)..(2089)
<220>
<221>exon
<222>(2090)..(2249)
<220>
<221>exon
<222>(2250)..(2313)
<220>
<221>exon
<222>(2314)..(2643)
<220>
<221>STS
<222>(2386)..(2555)
<220>
<221>polyA_signal
<222>(2618)..(2623)
<220>
<221>polyA site
<222>(2640)..(2640)
<400>1
gcg tca tct cgc gct tcc aac tgc cct gta acc acc aac tgc cat tat 48
Ala Ser Ser Arg Ala Ser Asn Cys Pro Val Thr Thr Asn Cys His Tyr
1 5 10 15
tcc ggc tgg gac cca gga ctt caa gcc atg tgg cgc gtc ttg ttt ctg 96
Ser Gly Trp Asp Pro Gly Leu Gln Ala Met Trp Arg Val Leu Phe Leu
20 25 30
ctc agc ggg ctc ggc ggg ctg cgg atg gac agt a at ttt gat agt tta 144
Leu Ser Gly Leu Gly Gly Leu Arg Met Asp Ser Asn Phe Asp Ser Leu
35 40 45
cct gtg caa att aca gtt ccg gag aaa ata cgg tca ata ata aag gaa 192
Pro Val Gln Ile Thr Val Pro Glu Lys Ile Arg Ser Ile Ile Lys Glu
50 55 60
gga att gaa tcg cag gca tcc tac aaa att gta att gaa ggg aaa cca 240
Gly Ile Glu Ser Gln Ala Ser Tyr Lys Ile Val Ile Glu Gly Lys Pro
65 70 75 80
tat act gtg aat tta atg caa aa a aac ttt tta ccc cat aat ttt aga 288
Tyr Thr Val Asn Leu Met Gln Lys Asn Phe Leu Pro His Asn Phe Arg
85 90 95
gtt tac agt tat agt ggc aca gga att atg aaa cca ctt gac caa gat 336
Val Tyr Ser Tyr Ser Gly Thr Gly Ile Met Lys Pro Leu Asp Gln Asp
100 105 110
ttt cag aat ttc tgc cac tac caa ggg tat att gaa ggt tat cca aaa 384
Phe Gln Asn Phe Cys His Tyr Gln Gly Tyr Ile Glu Gly Tyr Pro Lys
115 120 125
tct gtg gtg atg gtt agc aca tgt act gga ctc ag g ggc gta cta cag 432
Ser Val Val Met Val Ser Thr Cys Thr Gly Leu Arg Gly Val Leu Gln
130 135
ttt gaa aat gtt agt tat gga ata gaa ccc ctg gag tct tca gtt ggc 480
Phe Glu Asn Val Ser Tyr Gly Ile Glu Pro Leu Glu Ser Ser Val Gly
145 150 155 160
ttt gaa cat gta att tac caa gta aaa cat aag aaa gca gat gtt tcc 528
Phe Glu His Val Ile Tyr Gln Val Lys His Lys Lys Ala Asp Val Ser
165 170 175
tta tat aat gag aag gat att gaa tca aga gat ctg tcc ttt aaa tta 576
Leu Tyr Asn Glu Lys Asp Ile Glu Ser Arg Asp Leu Ser Phe Lys Leu
180 185 190
caa agc gta gag cca cag caa gat ttt gca aag tat ata gaa atg cat 624
Gln Ser Val Glu Pro Gln Gln Asp Phe Ala Lys Tyr Ile Glu Met His
195 200 205
gtt ata gtt gaa aaa caa ttg tat aat cat atg ggg tct gat aca act 672
Val Ile Val Glu Lys Gln Leu Tyr Asn His Met Gly Ser Asp Thr Thr
210 215 220
gtt gtc gct caa aaa gtt ttc cag ttg att gga ttg acg aat gct att 720
Val Val Ala Gln Lys Val Phe Gln Leu Ile Gly Leu Thr Asn Ala Ile
225 230 235 240
ttt gtt tca ttt aat att aca att att ctg tct tca ttg gag ctt tgg 768
Phe Val Ser Phe Asn Ile Thr Ile Ile Leu Ser Ser Leu Glu Leu Trp
245 250 255
ata gat gaa aat aaa att gca acc act gga gaa gct aat gag tta tta 816
Ile Asp Glu Asn Lys Ile Ala Thr Thr Gly Glu Ala Asn Glu Leu Leu
260 265 270
cac aca ttt tta aga tgg aaa aca tct tat ctt gtt tta cgt cct cat 864
His Thr Phe Leu Arg Trp Lys Thr Ser Tyr Leu Val Leu Arg Pro His
275 280 285
gat gtg gca ttt tta ctt gt t tac aga gaa aag tca aat tat gtt ggt 912
Asp Val Ala Phe Leu Leu Val Tyr Arg Glu Lys Ser Asn Tyr Val Gly
290 300
gca acc ttt caa ggg aag atg tgt gat gca aac tat gca gga ggt gtt 960
Ala Thr Phe Gln Gly Lys Met Cys Asp Ala Asn Tyr Ala Gly Gly Val
305 310 315 320
gtt ctg cac ccc aga acc ata agt ctg gaa tca ctt gca gtt att tta 1008
Val Leu His Pro Arg Thr Ile Ser Leu Glu Ser Leu Ala Val Ile Leu
325 330 335
gct caa tta ttg agc ctt agt atg ggg atc act tat gat gac att aac 1056
Ala Gln Leu Leu Ser Leu Ser Met Gly Ile Thr Tyr Asp Asp Ile Asn
340 345 350
aaa tgc cag tgc tca gga gct gtc tgc att atg aat cca gaa gca at t 1104
Lys Cys Gln Cys Ser Gly Ala Val Cys Ile Met Asn Pro Glu Ala Ile
355 360 365
cat ttc agt ggt gtg aag atc ttt agt aac tgc agc ttc gaa gac ttt 1152
His Phe Ser Gly Val Lys Ile Phe Ser Asn Cys Ser Phe Glu Asp Phe
370 375 380
gca cat ttt att tca aag cag aag tcc cag tgt ctt cac aat cag cct 1200
Ala His Phe Ile Ser Lys Gln Lys Ser Gln Cys Leu His Asn Gln Pro
385 390 395 400
cgc tta gat cct ttt ttc aaa cag caa gca gtg tgt ggt aat gca aag 1248
Arg Leu Asp Pro Phe Phe Lys Gln Gln Ala Val Cys Gly Asn Ala Lys
405 410 415
ctg gaa gca gga gag gag tgt gac tgt ggg act gaa cag gat tgt gcc 1296
Leu Glu Ala Gly Glu Glu Cys Asp Cys Gly Thr Glu Gln Asp Cys Ala
420 425 430
ctt att gga gaa aca tgc tgt gat att gcc aca tgt aga ttt aaa gcc 1344
Leu Ile Gly Glu Thr Cys Cys Asp Ile Ala Thr Cys Arg Phe Lys Ala
435 440 445
ggt tca aac tgt gct gaa gga cca tgc tgc gaa aac tgt cta ttt atg 1392
Gly Ser Asn Cys Ala Glu Gly Pro Cys Cys Glu Asn Cys Leu Phe Met
450 455 460
tca aaa gaa aga atg tgt agg cct tcc ttt gaa gaa tgc gac ctc cct 1440
Ser Lys Glu Arg Met Cys Arg Pro Ser Phe Glu Glu Cys Asp Leu Pro
465 470 475 480
gaa tat tgc aat gga tca tct gca tca tgc cca gaa aac cac tat gtt 1488
Glu Tyr Cys Asn Gly Ser Ser Ala Ser Cys Pro Glu Asn His Tyr Val
485 490 495
cag act ggg cat ccg tgt gga ctg aat caa tgg atc tgt ata gat gga 1536
Gln Thr Gly His Pro Cys Gly Leu Asn Gln Trp Ile Cys Ile Asp Gly
500 505 510
gtt tgt atg agt ggg gat aaa caa tgt aca gac aca ttt ggc aaa g aa 1584
Val Cys Met Ser Gly Asp Lys Gln Cys Thr Asp Thr Phe Gly Lys Glu
515 520 525
gta gag ttt ggc cct tca gaa tgt tat tct cac ctt aat tca aag act 1632
Val Glu Phe Gly Pro Ser Glu Cys Tyr Ser His Leu Asn Ser Lys Thr
530 535 540
gat gta tct gga aac tgt ggt ata agt gat tca gga tac aca cag tgt 1680
Asp Val Ser Gly Asn Cys Gly Ile Ser Asp Ser Gly Tyr Thr Gln Cys
545 550 555 560
gaa gct ga c aat ctg cag tgc gga aaa tta ata tgt aaa tat gta ggt 1728
Glu Ala Asp Asn Leu Gln Cys Gly Lys Leu Ile Cys Lys Tyr Val Gly
565 570 575
aaa ttt tta tta caa att cca aga gcc act att att tat gcc aac ata 1776
Lys Phe Leu Leu Gln Ile Pro Arg Ala Thr Ile Ile Tyr Ala Asn Ile
580 585 590
agt gga cat ctc tgc att gct gtg gaa ttt gcc agt gat cat gca gac 1824
Ser Gly His Leu Cys Ile Ala Val Glu Phe Ala Ser Asp His Ala Asp
595 600 605
agc caa aag atg tgg ata aaa gat gga act tct tgt ggt tca aat aag 1872
Ser Gln Lys Met Trp Ile Lys Asp Gly Thr Ser Cys Gly Ser Asn Lys
610 615 620
gtt tgc agg aat caa aga tgt gtg agt tct tca tac ttg ggt tat gat 1920
Val Cys Arg Asn Gln Arg Cys Val Ser Ser Ser Tyr Leu Gly Tyr Asp
625 630 635 640
tgt act act gac aaa tgc aat gat aga ggt gta tgc aat aac aaa aag 1968
Cys Thr Thr Asp Lys Cys Asn Asp Arg Gly Val Cys Asn Asn Lys Lys
645 650 655
cac tgt cac tgt agt gct tca tat tta cct cca gat tgc tca gtt caa 2016
His Cys His Cys Ser Ala Ser Tyr Leu Pro Pro Asp Cys Ser Val Gln
660 665 670
tca gat cta tgg cct ggt ggg agt att gac agt ggc aat ttt cca cct 2064
Ser Asp Leu Trp Pro Gly Gly Ser Ile Asp Ser Gly Asn Phe Pro Pro
675 680 685
gta gct ata cca gcc aga ctc cct g aa agg cgc tac att gag aac att 2112
Val Ala Ile Pro Ala Arg Leu Pro Glu Arg Arg Tyr Ile Glu Asn Ile
690 695 700
tac cat tcc aaa cca atg aga tgg cca ttt ttc tta ttc att cct ttc 2160
Tyr His Ser Lys Pro Met Arg Trp Pro Phe Phe Leu Phe Ile Pro Phe
705 710 715 720
ttt att att ttc tgt gta ctg att gct ata atg gtg aaa gtt aat ttc 2208
Phe Ile Ile Phe Cys Val Leu Ile Ala Ile Met Val Lys Val Asn Phe
725 730 735
caa agg aaa aaa tgg aga act gag gac tat tca agc gat ga g caa cct 2256
Gln Arg Lys Lys Trp Arg Thr Glu Asp Tyr Ser Ser Asp Glu Gln Pro
740 745
gaa agt gag agt gaa cct aaa ggg tag tct gga caa cag aga tgc cat 2304
Glu Ser Glu Ser Glu Pro Lys Gly Ser Gly Gln Gl nArg Cys His
755 760 765
gat atc act tct tct aga gta att atc tgt gat gga tgg aca caa aaa 2352
Asp Ile Thr Ser Ser Arg Val Ile Ile Cys Asp Gly Trp Thr Gln Lys
770 775 780
aat gga aag aaa aga atg tac att acc tgg ttt cct ggg att caa acc 2400
Asn Gly Lys Lys Arg Met Tyr Ile Thr Trp Phe Pro Gly Ile Gln Thr
785 790 795
tgc ata ttg tga ttt taa ttt gac cag aaa ata tga tat ata tgt ata 2448
Cys Ile Leu Phe Phe Asp Gln Lys Ile Tyr Ile Cys Ile
800 805 810
att tca cag ata att tac tta ttt aaa aat gca tga taa tga gtt tta 2496
Ilc Ser Gln Ile Ile Tyr Leu Phe Lys Asn Ala Val Leu
815 820 825
cat tac aaa ttt ctg ttt ttt taa agt tat ctt acg cta ttt ctg ttg 2544
His Tyr Lys Phe Leu Phe Phe Ser Tyr Leu Thr Leu Phe Leu Leu
830 835 840
gtt agt aga cac taa ttc tgt cag tag ggg cat ggt ata agg aaa tat 2592
Val Ser Arg His Phe Cys Gln Gly His Gly Ile Arg Lys Tyr
845 850
cat aat gta atg agg tgg tac tat gat taa aag cca ctg tta cat ttc 2640
His Asn Val Met Arg Trp Tyr Tyr Asp Lys Pro Leu Leu His Phe
855 860 865
aaa aaaaaaaaaa aaaa 2657
Lxs
870
SEQUENCE LISTING2
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_024052
<160>1
<170>PatentIn version 3.5
<210>1
<211>4232
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(606)
<220>
<221>exon
<222>(607)..(666)
<220>
<221>exon
<222>(667)..(774)
<220>
<221>exon
<222>(775)..(876)
<220>
<221>exon
<222>(877)..(1007)
<220>
<221>exon
<222>(1008)..(4232)
<220>
<221>polyA_signal
<222>(1094)..(1099)
<220>
<221>polyA_site
<222>(1117)..(1117)
<220>
<221>polyA_site
<222>(1151)..(1151)
<220>
<221>STS
<222>(3822)..(3950)
<400>1
gcc gct cgc gca ccg cgc cac gtg ttt tct cct ccc gcc aat ggg cgg 48
Ala Ala Arg Ala Pro Arg His Val Phe Ser Pro Pro Ala Asn Gly Arg
1 5 10 15
aag cgc cgc ctg agc ctg ctc ccg ccc ccc agg ctc gcc tga gcc aat 96
Lys Arg Arg Leu Ser Leu Leu Pro Pro Pro Arg Leu Ala Ala Asn
20 25 30
cgg aag ggg cgg ggt gtg tgt gtg tct gtg tgt gtt tgt gtg ttg tgt 144
Arg Lys Gly Arg Gly Val Cys Val Ser Val Cys Val Cys Val Leu Cys
35 40 45
gtc tgt gag tgt ctg tgt gtg tgt atg tgt gcg cga ggg caa gtc ggg 192
Val Cys Glu Cys Leu Cys Val Cys Met Cys Ala Arg Gly Gln Val Gly
50 55 60
agg ggg acc cag ctc agg act ggg agg ccc tgc tcg cag gtc cct ggg 240
Arg Gly Thr Gln Leu Arg Thr Gly Arg Pro Cys Ser Gln Val Pro Gly
65 70 75
tcc cgg tgg cgg ccg gag cgc ttg ctc cgc agg cag cgg gcg ggt ggt 288
Ser Arg Trp Arg Pro Glu Arg Leu Leu Arg Arg Gln Arg Ala Gly Gly
80 85 90 95
cgc ccc tcc cgc ccc cac ccc gcg cgt gcg cgc ccc ggc ctc tcc ctc 336
Arg Pro Ser Arg Pro His Pro Ala Arg Ala Arg Pro Gly Leu Ser Leu
100 105 110
ccc gcc acc ctc ctc ggc tcc cgc gcg gcg gcg gcg gtt cct ctc cca 384
Pro Ala Thr Leu Leu Gly Ser Arg Ala Ala Ala Ala Val Pro Leu Pro
115 120 125
ctc ccc cca gcc ctg gct ccg ggg gac ccc gcg atg ccg gtc cgc acc 432
Leu Pro Pro Ala Leu Ala Pro Gly Asp Pro Ala Met Pro Val Arg Thr
130 135 140
gag tgt ccc ccg ccg gcc ggt gcc tcc gct gcc tcc gcg gcc tca ctc 480
Glu Cys Pro Pro Pro Ala Gly Ala Ser Ala Ala Ser Ala Ala Ser Leu
145 150 155
atc ccg ccg ccg ccc atc aac acc cag cag ccc ggc gtg gcc acc agc 528
Ile Pro Pro Pro Pro Ile Asn Thr Gln Gln Pro Gly Val Ala Thr Ser
160 165 170 175
ctg ctc tac agc ggc tcc aag ttc cgc ggc cac cag aag agc aag ggg 576
Leu Leu Tyr Ser Gly Ser Lys Phe Arg Gly His Gln Lys Ser Lys Gly
180 185 190
aac tcg tac gac gta gag gtg gtg ctg cag cac gtg gac acg ggg aac 624
Asn Ser Tyr Asp Val Glu Val Val Leu Gln His Val Asp Thr Gly Asn
195 200 205
tct tac ctt tgt ggg tac ttg aag att aaa ggc ctt act gag gag tat 672
Ser Tyr Leu Cys Gly Tyr Leu Lys Ile Lys Gly Leu Thr Glu Glu Tyr
210 215 220
cca acc ctt aca acc ttc ttc gaa gga gaa ata atc agc aaa aaa cac 720
Pro Thr Leu Thr Thr Phe Phe Glu Gly Glu Ile Ile Ser Lys Lys His
225 230 235
cct ttc tta act cgc aag tgg gat gca gat gaa gat gtt gat cgg aaa 768
Pro Phe Leu Thr Arg Lys Trp Asp Ala Asp Glu Asp Val Asp Arg Lys
240 245 250 255
cac tgg ggc aag ttt ctg gct ttt tat cag tat gca aaa tca ttt aac 816
His Trp Gly Lys Phe Leu Ala Phe Tyr Gln Tyr Ala Lys Ser Phe Asn
260 265 270
tca gat gac ttt gat tat gaa gag ctg aag aat gga gac tac gtc ttc 864
Ser Asp Asp Phe Asp Tyr Glu Glu Leu Lys Asn Gly Asp Tyr Val Phe
275 280 285
atg agg tgg aag gaa cag ttt ctg gtc cca gat cac acg atc aaa gac 912
Met Arg Trp Lys Glu Gln Phe Leu Val Pro Asp His Thr Ile Lys Asp
290 295 300
atc agt ggt gct tct ttt gcc ggg ttc tac tac atc tgc ttt cag aag 960
Ile Ser Gly Ala Ser Phe Ala Gly Phe Tyr Tyr Ile Cys Phe Gln Lys
305 310 315
tca gca gcc tcc ata gag ggc tac tac tac cat agg agt tca gaa tg g 1008
Ser Ala Ala Ser Ile Glu Gly Tyr Tyr Tyr His Arg Ser Ser Glu Trp
320 325 330
tat cag tcc ctc aat cta acc cat gtt cct gaa cac agt gca ccc atc 1056
Tyr Gln Ser Leu Asn Leu Thr His Val Pro Glu His Ser Ala Pro Ile
340 345 350
tat gaa ttc cgg tga caa cgg ttc aga aca gca acc aaa taa aac tga 1104
Tyr Glu Phe Arg Gln Arg Phe Arg Thr Ala Thr Lys Asn
355 360
act tgg caa aaa aga act ttg ccg aga aaa ttg tgt acc tgc cag aac 1152
Thr Trp Gln Lys Arg Thr Leu Pro Arg Lys Leu Cys Thr Cys Gln Asn
365 370 375 380
cag gag aag tgt gtt cct gtt tct tca cga gca gac tcg cat cac aaa 1200
Gln Glu Lys Cys Val Pro Val Ser Ser Arg Ala Asp Ser His His Lys
385 390 395
gca tga atg tta acc cac aga atc caa gga gca tgg ctg gcc cgt ggg 1248
Ala Met Leu Thr His Arg Ile Gln Gly Ala Trp Leu Ala Arg Gly
400 405 410
gca ggt gga ggg agc agt ctt cgt tct tcc tcc cct cag tgg cag ttt 1296
Ala Gly Gly Gly Ser Ser Leu Arg Ser Ser Ser Pro Gln Trp Gln Phe
415 420 425
ggt ctt cac ctg ttt tta agc tac ctt aaa cgc act ttt cct tcc tgc 1344
Gly Leu His Leu Phe Leu Ser Tyr Leu Lys Arg Thr Phe Pro Ser Cys
430 435 440
aca gct aac ttc tac atc act gaa atg ccc att cct tcc tcc gtc cca 1392
Thr Ala Asn Phe Tyr Ile Thr Glu Met Pro Ile Pro Ser Ser Val Pro
445 450 455
cct cca gcc gaa tag aag gtc tgc tcc cgg atc acc ctc agc ctt ggt 1440
Pro Pro Ala Glu Lys Val Cys Ser Arg Ile Thr Leu Ser Leu Gly
460 465 470
gct cag tgg tcc cga ggc cct aga ccc cca ccc ccc gcc agt tgc ttt 1488
Ala Gln Trp Ser Arg Gly Pro Arg Pro Pro Pro Pro Ala Ser Cys Phe
475 480 485 490
gtc tgg tag ctc aag aga agg cag agc ccc agc acc tct gtg ccc ccc 1536
Val Trp Leu Lys Arg Arg Gln Ser Pro Ser Thr Ser Val Pro Pro
495 500 505
aga gct ctg tgc agg gag ttg gcc agc tgc cgc atc atc ggc cac caa 1584
Arg Ala Leu Cys Arg Glu Leu Ala Ser Cys Arg Ile Ile Gly His Gln
510 515 520
ggg cac aag agg cgg agg ctc cag tcc ctg ctg ggc tgc ctc agt ctt 1632
Gly His Lys Arg Arg Arg Leu Gln Ser Leu Leu Gly Cys Leu Ser Leu
525 530 535
cag tgc tga ttg tgt cac ggg tca gcg tgc gct gct gag ccc tgt act 1680
Gln Cys Leu Cys His Gly Ser Ala Cys Ala Ala Glu Pro Cys Thr
540 545 550
gtt aac agt gca aag cta gtg agt agc tgt cag gtt ccc tgg gcc tgc 1728
Val Asn Ser Ala Lys Leu Val Ser Ser Cys Gln Val Pro Trp Ala Cys
555 560 565
cat cag gga tca cta aat tta agg ctt cca gat ccc tgg cag gaa cag 1776
His Gln Gly Ser Leu Asn Leu Arg Leu Pro Asp Pro Trp Gln Glu Gln
570 575 580
att cca gtc ctg ctt act cag tac att tgc tcc aaa ctt ttc aac ttg 1824
Ile Pro Val Leu Leu Thr Gln Tyr Ile Cys Ser Lys Leu Phe Asn Leu
585 590 595 600
agg gca ata cta aac tta aaa ata aga gtt ttt tta tta caa aat tat 1872
Arg Ala Ile Leu Asn Leu Lys Ile Arg Val Phe Leu Leu Gln Asn Tyr
605 610 615
ttt tat ggt ccc ttt aac gag gac cct atg gca aat gca caa tta ttc 1920
Phe Tyr Gly Pro Phe Asn Glu Asp Pro Met Ala Asn Ala Gln Leu Phe
620 625 630
aga att aca ttt tat cgt ttt cac att gaa aac agc aaa tgt tga ctt 1968
Arg Ile Thr Phe Tyr Arg Phe His Ile Glu Asn Ser Lys Cys Leu
635 640 645
agt aat ttt tat atc gat atc tat atg tat atg tat att taa tca acc 2016
Ser Asn Phe Tyr Ile Asp Ile Tyr Met Tyr Met Tyr Ile Ser Thr
650 655 660
agc agt ttt gaa act agt cat cct ggt aca aaa gtt ttg cag cat tgc 2064
Ser Ser Phe Glu Thr Ser His Pro Gly Thr Lys Val Leu Gln His Cys
665 670 675
cta aat tat agt gct caa cac aag aac tgt ttt tgg ggc cag ttt agc 2112
Leu Asn Tyr Ser Ala Gln His Lys Asn Cys Phe Trp Gly Gln Phe Ser
680 685 690
att tgt gcc gcc tcc ttt tgc tac tca aaa cag caa tgc ttg gcg gca 2160
Ile Cys Ala Ala Ser Phe Cys Tyr Ser Lys Gln Gln Cys Leu Ala Ala
695 700 705 710
gcc ttc cat gag gca gaa ggg gtc gtc gtt ctc tga aaa cag tga ctc 2208
Ala Phe His Glu Ala Glu Gly Val Val Val Leu Lys Gln Leu
715 720
tga aat gtt ggg aca ggg gaa ggg gtg gga aac atg aac atg ctc aaa 2256
Asn Val Gly Thr Gly Glu Gly Val Gly Asn Met Asn Met Leu Lys
725 730 735
taa ctc gag gct cac gtg cca aag tgt gtg tgt gtg tgt gtg tgt gtg 2304
Leu Glu Ala His Val Pro Lys Cys Val Cys Val Cys Val Cys Val
740 745 750
tgt gtg tgt atg atg ttt tgt ttt ttt aaa tgt ttt aaa agc tta ata 2352
Cys Val Cys Met Met Phe Cys Phe Phe Lys Cys Phe Lys Ser Leu Ile
755 760 765 770
ggt tgg cat cag ttg tag ccc aca aac atg gct agg gct ttg ggg att 2400
Gly Trp His Gln Leu Pro Thr Asn Met Ala Arg Ala Leu Gly Ile
775 780 785
tgg cat ttt tct ggt ggt tta caa gac tta ctc cga ata caa gag gaa 2448
Trp His Phe Ser Gly Gly Leu Gln Asp Leu Leu Arg Ile Gln Glu Glu
790 795 800
aag ctt taa aaa caa gat tgc atc ata acc ccc agg agc aaa gca acc 2496
Lys Leu Lys Gln Asp Cys Ile Ile Thr Pro Arg Ser Lys Ala Thr
805 810 815
tgg agg ctg cat atc cat ggg cgg gca gca taagag aat gtg aag ccc 2544
Trp Arg Leu His Ile His Gly Arg Ala Ala Glu Asn Val Lys Pro
820 825 830
ttc agt gag acg aga cga gca atg gga aac ctt ttc tgt tct taa gaa 2592
Phe Ser Glu Thr Arg Arg Ala Met Gly Asn Leu Phe Cys Ser Glu
835 840 845
gtg act tta att tta ttg aca tat gta ctg tat gtt act gag att gaa 2640
Val Thr Leu Ile Leu Leu Thr Tyr Val Leu Tyr Val Thr Glu Ile Glu
850 855 860
tgt tag ggg aag cct taa ggt aga ggt att tgg gaa agt agc cag tgg 2688
Cys Gly Lys Pro Gly Arg Gly Ile Trp Glu Ser Ser Gln Trp
865 870 875
gca ctt gtg ata tct aaa atc tgt tat ccc agg act gtg tac aga ggg 2736
Ala Leu Val Ile Ser Lys Ile Cys Tyr Pro Arg Thr Val Tyr Arg Gly
880 885 890
gca acc tac cca ttc agg aag gtc agg gct ttg gaa ccc taa aaa gtt 2784
Ala Thr Tyr Pro Phe Arg Lys Val Arg Ala Leu Glu Pro Lys Val
895 900 905
ggc ccg atg act taa agg gaa aaa taa ttc att ccc aga gat gag tca 2832
Gly Pro Met Thr Arg Glu Lys Phe Ile Pro Arg Asp Glu Ser
910 915 920
gaa cag tct cct caa tcc tga aat tca aca agg cat cag aag ggc tgg 2880
Glu Gln Ser Pro Gln Ser Asn Ser Thr Arg His Gln Lys Gly Trp
925 930 935
ctg tgg tca agc cca gct gct gtc atg tga gga gat gct cac tgt ggt 2928
Leu Trp Ser Ser Pro Ala Ala Val Met Gly Asp Ala His Cys Gly
940 945 950
ctt gtt gag ctg atg gcc ttg gtt gag ctg atg gac aag tga agg agg 2976
Leu Val Glu Leu Met Ala Leu Val Glu Leu Met Asp Lys Arg Arg
955 960 965
cca tgg ggc tgt gct gtc ctt cct gcc gta cgt gcc att cca ctc tct 3024
Pro Trp Gly Cys Ala Val Leu Pro Ala Val Arg Ala Ile Pro Leu Ser
970 975 980
tca gct ctc ccc tca aca gca tgc gag ccc ata cct tct gca ttt ttc 3072
Ser Ala Leu Pro Ser Thr Ala Cys Glu Pro Ile Pro Ser Ala Phe Phe
985 990 995
cag gcc tgt gag gga tat agg cct ccc ctt gga gca ctg agt ccg 3117
Gln Ala Cys Glu Gly Tyr Arg Pro Pro Leu Gly Ala Leu Ser Pro
1000 1005 1010
gag gtc atc cct gag ctc atc cac ggc tca tgc tgt ggc tcc gag 3162
Glu Val Ile Pro Glu Leu Ile His Gly Ser Cys Cys Gly Ser Glu
1015 1020 1025
tag tgg ttt gag tgg gca gga agg gcc att tgc aaa cac tgc tgt 3207
Trp Phe Glu Trp Ala Gly Arg Ala Ile Cys Lys His Cys Cys
1030 1035 1040
gtt cta gac aaa caa ccc aag tcc tat ggc agg att tct tcc ttc 3252
Val Leu Asp Lys Gln Pro Lys Ser Tyr Gly Arg Ile Ser Ser Phe
1045 1050 1055
ctt cct ttt tta ccc agg tga tga agt gca ccc att gta ctg gga 3297
Leu Pro Phe Leu Pro Arg Ser Ala Pro Ile Val Leu Gly
1060 1065 1070
aga atg aag agg tga tac ctt tac tag atc ctt cag aca cat cta tga 3345
Arg Met Lys Arg Tyr Leu Tyr Ile Leu Gln Thr His Leu
1075 1080
gaa gat ttg ttc att taa aag tct gcc cac tga gga tag gga aag 3390
Glu Asp Leu Phe Ile Lys Ser Ala His Gly Gly Lys
1085 1090 1095
gat taa gga ttt ttc cac ctc ctc tta gta act cct gaa tta cca 3435
Asp Gly Phe Phe His Leu Leu Leu Val Thr Pro Glu Leu Pro
1100 1105
aca tca act tct ttc tct ccg ttc ctg aag gaa ctt tgg gga atc 3480
Thr Ser Thr Ser Phe Ser Pro Phe Leu Lys Glu Leu Trp Gly Ile
1110 1115 1120
atc ttc atc cgt agt tac gct ttc ctg aac ctt ctc agt ggt tta 3525
Ile Phe Ile Arg Ser Tyr Ala Phe Leu Asn Leu Leu Ser Gly Leu
1125 1130 1135
cat gcc tct gaa act atg tgc aat att ttt ggt tga cac ttg tat 3570
His Ala Ser Glu Thr Met Cys Asn Ile Phe Gly His Leu Tyr
1140 1145 1150
cca tcc tta aga aat tag tgc aga ttg cag atg ttc tgt ctt cca 3615
Pro Ser Leu Arg Asn Cys Arg Leu Gln Met Phe Cys Leu Pro
1155 1160 1165
tcc caa aca agc ctg cca tga ggt agg atc cta ggg gtt tgg ctg 3660
Ser Gln Thr Ser Leu Pro Gly Arg Ile Leu Gly Val Trp Leu
1170 1175 1180
ttc tta ctc cac tgc tca gaa agc ttc cat tct gct gtc ctc agc 3705
Phe Leu Leu His Cys Ser Glu Ser Phe His Ser Ala Val Leu Ser
1185 1190 1195
ctc gac cct ctt ctg tgc tgg act tcc acc cac cca ccc ttt tca 3750
Leu Asp Pro Leu Leu Cys Trp Thr Ser Thr His Pro Pro Phe Ser
1200 1205 1210
agt tta gat agt gtt tca gct gct gtc cca aag taa caa aac aat 3795
Ser Leu Asp Ser Val Ser Ala Ala Val Pro Lys Gln Asn Asn
1215 1220 1225
acc tac tgt taa gta gga agt caa tct gtg tgc tgg ttt tgt tgg 3840
Thr Tyr Cys Val Gly Ser Gln Ser Val Cys Trp Phe Cys Trp
1230 1235
tta tgt gga aat cac aaa ctc cag agg agc aaa ggg gtt ttt caa 3885
Leu Cys Gly Asn His Lys Leu Gln Arg Ser Lys Gly Val Phe Gln
1240 1245 1250
tgt ctt ttg ctt tca gaa aca gag aat ata ata ttc tca cta agg 3930
Cys Leu Leu Leu Ser Glu Thr Glu Asn Ile Ile Phe Ser Leu Arg
1255 1260 1265
cct tga att gat ttt ttt ctc ata aaa tag tct gat aag cta att 3975
Pro Ile Asp Phe Phe Leu Ile Lys Ser Asp Lys Leu Ile
1270 1275 1280
ttt aaa aag aaa tgc cat taa ctg tgt tgt atc gtg gtt taa aat 4020
Phe Lys Lys Lys Cys His Leu Cys Cys Ile Val Val Asn
1285 1290 1295
tac taa caa gtt gtg gga aag aaa aat aat att tga ttt tga atc tta 4068
Tyr Gln Val Val Gly Lys Lys Asn Asn Ile Phe Ile Leu
1300 1305
aat gtt ttt aaa aat tag act tga atg ggc aca aag tat aaa tat 4113
Asn Val Phe Lys Asn Thr Met Gly Thr Lys Tyr Lys Tyr
1310 1315 1320
ttt gtt tct tta tgg agg aca tgt gga agg agt ttg agg gtt tgg 4158
Phe Val Ser Leu Trp Arg Thr Cys Gly Arg Ser Leu Arg Val Trp
1325 1330 1335
gat ggg aga agt att ttg cag agc tat caa tgt cca aat aat tta 4203
Asp Gly Arg Ser Ile Leu Gln Ser Tyr Gln Cys Pro Asn Asn Leu
1340 1345 1350
aaa aaa aaa ata aag gta ttt aag cag tg 4232
Lys Lys Lys Ile Lys Val Phe Lys Gln
1355 1360
SEQUENCE LISTING3
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_145036
<160>1
<170>PatentIn version 3.5
<210>1
<211>3525
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(211)
<220>
<221>exon
<222>(212)..(325)
<220>
<221>exon
<222>(326)..(516)
<220>
<221>exon
<222>(517)..(689)
<220>
<221>exon
<222>(690)..(783)
<220>
<221>exon
<222>(784)..(861)
<220>
<221>exon
<222>(862)..(909)
<220>
<221>exon
<222>(910)..(987)
<220>
<221>exon
<222>(988)..(1074)
<220>
<221>exon
<222>(1075)..(1174)
<220>
<221>exon
<222>(1175)..(1293)
<220>
<221>exon
<222>(1294)..(1437)
<220>
<221>exon
<222>(1438)..(1592)
<220>
<221>exon
<222>(1593)..(1722)
<220>
<221>exon
<222>(1723)..(1815)
<220>
<221>exon
<222>(1816)..(1875)
<220>
<221>exon
<222>(1876)..(1955)
<220>
<221>exon
<222>(1956)..(2091)
<220>
<221>exon
<222>(2092)..(2199)
<220>
<221>exon
<222>(2200)..(2382)
<220>
<221>exon
<222>(2383)..(2613)
<220>
<221>exon
<222>(2614)..(2676)
<220>
<221>exon
<222>(2677)..(2826)
<220>
<221>exon
<222>(2827)..(2916)
<220>
<221>exon
<222>(2917)..(3018)
<220>
<221>exon
<222>(3019)..(3083)
<220>
<221>STS
<222>(3024)..(3150)
<220>
<221>exon
<222>(3084)..(3518)
<400>1
ggg ccc gtt ctc cgg gcc tgg ggg gcg cgc gcc cct ggg gtc ccg gcg 48
Gly Pro Val Leu Arg Ala Trp Gly Ala Arg Ala Pro Gly Val Pro Ala
1 5 10 15
ctg ccc gct gtg gtg tcc ccg gca ggc aga gcg cga tcc agg ccg gga 96
Leu Pro Ala Val Val Ser Pro Ala Gly Arg Ala Arg Ser Arg Pro Gly
20 25 30
cga ctt ggg aaa gtt cta agt aaa gtt tga tca gcc ggt ttg atc ggt 144
Arg Leu Gly Lys Val Leu Ser Lys Val Ser Ala Gly Leu Ile Gly
35 40 45
ctg acg tgg tcc aag agt ctg acc caa ggg ttt gcg act ggg aga gga 192
Leu Thr Trp Ser Lys Ser Leu Thr Gln Gly Phe Ala Thr Gly Arg Gly
50 55 60
aat ctg tgt cct gga caa g at tgg att atg gaa gtg gga agt gaa gaa 240
Asn Leu Cys Pro Gly Gln Asp Trp Ile Met Glu Val Gly Ser Glu Glu
65 75
gaa aaa tgg gag aag ctg gat gca gaa ttt gat cac ttt gtg gtt gat 288
Glu Lys Trp Glu Lys Leu Asp Ala Glu Phe Asp His Phe Val Val Asp
80 85 90 95
atg aag ccc ttt gtt cta aaa tta cct cat agg aca g aa cgg cag agg 336
Met Lys Pro Phe Val Leu Lys Leu Pro His Arg Thr Glu Arg Gln Arg
100 105 110
tgt gct ctt tgg att aga aag ctg tgc gaa cct tca gga aca ggt gca 384
Cys Ala Leu Trp Ile Arg Lys Leu Cys Glu Pro Ser Gly Thr Gly Ala
115 120 125
gga ata atg ggg agg aag aat cgg aac ctg tat gca aaa ttg tta ttg 432
Gly Ile Met Gly Arg Lys Asn Arg Asn Leu Tyr Ala Lys Leu Leu Leu
130 135 140
cat atg ctt aaa cga ggt gcg ctt gaa ggc cct ttt aca cac cga cct 480
His Met Leu Lys Arg Gly Ala Leu Glu Gly Pro Phe Thr His Arg Pro
145 150 155
gaa ccc ggg aca cta aaa att cta cct tca tac atg tcc atc tat ttt 528
Glu Pro Gly Thr Leu Lys Ile Leu Pro Ser Tyr Met Ser Ile Tyr Phe
160 165 170 175
gat gaa cca aat cca gca cga gca aaa ggt tca agc cca gag gga tta 576
Asp Glu Pro Asn Pro Ala Arg Ala Lys Gly Ser Ser Pro Glu Gly Leu
180 185 190
cca gcc tgg gta ctg ggt gag ctg gag aca agt gaa cac aaa tta aat 624
Pro Ala Trp Val Leu Gly Glu Leu Glu Thr Ser Glu His Lys Leu Asn
195 200 205
gaa tca tgg aaa ctc tct tct gga gaa gat aac act tta gta cag tcg 672
Glu Ser Trp Lys Leu Ser Ser Gly Glu Asp Asn Thr Leu Val Gln Ser
210 215 220
cca act gat gtc tac ag c agg gaa cag tac act ggg aag ctc cga gtg 720
Pro Thr Asp Val Tyr Ser Arg Glu Gln Tyr Thr Gly Lys Leu Arg Val
225 230 235
aga tca cac tcc ttg agt cca act cac aga gaa gat gga caa aat att 768
Arg Ser His Ser Leu Ser Pro Thr His Arg Glu Asp Gly Gln Asn Ile
240 245 250 255
acc cca aag att tgt gaa gtt tat tcg aaa aaa tct cct gtt tct ttg 816
Thr Pro Lys Ile Cys Glu Val Tyr Ser Lys Lys Ser Pro Val Ser Leu
260 265 270
gat gat agt gac att gaa gct cgc ctt aat agt tgg aat ctt ggg ata 864
Asp Asp Ser Asp Ile Glu Ala Arg Leu Asn Ser Trp Asn Leu Gly Ile
275 280 285
gaa aat cct cga tac ctg aga cag aag cct atc cca gtt tct ctg atg 912
Glu Asn Pro Arg Tyr Leu Arg Gln Lys Pro Ile Pro Val Ser Leu Met
290 295 300
aca ccg aaa ttc agc ctg aga aaa tcc agc agt ttc cat gat gat cat 960
Thr Pro Lys Phe Ser Leu Arg Lys Ser Ser Ser Phe His Asp Asp His
305 310 315
ttt ctc tct cga ata cgt gag aaa gag ctg gac atg aaa aca aaa atg 1008
Phe Leu Ser Arg Ile Arg Glu Lys Glu Leu Asp Met Lys Thr Lys Met
320 325 330 335
atg gaa gct aaa ttt cat gaa gaa aag ctt aaa ctg caa cag aaa cat 1056
Met Glu Ala Lys Phe His Glu Glu Lys Leu Lys Leu Gln Gln Lys His
340 345 350
gat gct gat gtt cag aag att tta gaa aga aag aat aat gaa ata gaa 1104
Asp Ala Asp Val Gln Lys Ile Leu Glu Arg Lys Asn Asn Glu Ile Glu
355 360 365
gaa ctg aaa act tta tac agg agt aaa caa cat gaa act gaa gag act 1152
Glu Leu Lys Thr Leu Tyr Arg Ser Lys Gln His Glu Thr Glu Glu Thr
370 375 380
att aga aag ctt gaa aag aaa g tt cag aca ctg ata cgt gac tgt caa 1200
Ile Arg Lys Leu Glu Lys Lys Val Gln Thr Leu Ile Arg Asp Cys Gln
385 390 395
gtt atc aga gag act aaa gaa gac cag att gca gag ctg aaa aag ata 1248
Val Ile Arg Glu Thr Lys Glu Asp Gln Ile Ala Glu Leu Lys Lys Ile
400 405 410 415
tgt gaa caa agt acg gaa tct cta aat aat gac tgg gaa aaa aag ctt 1296
Cys Glu Gln Ser Thr Glu Ser Leu Asn Asn Asp Trp Glu Lys Lys Leu
420 425 430
cac aat gct gta gca gaa atg gaa cag gaa aag ttt gat ctt caa aag 1344
His Asn Ala Val Ala Glu Met Glu Gln Glu Lys Phe Asp Leu Gln Lys
435 440 445
caa cac act gaa aac att caa gaa ttg ctt gag gat aca aat gtg cgt 1392
Gln His Thr Glu Asn Ile Gln Glu Leu Leu Glu Asp Thr Asn Val Arg
450 455 460
ctg aat aaa atg gag agt gaa tac atg gcg caa aca cag tcc aca aac 1440
Leu Asn Lys Met Glu Ser Glu Tyr Met Ala Gln Thr Gln Ser Thr Asn
465 470 475
cac atg atc aaa gaa ctg gag gcc cgt gtc cag cag ctg act gga gaa 1488
His Met Ile Lys Glu Leu Glu Ala Arg Val Gln Gln Leu Thr Gly Glu
480 485 490 495
gca gag aac agt aat tta cag agg cag aaa tta att caa gaa aaa gca 1536
Ala Glu Asn Ser Asn Leu Gln Arg Gln Lys Leu Ile Gln Glu Lys Ala
500 505 510
gaa ctt gaa aga tgt tac cag ata acg tgt agt gaa tta caa gaa gta 1584
Glu Leu Glu Arg Cys Tyr Gln Ile Thr Cys Ser Glu Leu Gln Glu Val
515 520 525
aag gca ag g cgt aac aca ctg cat aaa gag aag gac cat ctt gta aat 1632
Lys Ala Arg Arg Asn Thr Leu His Lys Glu Lys Asp His Leu Val Asn
535 540
gat tat gag caa aac atg aaa ctg tta caa acc aaa tat gat gct gat 1680
Asp Tyr Glu Gln Asn Met Lys Leu Leu Gln Thr Lys Tyr Asp Ala Asp
545 550 555
ata aac ctt cta aaa caa gaa cat gct ctt tca gct tct aag gca tct 1728
Ile Asn Leu Leu Lys Gln Glu His Ala Leu Ser Ala Ser Lys Ala Ser
560 565 570 575
agt atg att gaa gaa tta gag cag aat gtc tgt caa tta aaa cag cag 1776
Ser Met Ile Glu Glu Leu Glu Gln Asn Val Cys Gln Leu Lys Gln Gln
580 585 590
tta cag gaa tca gaa ctt caa aga aag caa caa cta agg gat caa gaa 1824
Leu Gln Glu Ser Glu Leu Gln Arg Lys Gln Gln Leu Arg Asp Gln Glu
595 600 605
aat aag ttt cag atg gag aaa agt cat tta aaa cac atc tat gaa aaa 1872
Asn Lys Phe Gln Met Glu Lys Ser His Leu Lys His Ile Tyr Glu Lys
610 615 620
aag gct cat gac ttg cag agt gaa ctt gat aaa gga aaa gaa gat act 1920
Lys Ala His Asp Leu Gln Ser Glu Leu Asp Lys Gly Lys Glu Asp Thr
625 630 635
caa aag aaa att cat aaa ttt gag gaa gct ttg aa g gaa aaa gag gag 1968
Gln Lys Lys Ile His Lys Phe Glu Glu Ala Leu Lys Glu Lys Glu Glu
640 645 650 655
cag cta act cgt gtg act gaa gtt cag agg ttg cag gcc cag cag gca 2016
Gln Leu Thr Arg Val Thr Glu Val Gln Arg Leu Gln Ala Gln Gln Ala
660 665 670
gat gcc gct ctg gaa gag ttt aag cgg cag gtg gaa ctg aac tca gag 2064
Asp Ala Ala Leu Glu Glu Phe Lys Arg Gln Val Glu Leu Asn Ser Glu
675 680 685
aaa gtc tat gct gaa atg aaa gag cag atg gaa aaa gtg gag gca gat 2112
Lys Val Tyr Ala Glu Met Lys Glu Gln Met Glu Lys Val Glu Ala Asp
690 695 700
cta act aga tcc aaa tct ctt cgt gag aaa caa tca aag gag ttt tta 2160
Leu Thr Arg Ser Lys Ser Leu Arg Glu Lys Gln Ser Lys Glu Phe Leu
705 710 715
tgg caa ctg gag gac atc aga cag cgg tat gaa caa cag ata gta gag 2208
Trp Gln Leu Glu Asp Ile Arg Gln Arg Tyr Glu Gln Gln Ile Val Glu
720 725 730 735
ctg aag ctg gag cat gaa cag gag aag acg cac cta tta cag cag cat 2256
Leu Lys Leu Glu His Glu Gln Glu Lys Thr His Leu Leu Gln Gln His
740 745 750
aac gca gag aag gat agc cta gtc cga gac cat gaa cgg gaa att gaa 2304
Asn Ala Glu Lys Asp Ser Leu Val Arg Asp His Glu Arg Glu Ile Glu
755 760 765
aac ctg gaa aaa cag ctt cgc gct gcc aat atg gag cac gaa aat caa 2352
Asn Leu Glu Lys Gln Leu Arg Ala Ala Asn Met Glu His Glu Asn Gln
770 775 780
att cag gag ttc aag aaa cga gat gca cag gtt att gcc gac atg gag 2400
Ile Gln Glu Phe Lys Lys Arg Asp Ala Gln Val Ile Ala Asp Met Glu
785 790 795
gcc cag gtt cac aag ttg aga gaa gaa ttg atc aat gtg aac tca cag 2448
Ala Gln Val His Lys Leu Arg Glu Glu Leu Ile Asn Val Asn Ser Gln
800 805 810 815
cgg aaa cag cag ctg gta gag ctt ggt ctt ctt cgt gaa gag gaa aag 2496
Arg Lys Gln Gln Leu Val Glu Leu Gly Leu Leu Arg Glu Glu Glu Lys
820 825 830
caa agg gct aca agg gaa cat gag att gtc gtc aat aaa ctg aag gct 2544
Gln Arg Ala Thr Arg Glu His Glu Ile Val Val Asn Lys Leu Lys Ala
835 840 845
gaa tca gaa aag atg aaa ata gag ctg aaa aag act cat gct gct gag 2592
Glu Ser Glu Lys Met Lys Ile Glu Leu Lys Lys Thr His Ala Ala Glu
850 855 860
aca gag atg aca ctg gaa aag gcc aac agc aag ctg aag cag att gag 2640
Thr Glu Met Thr Leu Glu Lys Ala Asn Ser Lys Leu Lys Gln Ile Glu
865 870 875
aag gaa tac act cag aag ctt gcc aaa tct tca cag atc ata gca gaa 2688
Lys Glu Tyr Thr Gln Lys Leu Ala Lys Ser Ser Gln Ile Ile Ala Glu
880 885 890 895
ctt cag aca acc att tcc tct ctg aaa gaa gag aac agc cag cag cag 2736
Leu Gln Thr Thr Ile Ser Ser Leu Lys Glu Glu Asn Ser Gln Gln Gln
900 905 910
ctt gct gca gaa agg cgg ctc cag gat gtt aga caa aag ttt gaa gat 2784
Leu Ala Ala Glu Arg Arg Leu Gln Asp Val Arg Gln Lys Phe Glu Asp
915 920 925
gag aag aag cag ctg att aga gat aat gac caa gca atc aag gtt tta 2832
Glu Lys Lys Gln Leu Ile Arg Asp Asn Asp Gln Ala Ile Lys Val Leu
930 935 940
caa gat gaa tta gaa aac cgt tct aat cag gtg cga tgt gca gag aaa 2880
Gln Asp Glu Leu Glu Asn Arg Ser Asn Gln Val Arg Cys Ala Glu Lys
945 950 955
aaa tta caa cac aaa gaa ttg gag tca cag gaa cag ata act tac ata 2928
Lys Leu Gln His Lys Glu Leu Glu Ser Gln Glu Gln Ile Thr Tyr Ile
960 965 970 975
cga caa gaa tat gaa aca aaa ttg aaa gga ttg atg cca gca tcc cta 2976
Arg Gln Glu Tyr Glu Thr Lys Leu Lys Gly Leu Met Pro Ala Ser Leu
980 985 990
aga caa gaa ctt gaa gac acc att tcc tcc cta aaa tca cag gtt aat 3024
Arg Gln Glu Leu Glu Asp Thr Ile Ser Ser Leu Lys Ser Gln Val Asn
995 1000 1005
ttt ctg caa aag aga gct tcc atc ctt cag gaa gaa ctg act aca 3069
Phe Leu Gln Lys Arg Ala Ser Ile Leu Gln Glu Glu Leu Thr Thr
1010 1015 1020
tat caa ggc aga ag g taa ctg cac gag aga atg caa cgg atg caa 3114
Tyr Gln Gly Arg Arg Leu His Glu Arg Met Gln Arg Met Gln
1025 1030 1035
ttt cca ggc tgt gct gtg gac ttc ttc cag cag gtt tga aga ttt 3159
Phe Pro Gly Cys Ala Val Asp Phe Phe Gln Gln Val Arg Phe
1040 1045 1050
gga tat tgt aaa ctg tga gat cag tgg cat ttt tta aat cct taa atg 3207
Gly Tyr Cys Lys Leu Asp Gln Trp His Phe Leu Asn Pro Met
1055 1060
taa tta aga tca taa aaa cat gca tca ttc ata cac tag tgg ggt 3252
Leu Arg Ser Lys His Ala Ser Phe Ile His Trp Gly
1065 1070 1075
ggt ttt att tgt gtc tgc cta agt tat ttt ttt aac att cct tta 3297
Gly Phe Ile Cys Val Cys Leu Ser Tyr Phe Phe Asn Ile Pro Leu
1080 1085 1090
ttt ccg att ttc atg ttt gtg tgc att tga gta tgt gct gag aac 3342
Phe Pro Ile Phe Met Phe Val Cys Ile Val Cys Ala Glu Asn
1095 1100 1105
tgc tta tat tgg gca aag tga ttt cct atg ata tgc ctt gtt aat 3387
Cys Leu Tyr Trp Ala Lys Phe Pro Met Ile Cys Leu Val Asn
1110 1115
cct ttt gca tag aat ttt acc agt tgc gta cga tca aaa tca cgt 3432
Pro Phe Ala Asn Phe Thr Ser Cys Val Arg Ser Lys Ser Arg
1120 1125 1130
ttg tag tat cat atc aaa aat tct aac ctg ttt aca ttg ttt tca 3477
Leu Tyr His Ile Lys Asn Ser Asn Leu Phe Thr Leu Phe Ser
1135 1140 1145
tgt tca tgt tcc tat gtt att aaa ata tta ttt tgt act ta aaaaaaa 3525
Cys Ser Cys Ser Tyr Val Ile Lys Ile Leu Phe Cys Thr
1150 1155 1160 SEQUENCE LISTING4
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_001304
<160>1
<170>PatentIn version 3.5
<210>1
<211>8025
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(761)
<220>
<221>sig_peptide
<222>(16)..(105)
<220>
<221>misc_feature
<222>(106)..(1395)
<220>
<221>exon
<222>(762)..(1009)
<220>
<221>exon
<222>(1010)..(1152)
<220>
<221>exon
<222>(1153)..(1322)
<220>
<221>exon
<222>(1323)..(1672)
<220>
<221>misc_feature
<222>(1396)..(1497)
<220>
<221>misc_feature
<222>(1498)..(2616)
<220>
<221>exon
<222>(1673)..(1864)
<220>
<221>exon
<222>(1865)..(2032)
<220>
<221>exon
<222>(2033)..(2142)
<220>
<221>exon
<222>(2143)..(2245)
<220>
<221>exon
<222>(2246)..(2388)
<220>
<221>exon
<222>(2389)..(2558)
<220>
<221>exon
<222>(2559)..(2888)
<220>
<221>misc_feature
<222>(2617)..(2703)
<220>
<221>misc_feature
<222>(2704)..(3912)
<220>
<221>exon
<222>(2889)..(3084)
<220>
<221>exon
<222>(3085)..(3220)
<220>
<221>exon
<222>(3221)..(3352)
<220>
<221>exon
<222>(3353)..(3448)
<220>
<221>exon
<222>(3449)..(3513)
<220>
<221>exon
<222>(3524)..(3645)
<220>
<221>exon
<222>(3646)..(3831)
<220>
<221>exon
<222>(3832)..(3931)
<220>
<221>misc_feature
<222>(3904)..(3981)
<220>
<221>misc_feature
<222>(3904)..(3981)
<220>
<221>exon
<222>(3932)..(8025)
<220>
<221>STS
<222>(4493)..(4622)
<220>
<221>STS
<222>(5585)..(5734)
<220>
<221>polyA_site
<222>(5764)..(5764)
<220>
<221>STS
<222>(6399)..(6505)
<220>
<221>STS
<222>(6820)..(6939)
<220>
<221>STS
<222>(6830)..(6978)
<220>
<221>polyA_signal
<222>(7014)..(7019)
<220>
<221>polyA_signal
<222>(7018)..(7023)
<220>
<221>polyA_site
<222>(7042)..(7042)
<220>
<221>STS
<222>(7838)..(7967)
<220>
<221>polyA_site
<222>(8025)..(8025)
<400>1
cgg cgc tgc tgg aag atg gcg agc ggc cgg gac gag cgg ccg cct tgg 48
Arg Arg Cys Trp Lys Met Ala Ser Gly Arg Asp Glu Arg Pro Pro Trp
1 5 10 15
cgg cta ggg cgg ctc ctg ttg ctc atg tgc ctg ctg ctg ctg ggg agc 96
Arg Leu Gly Arg Leu Leu Leu Leu Met Cys Leu Leu Leu Leu Gly Ser
20 25 30
tcg gcc cgg gcg gct cac atc aag aag gcg gag gcg act acc aca act 144
Ser Ala Arg Ala Ala His Ile Lys Lys Ala Glu Ala Thr Thr Thr Thr
35 40 45
acg agc gcg ggc gcc gag gcg gcc gag ggc cag ttc gac cgc tac tac 192
Thr Ser Ala Gly Ala Glu Ala Ala Glu Gly Gln Phe Asp Arg Tyr Tyr
50 55 60
cac gaa gag gag ttg gag tcg gcg ctg agg gag gcg gcg gcc gcg ggc 240
His Glu Glu Glu Leu Glu Ser Ala Leu Arg Glu Ala Ala Ala Ala Gly
65 70 75 80
ctc ccc ggc ctg gcc cgc ctc ttt agc atc ggc cgc tcg gtg gaa ggc 288
Leu Pro Gly Leu Ala Arg Leu Phe Ser Ile Gly Arg Ser Val Glu Gly
85 90 95
cgg ccg ctg tgg gtg ctt cgc ctc acc gcc ggc ctg ggg tcg cta atc 336
Arg Pro Leu Trp Val Leu Arg Leu Thr Ala Gly Leu Gly Ser Leu Ile
100 105 110
cct gag ggc gac gcg ggg cct gac gct gcc ggg ccc gac gct gcg ggg 384
Pro Glu Gly Asp Ala Gly Pro Asp Ala Ala Gly Pro Asp Ala Ala Gly
115 120 125
ccg ctg ctg ccc ggc cgg ccc cag gtg aag ctg gtg ggc aac atg cat 432
Pro Leu Leu Pro Gly Arg Pro Gln Val Lys Leu Val Gly Asn Met His
130 135 140
ggc gac gag acc gtg tcg cgc cag gtg ttg atc tac ttg gcc cgc gag 480
Gly Asp Glu Thr Val Ser Arg Gln Val Leu Ile Tyr Leu Ala Arg Glu
145 150 155 160
ctg gcg gcc ggc tac cgc cgc ggg gac ccg cgc ctg gtc cgc ctg ctc 528
Leu Ala Ala Gly Tyr Arg Arg Gly Asp Pro Arg Leu Val Arg Leu Leu
165 170 175
aac acc acc gac gtg tac ctg ctg ccc agc ctc aac ccc gat ggc ttc 576
Asn Thr Thr Asp Val Tyr Leu Leu Pro Ser Leu Asn Pro Asp Gly Phe
180 185 190
gag cgt gcc cgc gag ggc gac tgt ggc ttc ggc gac ggc ggc ccg tcc 624
Glu Arg Ala Arg Glu Gly Asp Cys Gly Phe Gly Asp Gly Gly Pro Ser
195 200 205
ggg gcc agc ggc cgc gac aat agt cgc ggc cgc gac ctc aac cga agc 672
Gly Ala Ser Gly Arg Asp Asn Ser Arg Gly Arg Asp Leu Asn Arg Ser
210 215 220
ttt ccc gac cag ttt agc acc ggc gaa ccc ccc gcc ctg gac gag gtg 720
Phe Pro Asp Gln Phe Ser Thr Gly Glu Pro Pro Ala Leu Asp Glu Val
225 230 235 240
ccc gag gtg cgc gcc ctc atc gag tgg atc cgc agg aac aa g ttt gtg 768
ProGlu Val Arg Ala Leu Ile Glu Trp Ile Arg Arg Asn Lys Phe Val
245 250 255
ctt tct gga aat ctg cat ggt ggc tca gtg gta gca agc tat cct ttt 816
Leu Ser Gly Asn Leu His Gly Gly Ser Val Val Ala Ser Tyr Pro Phe
260 265 270
gat gat tct cca gaa cat aag gcc act gga atc tat agc aaa acc tca 864
Asp Asp Ser Pro Glu His Lys Ala Thr Gly Ile Tyr Ser Lys Thr Ser
275 280 285
gat gat gaa gta ttt aaa tac ttg gca aaa gct tat gct tca aac cac 912
Asp Asp Glu Val Phe Lys Tyr Leu Ala Lys Ala Tyr Ala Ser Asn His
290 295 300
ccc ata atg aaa act ggt gag cct cat tgt cca gga gat gaa gac gag 960
Pro Ile Met Lys Thr Gly Glu Pro His Cys Pro Gly Asp Glu Asp Glu
305 310 315 320
act ttc aaa gat gga atc aca aac ggc gca cat tgg tat gat gtg gaa g 1009
Thr Phe Lys Asp Gly Ile Thr Asn Gly Ala His Trp Tyr Asp Val Glu
325 330 335
gt ggt atg caa gat tac aat tat gtg tgg gcc aac tgt ttt gag atc 1056
Gly Gly Met Gln Asp Tyr Asn Tyr Val Trp Ala Asn Cys Phe Glu Ile
340 345 350
aca tta gaa ctg tct tgt tgc aag tac cca cct gct tca cag ctt cga 1104
Thr Leu Glu Leu Ser Cys Cys Lys Tyr Pro Pro Ala Ser Gln Leu Arg
355 360 365
cag gaa tgg gag aac aat cgt gag tct ttg atc aca ttg att gaa aag 1152
Gln Glu Trp Glu Asn Asn Arg Glu Ser Leu Ile Thr Leu Ile Glu Lys
370 375 380
gtt cac att gga gtg aaa gga ttt gtt aaa gat tcc ata aca gga tct 1200
Val His Ile Gly Val Lys Gly Phe Val Lys Asp Ser Ile Thr Gly Ser
385 390 395 400
ggg tta gag aat gca acc atc tca gtg gct ggt att aat cat aat atc 1248
Gly Leu Glu Asn Ala Thr Ile Ser Val Ala Gly Ile Asn His Asn Ile
405 410 415
aca aca ggc aga ttt ggt gat ttc tac cga tta ctt gtt cct gga act 1296
Thr Thr Gly Arg Phe Gly Asp Phe Tyr Arg Leu Leu Val Pro Gly Thr
420 425 430
tac aac ctt aca gta gtt tta act gg g tat atg cca ttg act gtt act 1344
Tyr Asn Leu Thr Val Val Leu Thr Gly Tyr Met Pro Leu Thr Val Thr
435 440 445
aat gta gtg gtg aaa gaa gga cca gcc aca gag gtg gat ttt tct ctt 1392
Asn Val Val Val Lys Glu Gly Pro Ala Thr Glu Val Asp Phe Ser Leu
450 455 460
agg cca act gta act tca gta atc cct gac acg aca gag gct gta tca 1440
Arg Pro Thr Val Thr Ser Val Ile Pro Asp Thr Thr Glu Ala Val Ser
465 470 475 480
act gct agc aca gtt gct ata cct aat att ctt tct gga aca tca tcc 1488
Thr Ala Ser Thr Val Ala Ile Pro Asn Ile Leu Ser Gly Thr Ser Ser
485 490 495
tcc tac cag cca att cag cca aag gac ttt cac cac cac cat ttc cct 1536
Ser Tyr Gln Pro Ile Gln Pro Lys Asp Phe His His His His Phe Pro
500 505 510
gat atg gaa atc ttc ttg aga agg ttt gcc aat gaa tat cct aac att 1584
Asp Met Glu Ile Phe Leu Arg Arg Phe Ala Asn Glu Tyr Pro Asn Ile
515 520 525
acc cgg ctt tat tcc ttg gga aaa tca gta gag tca aga gaa ctt tat 1632
Thr Arg Leu Tyr Ser Leu Gly Lys Ser Val Glu Ser Arg Glu Leu Tyr
530 535 540
gtg atg gag ata tct gat aat ccg ggt gtc cat gaa cca g gt gaa cca 1680
Val Met Glu Ile Ser Asp Asn Pro Gly Val His Glu Pro Gly Glu Pro
545 550 555 560
gaa ttt aag tac att gga aat atg cat gga aat gaa gtg gtt gga aga 1728
Glu Phe Lys Tyr Ile Gly Asn Met His Gly Asn Glu Val Val Gly Arg
565 570 575
gaa ctg ctg ttg aac ctc ata gaa tac ctt tgt aag aac ttt gga aca 1776
Glu Leu Leu Leu Asn Leu Ile Glu Tyr Leu Cys Lys Asn Phe Gly Thr
580 585 590
gac cct gaa gtc aca gat ttg gtt cat aac act aga att cac ctt atg 1824
Asp Pro Glu Val Thr Asp Leu Val His Asn Thr Arg Ile His Leu Met
595 600 605
cca tcc atg aat cct gat ggg tat gaa aag tcc cag gaa g ga gat tca 1872
Pro Ser Met Asn Pro Asp Gly Tyr Glu Lys Ser Gln Glu Gly Asp Ser
610 615 620
ata agt gta att ggc aga aac aac agc aac aac ttt gac ctg aac cga 1920
Ile Ser Val Ile Gly Arg Asn Asn Ser Asn Asn Phe Asp Leu Asn Arg
625 630 635 640
aat ttc cca gac cag ttt gtt cag atc aca gat cct acg caa cca gaa 1968
Asn Phe Pro Asp Gln Phe Val Gln Ile Thr Asp Pro Thr Gln Pro Glu
645 650 655
act att gct gta atg agc tgg atg aag tcc tat cca ttt gta ctt tca 2016
Thr Ile Ala Val Met Ser Trp Met Lys Ser Tyr Pro Phe Val Leu Ser
660 665 670
gca aac ctg cat gga g gt tct ttg gtg gtt aac tac cct ttt gat gat 2064
Ala Asn Leu His Gly Gly Ser Leu Val Val Asn Tyr Pro Phe Asp Asp
675 680 685
gat gaa caa gga ctt gcc aca tat agt aaa tca cca gat gat gct gtg 2112
Asp Glu Gln Gly Leu Ala Thr Tyr Ser Lys Ser Pro Asp Asp Ala Val
690 695 700
ttc caa caa ata gca ctt tct tat tcc aag gaa aat tcc cag atg ttt 2160
Phe Gln Gln Ile Ala Leu Ser Tyr Ser Lys Glu Asn Ser Gln Met Phe
705 710 715 720
caa ggt aga cct tgc aag aat atg tat cct aat gaa tat ttt cct cat 2208
Gln Gly Arg Pro Cys Lys Asn Met Tyr Pro Asn Glu Tyr Phe Pro His
725 730 735
gga ata aca aat gga gct agt tgg tat aat gtg cca g ga gga atg cag 2256
Gly Ile Thr Asn Gly Ala Ser Trp Tyr Asn Val Pro Gly Gly Met Gln
740 745 750
gac tgg aac tat tta caa aca aat tgc ttt gaa gtg act att gaa cta 2304
Asp Trp Asn Tyr Leu Gln Thr Asn Cys Phe Glu Val Thr Ile Glu Leu
755 760 765
ggt tgt gtg aaa tat cca ctt gag aaa gag ctg cca aac ttt tgg gaa 2352
Gly Cys Val Lys Tyr Pro Leu Glu Lys Glu Leu Pro Asn Phe Trp Glu
770 775 780
cag aat cga aga tca cta atc cag ttt atg aaa cag gtt cat cag ggc 2400
Gln Asn Arg Arg Ser Leu Ile Gln Phe Met Lys Gln Val His Gln Gly
785 790 795 800
gtc aga gga ttt gtt cta gat gcc aca gat ggc agg ggt ata tta aat 2448
Val Arg Gly Phe Val Leu Asp Ala Thr Asp Gly Arg Gly Ile Leu Asn
805 810 815
gcc acc att agt gtt gct gag att aat cac cca gtg act act tac aaa 2496
Ala Thr Ile Ser Val Ala Glu Ile Asn His Pro Val Thr Thr Tyr Lys
820 825 830
act gga gat tac tgg cgt ctc ttg gtt cca gga act tat aaa atc aca 2544
Thr Gly Asp Tyr Trp Arg Leu Leu Val Pro Gly Thr Tyr Lys Ile Thr
835 840 845
gca tct gct cga gg g tat aat cca gtt acc aag aat gtg act gtc aag 2592
Ala Ser Ala Arg Gly Tyr Asn Pro Val Thr Lys Asn Val Thr Val Lys
850 855 860
agt gaa ggc gct att cag gtc aac ttc aca ctt gtt cga tcc tca aca 2640
Ser Glu Gly Ala Ile Gln Val Asn Phe Thr Leu Val Arg Ser Ser Thr
865 870 875 880
gat tca aac aat gaa tca aag aaa gga aaa ggg gct agc agc agc acc 2688
Asp Ser Asn Asn Glu Ser Lys Lys Gly Lys Gly Ala Ser Ser Ser Thr
885 890 895
aat gat gcc agt gat cca act act aaa gag ttt gaa act tta att aaa 2736
Asn Asp Ala Ser Asp Pro Thr Thr Lys Glu Phe Glu Thr Leu Ile Lys
900 905 910
gac ctt tca gcg gag aat ggt ttg gaa agc ctc atg tta cgc tcc tcc 2784
Asp Leu Ser Ala Glu Asn Gly Leu Glu Ser Leu Met Leu Arg Ser Ser
915 920 925
tca aat ctg gct ctg gct ctt tat cga tac cat tcc tac aaa gac tta 2832
Ser Asn Leu Ala Leu Ala Leu Tyr Arg Tyr His Ser Tyr Lys Asp Leu
930 935 940
tca gag ttt ctg aga gga ctt gta atg aac tat cca cat att aca aat 2880
Ser Glu Phe Leu Arg Gly Leu Val Met Asn Tyr Pro His Ile Thr Asn
945 950 955 960
ctt acc aa t ttg gga cag agc act gaa tat cgt cac att tgg tcc ctt 2928
Leu Thr Asn Leu Gly Gln Ser Thr Glu Tyr Arg His Ile Trp Ser Leu
965 970 975
gaa atc tcc aat aag ccc aat gta tct gag cct gaa gaa cca aag att 2976
Glu Ile Ser Asn Lys Pro Asn Val Ser Glu Pro Glu Glu Pro Lys Ile
980 985 990
cgt ttt gtt gct ggt atc cat gga aat gcg cca gtt gga act gaa ctg 3024
Arg Phe Val Ala Gly Ile His Gly Asn Ala Pro Val Gly Thr Glu Leu
995 1000 1005
ctt ttg gct ctg gca gaa ttt ctc tgc ctg aac tac aaa aag aac 3069
Leu Leu Ala Leu Ala Glu Phe Leu Cys Leu Asn Tyr Lys Lys Asn
1010 1015 1020
cca gct gtt acc caa ttg gtt gac agg act agg att gtg att gtc 3114
Pro Ala Val Thr Gln Leu Val Asp Arg Thr Arg Ile Val Ile Val
1025 1030 1035
cct tct cta aat cca gat ggg cga gag aga gct caa gag aaa gac 3159
Pro Ser Leu Asn Pro Asp Gly Arg Glu Arg Ala Gln Glu Lys Asp
1040 1045 1050
tgt act tca aaa ata gga caa aca aat gct cgt ggc aaa gat ttg 3204
Cys Thr Ser Lys Ile Gly Gln Thr Asn Ala Arg Gly Lys Asp Leu
1055 1060 1065
gat aca gac ttc aca a at aat gcc tcc caa cct gag acc aaa gcc 3249
Asp Thr Asp Phe Thr Asn Asn Ala Ser Gln Pro Glu Thr Lys Ala
1070 1075 1080
atc att gaa aat ttg att caa aaa cag gac ttt agt ctt tct gtt 3294
Ile Ile Glu Asn Leu Ile Gln Lys Gln Asp Phe Ser Leu Ser Val
1085 1090 1095
gcc tta gat ggt ggt tcc atg ctg gtc aca tat cct tat gac aag 3339
Ala Leu Asp Gly Gly Ser Met Leu Val Thr Tyr Pro Tyr Asp Lys
1100 1105 1110
cca gta cag aca g tg gaa aat aaa gag act ctg aag cat ttg gca 3384
Pro Val Gln Thr Val Glu Asn Lys Glu Thr Leu Lys His Leu Ala
1115 1120 1125
tct ctt tat gca aat aat cat cca tcc atg cac atg ggt cag ccc 3429
Ser Leu Tyr Ala Asn Asn His Pro Ser Met His Met Gly Gln Pro
1130 1135 1140
agt tgc cca aat aaa tca g at gag aat att cca gga gga gta atg 3474
Ser Cys Pro Asn Lys Ser Asp Glu Asn Ile Pro Gly Gly Val Met
1145 1155
cgt gga gca gaa tgg cat agt cac ctg ggc agc atg aag gattatagtg 3523
Arg Gly Ala Glu Trp His Ser His Leu Gly Ser Met Lys
1160 1165 1170
tca cct atg gcc att gtc cgg aaa tca cag tat aca caa gct gct 3568
Ser Pro Met Ala Ile Val Arg Lys Ser Gln Tyr Thr Gln Ala Ala
1175 1180 1185
gtt act ttc cta gtg ctg cac gac tcc ctt cct tgt ggg cag aca 3613
Val Thr Phe Leu Val Leu His Asp Ser Leu Pro Cys Gly Gln Thr
1190 1195 1200
ata aga gat ctc ttc tta gta tgt tag tgg ag g ttc aca agg gag 3658
Ile Arg Asp Leu Phe Leu Val Cys Trp Arg Phe Thr Arg Glu
1205 1210 1215
ttc atg gat ttg tta aag ata aga ctg gaa agc caa tct cta aag 3703
Phe Met Asp Leu Leu Lys Ile Arg Leu Glu Ser Gln Ser Leu Lys
1220 1225 1230
cag tca ttg tac tta atg aag gaa taa agg tac aaa caa aag agg 3748
Gln Ser Leu Tyr Leu Met Lys Glu Arg Tyr Lys Gln Lys Arg
1235 1240
gag gtt att tcc atg tac tct tag cgc cag gtg tcc ata aca tta 3793
Glu Val Ile Ser Met Tyr Ser Arg Gln Val Ser Ile Thr Leu
1245 1250 1255
ttg cca tcg ctg atg ggt acc agc aac aac att cac ag g tct ttg 3838
Leu Pro Ser Leu Met Gly Thr Ser Asn Asn Ile His Arg Ser Leu
1260 1265 1270
tgc atc atg atg cag cta gtt ctg tgg tga tag tct ttg aca cag 3883
Cys Ile Met Met Gln Leu Val Leu Trp Ser Leu Thr Gln
1275 1280 1285
ata acc gga tat ttg gtt tgc caa ggg agc ttg tgg taa ctg tat 3928
Ile Thr Gly Tyr Leu Val Cys Gln Gly Ser Leu Trp Leu Tyr
1290 1295 1300
cag gtg cta cta tgt cgg cat tga tcc taa cag ctt gca tta ttt ggt 3976
Gln Val Leu Leu Cys Arg His Ser Gln Leu Ala Leu Phe Gly
1305 1310
gca tct gct caa tca agt cta ata gac aca agg atg gct ttc atc 4021
Ala Ser Ala Gln Ser Ser Leu Ile Asp Thr Arg Met Ala Phe Ile
1315 1320 1325
ggc tca ggc agc atc atg atg agt atg aag atg aaa ttc gca tga 4066
Gly Ser Gly Ser Ile Met Met Ser Met Lys Met Lys Phe Ala
1330 1335 1340
tgt cta ccg gct cca aga agt ccc tcc taa gcc atg agt tcc agg 4111
Cys Leu Pro Ala Pro Arg Ser Pro Ser Ala Met Ser Ser Arg
1345 1350 1355
atg aaa cag aca ctg aag agg aaa cat tat att cta gca aac att 4156
Met Lys Gln Thr Leu Lys Arg Lys His Tyr Ile Leu Ala Asn Ile
1360 1365 1370
gaa aaa cac att ttg cat atc tcc cag cat aag tac caa gca aaa 4201
Glu Lys His Ile Leu His Ile Ser Gln His Lys Tyr Gln Ala Lys
1375 1380 1385
ttacag ttc ctc ttg gga gaa cac tgc att aag aag aga gac tct 4246
Leu Gln Phe Leu Leu Gly Glu His Cys Ile Lys Lys Arg Asp Ser
1390 1395 1400
ctt gct tct tca aag agc ttt ggg aaa tta aat tgc taa att tgt 4291
Leu Ala Ser Ser Lys Ser Phe Gly Lys Leu Asn Cys Ile Cys
1405 1410 1415
att ctc tgt gaa ttt cac tgg cag ttt tga act tcc ctt cct taa 4336
Ile Leu Cys Glu Phe His Trp Gln Phe Thr Ser Leu Pro
1420 1425
agt act cta aac ctt taa aaa aaa atc tga ttt atg cag cag aga 4381
Ser Thr Leu Asn Leu Lys LysIle Phe Met Gln Gln Arg
1430 1435 1440
tgg gac agc cac ttt ttc ttt tta att taa gat gag cta ttt gga 4426
Trp Asp Ser His Phe Phe Phe Leu Ile Asp Glu Leu Phe Gly
1445 1450 1455
gct tat gta ata atg gca taa agc caa cta gag gat gtt gta ttt 4471
Ala Tyr Val Ile Met Ala Ser Gln Leu Glu Asp Val Val Phe
1460 1465 1470
tgc aca tca gat gtt tac tag tgg ctt tag tat ttt tct ttg ttt taa 4519
Cys Thr Ser Asp Val Tyr Trp Leu Tyr Phe Ser Leu Phe
1475 1480
atg gcc aaa aga atc cag aaa cat taa ggc agg gac agc agt cag 4564
Met Ala Lys Arg Ile Gln Lys His Gly Arg Asp Ser Ser Gln
1485 1490 1495
aat cga cat aaa gct tta aaa act caa ggt ttt ttc aac cta ctg 4609
Asn Arg His Lys Ala Leu Lys Thr Gln Gly Phe Phe Asn Leu Leu
1500 1505 1510
agg agt act ttt ctc tag ttg tta aat agc tgg agt ttt tct tat 4654
Arg Ser Thr Phe Leu Leu Leu Asn Ser Trp Ser Phe Ser Tyr
1515 1520 1525
tca ggt tta atg gag gtt gaa ttg att ttt aaa cac ata taa cag 4699
Ser Gly Leu Met Glu Val Glu Leu Ile Phe Lys His Ile Gln
1530 1535 1540
tag gaa atg aat aaa tgg gct tct gca ttt ggc ttt cta cct gtt 4744
Glu Met Asn Lys Trp Ala Ser Ala Phe Gly Phe Leu Pro Val
1545 1550
cca agg cta gat cgg aac tgg tag act acg ctg taa gca gga ttt 4789
Pro Arg Leu Asp Arg Asn Trp Thr Thr Leu Ala Gly Phe
1555 1560 1565
cac tac ctc tct taa ggt tta gca aac ttc taa ata gcc cat ttt 4834
His Tyr Leu Ser Gly Leu Ala Asn Phe Ile Ala His Phe
1570 1575 1580
aag gga gaa ctt act aac ttt att gtg aaa ggt cta aat gcc cac 4879
Lys Gly Glu Leu Thr Asn Phe Ile Val Lys Gly Leu Asn Ala His
1585 1590 1595
ttg aat gaa gct gag aga gag atc tag caa aag cta aaa ctc atg 4924
Leu Asn Glu Ala Glu Arg Glu Ile Gln Lys Leu Lys Leu Met
1600 1605
ttg tct atc ttt gaa ctt ggt aaa aac cca cag gtg ctg ctg ctt 4969
Leu Ser Ile Phe Glu Leu Gly Lys Asn Pro Gln Val Leu Leu Leu
1610 1615 1620
ata tct gtg aag cac tag ctt att cta gga atg cct gat tct tta 5014
Ile Ser Val Lys His Leu Ile Leu Gly Met Pro Asp Ser Leu
1625 1630 1635
ata ttg cct aaa tcg gaa cct ttt tct atg ttg cac aca tgg ttt 5059
Ile Leu Pro Lys Ser Glu Pro Phe Ser Met Leu His Thr Trp Phe
1640 1645 1650
tca gat gac cca gcc atc tac aag atc tga att cta ctg aaa ata 5104
Ser Asp Asp Pro Ala Ile Tyr Lys Ile Ile Leu Leu Lys Ile
1655 1660 1665
tct aga aat gtg gaa gag acc tac ttg cac att ctt aac ctg tat 5149
Ser Arg Asn Val Glu Glu Thr Tyr Leu His Ile Leu Asn Leu Tyr
1670 1675 1680
ttg aac aca aaa tat cta tac ttc atg ctc cag ccc aag cct ata 5194
Leu Asn Thr Lys Tyr Leu Tyr Phe Met Leu Gln Pro Lys Pro Ile
1685 1690 1695
ccc tgt aat agc ata cta tta ttg aaa tcg ctt gac cgg tct tgt 5239
Pro Cys Asn Ser Ile Leu Leu Leu Lys Ser Leu Asp Arg Ser Cys
1700 1705 1710
tca cat agg cct ctg gga gtg att tgg ttc ttt gcc cta atg ttt 5284
Ser His Arg Pro Leu Gly Val Ile Trp Phe Phe Ala Leu Met Phe
1715 1720 1725
cat ttg acg gtc tct ttt tga tca acc aat ttt tct aaa agt tca 5329
His Leu Thr Val Ser Phe Ser Thr Asn Phe Ser Lys Ser Ser
1730 1735 1740
gtc gaa agc ttt taa gta tag ctt cct ccc ttg aaa aaa aat gta 5374
Val Glu Ser Phe Val Leu Pro Pro Leu Lys Lys Asn Val
1745 1750
aac tat gac tgc tga gtg ata aaa cac tgt ggt gtg aaa gtg tca 5419
Asn Tyr Asp Cys Val Ile Lys His Cys Gly Val Lys Val Ser
1755 1760 1765
tct tca ctg cca atc agg caa aga ccg gaa aga ttt gca ttt tat 5464
Ser Ser Leu Pro Ile Arg Gln Arg Pro Glu Arg Phe Ala Phe Tyr
1770 1775 1780
tat gtc tgt ctt atc atg caa tgg aaa tga tgc ttt ttg taa gta 5509
Tyr Val Cys Leu Ile Met Gln Trp Lys Cys Phe Leu Val
1785 1790 1795
tgc atc tta cca atg atg taa cgg ttt aat acc ttt gaa tgt ttt 5554
Cys Ile Leu Pro Met Met Arg Phe Asn Thr Phe Glu Cys Phe
1800 1805 1810
aat aac caa gtt gct gct gaa ctt ata cta aat cag ggg acc aaa 5599
Asn Asn Gln Val Ala Ala Glu Leu Ile Leu Asn Gln Gly Thr Lys
1815 1820 1825
aaa ctt gct ctt atc ttc tca aat tgt att cta tat cca tta atg 5644
Lys Leu Ala Leu Ile Phe Ser Asn Cys Ile Leu Tyr Pro Leu Met
1830 1835 1840
tat cag tta tcc caa agc ctt cag gtg gag ggg ttt acc acc ttc 5689
Tyr Gln Leu Ser Gln Ser Leu Gln Val Glu Gly Phe Thr Thr Phe
1845 1850 1855
cta ggt cgt tca acc agg ttt tgt gag gaa tgc att caa agt ggc 5734
Leu Gly Arg Ser Thr Arg Phe Cys Glu Glu Cys Ile Gln Ser Gly
1860 1865 1870
ttt ata aaa gaa gat ttt ctt tag caa gaa taa tga ggt cat gtc att 5782
Phe Ile Lys Glu Asp Phe Leu Gln Glu Gly His Val Ile
1875 1880
tgt taa taa gta tct gtg ata aat ccg tgg ttc aag gtt aag cca 5827
Cys Val Ser Val Ile Asn Pro Trp Phe Lys Val Lys Pro
1885 1890 1895
ttc tgg tat tct ggt att agc aac tgt aaa ttc tgc cac ctc ata 5872
Phe Trp Tyr Ser Gly Ile Ser Asn Cys Lys Phe Cys His Leu Ile
1900 1905 1910
cat gga aca gag ctt gtg gga tgc taa tag tta gtg aag tat aca tga 5920
His Gly Thr Glu Leu Val Gly Cys Leu Val Lys Tyr Thr
1915 1920
ttt aat ttc taa taa tct tta tgt ttt ctt taa gga tgg tgg tgt 5965
Phe Asn Phe Ser Leu Cys Phe Leu Gly Trp Trp Cys
1925 1930 1935
att gct ctt ttt cag ctt tat ttt taa gag tac agt cag gaa acc 6010
Ile Ala Leu Phe Gln Leu Tyr Phe Glu Tyr Ser Gln Glu Thr
1940 1945 1950
aac aag ggg cct aag agt ggc tgc ccc tgc ttg gga cat tac agc 6055
Asn Lys Gly Pro Lys Ser Gly Cys Pro Cys Leu Gly His Tyr Ser
1955 1960 1965
aag tga aac aaa gtt aat gtg aca agc ttt gct ttg tta tca ttg 6100
Lys Asn Lys Val Asn Val Thr Ser Phe Ala Leu Leu Ser Leu
1970 1975
gtc ttc act aga gga tac ctt tta cat gta ctt ctc tct tgg atc 6145
Val Phe Thr Arg Gly Tyr Leu Leu His Val Leu Leu Ser Trp Ile
1980 1985 1990
aaa tat gtc ttt aac tgt aca tct cag tgg ctg gag gcc atg cct 6190
Lys Tyr Val Phe Asn Cys Thr Ser Gln Trp Leu Glu Ala Met Pro
1995 2000 2005
ttt aag cat gtg taa aat ttt taa aga aat gaa cat aca cat agt 6235
Phe Lys His Val Asn Phe Arg Asn Glu His Thr His Ser
2010 2015 2020
tat ttt agt aat att tcc tga aag aaa aac caa att ctg cta taa 6280
Tyr Phe Ser Asn Ile Ser Lys Lys Asn Gln Ile Leu Leu
2025 2030 2035
gtc ttg atc ttc aat gaa ctt tta aat aat gca ttt agc tgg aaa 6325
Val Leu Ile Phe Asn Glu Leu Leu Asn Asn Ala Phe Ser Trp Lys
2040 2045 2050
aca aga ctt tcc cag ctt gta tta cct aga agc gtg aat gta tag 6370
Thr Arg Leu Ser Gln Leu Val Leu Pro Arg Ser Val Asn Val
2055 2060
gat acc tga cta cta aga cta tat tct cag ccc tgc cct gtc ttt 6415
Asp Thr Leu Leu Arg Leu Tyr Ser Gln Pro Cys Pro Val Phe
2065 2070 2075
tat ttg cgg gtc taa tct aat att aga ata tat taa ccg ctt aag 6460
Tyr Leu Arg Val Ser Asn Ile Arg Ile Tyr Pro Leu Lys
2080 2085 2090
gca ttg aag cca tat ggg atg ggg aat gca ttt ctt cag tgt ttc 6505
Ala Leu Lys Pro Tyr Gly Met Gly Asn Ala Phe Leu Gln Cys Phe
2095 2100 2105
tcc gag aga ctt tcc att tcc ttg gag tta tgg cgg caa gta agt 6550
Ser Glu Arg Leu Ser Ile Ser Leu Glu Leu Trp Arg Gln Val Ser
2110 2115 2120
atc ata gta tta aga aat ttg cct aaa tct gag ttg tgc ctt tct 6595
Ile Ile Val Leu Arg Asn Leu Pro Lys Ser Glu Leu Cys Leu Ser
2125 2130 2135
tta ctc aca agg cat ggg ctt tgt cct ggt gat cag ttt gta agc 6640
Leu Leu Thr Arg His Gly Leu Cys Pro Gly Asp Gln Phe Val Ser
2140 2145 2150
ctt ctt cct tcc cag ctc ctt aat aaa agc aaa gtg att gag tag 6685
Leu Leu Pro Ser Gln Leu Leu Asn Lys Ser Lys Val Ile Glu
2155 2160 2165
gta atg ttc aaa gtg tct gcc tgt gta cat gta ctt gta ttg att 6730
Val Met Phe Lys Val Ser Ala Cys Val His Val Leu Val Leu Ile
2170 2175 2180
atg tag ttc agt aag atg tgc cca agt cat ttc aga aag aaa gac 6775
Met Phe Ser Lys Met Cys Pro Ser His Phe Arg Lys Lys Asp
2185 2190
cct tca gtt ttg atg cat ttt gct gaa cac ttg ggt agt gag tgg 6820
Pro Ser Val Leu Met His Phe Ala Glu His Leu Gly Ser Glu Trp
2195 2200 2205
gat cct atc cag ttg agg aat gct tgc aat gct cat tga agg gat 6865
Asp Pro Ile Gln Leu Arg Asn Ala Cys Asn Ala His Arg Asp
2210 2215 2220
ttg ctt tgg gac ttt gtc atc ttc cag aaa gga aac ata ttg tat 6910
Leu Leu Trp Asp Phe Val Ile Phe Gln Lys Gly Asn Ile Leu Tyr
2225 2230 2235
att tgg ccc agt gtg att gat tgc ttt atc ttt ggt aac ttt tac 6955
Ile Trp Pro Ser Val Ile Asp Cys Phe Ile Phe Gly Asn Phe Tyr
2240 2245 2250
ttg aat ggg att tgc tga att aat gac tat tga att taa aac taa 7000
Leu Asn Gly Ile Cys Ile Asn Asp Tyr Ile Asn
2255 2260
tta tga gtt gac aaa taa ata aaa ggt agt gtt tat gtc tga gct 7045
Leu Val Asp Lys Ile Lys Gly Ser Val Tyr Val Ala
2265 2270 2275
tat tgt gtt tga gct aac acc agg tta ctc agt aac cat gac ctg 7090
Tyr Cys Val Ala Asn Thr Arg Leu Leu Ser Asn His Asp Leu
2280 2285 2290
ctc ctc cat ttc cat tta ttc tca aca tta aat agt ttt atc ttg 7135
Leu Leu His Phe His Leu Phe Ser Thr Leu Asn Ser Phe Ile Leu
2295 2300 2305
ttg ttg cca gaa atg cac ttg tgc cag gta ttg tcc ctg ctg tat 7180
Leu Leu Pro Glu Met His Leu Cys Gln Val Leu Ser Leu Leu Tyr
2310 2315 2320
gaa aag ctt ctt ggc aat gaa ttc tgt aat agt gcc cta cat tat 7225
Glu Lys Leu Leu Gly Asn Glu Phe Cys Asn Ser Ala Leu His Tyr
2325 2330 2335
ggt ttt ctg gtg gaa ttg ttt taa cag tga caa ccc agg att tcc aat 7273
Gly Phe Leu Val Glu Leu Phe Gln Gln Pro Arg Ile Ser Asn
2340 2345
ata ttt ttg ttt tat tgt tat tac caa aaa ttc cac tat gat tga 7318
Ile Phe Leu Phe Tyr Cys Tyr Tyr Gln Lys Phe His Tyr Asp
2350 2355 2360
tgt tca gtg att ttc tat agc aac ttt ttt ggt aac tct ttg ggt 7363
Cys Ser Val Ile Phe Tyr Ser Asn Phe Phe Gly Asn Ser Leu Gly
2365 2370 2375
ttc tga ttt gtt tta gct aaa att ttg ggg ata tga ttt ggg tct 7408
Phe Phe Val Leu Ala Lys Ile Leu Gly Ile Phe Gly Ser
2380 2385 2390
ttg att aat gtc agc tga act tgg att tct agt tca tga aga aat 7453
Leu Ile Asn Val Ser Thr Trp Ile Ser Ser Ser Arg Asn
2395 2400
ctc tcc caa tac cca ttt atc cta ttt tta gca ata att cgt taa 7498
Leu Ser Gln Tyr Pro Phe Ile Leu Phe Leu Ala Ile Ile Arg
2405 2410 2415
tga ttc cac ttg att ttc aga ata ttg tcc tgg ttg att ttg att 7543
Phe His Leu Ile Phe Arg Ile Leu Ser Trp Leu Ile Leu Ile
2420 2425 2430
tga cag cat aca tta tga aat ttg aaa gta ggt tac cat ttt gag 7588
Gln His Thr Leu Asn Leu Lys Val Gly Tyr His Phe Glu
2435 2440 2445
gca gtt gga tat aaa tta tgt aaa tat gta tga tta tga ttt tta taa 7636
Ala Val Gly Tyr Lys Leu Cys Lys Tyr Val Leu Phe Leu
2450 2455
atg gca taa cat gag tgt act aac tac ctt cta tgc tgg cca tgc 7681
Met Ala His Glu Cys Thr Asn Tyr Leu Leu Cys Trp Pro Cys
2460 2465 2470
tac aga ttt tct gga ggt atg aca ata gta ttt ttt tat gct cag 7726
Tyr Arg Phe Ser Gly Gly Met Thr Ile Val Phe Phe Tyr Ala Gln
2475 2480 2485
att aaa aat cag ctt ttc acc tct cca gtt ttt cca agt gat act 7771
Ile Lys Asn Gln Leu Phe Thr Ser Pro Val Phe Pro Ser Asp Thr
2490 2495 2500
ccc agt tct aga gca atc tac agc tgt tta tgt gag gtg ccc aac 7816
Pro Ser Ser Arg Ala Ile Tyr Ser Cys Leu Cys Glu Val Pro Asn
2505 2510 2515
acc cat tca tct caa gtg ctt cag tct ttg gtt tat ttc atg cac 7861
Thr His Ser Ser Gln Val Leu Gln Ser Leu Val Tyr Phe Met His
2520 2525 2530
tgt gcc ttc aaa atg aaa ttt tta aaa ggg act tta aat gaa gtt 7906
Cys Ala Phe Lys Met Lys Phe Leu Lys Gly Thr Leu Asn Glu Val
2535 2540 2545
gaa tag tag ttt tta aaa gtc aat ttg taa ttt atg tga aat cta act 7954
Glu Phe Leu Lys Val Asn Leu Phe Met Asn Leu Thr
2550 2555
gta atg agg tcc ttt ctg ttt ttt ata tgt aaa cag atc tac taa 7999
Val Met Arg Ser Phe Leu Phe Phe Ile Cys Lys Gln Ile Tyr
2560 2565 2570
tcc tgt ata aaa gtt att tta cga tg 8025
Ser Cys Ile Lys Val Ile Leu Arg
2575 2580
SEQUENCE LISTING5
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_144782
<160>1
<170>PatentIn version 3.5
<210>1
<211>2558
<212>DNA
<213>Homo sapiens
<220>
<221>STS
<222>(80)..(312)
<220>
<221>transit_peptide
<222>(296)..(328)
<220>
<221>misc_feature
<222>(1139)..(1140)
<220>
<221>STS
<222>(1688)..(2398)
<220>
<221>STS
<222>(1921)..(2176)
<220>
<221>STS
<222>(2156)..(2430)
<220>
<221>STS
<222>(2348)..(2493)
<220>
<221>polyA_signal
<222>(2509)..(2514)
<220>
<221>polyA_site
<222>(2533)..(2533)
<400>1
atcgatgccc cgcccccgcc ccacagccaa cctcccgggc accgttgccc gcccggggcc 60
cgctaccggc ccaggccccg cctcgcgagt cctcctcccc gggtgcctgc ccgcagcccg 120
ctcggcccag agggtgggcg cggggctgcc tctaccggct ggcggctgta actcagcgac 180
cttggcccga aggctctagc aaggacccac cgaccccagc cgcggcggcg gcggcgcgga 240
ctttgcccgg tgtgtggggc ggagcggact gcgtgtccgc ggacgggcag cgaagatgtt 300
agccttcgct gccaggaccg tggtgaagcc tctgggcttc ctgaagccct tctccttgat 360
gaaggcttcc agccgcttca aggcacacca ggatgcactg ccacggctgc ccgtgccccc 420
tctccagcag tccctggacc actacctgaa ggcgctgcag cccatcgtga gtgaggagga 480
gtgggcccac accaagcagc tggtggatga gtttcaggcc tcaggaggtg taggggagcg 540
cctgcagaag gggctggagc gtcgggccag gaagacggag aactggctgt ctgagtggtg 600
gctcaagacc gcctacctcc agtaccgcca gcctgtggtc atctactcga gcccaggcgt 660
gatgctaccc aagcaggact tcgtggacct gcagggtcag ctccgatttg ctgccaaact 720
cattgagggt gtgttggatt tcaaggtcat gattgacaac gagaccctgc ccgtggagta 780
cctggggggg aagccactgt gcatgaacca gtactatcag atcttgtcct cctgccgagt 840
gccgggcccc aagcaggaca cagtcagcaa cttcagcaag accaagaagc ctcccacgca 900
catcaccgtg gtacacaact accagttttt tgagctggat gtgtaccaca gtgacgggac 960
acccctcact gcggatcaga tctttgtgca gctggagaag atctggaact catccctaca 1020
gaccaacaag gagcctgtgg gcatcctcac ctccaaccac cgcaactcct gggccaaggc 1080
atacaacacc ctcatcaaag acaaggtgaa ccgggattcc gtgcgctcca tccagaagaa 1140
acccgagctt gtgcggtctc ccatggtgcc cctgcccatg cccaagaagc tgcggttcaa 1200
catcaccccc gagatcaaga gcgacatcga gaaggccaag cagaacctca gcatcatgat 1260
ccaggacctg gatatcaccg tgatggtgtt ccaccatttt ggaaaagact tccccaagtc 1320
ggagaagcta agcccagatg ccttcatcca gatggctttg cagctggcct actacaggat 1380
ctacggacag gcatgtgcca cctatgaaag tgcctccctg cgcatgtttc acctgggccg 1440
caccgacacc atccgctcgg cttccatgga ctcactcacc tttgtcaagg ccatggatga 1500
ctccagcgtc acggagcacc agaaggtgga gctgctgcgg aaggccgtgc aggcccaccg 1560
aggctacacc gaccgggcca tccgcgggga ggcctttgat cgacacctgc tgggcctgaa 1620
gctgcaggcc atcgaggacc tggtgagcat gcccgacatc ttcatggaca cctcctacgc 1680
catcgccatg cacttccacc tctccaccag ccaggtccct gccaagacag actgtgtcat 1740
gttcttcggg cccgtggtcc ccgacggcta cggtgtctgc tataacccca tggaggccca 1800
catcaacttc tccctgtcgg cctacaacag ctgcgcggag accaacgccg cccgcctggc 1860
gcattacctg gagaaggcgc tcctggacat gcgtgccctg ctgcagagcc acccccgggc 1920
caagctctga gcccctagga ctcaggcctg ccaatgccac agccaagccc accctgggat 1980
gggccaccca ccagggctca gctccttggt tccctcttcc ttggttccct cttccctggt 2040
ccccccaaat ctactgagcc acggaccgca tcctccaggg ggcctgcagg ccccagccaa 2100
gtgccttccg tgggtcatcc cagcacctgc cagggcccga cctggggctg agtgcagagg 2160
ctgagcagga cgttaggccc gggcccctgg cacgtcctcc accggtgcct cctctgggga 2220
agggaaccag ccctccagag caggagactg gcaagagctc tttgtctcac cagctcagcc 2280
ccggccactc cctgccaact ccatgaccag gccaccatct gtaccctgct tcccaaactc 2340
ccaggacctg gagacaggat tgtctggggc cgaggggcca gggtgtgagg tttcacctcc 2400
gttgcggctg tgctcctgtg gataacattg ctagcgagcc gcctctggtt ccactcagct 2460
tggttcctgc ccccgccctg ctgtatgata ttaatgtgga aggtcatcaa taaaggggaa 2520
ttgtgttggt gaaaaaaaaa aaaaaaaaaa aaaaaaaa 2558
SEQUENCE LISTING6
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_001896
<160>1
<170>PatentIn version 3.5
<210>1
<211>1674
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(246)
<220>
<221>exon
<222>(247)..(358)
<220>
<221>exon
<222>(359)..(460)
<220>
<221>exon
<222>(461)..(511)
<220>
<221>exon
<222>(512)..(571)
<220>
<221>exon
<222>(572)..(655)
<220>
<221>exon
<222>(656)..(766)
<220>
<221>exon
<222>(767)..(868)
<220>
<221>STS
<222>(783)..(987)
<220>
<221>exon
<222>(869)..(969)
<220>
<221>exon
<222>(970)..(1118)
<220>
<221>exon
<222>(1119)..(1212)
<220>
<221>exon
<222>(1213)..(1659)
<220>
<221>STS
<222>(1293)..(1569)
<220>
<221>STS
<222>(1376)..(1558)
<400>1
gcg gcc gcc cgc cgc cgc gct cct cct cct cct cct cca gcg ccc ggc 48
Ala Ala Ala Arg Arg Arg Ala Pro Pro Pro Pro Pro Pro Ala Pro Gly
1 5 10 15
ggc ccg ctg cct cct ccg ccc gac gcc ccg cgt ccc ccg ccg cgc cgc 96
Gly Pro Leu Pro Pro Pro Pro Asp Ala Pro Arg Pro Pro Pro Arg Arg
20 25 30
cgc cgc cac cct ctg cgc ccc gcg ccg ccc ccc ggt ccc gcc cgc cat 144
Arg Arg His Pro Leu Arg Pro Ala Pro Pro Pro Gly Pro Ala Arg His
35 40 45
gcc cgg ccc ggc cgc ggg cag cag ggc ccg ggt cta cgc cga ggt gaa 192
Ala Arg Pro Gly Arg Gly Gln Gln Gly Pro Gly Leu Arg Arg Gly Glu
50 55 60
cag tct gag gag ccg cga gta ctg gga cta cga ggc tca cgt ccc gag 240
Gln Ser Glu Glu Pro Arg Val Leu Gly Leu Arg Gly Ser Arg Pro Glu
65 70 75 80
ctg ggg taa tca aga tga tta cca act ggt tcg aaa act tgg tcg ggg 288
Leu Gly Ser Arg Leu Pro Thr Gly Ser Lys Thr Trp Ser Gly
85 90
aaa ata tag tga agt att tga ggc cat taa tat cac caa caa tga gag 336
Lys Ile Ser Ile Gly His Tyr His Gln Gln Glu
95 100 105
agt ggt tgt aaa aat cct gaa g cc agt gaa gaa aaa gaa gat aaa acg 384
Ser Gly Cys Lys Asn Pro Glu Ala Ser Glu Glu Lys Glu Asp Lys Thr
110 115 120
aga ggt taa gat tct gga gaa cct tcg tgg tgg aac aaa tat cat taa 432
Arg Gly Asp Ser Gly Glu Pro Ser Trp Trp Asn Lys Tyr His
125 130 135
gct gat tga cac tgt aaa gga ccc cgt g tc aaa gac acc agc ttt ggt 480
Ala Asp His Cys Lys Gly Pro Arg Val Lys Asp Thr Ser Phe Gly
140 145 150
att tga ata tat caa taa tac aga ttt taa g ca act cta cca gat cct 528
Ile Ile Tyr Gln Tyr Arg Phe Ala Thr Leu Pro Asp Pro
155 160
gac aga ctt tga tat ccg gtt tta tat gta tga act act taa a gc tct 576
Asp Arg Leu Tyr Pro Val Leu Tyr Val Thr Thr Ser Ser
165 170
gga tta ctg cca cag caa ggg aat cat gca cag gga tgt gaa acc tca 624
Gly Leu Leu Pro Gln Gln Gly Asn His Ala Gln Gly Cys Glu Thr Ser
180 185 190
caa tgt cat gat aga tca cca aca gaa aaa g ct gcg act gat aga ttg 672
Gln Cys His Asp Arg Ser Pro Thr Glu Lys Ala Ala Thr Asp Arg Leu
195 200 205
ggg tct ggc aga att cta tca tcc tgc tca gga gta caa tgt tcg tgt 720
Gly Ser Gly Arg Ile Leu Ser Ser Cys Ser Gly Val Gln Cys Ser Cys
210 215 220
agc ctc aag gta ctt caa ggg acc aga gct cct cgt gga cta tca g at 768
Ser Leu Lys Val Leu Gln Gly Thr Arg Ala Pro Arg Gly Leu Ser Asp
225 230 235
gta tga tta tag ctt gga cat gtg gag ttt ggg ctg tat gtt agc aag 816
Val Leu Leu Gly His Val Glu Phe Gly Leu Tyr Val Ser Lys
245 250
cat gat ctt tcg aag gga acc att ctt cca tgg aca gga caa cta tga 864
His Asp Leu Ser Lys Gly Thr Ile Leu Pro Trp Thr Gly Gln Leu
255 260 265
cca g ct tgt tcg cat tgc caa ggt tct ggg tac aga aga act gta tgg 912
Pro Ala Cys Ser His Cys Gln Gly Ser Gly Tyr Arg Arg Thr Val Trp
270 275 280 285
gta tct gaa gaa gta tca cat aga cct aga tcc aca ctt caa cga tat 960
Val Ser Glu Glu Val Ser His Arg Pro Arg Ser Thr Leu Gln Arg Tyr
290 295 300
cct ggg aca aca ttc acg gaa acg ctg gga aaa ctt tat cca tag tga 1008
Pro Gly Thr Thr Phe Thr Glu Thr Leu Gly Lys Leu Tyr Pro
305 310 315
gaa cag aca cct tgt cag ccc tga ggc cct aga tct tct gga caa act 1056
Glu Gln Thr Pro Cys Gln Pro Gly Pro Arg Ser Ser Gly Gln Thr
320 325 330
tct gcg ata cga cca tca aca gag act gac tgc caa aga ggc cat gga 1104
Ser Ala Ile Arg Pro Ser Thr Glu Thr Asp Cys Gln Arg Gly His Gly
335 340 345
gca ccc ata ctt ct a ccc tgt ggt gaa gga gca gtc cca gcc ttg tgc 1152
Ala Pro Ile Leu Leu Pro Cys Gly Glu Gly Ala Val Pro Ala Leu Cys
350 355 360
aga caa tgc tgt gct ttc cag tgg tct cac ggc agc acg atg aag act 1200
Arg Gln Cys Cys Ala Phe Gln Trp Ser His Gly Ser Thr Met Lys Thr
365 370 375
gga aag cga cgg gtc tgt tgc ggt tct ccc act ttt cca taa gca gaa 1248
Gly Lys Arg Arg Val Cys Cys Gly Ser Pro Thr Phe Pro Ala Glu
380 385 390
caa gaa cca aat caa acg tct taa cgc gta tag aga gat cac gtt ccg 1296
Glu Glu Pro Asn Gln Thr Ser Arg Val Arg Asp His Val Pro
395 400 405
tga gca gac aca aaa cgg tgg cag gtt tgg cga gca cga act aga cca 1344
Ala Asp Thr Lys Arg Trp Gln Val Trp Arg Ala Arg Thr Arg Pro
410 415 420
agc gaa ggg cag ccc acc acc gta tat caa acc tca ctt ccg aat gta 1392
Ser Glu Gly Gln Pro Thr Thr Val Tyr Gln Thr Ser Leu Pro Asn Val
425 430 435
aaa ggc tca ctt gcc ttt ggc ttc ctg ttg act tct tcc cga ccc aga 1440
Lys Gly Ser Leu Ala Phe Gly Phe Leu Leu Thr Ser Ser Arg Pro Arg
440 445 450
aag cat ggg gaa tgt gaa ggg tat gca gaa tgt tgt tgg tta ctg ttg 1488
Lys His Gly Glu Cys Glu Gly Tyr Ala Glu Cys Cys Trp Leu Leu Leu
455 460 465 470
ctc ccc gag ccc ctc aac tcg tcc cgt ggc cgc ctg ttt ttc cag caa 1536
Leu Pro Glu Pro Leu Asn Ser Ser Arg Gly Arg Leu Phe Phe Gln Gln
475 480 485
acc acg cta act agc tga cca cag act cca cag tgg ggg gac ggg cgc 1584
Thr Thr Leu Thr Ser Pro Gln Thr Pro Gln Trp Gly Asp Gly Arg
490 495 500
agt atg tgg cat ggc ggc agt tac ata tta tta ttt taa aag tat ata 1632
Ser Met Trp His Gly Gly Ser Tyr Ile Leu Leu Phe Lys Tyr Ile
505 510 515
tta ttg aat aaa agg ttt taa aag aaa aaaaaaaaaaa aaaaa 1674
Leu Leu Asn Lys Arg Phe Lys Lys
520
SEQUENCE LISTING7
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_003462
<160>1
<170>PatentIn version 3.5
<210>1
<211>2663
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(157)
<220>
<221>exon
<222>(158)..(303)
<220>
<221>exon
<222>(304)..(473)
<220>
<221>exon
<222>(474)..(652)
<220>
<221>exon
<222>(653)..(817)
<220>
<221>STS
<222>(653)..(817)
<220>
<221>exon
<222>(818)..(2649)
<220>
<221>STS
<222>(1639)..(1769)
<220>
<221>STS
<222>(2489)..(2621)
<220>
<221>polyA_signal
<222>(2628)..(2633)
<220>
<221>polyA_site
<222>(2649)..(2649)
<400>1
ggc ggt ttc cat ggt gac ggc aaa caa ggc cca cac tgg aca ggg cag 48
Gly Gly Phe His Gly Asp Gly Lys Gln Gly Pro His Trp Thr Gly Gln
1 5 10 15
ctg ctg ggt tgc tac tct cgc ctc cgc cat gat tcc gcc cgc aga ctc 96
Leu Leu Gly Cys Tyr Ser Arg Leu Arg His Asp Ser Ala Arg Arg Leu
20 25 30
ttt gct caa gta cga cac ccc agt gct ggt gag ccg gaa cac gga gaa 144
Phe Ala Gln Val Arg His Pro Ser Ala Gly Glu Pro Glu His Gly Glu
35 40 45
acg gag ccc caa g gc tcg gct act gaa agt cag ccc cca gca gcc tgg 192
Thr Glu Pro Gln Gly Ser Ala Thr Glu Ser Gln Pro Pro Ala Ala Trp
50 55 60
acc ttc agg ttc agc ccc aca gcc acc caa gac caa gct ccc ctc aac 240
Thr Phe Arg Phe Ser Pro Thr Ala Thr Gln Asp Gln Ala Pro Leu Asn
65 70 75 80
tcc ctg tgt ccc aga tcc tac aaa gca ggc aga aga aat ctt gaa tgc 288
Ser Leu Cys Pro Arg Ser Tyr Lys Ala Gly Arg Arg Asn Leu Glu Cys
85 90 95
cat act acc ccc aag gga gtg ggt gga aga cac gca gct atg gat cca 336
His Thr Thr Pro Lys Gly Val Gly Gly Arg His Ala Ala Met Asp Pro
100 105 110
gca ggt gtc cag cac ccc tag cac cag gat gga cgt ggt gca cct cca 384
Ala Gly Val Gln His Pro His Gln Asp Gly Arg Gly Ala Pro Pro
115 120 125
gga gca gtt aga ctt aaa gct gca gca gcg gca ggc cag gga aac agg 432
Gly Ala Val Arg Leu Lys Ala Ala Ala Ala Ala Gly Gln Gly Asn Arg
130 135 140
cat ctg ccc tgt ccg cag gga act cta ctc aca gtg ttt tg a tga gtt 480
His Leu Pro Cys Pro Gln Gly Thr Leu Leu Thr Val Phe Val
145 150 155
gat ccg gga ggt cac cat caa ctg tgc gga gag ggg gct gct gct gct 528
Asp Pro Gly Gly His His Gln Leu Cys Gly Glu Gly Ala Ala Ala Ala
160 165 170
gcg agt ccg gga cga gat ccg cat gac cat cgc tgc cta cca gac cct 576
Ala Ser Pro Gly Arg Asp Pro His Asp His Arg Cys Leu Pro Asp Pro
175 180 185 190
gta cga gag cag cgt ggc gtt tgg cat gag gaa ggc act gca ggc tga 624
Val Arg Glu Gln Arg Gly Val Trp His Glu Glu Gly Thr Ala Gly
195 200 205
gca ggg gaa gtc aga cat gga gag gaa a at cgc aga att gga gac gga 672
Ala Gly Glu Val Arg His Gly Glu Glu Asn Arg Arg Ile Gly Asp Gly
210 220
aaa gag aga cct gga gag gca agt gaa cga gca gaa ggc aaa atg tga 720
Lys Glu Arg Pro Gly Glu Ala Ser Glu Arg Ala Glu Gly Lys Met
225 230 235
agc cac tga gaa gcg gga gag cga gag gcg gca ggt gga gga gaa gaa 768
Ser His Glu Ala Gly Glu Arg Glu Ala Ala Gly Gly Gly Glu Glu
240 245 250
gca caa tga gga gat tca gtt cct gaa gcg aac aaa tca gca gct gaa g 817
Ala Gln Gly Asp Ser Val Pro Glu Ala Asn Lys Ser Ala Ala Glu
255 260 265
gc cca act gga agg cat tat tgc acc aaa gaa gtg ata att tcc aca 864
Gly Pro Thr Gly Arg His Tyr Cys Thr Lys Glu Val Ile Ile Ser Thr
270 275 280
tga tta att tcc aac aag aca ctt ggg agt tat tta ctg tgt tcc tct 912
Leu Ile Ser Asn Lys Thr Leu Gly Ser Tyr Leu Leu Cys Ser Ser
285 290 295
ggc agc caa taa aat cat cat aag ccc ttt gta ata aaa agc tag ttt 960
Gly Ser Gln Asn His His Lys Pro Phe Val Ile Lys Ser Phe
300 305 310
cct gag tga aca agc cat aac ctc ccc taa aca cca cct agg tat ttg 1008
Pro Glu Thr Ser His Asn Leu Pro Thr Pro Pro Arg Tyr Leu
315 320 325
tta gaa gtc aca cta tta ctc caa tgt cat cag aca cct aag gtc tgc 1056
Leu Glu Val Thr Leu Leu Leu Gln Cys His Gln Thr Pro Lys Val Cys
330 335 340
cag cca ggc tcc tgg ctg ggc aat gga aga tgg tgt ggc cct gtt agt 1104
Gln Pro Gly Ser Trp Leu Gly Asn Gly Arg Trp Cys Gly Pro Val Ser
345 350 355
ctc cgt gtg tgg ctt act agc cag cct tgg gaa ctg cca act caa att 1152
Leu Arg Val Trp Leu Thr Ser Gln Pro Trp Glu Leu Pro Thr Gln Ile
360 365 370
cta aga aag cca ctg ctt tct cat cat cac tct ata cca ata ctt att 1200
Leu Arg Lys Pro Leu Leu Ser His His His Ser Ile Pro Ile Leu Ile
375 380 385
tct ggc caa atg aat ctg ctt ctc tgc ccc tca aac ttt tag ttc aca 1248
Ser Gly Gln Met Asn Leu Leu Leu Cys Pro Ser Asn Phe Phe Thr
390 395 400
att cat ctt cta cct taa ctt ggg ctt ctt ggg cct ctg gcc ttc ctt 1296
Ile His Leu Leu Pro Leu Gly Leu Leu Gly Pro Leu Ala Phe Leu
405 410 415
act taa tgt ctt ctt ttc cct act cta atg cat ttc taa ctc act ttg 1344
Thr Cys Leu Leu Phe Pro Thr Leu Met His Phe Leu Thr Leu
420 425 430
gag ctt tgg ttt tct aat gta tta tcc cca ctt gcc agt caa ctg gac 1392
Glu Leu Trp Phe Ser Asn Val Leu Ser Pro Leu Ala Ser Gln Leu Asp
435 440 445
ccc ttc ctc ctc ggt ttc aga ctg cct aca tta gga aac aat ggc agt 1440
Pro Phe Leu Leu Gly Phe Arg Leu Pro Thr Leu Gly Asn Asn Gly Ser
450 455 460 465
caa acc cat ggc ttt gga gaa agt aaa tgt ttg cca gaa agg aat act 1488
Gln Thr His Gly Phe Gly Glu Ser Lys Cys Leu Pro Glu Arg Asn Thr
470 475 480
agt cac agt ggc ctt tgt gag ttg tct gca act cag ctc ttc ccc cag 1536
Ser His Ser Gly Leu Cys Glu Leu Ser Ala Thr Gln Leu Phe Pro Gln
485 490 495
cac aga tct gtt ccc ctt atc ctg cag aaa atc aag ccc tga ctc tgc 1584
His Arg Ser Val Pro Leu Ile Leu Gln Lys Ile Lys Pro Leu Cys
500 505 5l0
act ccc cga agt agt gat gtt aat taa caa ctg aag agg taa cta aat 1632
Thr Pro Arg Ser Ser Asp Val Asn Gln Leu Lys Arg Leu Asn
515 520 525
ctc aca tgc agg tct aat gac taa taa ttg gag tac ggc tgc tag aca 1680
Leu Thr Cys Arg Ser Asn Asp Leu Glu Tyr Gly Cys Thr
530 535
act gca ttt tag tat ttc tct tcc att ctc ctg gtt ttg tag acc cag 1728
Thr Ala Phe Tyr Phe Ser Ser Ile Leu Leu Val Leu Thr Gln
540 545 550
aag att gaa tga gtg aca taa atc ttt agt tcg ggg caa gcc agg gtg 1776
Lys Ile Glu Val Thr Ile Phe Ser Ser Gly Gln Ala Arg Val
555 560 565
ggc tag ggt ggt aag ctg gag gac ttc atc ctt cag tta ggc tgc aca 1824
Gly Gly Gly Lys Leu Glu Asp Phe Ile Leu Gln Leu Gly Cys Thr
570 575 580
agt aac att acc taa aag gca cta aca tgc tca ggt tcc cca gaa aga 1872
Ser Asn Ile Thr Lys Ala Leu Thr Cys Ser Gly Ser Pro Glu Arg
585 590 595
ggc gta aga agg gcc tct cct tag cag agc ttc cac ctg cca tcc gtc 1920
Gly Val Arg Arg Ala Ser Pro Gln Ser Phe His Leu Pro Ser Val
600 605 610
ttg ggt tca gtg agc ttc aag gct cac aat gga agc act gtc att tcc 1968
Leu Gly Ser Val Ser Phe Lys Ala His Asn Gly Ser Thr Val Ile Ser
615 620 625
cca gaa aag ctg tgt tcc cta tgc tga aca cac cat aca cat tct cat 2016
Pro Glu Lys Leu Cys Ser Leu Cys Thr His His Thr His Ser His
630 635 640
ctg gaa tct aag gag cag ctt tta ccc tga tcc agt atc ctg agg aat 2064
Leu Glu Ser Lys Glu Gln Leu Leu Pro Ser Ser Ile Leu Arg Asn
645 650 655
ttt aag cct cca ctc aaa tga cct gcc tgt gtt gtc att tcc atg gga 2112
Phe Lys Pro Pro Leu Lys Pro Ala Cys Val Val Ile Ser Met Gly
660 665 670
aag aac tct ttc cac gag atc tgc tag ttc cag gcc tct aag aca gga 2160
Lys Asn Ser Phe His Glu Ile Cys Phe Gln Ala Ser Lys Thr Gly
675 680 685
acg tat gtg cca taa gtg ggt cta ctt cac aga ctc aat gag gca gaa 2208
Thr Tyr Val Pro Val Gly Leu Leu His Arg Leu Asn Glu Ala Glu
690 695 700
att att gta gtt ttc tcc tat ttc ttc tgc acc caa ctt tct cct tgt 2256
Ile Ile Val Val Phe Ser Tyr Phe Phe Cys Thr Gln Leu Ser Pro Cys
705 710 715
att tca aag gcc agg cca tgt aca cta acg tcc ttg aaa ttt gca gtt 2304
Ile Ser Lys Ala Arg Pro Cys Thr Leu Thr Ser Leu Lys Phe Ala Val
720 725 730 735
ctg tat gct tct att cca aat cat tca tta cca ata aaa acg aaa tac 2352
Leu Tyr Ala Ser Ile Pro Asn His Ser Leu Pro Ile Lys Thr Lys Tyr
740 745 750
cac cct ttc cat ttt ata gac ctc atc ccc tat ttc tgt cag aca gtt 2400
His Pro Phe His Phe Ile Asp Leu Ile Pro Tyr Phe Cys Gln Thr Val
755 760 765
ata tga cag ggt gac tgt gga acc tct tag ttc atc caa agt cta cct 2448
Ile Gln Gly Asp Cys Gly Thr Ser Phe Ile Gln Ser Leu Pro
770 775 780
gaa gtg cta gac ttt cag act ctt atc act gaa atc ctt aag gtt gag 2496
Glu Val Leu Asp Phe Gln Thr Leu Ile Thr Glu Ile Leu Lys Val Glu
785 790 795
gag gct tta ttt ccc tag cac tgg tga agg gct tca act gtc aaa cct 2544
Glu Ala Leu Phe Pro His Trp Arg Ala Ser Thr Val Lys Pro
800 805 810
cag aac aaa tgc att agg gcc tta gaa atg tca atg ggg cag gaa gaa 2592
Gln Asn Lys Cys Ile Arg Ala Leu Glu Met Ser Met Gly Gln Glu Glu
815 820 825
aac aca att tct aac tgc ctg ttt ttg tat aat tta ata aaa acc ttt 2640
Asn Thr Ile Ser Asn Cys Leu Phe Leu Tyr Asn Leu Ile Lys Thr Phe
830 835 840
taa aca tta aaaaaaaaaa aaaa 2663
Thr Leu
845
SEQUENCE LISTING8
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_033214
<160>1
<170>PatentIn version 3.5
<210>1
<211>1899
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(1866)
<220>
<221>CDS
<222>(19)..(1680)
<220>
<221>STS
<222>(943)..(1214)
<220>
<221>STS
<222>(1362)..(1690)
<220>
<221>STS
<222>(1686)..(1872)
<400>1
agc cga cct act ggt gtc atg gca gcc cca aag aca gca gct gtg ggg 48
Ser Arg Pro Thr Gly Val Met Ala Ala Pro Lys Thr Ala Ala Val Gly
1 5 10 15
ccg ttg gtg gga gcg gtg gtc cag ggc acc aac tcc act cgc ttt ctg 96
Pro Leu Val Gly Ala Val Val Gln Gly Thr Asn Ser Thr Arg Phe Leu
20 25 30
gtt ttc aat tca aaa aca gcg gaa cta ctt agt cat cac aaa gtg gaa 144
Val Phe Asn Ser Lys Thr Ala Glu Leu Leu Ser His His Lys Val Glu
35 40 45
tta aca caa gag ttc cca aaa gaa gga tgg gtg gaa caa gac cct aaa 192
Leu Thr Gln Glu Phe Pro Lys Glu Gly Trp Val Glu Gln Asp Pro Lys
50 55 60
gaa att ctt cag tct gtc tac gag tgt ata gcg aga acg tgt gag aaa 240
Glu Ile Leu Gln Ser Val Tyr Glu Cys Ile Ala Arg Thr Cys Glu Lys
65 70 75 80
ctt gac gaa ctg aat att gat ata tcc aac ata aaa gct gtt ggt gtc 288
Leu Asp Glu Leu Asn Ile Asp Ile Ser Asn Ile Lys Ala Val Gly Val
85 90 95
agc aat cag agg gaa acc act gta atc tgg gac aag tta aca gga gag 336
Ser Asn Gln Arg Glu Thr Thr Val Ile Trp Asp Lys Leu Thr Gly Glu
100 105 110
cct ctc tac aat gct gtg gtg tgg ctt gat cta aga acc cag act act 384
Pro Leu Tyr Asn Ala Val Val Trp Leu Asp Leu Arg Thr Gln Thr Thr
115 120 125
gtt gag gat ctt agt aaa aaa att cca gga aat agt aac ttc gtc aag 432
Val Glu Asp Leu Ser Lys Lys Ile Pro Gly Asn Ser Asn Phe Val Lys
130 135 140
tct aag aca ggc ctt cca ctc agc act tac ttc agt gca gta aaa ctt 480
Ser Lys Thr Gly Leu Pro Leu Ser Thr Tyr Phe Ser Ala Val Lys Leu
145 150 155 160
cgt tgg atg ctt gac aat gtg aga aac gtc caa aag gct gtt gaa gaa 528
Arg Trp Met Leu Asp Asn Val Arg Asn Val Gln Lys Ala Val Glu Glu
165 170 175
ggt aga gct ctt ttt ggt acc att gat tca tgg ctt atc tgg agt ttg 576
Gly Arg Ala Leu Phe Gly Thr Ile Asp Ser Trp Leu Ile Trp Ser Leu
180 185 190
aca gga gga gtt aat gga ggc gtg cat tgt aca gat gta aca aat gca 624
Thr Gly Gly Val Asn Gly Gly Val His Cys Thr Asp Val Thr Asn Ala
195 200 205
agt agg aca atg ctt ttt aat atc cat tct ttg gaa tgg gat aaa gag 672
Ser Arg Thr Met Leu Phe Asn Ile His Ser Leu Glu Trp Asp Lys Glu
210 215 220
ctc tgt gac ttt ttt gaa att cca atg gac ctt ctt cca aat gtc ttc 720
Leu Cys Asp Phe Phe Glu Ile Pro Met Asp Leu Leu Pro Asn Val Phe
225 230 235 240
agt tct tct gag atc tat ggc cta att aaa act gga gcc ctg gaa ggt 768
Ser Ser Ser Glu Ile Tyr Gly Leu Ile Lys Thr Gly Ala Leu Glu Gly
245 250 255
gtg cca ata tct ggg tgt ttg ggg gac caa tgt gct gca tta gta gga 816
Val Pro Ile Ser Gly Cys Leu Gly Asp Gln Cys Ala Ala Leu Val Gly
260 265 270
caa atg tgc ttc cag gag gga caa gcc aaa aac acc tat gga aca ggt 864
Gln Met Cys Phe Gln Glu Gly Gln Ala Lys Asn Thr Tyr Gly Thr Gly
275 280 285
tgc ttc tta ctg tgt aat acg ggt cgt aaa tgt gtg ttt tct gaa cat 912
Cys Phe Leu Leu Cys Asn Thr Gly Arg Lys Cys Val Phe Ser Glu His
290 295 300
ggc ctt ttg acc aca gta gct tac aaa cta ggc aga gag aag cca gca 960
Gly Leu Leu Thr Thr Val Ala Tyr Lys Leu Gly Arg Glu Lys Pro Ala
305 310 315 320
tat tat gca ctg gaa ggt tct gtt gct ata gca ggt gct gtt att cgt 1008
Tyr Tyr Ala Leu Glu Gly Ser Val Ala Ile Ala Gly Ala Val Ile Arg
325 330 335
tgg cta aga gac aat ctt gga att ata gag acc tca gga gac att gaa 1056
Trp Leu Arg Asp Asn Leu Gly Ile Ile Glu Thr Ser Gly Asp Ile Glu
340 345 350
aga ctt gct aaa gaa gta gga act tct tat ggc tgt tac ttt gtc cca 1104
Arg Leu Ala Lys Glu Val Gly Thr Ser Tyr Gly Cys Tyr Phe Val Pro
355 360 365
gcc ttt tca ggg tta tat gca cct tat tgg gag ccc agt gca aga ggg 1152
Ala Phe Ser Gly Leu Tyr Ala Pro Tyr Trp Glu Pro Ser Ala Arg Gly
370 375 380
ata ctc tgt ggc ctc act cag ttt acc aat aaa tgt cat att gct ttt 1200
Ile Leu Cys Gly Leu Thr Gln Phe Thr Asn Lys Cys His Ile Ala Phe
385 390 395 400
gct gca tta gaa gct gtt tgt ttc caa acc cga gag att ttg gaa gcc 1248
Ala Ala Leu Glu Ala Val Cys Phe Gln Thr Arg Glu Ile Leu Glu Ala
405 410 415
atg aac cgt gac tgt gga att cca ctt cgt cat ttg cag gta gat gga 1296
Met Asn Arg Asp Cys Gly Ile Pro Leu Arg His Leu Gln Val Asp Gly
420 425 430
gga atg acc aac aac aaa gtt ctt atg cag cta caa gca gat att ctt 1344
Gly Met Thr Asn Asn Lys Val Leu Met Gln Leu Gln Ala Asp Ile Leu
435 440 445
cat att cca gta ata aaa ccc ttt atg cct gaa aca act gca cta gga 1392
His Ile Pro Val Ile Lys Pro Phe Met Pro Glu Thr Thr Ala Leu Gly
450 455 460
gct gcc atg gca gca ggg gct gca gag gga gta agc gtt tgg agc ctt 1440
Ala Ala Met Ala Ala Gly Ala Ala Glu Gly Val Ser Val Trp Ser Leu
465 470 475 480
gaa ccc cag gct ttg tca gtt ctc agg atg gaa cga ttt gaa cca cag 1488
Glu Pro Gln Ala Leu Ser Val Leu Arg Met Glu Arg Phe Glu Pro Gln
485 490 495
atc cag gcc aca gaa agt gaa att cgt tat gcc aca tgg aag aaa gcc 1536
Ile Gln Ala Thr Glu Ser Glu Ile Arg Tyr Ala Thr Trp Lys Lys Ala
500 505 510
gta atg aag tca atg ggt tgg gtt acc agt cag tct cct gaa ggt ggt 1584
Val Met Lys Ser Met Gly Trp Val Thr Ser Gln Ser Pro Glu Gly Gly
515 520 525
gat cct tct atc ttc tct agt ctg cct ttg gga ttt ttt ata gtg agt 1632
Asp Pro Ser Ile Phe Ser Ser Leu Pro Leu Gly Phe Phe Ile Val Ser
530 535 540
agc atg gta atg cta att gga gca aga tat atc tcg ggt gtg cca taa 1680
Ser Met Val Met Leu Ile Gly Ala Arg Tyr Ile Ser Gly Val Pro
545 550 555
taa tac cag cta tgg agt ccc aag atg taa aca ttt tac ata atg aaa 1728
Tyr Gln Leu Trp Ser Pro Lys Met Thr Phe Tyr Ile Met Lys
560 565 570
gca tat agc agt tct gcc tct taa tat aat gac act att ata gac tct 1776
Ala Tyr Ser Ser Ser Ala Ser Tyr Asn Asp Thr Ile Ile Asp Ser
575 580 585
gat ttt gtt tat aaa cca ctt gct aca tga ccc atg aaa acc cta gac 1824
Asp Phe Val Tyr Lys Pro Leu Ala Thr Pro Met Lys Thr Leu Asp
590 595 600
ttg tga cct gaa ata aag aaa ata cgt tag aag agc act gta 1866
Leu Pro Glu Ile Lys Lys Ile Arg Lys Ser Thr Val
605 610 615
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaa 1899
SEQUENCE LISTING9
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_153823
<160>1
<170>PatentIn version 3.5
<210>1
<211>1942
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(177)
<220>
<221>exon
<222>(178)..(493)
<220>
<221>exon
<222>(494)..(541)
<220>
<221>exon
<222>(542)..(694)
<220>
<221>exon
<222>(695)..(806)
<220>
<221>exon
<222>(807)..(1942)
<220>
<221>STS
<222>(884)..(1736)
<220>
<221>polyA_site
<222>(1225)..(1225)
<400>1
agc att taa tca tga ggc act cca aag aat atg aga tag aag ggg agg 48
Ser Ile Ser Gly Thr Pro Lys Asn Met Arg Lys Gly Arg
1 5 10
ggt agg agg aga ggg agg agg gta gga aga cag ttt gca ttc ttg caa 96
Gly Arg Arg Arg Gly Arg Arg Val Gly Arg Gln Phe Ala Phe Leu Gln
15 20 25
cat taa acc aaa ggg act tgg agt gca gat ggc atc ctt cgg ttc ttc 144
His Thr Lys Gly Thr Trp Ser Ala Asp Gly Ile Leu Arg Phe Phe
30 35 40
cag aca agc tgc aag acg ctg acc atg gcc aag atg gag ctc tcg aag 192
Gln Thr Ser Cys Lys Thr Leu Thr Met Ala Lys Met Glu Leu Ser Lys
45 50 55 60
gcc ttc tct ggc cag cgg aca ctc cta tct gcc atc ctc agc atg cta 240
Ala Phe Ser Gly Gln Arg Thr Leu Leu Ser Ala Ile Leu Ser Met Leu
65 70 75
tca ctc agc ttc tcc aca aca tcc ctg ctc agc aac tac tgg ttt gtg 288
Ser Leu Ser Phe Ser Thr Thr Ser Leu Leu Ser Asn Tyr Trp Phe Val
80 85 90
ggc aca cag aag gtg ccc aag ccc ctg tgc gag aaa ggt ctg gca gcc 336
Gly Thr Gln Lys Val Pro Lys Pro Leu Cys Glu Lys Gly Leu Ala Ala
95 100 105
aag tgc ttt gac atg cca gtg tcc ctg gat gga gat acc aac aca tcc 384
Lys Cys Phe Asp Met Pro Val Ser Leu Asp Gly Asp Thr Asn Thr Ser
110 115 120
acc cag gag gtg gta caa tac aac tgg gag act ggg gat gac cgg ttc 432
Thr Gln Glu Val Val Gln Tyr Asn Trp Glu Thr Gly Asp Asp Arg Phe
125 130 135 140
tcc ttc cgg agc ttc cgg agt ggc atg tgg cta tcc tgt gag gaa act 480
Ser Phe Arg Ser Phe Arg Ser Gly Met Trp Leu Ser Cys Glu Glu Thr
145 150 155
gtg gaa gaa cca g gg gag agg tgc cga agt ttc att gaa ctt aca cca 528
Val Glu Glu Pro Gly Glu Arg Cys Arg Ser Phe Ile Glu Leu Thr Pro
160 165 170
cca gcc aag aga g aa atc cta tgg tta tcc ctg gga acg cag atc acc 576
Pro Ala Lys Arg Glu Ile Leu Trp Leu Ser Leu Gly Thr Gln Ile Thr
175 180 185
tac atc gga ctt caa ttc atc agc ttc ctc ctg cta cta aca gac ttg 624
Tyr Ile Gly Leu Gln Phe Ile Ser Phe Leu Leu Leu Leu Thr Asp Leu
190 195 200
cta ctc act ggg aac cct gcc tgt ggg ctc aaa ctg agc gcc ttt gct 672
Leu Leu Thr Gly Asn Pro Ala Cys Gly Leu Lys Leu Ser Ala Phe Ala
205 210 215 220
gct gtt tcc tct gtc ctg tca g gt ctc ctg ggg atg gtg gcc cac atg 720
Ala Val Ser Ser Val Leu Ser Gly Leu Leu Gly Met Val Ala His Met
225 230 235
atg tat tca caa gtc ttc caa gcg act gtc aac ttg ggt cca gaa gac 768
Met Tyr Ser Gln Val Phe Gln Ala Thr Val Asn Leu Gly Pro Glu Asp
240 245 250
tgg aga cca cat gtt tgg aat tat ggc tgg gcc ttc ta c atg gcc tgg 816
Trp Arg Pro His Val Trp Asn Tyr Gly Trp Ala Phe Tyr Met Ala Trp
255 260
ctc tcc ttc acc tgc tgc atg gcg tcg gct gtc acc acc ttc aac acg 864
Leu Ser Phe Thr Cys Cys Met Ala Ser Ala Val Thr Thr Phe Asn Thr
270 275 280
tac acc agg atg gtg ctg gag ttc aag tgc aag cat agt aag agc ttc 912
Tyr Thr Arg Met Val Leu Glu Phe Lys Cys Lys His Ser Lys Ser Phe
285 290 295 300
aag gaa aac ccg aac tgc cta cca cat cac cat cag tgt ttc cct cgg 960
Lys Glu Asn Pro Asn Cys Leu Pro His His His Gln Cys Phe Pro Arg
305 310 315
cgg ctg tca agt gca gcc ccc accgtg ggt cct ttg acc agc tac cac 1008
Arg Leu Ser Ser Ala Ala Pro Thr Val Gly Pro Leu Thr Ser Tyr His
320 325 330
cag tat cat aat cag ccc atc cac tct gtc tct gag gga gtc gac ttc 1056
Gln Tyr His Asn Gln Pro Ile His Ser Val Ser Glu Gly Val Asp Phe
335 340 345
tac tcc gag ctg cgg aac aag gga ttt caa aga ggg gcc agc cag gag 1104
Tyr Ser Glu Leu Arg Asn Lys Gly Phe Gln Arg Gly Ala Ser Gln Glu
350 355 360
ctg aaa gaa gca gtt agg tca tct gta gag gaa gag cag tgt tag gag 1152
Leu Lys Glu Ala Val Arg Ser Ser Val Glu Glu Glu Gln Cys Glu
365 370 375
tta agc ggg ttt ggg gag tag gct tga gcc cta cct tac acg tct gct 1200
Leu Ser Gly Phe Gly Glu Ala Ala Leu Pro Tyr Thr Ser Ala
380 385 390
gat tat caa cat gtg ctt aag cca aca tcc gtc tct tga gca tgg ttt 1248
Asp Tyr Gln His Val Leu Lys Pro Thr Ser Val Ser Ala Trp Phe
395 400 405
tta gag gct acg aat aag gct atg aat aag ggt tat ctt taa gtc cta 1296
Leu Glu Ala Thr Asn Lys Ala Met Asn Lys Gly Tyr Leu Val Leu
410 415 420
agg gat tcc tgg gtg cca ctg ctc tct ttt cct cta cag ctc cat ctt 1344
Arg Asp Ser Trp Val Pro Leu Leu Ser Phe Pro Leu Gln Leu His Leu
425 430 435
gtt tca ccc acc cca cat ctc aca cat cca gaa ttc cct tct tta ctg 1392
Val Ser Pro Thr Pro His Leu Thr His Pro Glu Phe Pro Ser Leu Leu
440 445 450 455
ata gtt tct gtg cca ggt tct ggg cta aac cat gga gat aaa aag aag 1440
Ile Val Ser Val Pro Gly Ser Gly Leu Asn His Gly Asp Lys Lys Lys
460 465 470
agt aaa ata cac ttc ccg acc tta agg atc tga tac atc tag tta ttg 1488
Ser Lys Ile His Phe Pro Thr Leu Arg Ile Tyr Ile Leu Leu
475 480 485
gtc tgg aaa ttg gag aaa tgg agg tga gca aat taa cgg tag tgt gac 1536
Val Trp Lys Leu Glu Lys Trp Arg Ala Asn Arg Cys Asp
490 495
tgt ggc tca act ttc cat ggt acg cgc gaa ttg ttc tgg aag tca cag 1584
Cys Gly Ser Thr Phe His Gly Thr Arg Glu Leu Phe Trp Lys Ser Gln
500 505 510
atg gga aga cag aag cgc ccc tga gtg ctt tgt cat ata gca cag aag 1632
Met Gly Arg Gln Lys Arg Pro Val Leu Cys His Ile Ala Gln Lys
515 520 525
tcc tcc aca ctg cct ggg aca gtg tcc tgc atc cac aca gta ggt acc 1680
Ser Ser Thr Leu Pro Gly Thr Val Ser Cys Ile His Thr Val Gly Thr
530 535 540 545
cag taa aag tgt tat taa ata ttg tcc cag gag ccc tta gga gag tgg 1728
Gln Lys Cys Tyr Ile Leu Ser Gln Glu Pro Leu Gly Glu Trp
550 555
ttt aac atg aga agg cgc caa cag cac aca ggg tca ggg tca ctt cta 1776
Phe Asn Met Arg Arg Arg Gln Gln His Thr Gly Ser Gly Ser Leu Leu
560 565 570 575
gaa ata gcc cac caa ggc tat tca gat tgg act gtg gtt ccc ttc tgg 1824
Glu Ile Ala His Gln Gly Tyr Ser Asp Trp Thr Val Val Pro Phe Trp
580 585 590
aca gtc aca cca ggg act tcc cag tga aca agg ggg cat agg ctc ctc 1872
Thr Val Thr Pro Gly Thr Ser Gln Thr Arg Gly His Arg Leu Leu
595 600 605
tct gga tcc cac ctt ttc atc cct tct gag aaa tgt acc cta tta ttt 1920
Ser Gly Ser His Leu Phe Ile Pro Ser Glu Lys Cys Thr Leu Leu Phe
610 615 620
cct tca taa aga atg ccaccc a 1942
Pro Ser Arg Met Pro Pro
625
SEQUENCE LISTING10
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_000849
<160>1
<170>PatentIn version 3.5
<210>1
<211>4144
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(86)
<220>
<221>exon
<222>(87)..(358)
<220>
<221>exon
<222>(359)..(434)
<220>
<221>exon
<222>(435)..(499)
<220>
<221>exon
<222>(500)..(581)
<220>
<221>exon
<222>(582)..(682)
<220>
<221>exon
<222>(683)..(778)
<220>
<221>exon
<222>(779)..(889)
<220>
<221>STS
<222>(826)..(1064)
<220>
<221>exon
<222>(890)..(4127)
<220>
<221>polyA_site
<222>(1084)..(1084)
<220>
<221>STS
<222>(1092)..(1277)
<220>
<221>polyA_site
<222>(1133)..(1133)
<220>
<221>polyA_signal
<222>(1532)..(1537)
<220>
<221>polyA_site
<222>(1557)..(1557)
<220>
<221>polyA_signal
<222>(4098)..(4103)
<220>
<221>polyA_site
<222>(4127)..(4127)
<400>1
ggt tgg ttc tga gaa ggc ttc aag gaa tag gca gac att tca gca agg 48
Gly Trp Phe Glu Gly Phe Lys Glu Ala Asp Ile Ser Ala Arg
1 5 10
ctg ctg agg aag gat agg ctg tgg aaa tta gga tgc ag c act cct gcc 96
Leu Leu Arg Lys Asp Arg Leu Trp Lys Leu Gly Cys Ser Thr Pro Ala
15 20 25 30
cgg gtc ccg cct cgg ggt cgc cag gcc ctg aac ccc aac gcc ggc att 144
Arg Val Pro Pro Arg Gly Arg Gln Ala Leu Asn Pro Asn Ala Gly Ile
35 40 45
agt cgc gcc tgc gca cgg ccc tgt gga gcc gcg gag gca agg gac gga 192
Ser Arg Ala Cys Ala Arg Pro Cys Gly Ala Ala Glu Ala Arg Asp Gly
50 55 60
gaa cgg ggc gga ggc gga gtc agg gcg ccc gcg cgt ggg ccc cgc ccc 240
Glu Arg Gly Gly Gly Gly Val Arg Ala Pro Ala Arg Gly Pro Arg Pro
65 70 75
ctt atg tcg ggt ata aag ccc ctc ccg ctc aca gtt tcc cta gtc ctc 288
Leu Met Ser Gly Ile Lys Pro Leu Pro Leu Thr Val Ser Leu Val Leu
80 85 90
gaa ggc tcg gaa gcc cgt cac cat gtc gtg cga gtc gtc tat ggt tct 336
Glu Gly Ser Glu Ala Arg His His Val Val Arg Val Val Tyr Gly Ser
95 100 105 110
cgg gta ctg gga tat tcg tgg g ct ggc gca cgc cat ccg cct gct cct 384
Arg Val Leu Gly Tyr Ser Trp Ala Gly Ala Arg His Pro Pro Ala Pro
115 120 125
gga gtt cac gga tac ctc tta tga gga gaa acg gta cac gtg cgg gga 432
Gly Val His Gly Tyr Leu Leu Gly Glu Thr Val His Val Arg Gly
130 135 140
ag c tcc tga cta tga tcg aag cca atg gct gga tgt gaa att caa gct 480
Ser Ser Leu Ser Lys Pro Met Ala Gly Cys Glu Ile Gln Ala
145 150 155
aga cct gga ctt tcc taa t ct gcc cta cct cct gga tgg gaa gaa caa 528
Arg Pro Gly Leu Ser Ser Ala Leu Pro Pro Gly Trp Glu Glu Gln
160 165 170
gat cac cca gag caa tgc cat ctt gcg cta cat cgc tcg caa gca caa 576
Asp His Pro Glu Gln Cys His Leu Ala Leu His Arg Ser Gln Ala Gln
175 180 185
cat gt g tgg tga gac tga aga aga aaa gat tcg agt gga cat cat aga 624
His Val Trp Asp Arg Arg Lys Asp Ser Ser Gly His His Arg
190 195 200
gaa cca agt aat gga ttt ccg cac aca act gat aag gct ctg tta cag 672
Glu Pro Ser Asn Gly Phe Pro His Thr Thr Asp Lys Ala Leu Leu Gln
205 210 215
ctc tga cca c ga aaa act gaa gcc tca gta ctt gga aga gct acc tgg 720
Leu Pro Arg Lys Thr Glu Ala Ser Val Leu Gly Arg Ala Thr Trp
220 225 230
aca act gaa aca att ctc cat gtt tct ggg gaa att ctc atg gtt tgc 768
Thr Thr Glu Thr Ile Leu His Val Ser Gly Glu Ile Leu Met Val Cys
235 240 245
cgg gga aaa g ct cac ctt tgt gga ttt tct cac cta tga tat ctt gga 816
Arg Gly Lys Ala His Leu Cys Gly Phe Ser His Leu Tyr Leu Gly
250 255 260
tca gaa ccg tat att tga ccc caa gtg cct gga tga gtt ccc aaa cct 864
Ser Glu Pro TyrIle Pro Gln Val Pro Gly Val Pro Lys Pro
265 270 275
gaa ggc ttt cat gtg ccg ttt tga g gc ttt gga gaa aat cgc tgc cta 912
Glu Gly Phe His Val Pro Phe Gly Phe Gly Glu Asn Arg Cys Leu
280 285 290
ctt aca gtc tga tca gtt ctg caa gat gcc cat caa caa caa gat ggc 960
Leu Thr Val Ser Val Leu Gln Asp Ala His Gln Gln Gln Asp Gly
295 300 305
cca gtg ggg caa caa gcc tgt atg ctg agc agg agg cag act tgc aga 1008
Pro Val Gly Gln Gln Ala Cys Met Leu Ser Arg Arg Gln Thr Cys Arg
310 315 320
gct tgt ttt gtt tca tcc tgt ccg taa ggg gtc agc gct ctt gct ttg 1056
Ala Cys Phe Val Ser Ser Cys Pro Gly Val Ser Ala Leu Ala Leu
325 330 335
ctc ttt tca atg aat agc act tat gtt act ggt gtc cag ctg agt ttc 1104
Leu Phe Ser Met Asn Ser Thr Tyr Val Thr Gly Val Gln Leu Ser Phe
340 345 350
tct tgg gta taa agg cta aaa ggg aaa aag gat atg tgg aga atc atc 1152
Ser Trp Val Arg Leu Lys Gly Lys Lys Asp Met Trp Arg Ile Ile
355 360 365
aag ata tga att gaa tcg ctg cga tac tgg cat ttc cct act ccc caa 1200
Lys Ile Ile Glu Ser Leu Arg Tyr Trp His Phe Pro Thr Pro Gln
370 375 380
ctg agt tca agg gct gta ggt tca tgc cca agc cct gag agt ggg tac 1248
Leu Ser Ser Arg Ala Val Gly Ser Cys Pro Ser Pro Glu Ser Gly Tyr
385 390 395
tag aaa aaa cga gat tgc aca gtt gga gag agc agg tgt gtt aaa tgg 1296
Lys Lys Arg Asp Cys Thr Val Gly Glu Ser Arg Cys Val Lys Trp
400 405 410
gac tgg agt ccc tgt gaa gac tgg gtg agg ata aca caa gta aaa ctg 1344
Asp Trp Ser Pro Cys Glu Asp Trp Val Arg Ile Thr Gln Val Lys Leu
415 420 425 430
tgg tac tga tgg act taa ccg gag ttc gga aac cgt cct gtg tac aca 1392
Trp Tyr Trp Thr Pro Glu Phe Gly Asn Arg Pro Val Tyr Thr
435 440
tgg gag ttt agt gtg ata aag gca gta ttt cag act ggt ggg cta gcc 1440
Trp Glu Phe Ser Val Ile Lys Ala Val Phe Gln Thr Gly Gly Leu Ala
445 450 455 460
aat aga gtt ggg aca att gct tac tca tta aaa ata ata gag ccc cac 1488
Asn Arg Val Gly Thr Ile Ala Tyr Ser Leu Lys Ile Ile Glu Pro His
465 470 475
ttg aca cta ttc act aaa att aat ctg gaa ttt aag gcc caa cat taa 1536
Leu Thr Leu Phe Thr Lys Ile Asn Leu Glu Phe Lys Ala Gln His
480 485 490
aca caa agc tgt tga aat att gat gaa aat gta aga att ttt gtg acc 1584
Thr Gln Ser Cys Asn Ile Asp Glu Asn Val Arg Ile Phe Val Thr
495 500 505
acg ggg tag gag aag ttt ctt taa aga cgt aaa aag aaa aaa acc ata 1632
Thr Gly Glu Lys Phe Leu Arg Arg Lys Lys Lys Lys Thr Ile
510 515 520
ggc tgc tct gcc tgt gga gta gcc att ctt tat tct ttt act ttt taa 1680
Gly Cys Ser Ala Cys Gly Val Ala Ile Leu Tyr Ser Phe Thr Phe
525 530 535
aat aat aac aat cac aaa gga aag att tgc caa ttg aat agg atc aaa 1728
Asn Asn Asn Asn His Lys Gly Lys Ile Cys Gln Leu Asn Arg Ile Lys
540 545 550
ttc tac aac ttt tcc taa ggc acc cac aaa taa atg aca agt gag aca 1776
Phe Tyr Asn Phe Ser Gly Thr His Lys Met Thr Ser Glu Thr
555 560 565
aaa agc act agt ata aag att ata taa aga cct ata aat cat taa gac 1824
Lys Ser Thr Ser Ile Lys Ile Ile Arg Pro Ile Asn His Asp
570 575
aac tga gtt ttt aaa aat gga caa aat cca tga aca att tat aaa ata 1872
Asn Val Phe Lys Asn Gly Gln Asn Pro Thr Ile Tyr Lys Ile
580 585 590
gaa ata tag cca aaa atg tct aaa aga tgt tta tga tgt aag gaa tta 1920
Glu Ile Pro Lys Met Ser Lys Arg Cys Leu Cys Lys Glu Leu
595 600 605
tca att aca aca gtg aga aac cat att tcc ttc tat ccg atg agt aaa 1968
Ser Ile Thr Thr Val Arg Asn His Ile Ser Phe Tyr Pro Met Ser Lys
610 615 620
aag ttt cta aag tgt tgg caa ggc tta gga aag tga tat gca ttt cct 2016
Lys Phe Leu Lys Cys Trp Gln Gly Leu Gly Lys Tyr Ala Phe Pro
625 630 635
gct ggt caa gtt gta aat tag tat agc tac ttt gga gga caa ttg taa 2064
Ala Gly Gln Val Val Asn Tyr Ser Tyr Phe Gly Gly Gln Leu
640 645 650
aat tta aat cat atc cta tga ccc agc aat tcc atg cta taa aaa ctc 2112
Asn Leu Asn His Ile Leu Pro Ser Asn Ser Met Leu Lys Leu
655 660 665
atc cat ggc cgg gct tgg tgg ctc acg cct gta atc cca gca ctt tgg 2160
Ile His Gly Arg Ala Trp Trp Leu Thr Pro Val Ile Pro Ala Leu Trp
670 675 680
gag gct gag gtg ggc aga tca cga ggt caa gag atc gag acc atc ctg 2208
Glu Ala Glu Val Gly Arg Ser Arg Gly Gln Glu Ile Glu Thr Ile Leu
685 690 695
gcc aac atg atg aaa ccc cgt ttc tac taa aaa tac aaa aat tag ctg 2256
Ala Asn Met Met Lys Pro Arg Phe Tyr Lys Tyr Lys Asn Leu
700 705 710
ggc atg gtg gca tgt gcc tat agt ccc agc tac tca gga ggc tga ggc 2304
Gly Met Val Ala Cys Ala Tyr Ser Pro Ser Tyr Ser Gly Gly Gly
715 720 725
agg aga att gct tga acc tgg gag gca gag gtt gca gtg agc cga gat 2352
Arg Arg Ile Ala Thr Trp Glu Ala Glu Val Ala Val Ser Arg Asp
730 735 740
cac gcc act gca ctc cag cct ggc tac agg gcg aga ctc tgt ctc aaa 2400
His Ala Thr Ala Leu Gln Pro Gly Tyr Arg Ala Arg Leu Cys Leu Lys
745 750 755
aaa aaa aaa aaa aaa aaa aaa aaa aca ttc aaa gag aca tat act aag 2448
Lys Lys Lys Lys Lys Lys Lys Lys Thr Phe Lys Glu Thr Tyr Thr Lys
760 765 770
atg ttc act gtg gca ttg tct gta atg aca aat aag tgg aaa ccg tgt 2496
Met Phe Thr Val Ala Leu Ser Val Met Thr Asn Lys Trp Lys Pro Cys
775 780 785 790
aaa tac ctg tca ata cta tgg agt acc atg tgg caa cgg aag aat gag 2544
Lys Tyr Leu Ser Ile Leu Trp Ser Thr Met Trp Gln Arg Lys Asn Glu
795 800 805
act gaa ctg tgt gaa cta aca tgc aaa gat ccc caa aac agg cca ggt 2592
Thr Glu Leu Cys Glu Leu Thr Cys Lys Asp Pro Gln Asn Arg Pro Gly
810 815 820
gtg gtt gct cac agc tgt aat aac aac acc ttc aga ggc tga ggt gag 2640
Val Val Ala His Ser Cys Asn Asn Asn Thr Phe Arg Gly Gly Glu
825 830 835
agg atc agt tga ggc cag gag ttt aag acc agc ctg ggc aac ata gtg 2688
ArgIle Ser Gly Gln Glu Phe Lys Thr Ser Leu Gly Asn Ile Val
840 845 850
aga ccc ctg tct ccc aaa aat ttt ttt taa tta gct gtg cgc aat tgc 2736
Arg Pro Leu Ser Pro Lys Asn Phe Phe Leu Ala Val Arg Asn Cys
855 860 865
tca tgc ata gtc cca gct acc cag gag gct gag gtg gga gga tca ctt 2784
Ser Cys Ile Val Pro Ala Thr Gln Glu Ala Glu Val Gly Gly Ser Leu
870 875 880
gag ccc agg aat ttg aag ctg cag tga gct gtg ttc ttg cca ctg cac 2832
Glu Pro Arg Asn Leu Lys Leu Gln Ala Val Phe Leu Pro Leu His
885 890 895
tcc aat ctg ggt gac tga gca aga ccc tgt ctc tta aaa aaa taa aaa 2880
Ser Asn Leu Gly Asp Ala Arg Pro Cys Leu Leu Lys Lys Lys
900 905 910
aga tct cca agc ata gag aag agt ctg gag gga aac acc aaa ctc ata 2928
Arg Ser Pro Ser Ile Glu Lys Ser Leu Glu Gly Asn Thr Lys Leu Ile
915 920 925
aca gtc tta ctg cag gca agt ggg ata aag gcc cag act cca tgg tgg 2976
Thr Val Leu Leu Gln Ala Ser Gly Ile Lys Ala Gln Thr Pro Trp Trp
930 935 940
aag tta aag ggc att tcc aag tta agg cta aga ctt gct ttt cta act 3024
Lys Leu Lys Gly Ile Ser Lys Leu Arg Leu Arg Leu Ala Phe Leu Thr
945 950 955 960
aag aga atg tgc tca tgc att gct tgt gta gta gaa act agt ttt tag 3072
Lys Arg Met Cys Ser Cys Ile Ala Cys Val Val Glu Thr Ser Phe
965 970 975
aaa aga aag caa act taa gaa aca ctg act cct gtg gag atg act tgg 3120
Lys Arg Lys Gln Thr Glu Thr Leu Thr Pro Val Glu Met Thr Trp
980 985 990
cac cac tct cct ttc aca gag cag agt ctg aat agt ctt cag aga tag 3168
His His Ser Pro Phe Thr Glu Gln Ser Leu Asn Ser Leu Gln Arg
995 1000 1005
gcc tgt ggg cca gat tgc cat ccc cta tgg acc aga agc caa gga 3213
Ala Cys Gly Pro Asp Cys His Pro Leu Trp Thr Arg Ser Gln Gly
1010 1015 1020
tct ctc tag tga tgg tca gag ggc cca aat ggc agg gat acc cag tga 3261
Ser Leu Trp Ser Glu Gly Pro Asn Gly Arg Asp Thr Gln
1025 1030
tgt cag gag gaa tag tac aga cag aag gtg cta agc aga caa ttc 3306
Cys Gln Glu Glu Tyr Arg Gln Lys Val Leu Ser Arg Gln Phe
1035 1040 1045
aac tgc cat gtt ttg cca ccc cct gtg agc agg gat tag gtg ttc 3351
Asn Cys His Val Leu Pro Pro Pro Val Ser Arg Asp Val Phe
1050 1055 1060
agg cca gta tct tgg gca tgg ggg agc ctt tgg cca gaa gag gta 3396
Arg Pro Val Ser Trp Ala Trp Gly Ser Leu Trp Pro Glu Glu Val
1065 1070 1075
taa agc tca gaa gtt ttt cag tct gat aac tat tga tat aat ttc 3441
Ser Ser Glu Val Phe Gln Ser Asp Asn Tyr Tyr Asn Phe
1080 1085
cat agt gtg agg gag cgg tat gct cta ccc ttg tgt att taa ggc 3486
His Ser Val Arg Glu Arg Tyr Ala Leu Pro Leu Cys Ile Gly
1090 1095 1100
agg aca gag aaa ttg agg atg ccc ctg ggg cta gat cga tga tat 3531
Arg Thr Glu Lys Leu Arg Met Pro Leu Gly Leu Asp Arg Tyr
1105 1110 1115
gac cag aaa tca aaa agg gaa tgc att att tat tgc tgt gta aca 3576
Asp Gln Lys Ser Lys Arg Glu Cys Ile Ile Tyr Cys Cys Val Thr
1120 1125 1130
ctg tta aga gag gag gta gtt aag gga tgg ata ggc aca tag aga 3621
Leu Leu Arg Glu Glu Val Val Lys Gly Trp Ile Gly Thr Arg
1135 1140 1145
ggg aag gtc tca gga gaa ggg ata gaa agg aac tat gtt cac aag 3666
Gly Lys Val Ser Gly Glu Gly Ile Glu Arg Asn Tyr Val His Lys
1150 1155 1160
aac aac ggc aag aca gtg cct ata ctg cct cta cag tta ata gga 3711
Asn Asn Gly Lys Thr Val Pro Ile Leu Pro Leu Gln Leu Ile Gly
1165 1170 1175
aaa acg gaa gaa gtt acc ctt aag cta gga tgt tgc tca gaa gtg 3756
Lys Thr Glu Glu Val Thr Leu Lys Leu Gly Cys Cys Ser Glu Val
1180 1185 1190
acc atc cca act ttg gtg cgg gca caa taa atc agc cta aat gtc 3801
Thr Ile Pro Thr Leu Val Arg Ala Gln Ile Ser Leu Asn Val
1195 1200 1205
cct aat tta acc cag ctc att ata atg tca tta aac atg aca tta 3846
Pro Asn Leu Thr Gln Leu Ile Ile Met Ser Leu Asn Met Thr Leu
1210 1215 1220
gca ttg tgg ttt tag cac ccc cat ggg ttt tgc tta ggc act cat 3891
Ala Leu Trp Phe His Pro His Gly Phe Cys Leu Gly Thr His
1225 1230
ggg taa taa cca aga tgg agt ccc ttt ggc aaa act tag gca tgc 3936
Gly Pro Arg Trp Ser Pro Phe Gly Lys Thr Ala Cys
1235 1240 1245
aca gct gta gta ccc caa gaa gaa aat gtt act tct ctc atc tgg 3981
Thr Ala Val Val Pro Gln Glu Glu Asn Val Thr Ser Leu Ile Trp
1250 1255 1260
gca aaa ccc aca gaa gac ttc cca gct tct gcc aca taa aag aca 4026
Ala Lys Pro Thr Glu Asp Phe Pro Ala Ser Ala Thr Lys Thr
1265 1270 1275
cag aac aca gac gcc tta ctg gca acc tgc ttt caa gac ccc tgt 4071
Gln Asn Thr Asp Ala Leu Leu Ala Thr Cys Phe Gln Asp Pro Cys
1280 1285 1290
ctt tgc tga gag ctt tcc ttt ttc cca ata aat tct act ctg ccc 4116
Leu Cys Glu Leu Ser Phe Phe Pro Ile Asn Ser Thr Leu Pro
1295 1300
tac tca ctc tc aaaaaaaaaa aaaaaaa 4144
Tyr Ser Leu
1305
SEQUENCE LISTING11
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_000640
<160>1
<170>PatentIn version 3.5
<210>1
<211>1376
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(92)
<220>
<221>exon
<222>(93)..(219)
<220>
<221>sig_peptide
<222>(126)..(203)
<220>
<221>exon
<222>(220)..(371)
<220>
<221>exon
<222>(372)..(525)
<220>
<221>exon
<222>(526)..(646)
<220>
<221>exon
<222>(647)..(831)
<220>
<221>exon
<222>(832)..(977)
<220>
<221>exon
<222>(978)..(1122)
<220>
<221>exon
<222>(1123)..(1241)
<220>
<221>exon
<222>(1242)..(1373)
<220>
<221>polyA_signal
<222>(1343)..(1348)
<220>
<221>polyA_site
<222>(1366)..(1366)
<220>
<221>polyA_site
<222>(1373)..(1373)
<400>1
gta aga aca ctc tcg tga gtc taa cgg tct tcc gga tga agg cta ttt 48
Val Arg Thr Leu Ser Val Arg Ser Ser Gly Arg Leu Phe
1 5 10
gaa gtc gcc ata acc tgg tca gaa gtg tgc ctg tcg gcg ggg ag a gag 96
Glu Val Ala Ile Thr Trp Ser Glu Val Cys Leu Ser Ala Gly Arg Glu
15 20 25
gca ata tca agg ttt taa atc tcg gag aaa tgg ctt tcg ttt gct tgg 144
Ala Ile Ser Arg Phe Ile Ser Glu Lys Trp Leu Ser Phe Ala Trp
30 35 40
cta tcg gat gct tat ata cct ttc tga taa gca caa cat ttg gct gta 192
Leu Ser Asp Ala Tyr Ile Pro Phe Ala Gln His Leu Ala Val
45 50 55
ctt cat ctt cag aca ccg aga taa aag tta acc ctc ctc agg att ttg 240
Leu His Leu Gln Thr Pro Arg Lys Leu Thr Leu Leu Arg Ile Leu
60 65 70
aga tag tgg atc ccg gat act tag gtt atc tct att tgc aat ggc aac 288
Arg Trp Ile Pro Asp Thr Val Ile Ser Ile Cys Asn Gly Asn
75 80 85
ccc cac tgt ctc tgg atc att tta agg aat gca cag tgg aat atg aac 336
Pro His Cys Leu Trp Ile Ile Leu Arg Asn Ala Gln Trp Asn Met Asn
90 95 100
taa aat acc gaa aca ttg gta gtg aaa cat gga ag a cca tca tta cta 384
Asn Thr Glu Thr Leu Val Val Lys His Gly Arg Pro Ser Leu Leu
105 110 115
aga atc tac att aca aag atg ggt ttg atc tta aca agg gca ttg aag 432
Arg Ile Tyr Ile Thr Lys Met Gly Leu Ile Leu Thr Arg Ala Leu Lys
120 125 130
cga aga tac aca cgc ttt tac cat ggc aat gca caa atg gat cag aag 480
Arg Arg Tyr Thr Arg Phe Tyr His Gly Asn Ala Gln Met Asp Gln Lys
135 140 145 150
ttc aaa gtt cct ggg cag aaa cta ctt att gga tat cac cac aag gaa 528
Phe Lys Val Pro Gly Gln Lys Leu Leu Ile Gly Tyr His His Lys Glu
155 160 165
ttc cag aaa cta aag ttc agg ata tgg att gcg tat att aca att ggc 576
Phe Gln Lys Leu Lys Phe Arg Ile Trp Ile Ala Tyr Ile Thr Ile Gly
170 175 180
aat att tac tct gtt ctt gga aac ctg gca tag gtg tac ttc ttg ata 624
Asn Ile Tyr Ser Val Leu Gly Asn Leu Ala Val Tyr Phe Leu Ile
185 190 195
cca att aca act tgt ttt act g gt atg agg gct tgg atc atg cat tac 672
Pro Ile Thr Thr Cys Phe Thr Gly Met Arg Ala Trp Ile Met His Tyr
200 210
agt gtg ttg att aca tca agg ctg atg gac aaa ata tag gat gca gat 720
Ser Val Leu Ile Thr Ser Arg Leu Met Asp Lys Ile Asp Ala Asp
215 220 225
ttc cct att tgg agg cat cag act ata aag att tct ata ttt gtg tta 768
Phe Pro Ile Trp Arg His Gln Thr Ile Lys Ile Ser Ile Phe Val Leu
230 235 240
atg gat cat cag aga aca agc cta tca gat cca gtt att tca ctt ttc 816
Met Asp His Gln Arg Thr Ser Leu Ser Asp Pro Val Ile Ser Leu Phe
245 250 255 260
agc ttc aaa ata tag tta aac ctt tgc cgc cag tct atc tta ctt tta 864
Ser Phe Lys Ile Leu Asn Leu Cys Arg Gln Ser Ile Leu Leu Leu
265 270 275
ctc ggg aga gtt cat gtg aaa tta agc tga aat gga gca tac ctt tgg 912
Leu Gly Arg Val His Val Lys Leu Ser Asn Gly Ala Tyr Leu Trp
280 285 290
gac cta ttc cag caa ggt gtt ttg att atg aaa ttg aga tca gag aag 960
Asp Leu Phe Gln Gln Gly Val Leu Ile Met Lys Leu Arg Ser Glu Lys
295 300 305
atg ata cta cct tgg tg a ctg cta cag ttg aaa atg aaa cat aca cct 1008
Met Ile Leu Pro Trp Leu Leu Gln Leu Lys Met Lys His Thr Pro
310 315 320
tga aaa caa caa atg aaa ccc gac aat tat gct ttg tag taa gaa gca 1056
Lys Gln Gln MetLys Pro Asp Asn Tyr Ala Leu Glu Ala
325 330 335
aag tga ata ttt att gct cag atg acg gaa ttt gga gtg agt gga gtg 1104
Lys Ile Phe Ile Ala Gln Met Thr Glu Phe Gly Val Ser Gly Val
340 345 350
ata aac aat gct ggg aag gtg aag acc tat cga aga aaa ctt tgc tac 1152
Ile Asn Asn Ala Gly Lys Val Lys Thr Tyr Arg Arg Lys Leu Cys Tyr
355 360 365
gtt tct ggc tac cat ttg gtt tca tct taa tat tag tta tat ttg taa 1200
Val Ser Gly Tyr His Leu Val Ser Ser Tyr Leu Tyr Leu
370 375
ccg gtc tgc ttt tgc gta agc caa aca cct acc caa aaa tg a ttc cag 1248
Pro Val Cys Phe Cys Val Ser Gln Thr Pro Thr Gln Lys Phe Gln
380 385 390 395
aat ttt tct gtg ata cat gaa gac ttt cca tat caa gag aca tgg tat 1296
Asn Phe Ser Val Ile His Glu Asp Phe Pro Tyr Gln Glu Thr Trp Tyr
400 405 410
tga ctc aac agt ttc cag tca tgg cca aat gtt caa tat gag tct caa 1344
Leu Asn Ser Phe Gln Ser Trp Pro Asn Val Gln Tyr Glu Ser Gln
415 420 425
taa act gaa ttt ttc ttg cga atg ttg aa aaa 1376
Thr Glu Phe Phe Leu Arg Met Leu
430
SEQUENCE LISTING12
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_016368
<160>1
<170>PatentIn version 3.5
<210>1
<211>1852
<212>DNA
<213>Homo sapiens<220>
<221>exon
<222>(1)..(41)
<220>
<221>exon
<222>(42)..(170)
<220>
<221>exon
<222>(171)..(332)
<220>
<221>exon
<222>(333)..(465)
<220>
<221>exon
<222>(466)..(659)
<220>
<221>exon
<222>(660)..(809)
<220>
<221>STS
<222>(715)..(970)
<220>
<221>exon
<222>(810)..(1025)
<220>
<221>exon
<222>(1026)..(1190)
<220>
<221>exon
<222>(1191)..(1304)
<220>
<221>exon
<222>(1305)..(1522)
<220>
<221>exon
<222>(1523)..(1825)
<220>
<221>STS
<222>(1559)..(1791)
<400>1
ccg cgc tgt ccg ccg ccg ctg cct gag tcg act ctg cgc cg c ccg ccg 48
Pro Arg Cys Pro Pro Pro Leu Pro Glu Ser Thr Leu Arg Arg Pro Pro
1 5 10 15
cga tgg agg ccg ccg ccc agt tct tcg tcg aga gcc cgg acg tgg tct 96
Arg Trp Arg Pro Pro Pro Ser Ser Ser Ser Arg Ala Arg Thr Trp Ser
20 25 30
acg gcc ccg agg cca tcg agg cgc aat acg agt acc gga cga cgc gcg 144
Thr Ala Pro Arg Pro Ser Arg Arg Asn Thr Ser Thr Gly Arg Arg Ala
35 40 45
tca gcc gcg agg gtg gcg ttc tca ag g tgc acc cca cgt cca cgc gct 192
Ser Ala Ala Arg Val Ala Phe Ser Arg Cys Thr Pro Arg Pro Arg Ala
50 55 60
tca cct tcc gga ccg ccc ggc agg tgc ccc ggc tcg ggg tca tgc ttg 240
Ser Pro Ser Gly Pro Pro Gly Arg Cys Pro Gly Ser Gly Ser Cys Leu
65 70 75 80
tcg gct ggg gcg gga aca acg gct cca cac tca ccg ccg cgg tgc tgg 288
Ser Ala Gly Ala Gly Thr Thr Ala Pro His Ser Pro Pro Arg Cys Trp
85 90 95
cca atc gac tgc gtt tgt cct ggc cca cgc gca gcg gcc gca ag g agg 336
Pro Ile Asp Cys Val Cys Pro Gly Pro Arg Ala Ala Ala Ala Arg Arg
100 105 110
cca act act acg gct cgc tga ctc agg cgg gca ccg tga gcc tgg gcc 384
Pro Thr Thr Thr Ala Arg Leu Arg Arg Ala Pro Ala Trp Ala
115 120 125
tgg acg ccg agg gcc agg agg tgt tcg tac cct tca gcg cgg tgc tgc 432
Trp Thr Pro Arg Ala Arg Arg Cys Ser Tyr Pro Ser Ala Arg Cys Cys
130 135 140
cca tgg tgg cgc cca acg acc tcg tgt tcg atg gct ggg aca tct cgt 480
Pro Trp Trp Arg Pro Thr Thr Ser Cys Ser Met Ala Gly Thr Ser Arg
145 150 155
cgc tga acc tgg ccg agg cga tgc ggc gcg cga agg tgc tgg act ggg 528
Arg Thr Trp Pro Arg Arg Cys Gly Ala Arg Arg Cys Trp Thr Gly
160 165 170
ggc tgc agg agc aac tgt ggc cgc aca tgg agg ccc tgc ggc ccc ggc 576
Gly Cys Arg Ser Asn Cys Gly Arg Thr Trp Arg Pro Cys Gly Pro Gly
175 180 185
ctt ctg ttt aca tcc ccg aat tca tcg cgg cca acc aga gcg cgc gcg 624
Leu Leu Phe Thr Ser Pro Asn Ser Ser Arg Pro Thr Arg Ala Arg Ala
190 195 200 205
cgg aca acc tca tcc cag gct cgc gtg cgc agc ag c tgg agc aga tcc 672
Arg Thr Thr Ser Ser Gln Ala Arg Val Arg Ser Ser Trp Ser Arg Ser
210 215 220
gca ggg aca tcc gag act tcc ggt cta gcg cgg ggc tgg aca aag tca 720
Ala Gly Thr Ser Glu Thr Ser Gly Leu Ala Arg Gly Trp Thr Lys Ser
225 230 235
tag tgc tgt gga cgg cga aca cgg agc gct tct gtg agg tga ttc cag 768
Cys Cys Gly Arg Arg Thr Arg Ser Ala Ser Val Arg Phe Gln
240 245 250
gcc tca acg aca cag ccg aga acc tgc tgc gca cca ttg ag c tcg gtc 816
Ala Ser Thr Thr Gln Pro Arg Thr Cys Cys Ala Pro Leu Ser Ser Val
255 260
tgg agg tgt cgc cct cca cgc tct tcg ccg tgg cca gca tcc tgg agg 864
Trp Arg Cys Arg Pro Pro Arg Ser Ser Pro Trp Pro Ala Ser Trp Arg
270 275 280
gct gtg cct tcc tca atg ggt ctc cgc aga aca ccc tgg tgc ccg gag 912
Ala Val Pro Ser Ser Met Gly Leu Arg Arg Thr Pro Trp Cys Pro Glu
285 290 295
ctc ttg agc tcg cgt ggc agc acc ggg ttt ttg tgg gcg gag atg act 960
Leu Leu Ser Ser Arg Gly Ser Thr Gly Phe Leu Trp Ala Glu Met Thr
300 305 310 315
tca agt cag gcc aga cca aag tca agt ccg tgc ttg tgg act tcc tca 1008
Ser Ser Gln Ala Arg Pro Lys Ser Ser Pro Cys Leu Trp Thr Ser Ser
320 325 330
ttg gct ccg gcc tca ag a cca tgt cca tcgtga gtt aca acc acc tgg 1056
Leu Ala Pro Ala Ser Arg Pro Cys Pro Ser Val Thr Thr Thr Trp
335 340 345
gca aca acg atg ggg aga acc tat cgg cgc cat tgc agt tcc gct cta 1104
Ala Thr Thr Met Gly Arg Thr Tyr Arg Arg His Cys Ser Ser Ala Leu
350 355 360
agg agg tgt cca aga gca acg tgg tgg acg aca tgg tgc aga gca acc 1152
Arg Arg Cys Pro Arg Ala Thr Trp Trp Thr Thr Trp Cys Arg Ala Thr
365 370 375
cag tgc tct ata cgc ccg gcg aag agc ctg acc act gc g tgg tca tca 1200
Gln Cys Ser Ile Arg Pro Ala Lys Ser Leu Thr Thr Ala Trp Ser Ser
380 385 390
agt atg tgc cgt acg tgg gtg aca gca agc gcg cgc tgg atg agt ata 1248
Ser Met Cys Arg Thr Trp Val Thr Ala Ser Ala Arg Trp Met Ser Ile
395 400 405 410
cct cgg agc tga tgc tgg gcg gaa cca aca cac tgg tgc tgc aca aca 1296
Pro Arg Ser Cys Trp Ala Glu Pro Thr His Trp Cys Cys Thr Thr
415 420 425
cgt gtg ag g act cgc tgc tgg ccg cac cca tca tgc tgg acc tag cgc 1344
Arg Val Arg Thr Arg Cys Trp Pro His Pro Ser Cys Trp Thr Arg
430 435 440
tgc tga ccg agc tgt gcc agc gcg tga gct tct gca ctg aca tgg acc 1392
Cys Pro Ser Cys Ala Ser Ala Ala Ser Ala Leu Thr Trp Thr
445 450
ccg agc cgc aga cct tcc acc ccg tgc tgt ccc tgc tca gct tcc tct 1440
Pro Ser Arg Arg Pro Ser Thr Pro Cys Cys Pro Cys Ser Ala Ser Ser
455 460 465 470
tca agg cgc cac tag tgc cgc ccg gca gcc cgg tgg tca atg cgc ttt 1488
Ser Arg Arg His Cys Arg Pro Ala Ala Arg Trp Ser Met Arg Phe
475 480 485
tcc gcc agc gca gct gca tcg aga aca tcc tca g gg cct gcg tgg ggc 1536
Ser Ala Ser Ala Ala Ala Ser Arg Thr Ser Ser Gly Pro Ala Trp Gly
490 495 500
tcc cgc cac aga acc aca tgc tcc tgg aac aca aaa tgg agc gcc cag 1584
Ser Arg His Arg Thr Thr Cys Ser Trp Asn Thr Lys Trp Ser Ala Gln
505 510 515
ggc cca gcc tca agc gag ttg gac ccg tgg ctg cca cct acc cta tgt 1632
Gly Pro Ala Ser Ser Glu Leu Asp Pro Trp Leu Pro Pro Thr Leu Cys
520 525 530
tga aca aga aag gac cgg tac ccg ctg cca cca atg gct gca ccg gtg 1680
Thr Arg Lys Asp Arg Tyr Pro Leu Pro Pro Met Ala Ala Pro Val
535 540 545
atg cca atg ggc atc tgc aag agg agc ccc caa tgc cca cca cct gag 1728
Met Pro Met Gly Ile Cys Lys Arg Ser Pro Gln Cys Pro Pro Pro Glu
550 555 560
gcc ccg gtc aca cag ttt ctc ggc tct tcc tcc ccg ctg ccc ccc acg 1776
Ala Pro Val Thr Gln Phe Leu Gly Ser Ser Ser Pro Leu Pro Pro Thr
565 570 575 580
acc cta cct tga agg ccc cca caa ata aag gcg ctg cca ctc agc cct c 1825
Thr Leu Pro Arg Pro Pro Gln Ile Lys Ala Leu Pro Leu Ser Pro
585 590 595
aaaaaaaaaa aaaaaaaaaa aaaaaaa 1852
SEQUENCE LISTING13
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_004923
<160>1
<170>PatentIn version 3.5
<210>1
<211>2535
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(101)
<220>
<221>exon
<222>(102)..(611)
<220>
<221>exon
<222>(612)..(770)
<220>
<221>exon
<222>(771)..(891)
<220>
<221>exon
<222>(892)..(968)
<220>
<221>exon
<222>(969)..(1057)
<220>
<221>exon
<222>(1058)..(1160)
<220>
<221>exon
<222>(1161)..(1298)
<220>
<221>exon
<222>(1299)..(1474)
<220>
<221>exon
<222>(1475)..(2535)
<220>
<221>STS
<222>(2123)..(2304)
<220>
<221>polyA_signal
<222>(2512)..(2517)
<220>
<221>polyA_site
<222>(2535)..(2535)
<400>1
acc ctt ccc cct tct cca acc gcc aac ggc cgc ctg cgc ctg agg ccc 48
Thr Leu Pro Pro Ser Pro Thr Ala Asn Gly Arg Leu Arg Leu Arg Pro
1 5 10 15
ggc cca cgc ccc atc ccg ctc gct cca cgc tgc ggc agc ccc ggc ggc 96
Gly Pro Arg Pro Ile Pro Leu Ala Pro Arg Cys Gly Ser Pro Gly Gly
20 25 30
ccc ag g tgc gcg gcc ccc gcc atc ccg ccc cgc cgc cct gcg cca tgg 144
Pro Arg Cys Ala Ala Pro Ala Ile Pro Pro Arg Arg Pro Ala Pro Trp
35 40 45
agg agg gcc ctc tgc cgg gcg ggc tgc cca gcc ccg agg atg cga tgg 192
Arg Arg Ala Leu Cys Arg Ala Gly Cys Pro Ala Pro Arg Met Arg Trp
50 55 60
tga cgg agc tct taa gcc ccg agg gtc cgt tcg ctt cgg aga aca tcg 240
Arg Ser Ser Ala Pro Arg Val Arg Ser Leu Arg Arg Thr Ser
65 70 75
gcc tga agg ccc ccg tga agt acg agg agg acg agt tcc acg tct tca 288
Ala Arg Pro Pro Ser Thr Arg Arg Thr Ser Ser Thr Ser Ser
80 85 90
aag aag cgt acc tgg gcc cgg cgg acc cca agg aac ccg tcc tgc acg 336
Lys Lys Arg Thr Trp Ala Arg Arg Thr Pro Arg Asn Pro Ser Cys Thr
95 100 105
cgt tca acc ccg cgc tgg gcg ccg act gca agg gcc agg tca agg cga 384
Arg Ser Thr Pro Arg Trp Ala Pro Thr Ala Arg Ala Arg Ser Arg Arg
110 115 120
agc tcg cgg ggg gcg aca gcg acg gcg ggg agc tcc tcg ggg agt acc 432
Ser Ser Arg Gly Ala Thr Ala Thr Ala Gly Ser Ser Ser Gly Ser Thr
125 130 135 140
ccg gga tcc cag agc tca gcg cgc tgg agg acg tcg cgc tcc tgc agg 480
Pro Gly Ser Gln Ser Ser Ala Arg Trp Arg Thr Ser Arg Ser Cys Arg
145 150 155
ccc cgc agc cgc ccg cct gca acg tgc act tcc tgt cct cgc tgc tac 528
Pro Arg Ser Arg Pro Pro Ala Thr Cys Thr Ser Cys Pro Arg Cys Tyr
160 165 170
ccg cgc acc gca gcc cgg cgg tgt tgc ccc tgg gcg cct ggg tcc tgg 576
Pro Arg Thr Ala Ala Arg Arg Cys Cys Pro Trp Ala Pro Gly Ser Trp
175 180 185
aag gag cct ccc acc cgg gcg tcc gca tga tcc ca g ttg aaa tca agg 624
Lys Glu Pro Pro Thr Arg Ala Ser Ala Ser Gln Leu Lys Ser Arg
190 195 200
aag cag gtg gta cta cta caa gta ata atc cgg aag aag caa ctt tgc 672
Lys Gln Val Val Leu Leu Gln Val Ile Ile Arg Lys Lys Gln Leu Cys
205 210 215
aga atc ttc ttg ctc agg aat cct gtt gca agt tcc cat cgt ccc agg 720
Arg Ile Phe Leu Leu Arg Asn Pro Val Ala Ser Ser His Arg Pro Arg
220 225 230 235
aac tag agg atg cct cct gct gtt ctc tta aga aag att cca acc caa 768
Asn Arg Met Pro Pro Ala Val Leu Leu Arg Lys Ile Pro Thr Gln
240 245 250
tg g tga tat gcc aat tga aag ggg gca cac aaa tgc tat gta tag aca 816
Trp Tyr Ala Asn Lys Gly Ala His Lys Cys Tyr Val Thr
255 260
att cta gaa caa gag aac taa aag cac tcc att tgg ttc ctc agt atc 864
Ile Leu Glu Gln Glu Asn Lys His Ser Ile Trp Phe Leu Ser Ile
265 270 275
aag atc aaa ata att atc tac agt cag atg tcc cta aac caa tga ctg 912
Lys Ile Lys Ile IleIle Tyr Ser Gln Met Ser Leu Asn Gln Leu
280 285 290
ctt tag tag gga gat ttt tgc cag cat caa caa aat taa atc tca tta 960
Leu Gly Asp Phe Cys Gln His Gln Gln Asn Ile Ser Leu
295 300 305
cac aac aa c ttg agg gag cct tac cat cgg tag tca acg ggt ctg ctt 1008
His Asn Asn Leu Arg Glu Pro Tyr His Arg Ser Thr Gly Leu Leu
310 315 320
tcc cct cgg gat caa ctc ttc cag gac cac caa aaa taa ctt tgg ctg g 1057
Ser Pro Arg Asp Gln Leu Phe Gln Asp His Gln Lys Leu Trp Leu
325 330 335
gt act gtg act gct ttg cca gtg ggg act ttt gca aca act gca att 1104
Gly Thr Val Thr Ala Leu Pro Val Gly Thr Phe Ala Thr Thr Ala Ile
340 345 350
gta ata att gtt gca aca act tgc atc atg ata ttg aac ggt tta aag 1152
Val Ile Ile Val Ala Thr Thr Cys Ile Met Ile Leu Asn Gly Leu Lys
355 360 365
cca tta ag g cat gtc ttg gta gaa atc cag aag ctt tcc agc caa aaa 1200
Pro Leu Arg His Val Leu Val Glu Ile Gln Lys Leu Ser Ser Gln Lys
370 375 380
ttg gga agg gcc aat tgg gca atg tca agc ccc agc aca aca aag ggt 1248
Leu Gly Arg Ala Asn Trp Ala Met Ser Ser Pro Ser Thr Thr Lys Gly
385 390 395 400
gca act gca gga ggt cag gct gcc tga aga att act gcg agt gct atg 1296
Ala Thr Ala Gly Gly Gln Ala Ala Arg Ile Thr Ala Ser Ala Met
405 410 415
ag g ccc aaa tta tgt gtt ctt cta ttt gca aat gca ttg gtt gca aaa 1344
Arg Pro Lys Leu Cys Val Leu Leu Phe Ala Asn Ala Leu Val Ala Lys
420 425 430
att atg aag aaa gcc cag aac gaa aga cac taa tga gca tgc caa act 1392
Ile Met Lys Lys Ala Gln Asn Glu Arg His Ala Cys Gln Thr
435 440 445
aca tgc aga ctg gag gtt tgg aag gca gcc att acc tgc cac caa cga 1440
Thr Cys Arg Leu Glu Val Trp Lys Ala Ala Ile Thr Cys His Gln Arg
450 455 460
aat ttt cag gac ttc caa gat tca gtc acg ata g gc ggc ctt cct cat 1488
Asn Phe Gln Asp Phe Gln Asp Ser Val Thr Ile Gly Gly Leu Pro His
465 470 475
gca tct cct ggg agg tgg tgg agg cca cat gcg cct gcc tgc ttg ctc 1536
Ala Ser Pro Gly Arg Trp Trp Arg Pro His Ala Pro Ala Cys Leu Leu
480 485 490
agg gag aag agg ccg aga aag aac act gct cca agt gcc tgg cag agc 1584
Arg Glu Lys Arg Pro Arg Lys Asn Thr Ala Pro Ser Ala Trp Gln Ser
495 500 505
aga tga tcc tgg agg aat ttg gaa ggt gct tat cac aga ttc tcc aca 1632
Arg Ser Trp Arg Asn Leu Glu Gly Ala Tyr His Arg Phe Ser Thr
510 515 520
ctg agt tta aat cta agg gat tga aaa tgg agt aga gta taa agt gtg 1680
Leu Ser Leu Asn Leu Arg Asp Lys Trp Ser Arg Val Ser Val
525 530 535
aat gca tgt tga ttt tgt ctt agt cta gaa atc tct agt tta gaa agg 1728
Asn Ala Cys Phe Cys Leu Ser Leu Glu Ile Ser Ser Leu Glu Arg
540 545 550
atg ttt agg gga aca tga ggc tgg ctc tgc agc aac aac cag gct ccc 1776
Met Phe Arg Gly Thr Gly Trp Leu Cys Ser Asn Asn Gln Ala Pro
555 560 565
ctg cat ccc tgg gcc cag gga gtt tac tca gag ctc tct gaa gat gtg 1824
Leu His Pro Trp Ala Gln Gly Val Tyr Ser Glu Leu Ser Glu Asp Val
570 575 580
gca acc cat gcc ccc ttt tct gag gag gtg cat ggc ctg agc att gtt 1872
Ala Thr His Ala Pro Phe Ser Glu Glu Val His Gly Leu Ser Ile Val
585 590 595 600
tgt ctg gcc cag agg aga gag ctt ggg ttc cca tag tcc tgg gag agt 1920
Cys Leu Ala Gln Arg Arg Glu Leu Gly Phe Pro Ser Trp Glu Ser
605 610 615
gtc tgc agg gcg gcg gag ggc aga gca ggg cag ggg agg gca cag cag 1968
Val Cys Arg Ala Ala Glu Gly Arg Ala Gly Gln Gly Arg Ala Gln Gln
620 625 630
gcc ctg cga agg gca gag cgg ggc agg gga ggg cag agc agg ccc tgc 2016
Ala Leu Arg Arg Ala Glu Arg Gly Arg Gly Gly Gln Ser Arg Pro Cys
635 640 645
gga gag ctc act ctg gtc gac tct tcc tct cag aga atg ttg ctc tgg 2064
Gly Glu Leu Thr Leu Val Asp Ser Ser Ser Gln Arg Met Leu Leu Trp
650 655 660
agg ctg ctc tgc atg aaa acc cta atg gtt tct tgt ttg ttt ttc aaa 2112
Arg Leu Leu Cys Met Lys Thr Leu Met Val Ser Cys Leu Phe Phe Lys
665 670 675
tta ttt aga aat aag ttc tcc gga tgg gct gtt gtg ata cca ctt aaa 2160
Leu Phe Arg Asn Lys Phe Ser Gly Trp Ala Val Val Ile Pro Leu Lys
680 685 690 695
atc tct aga gaa cta ctg aac acc taa aga ttt tct gta gcg tag ata 2208
Ile Ser Arg Glu Leu Leu Asn Thr Arg Phe Ser Val Ala Ile
700 705
ttt ccc cag agg cac gcg aac tgt cag tct ttc cta agg ccc ccg gga 2256
Phe Pro Gln Arg His Ala Asn Cys Gln Ser Phe Leu Arg Pro Pro Gly
710 715 720 725
gac gca ggc aat ggg gcc tcg cag gcc agg ctt gca cca gca tgt ctt 2304
Asp Ala Gly Ash Gly Ala Ser Gln Ala Arg Leu Ala Pro Ala Cys Leu
730 735 740
gag tta gag gac tta aaa tta tcc agt ttc ttc tgt gtt tct act tga 2352
Glu Leu Glu Asp Leu Lys Leu Ser Ser Phe Phe Cys Val Ser Thr
745 750 755
att gtg gaa aag ctc tat tat cca att aac ttc tcc ata att att gtt 2400
Ile Val Glu Lys Leu Tyr Tyr Pro Ile Asn Phe Ser Ile Ile Ile Val
760 765 770
gta ata tta tta ttg ttt gta aaa cat ggt tca cat aac tag ctt gtg 2448
Val Ile Leu Leu Leu Phe Val Lys His Gly Ser His Asn Leu Val
775 780 785
gaa acc agc agg taa aat gaa ttc tta agt tga cgc ttt tgg ttc tgt 2496
Glu Thr Ser Arg Asn Glu Phe Leu Ser Arg Phe Trp Phe Cys
790 795 800
tgt aaa gca aag atg aat aaa aat ttc caa tgt ctt caa 2535
Cys Lys Ala Lys Met Asn Lys Asn Phe Gln Cys Leu Gln
805 810
SEQUENCE LISTING14
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_153485
<160>1
<170>PatentIn vetsion 3.5
<210>1
<211>4355
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(275)
<220>
<221>exon
<222>(276)..(413)
<220>
<221>exon
<222>(414)..(510)
<220>
<221>exon
<222>(511)..(581)
<220>
<221>exon
<222>(582)..(674)
<220>
<221>exon
<222>(675)..(841)
<220>
<221>exon
<222>(842)..(947)
<220>
<221>exon
<222>(948)..(1021)
<220>
<221>exon
<222>(1022)..(1113)
<220>
<221>exon
<222>(1114)..(1211)
<220>
<221>exon
<222>(1212)..(1364)
<220>
<221>exon
<222>(1365)..(1465)
<220>
<221>exon
<222>(1466)..(1636)
<220>
<221>exon
<222>(1637)..(1747)
<220>
<221>exon
<222>(1748)..(1842)
<220>
<221>exon
<222>(1843)..(1931)
<220>
<221>exon
<222>(1932)..(1994)
<220>
<221>exon
<222>(1995)..(2142)
<220>
<221>exon
<222>(2143)..(2209)
<220>
<221>exon
<222>(2210)..(2325)
<220>
<221>exon
<222>(2326)..(2423)
<220>
<221>exon
<222>(2424)..(2554)
<220>
<221>exon
<222>(2555)..(2746)
<220>
<221>exon
<222>(2747)..(2885)
<220>
<221>exon
<222>(2886)..(3021)
<220>
<221>exon
<222>(3022)..(3175)
<220>
<221>exon
<222>(3176)..(3280)
<220>
<221>exon
<222>(3281)..(3435)
<220>
<221>exon
<222>(3436)..(3565)
<220>
<221>STS
<222>(3492)..(3653)
<220>
<221>exon
<222>(3566)..(3679)
<220>
<221>exon
<222>(3680)..(3800)
<220>
<221>exon
<222>(3801)..(3911)
<220>
<221>exon
<222>(3912)..(4048)
<220>
<221>exon
<222>(4049)..(4155)
<220>
<221>exon
<222>(4156)..(4355)
<220>
<221>polyA_signal
<222>(4333)..(4338)
<220>
<221>polyA_site
<222>(4355)..(4355)
<400>1
aag gcg ctc gtt tgg cgc gcg cgc cct agg cgg cgg atc taa gct aac 48
Lys Ala Leu Val Trp Arg Ala Arg Pro Arg Arg Arg Ile Ala Asn
1 5 10 15
ttc ttg gat ctt ttc ttg ttt ctc ctt ggt ttt tga ctt ttt ctg gac 96
Phe Leu Asp Leu Phe Leu Phe Leu Leu Gly Phe Leu Phe Leu Asp
20 25 30
cct ggt gtc tac gat ttc cga gat gcc gtc ttc ttt gtt ggg cgc ggc 144
Pro Gly Val Tyr Asp Phe Arg Asp Ala Val Phe Phe Val Gly Arg Gly
35 40 45
gat gcc ggc ctc tac atc tgc cgc agc cct gca gga agc tct gga aaa 192
Asp Ala Gly Leu Tyr Ile Cys Arg Ser Pro Ala Gly Ser Ser Gly Lys
50 55 60
tgc tgg acg gct cat cga ccg tca gtt gca aga gga ccg cat gta ccc 240
Cys Trp Thr Ala His Arg Pro Ser Val Ala Arg Gly Pro His Val Pro
65 70 75
gga cct ttc cga gct gct tat ggt gtc tgc ccc aa a taa tcc cac cgt 288
Gly Pro Phe Arg Ala Ala Tyr Gly Val Cys Pro Lys Ser His Arg
80 85
ttc tgg cat gtc aga tat gga tta tcc ttt aca agg acc tgg ttt gct 336
Phe Trp His Val Arg Tyr Gly Leu Ser Phe Thr Arg Thr Trp Phe Ala
95 100 105
gtc cgt acc caa cct tcc aga gat cag ttc cat ccg aag agt tcc tct 384
Val Arg Thr Gln Pro Ser Arg Asp Gln Phe His Pro Lys Ser Ser Ser
110 115 120 125
ccc acc tga act tgt tga gca gtt tgg ac a tat gca gtg taa ttg cat 432
Pro Thr Thr Cys Ala Val Trp Thr Tyr Ala Val Leu His
130 135
gat ggg tgt gtt ccc tcc tat cag cag agc ttg gct cac aat tga cag 480
Asp Gly Cys Val Pro Ser Tyr Gln Gln Ser Leu Ala His Asn Gln
140 145 150
tga tat att cat gtg gaa cta tga gga tgg agg aga cct tgc cta ttt 528
Tyr Ile His Val Glu Leu Gly Trp Arg Arg Pro Cys Leu Phe
155 160 165
tga tgg act tag tga gac tat tct tgc tgt ggg gct tgt gaa gcc aaa 576
Trp Thr Asp Tyr Ser Cys Cys Gly Ala Cys Glu Ala Lys
170 175 180
agc ag g cat ctt tca acc tca tgt gcg aca cct cct ggt ttt ggc gac 624
Ser Arg His Leu Ser Thr Ser Cys Ala Thr Pro Pro Gly Phe Gly Asp
185 190 195
ccc tgt aga cat agt aat tct tgg act cag cta tgc taa ttt gca aac 672
Pro Cys Arg His Ser Asn Ser Trp Thr Gln Leu Cys Phe Ala Asn
200 205 210
ag g ttc tgg agt tct taa tga tag ttt gtc tgg tgg aat gca gtt gct 720
Arg Phe Trp Ser Ser Phe Val Trp Trp Asn Ala Val Ala
215 220
tcc aga tcc ttt ata ttc tct tcc tac tga taa tac tta cct ttt aac 768
Ser Arg Ser Phe Ile Phe Ser Ser Tyr Tyr Leu Pro Phe Asn
225 230 235
aat aac ttc cac tga taa tgg cag aat ttt ctt ggc tgg aaa gga tgg 816
Asn Asn Phe His Trp Gln Asn Phe Leu Gly Trp Lys Gly Trp
240 245 250
ctg ttt ata tga agt agc cta cca g gc tga agc agg gtg gtt tag cca 864
Leu Phe Ile Ser Ser Leu Pro Gly Ser Arg Val Val Pro
255 265
aag atg tag gaa aat aaa cca ctc aaa gag ctc act ttc ttt cct tgt 912
Lys Met Glu Asn Lys Pro Leu Lys Glu Leu Thr Phe Phe Pro Cys
270 275 280
tcc ttc ctt gct aca att cac gtt ctc aga aga tg a tcc tat tct tca 960
Ser Phe Leu Ala Thr Ile His Val Leu Arg Arg Ser Tyr Ser Ser
285 290 295
aat tgc aat tga taa ttc tag aaa tat ttt ata tac acg atc tga gaa 1008
Asn Cys Asn Phe Lys Tyr Phe Ile Tyr Thr Ile Glu
300 305
agg agt aat aca g gt gta tga ttt ggg aca aga tgg aca agg aat gag 1056
Arg Ser Asn Thr Gly Val Phe Gly Thr Arg Trp Thr Arg Asn Glu
310 315 320
cag agt tgc ctc tgt gtc aca gaa tgc cat tgt ctc tgc tgc tgg taa 1104
Gln Ser Cys Leu Cys Val Thr Glu Cys His Cys Leu Cys Cys Trp
325 330 335
cat tgc tag gac cat cga tcg ttc tgt ttt taa acc aat tgt cca aat 1152
His Cys Asp His Arg Ser Phe Cys Phe Thr Asn Cys Pro Asn
340 345 350
agc agt gat tga aaa ttc tga atc act gga ctg tca gtt att ggc tgt 1200
Ser Ser Asp Lys Phe Ile Thr Gly Leu Ser Val Ile Gly Cys
355 360 365
cac aca tgc ag g tgt tag gtt ata ttt tag cac ttg tcc att cag aca 1248
His Thr Cys Arg Cys Val Ile Phe His Leu Ser Ile Gln Thr
375 380
gcc att agc acg gcc taa tac act gac gct ggt tca tgt ccg ctt acc 1296
Ala Ile Ser Thr Ala Tyr Thr Asp Ala Gly Ser Cys Pro Leu Thr
385 390 395
tcc tgg att ctc agc atc ttc aac cgt gga aaa gcc ttc aaa agt aca 1344
Ser Trp Ile Leu Ser Ile Phe Asn Arg Gly Lys Ala Phe Lys Ser Thr
400 405 410
tag agc tct tta tag taa ag g tat tct att gat ggc agc ctc aga aaa 1392
Ser Ser Leu Arg Tyr Ser Ile Asp Gly Ser Leu Arg Lys
420
tga gga taa tga tat ttt atg gtg tgt caa cca tga tac ttt tcc ttt 1440
Gly Tyr Phe Met Val Cys Gln Pro Tyr Phe Ser Phe
425 430 435
cca aaa gcc aat gat gga aac cca g at gac agc tgg tgt tga tgg tca 1488
Pro Lys Ala Asn Asp Gly Asn Pro Asp Asp Ser Trp Cys Trp Ser
440 450
ttc ctg ggc tct ttc tgc gat aga tga att gaa agt aga taa aat aat 1536
Phe Leu Gly Ser Phe Cys Asp Arg Ile Glu Ser Arg Asn Asn
455 460 465
tac acc ttt aaa caa gga tca tat tcc aat aac tga ttc acc agt tgt 1584
Tyr Thr Phe Lys Gln Gly Ser Tyr Ser Asn Asn Phe Thr Ser Cys
470 475 480
tgt aca gca gca cat gtt acc tcc gaa gaa att tgt tct cct ctc ag c 1632
Cys Thr Ala Ala His Val Thr Ser Glu Glu Ile Cys Ser Pro Leu Ser
485 490 495
aca g gg gag cct tat gtt tca taa act tag acc tgt aga tca act gag 1680
Thr Gly Glu Pro Tyr Val Ser Thr Thr Cys Arg Ser Thr Glu
500 505 510
gca tct act tgt gag taa tgt ggg agg aga tgg aga aga gat tga aag 1728
Ala Ser Thr Cys Glu Cys Gly Arg Arg Trp Arg Arg Asp Lys
515 520
att ctt taa att aca tca g ga aga cca ggc ttg tgc aac ttg cct tat 1776
Ile Leu Ile Thr Ser Gly Arg Pro Gly Leu Cys Asn Leu Pro Tyr
525 535
tct tgc ttg ctc cac tgc tgc ctg tga tag aga agt atc tgc ctg ggc 1824
Ser Cys Leu Leu His Cys Cys Leu Arg Ser Ile Cys Leu Gly
540 545 550
tac tcg ggc ttt ctt tag gta tgg tgg tga agc aca gat gag att tcc 1872
Tyr Ser Gly Phe Leu Val Trp Trp Ser Thr Asp Glu Ile Ser
555 560 565
aac cac tct tcc gcc tcc aag taa tgt tgg tcc cat ctt ggg gtc tcc 1920
Asn His Ser Ser Ala Ser Lys Cys Trp Ser His Leu Gly Val Ser
570 575 580
tgt cta ttc ta g ttc tcc tgt tcc tag tgg tag tcc cta tcc aaa tcc 1968
Cys Leu Phe Phe Ser Cys Ser Trp Ser Leu Ser Lys Ser
585 590 595
atc ctt ttt ggg aac acc gtc tca tg g tat aca gcc tcc tgc cat gtc 2016
Ile Leu Phe Gly Asn Thr Val Ser Trp Tyr Thr Ala Ser Cys His Val
600 610
aac tcc agt gtg tgc tct ggg aaaccc agc aac tca ggc cac aaa tat 2064
Asn Ser Ser Val Cys Ser Gly Lys Pro Ser Asn Ser Gly His Lys Tyr
615 620 625
gag ttg tgt gac tgg acc aga gat tgt gta ctc tgg aaa aca caa tgg 2112
Glu Leu Cys Asp Trp Thr Arg Asp Cys Val Leu Trp Lys Thr Gln Trp
630 635 640
tat ttg cat tta ctt ttc tcg gat cat ggg aaa cat ttg gga tgc aag 2160
Tyr Leu His Leu Leu Phe Ser Asp His Gly Lys His Leu Gly Cys Lys
645 650 655 660
ctt agt tgt gga gag aat att caa gag tgg caa cag aga gat cac tgc a 2209
Leu Ser Cys Gly Glu Asn Ile Gln Glu Trp Gln Gln Arg Asp His Cys
665 670 675
at tga aag tag tgt tcc ctg cca act gct aga gtc agt gct aca aga 2256
Asn Lys Cys Ser Leu Pro Thr Ala Arg Val Ser Ala Thr Arg
680 685 690
act aaa ggg ttt gca gga att tct aga cag aaa ctc cca gtt tgc agg 2304
Thr Lys Gly Phe Ala Gly Ile Ser Arg Gln Lys Leu Pro Val Cys Arg
695 700 705
agg acc att agg aaa tcc aaa tac tac tgc taa agt gca gca gag gct 2352
Arg Thr Ile Arg Lys Ser Lys Tyr Tyr Cys Ser Ala Ala Glu Ala
710 715 720
gat agg att cat gcg tcc tga aaa cgg aaa tcc cca gca aat gca aca 2400
Asp Arg Ile His Ala Ser Lys Arg Lys Ser Pro Ala Asn Ala Thr
725 730 735
gga act gca gag gaa gtt tca tg a ggc tca act aag tga aaa gat ttc 2448
Gly Thr Ala Glu Glu Val Ser Gly Ser Thr Lys Lys Asp Phe
740 745 750
act tca ggc aat tca gca gtt ggt tcg aaa atc ata tca ggc tct ggc 2496
Thr Ser Gly Asn Ser Ala Val Gly Ser Lys Ile Ile Ser Gly Ser Gly
755 760 765
ttt atg gaa act tct ttg tga aca tca att cac tat cat tgt ggc aga 2544
Phe Met Glu Thr Ser Leu Thr Ser Ile His Tyr His Cys Gly Arg
770 775 780
act tca gaa g ga act tca aga gcagct gaa gat cac cac ctt taa aga 2592
Thr Ser Glu Gly Thr Ser Arg Ala Ala Glu Asp His His Leu Arg
785 790 795
tct tgt aat cag gga caa aga act cac agg ggc att aat tgc ttc tct 2640
Ser Cys Asn Gln Gly Gln Arg Thr His Arg Gly Ile Asn Cys Phe Ser
800 805 810
tat caa ctg cta cat cag aga taa tgc cgc tgt tga tgg cat tag ttt 2688
Tyr Gln Leu Leu His Gln Arg Cys Arg Cys Trp His Phe
815 820 825
aca ttt aca gga tat ctg ccc act tct ata tag cac tga tga tgc aat 2736
Thr Phe Thr Gly Tyr Leu Pro Thr Ser Ile His Cys Asn
830 835
ttg ttc taa g gc aaa tga gct tct cca gcg ttc ccg aca agt tca aaa 2784
Leu Phe Gly Lys Ala Ser Pro Ala Phe Pro Thr Ser Ser Lys
840 845 850
taa gac tga aaa aga aag aat gtt aag gga atc att aaa gga ata tca 2832
Asp Lys Arg Lys Asn Val Lys Gly Ile Ile Lys Gly Ile Ser
855 860 865
aaa aat tag caa tca agt gga cct ttc caa tgt ttg tgc tca gta tag 2880
Lys Asn Gln Ser Ser Gly Pro Phe Gln Cys Leu Cys Ser Val
870 875 880
aca ag t gag att tta tga ggg tgt ggt gga act ttc tct tac ggc tgc 2928
Thr Ser Glu Ile Leu Gly Cys Gly Gly Thr Phe Ser Tyr Gly Cys
885 890 895
aga gaa aaa aga tcc tca agg tct tgg gct tca ttt cta taa aca tgg 2976
Arg Glu Lys Arg Ser Ser Arg Ser Trp Ala Ser Phe Leu Thr Trp
900 905 910
aga acc aga aga aga cat agt tgg act tca ggc ctt cca aga aag att 3024
Arg Thr Arg Arg Arg His Ser Trp Thr Ser Gly Leu Pro Arg Lys Ile
915 920 925
aaa cag tta caa atg cat tac aga cac act tca aga act ggt aaa tca 3072
Lys Gln Leu Gln Met His Tyr Arg His Thr Ser Arg Thr Gly Lys Ser
930 935 940
aag taa ggc cgc tcc tca gtc tcc cag tgt acc caa aaa acc tgg tcc 3120
Lys Gly Arg Ser Ser Val Ser Gln Cys Thr Gln Lys Thr Trp Ser
945 950 955
tcc agt gtt gtc atc tga tcc aaa tat gct gag taa tga aga agc agg 3168
Ser Ser Val Val Ile Ser Lys Tyr Ala Glu Arg Ser Arg
960 965 970
aca tca t tt tga aca aat gct taa att gtc aca gcg atc caa gga tga 3216
Thr Ser Phe Thr Asn Ala Ile Val Thr Ala Ile Gln Gly
975 980
gct ctt tag tat tgc cct tta taa ttg gct aat aca agt cga cct tgc 3264
Ala Leu Tyr Cys Pro Leu Leu Ala Asn Thr Ser Arg Pro Cys
985 990 995
aga taa gct gct aca g gt tgc ttc tcc att tct gga gcc aca tct 3309
Arg Ala Ala Thr Gly Cys Phe Ser Ile Ser Gly Ala Thr Ser
1000 1005 1010
agt ccg aat ggc caa agt tga tca aaa cag agt tcg tta tat gga 3354
Ser Pro Asn Gly Gln Ser Ser Lys Gln Ser Ser Leu Tyr Gly
1015 1020 1025
ttt act ctg gcg gta tta cga gaa gaa cag aag ttt cag taa tgc 3399
Phe Thr Leu Ala Val Leu Arg Glu Glu Gln Lys Phe Gln Cys
1030 1035 1040
tgc tcg tgt act gtc cag act ggc tga cat gca tag cac aga aat ttc 3447
Cys Ser Cys Thr Val Gln Thr Gly His Ala His Arg Asn Phe
1045 1050
act tca gca gcg act aga gta cat tgc tcg agc cat tct tag tgc 3492
Thr Ser Ala Ala Thr Arg Val His Cys Ser Ser His Ser Cys
1055 1060 1065
caa aag ttc cac tgc cat ttc atc aat agc tgc cga tgg tga att 3537
Gln Lys Phe His Cys His Phe Ile Asn Ser Cys Arg Trp Ile
1070 1075 1080
tct tca tga att aga aga aaa aat gga g gt tgc tag gat cca act 3582
Ser Ser Ile Arg Arg Lys Asn Gly Gly Cys Asp Pro Thr
1085 1090 1095
tca gat aca gga gac act aca aag gca gta ttc cca tca ttc tt 3627
Ser Asp Thr Gly Asp Thr Thr Lys Ala Val Phe Pro Ser Phe Phe
1100 1105 1110
tgt aca gga tgc agt ttc tca gct gga ttc tga gct gat gga cat 3672
Cys Thr Gly Cys Ser Phe Ser Ala Gly Phe Ala Asp Gly His
1115 1120
aac taa g ct tta tgg gga att tgc tga ccc att taa act tgc aga 3717
Asn Ala Leu Trp Gly Ile Cys Pro Ile Thr Cys Arg
1125 1130 1135
gtg caa act tgc aat aat tca ttg tgc cgg tta ttc aga ccc tat 3762
Val Gln Thr Cys Asn Asn Ser Leu Cys Arg Leu Phe Arg Pro Tyr
1140 1145 1150
att ggt gca gac act ttg gca aga tat cat aga gaa ag a att gag 3807
Ile Gly Ala Asp Thr Leu Ala Arg Tyr His Arg Glu Arg Ile Glu
1155 1160 1165
tga cag tgt gac att gag ctc ctc gga tag aat gca tgc tct tag tct 3855
Gln Cys Asp Ile Glu Leu Leu Gly Asn Ala Cys Ser Ser
1170 1175
caa gat tgt tct cct tgg caa aat tta tgc tgg cac acc acg ctt 3900
Gln Asp Cys Ser Pro Trp Gln Asn Leu Cys Trp His Thr Thr Leu
1180 1185 1190
ctt tcc ttt ag a ttt tat tgt aca gtt ttt aga aca gca ggt ttg 3945
Leu Ser Phe Arg Phe Tyr Cys Thr Val Phe Arg Thr Ala Gly Leu
1195 1200 1205
tac ttt gaa ctg gga tgt ggg ctt cgt aat aca gac aat gaa tga 3990
Tyr Phe Glu Leu Gly Cys Gly Leu Arg Asn Thr Asp Asn Glu
1210 1215 1220
aat tgg agt acc att acc tag act act aga agt tta tga tca gtt 4035
Asn Trp Ser Thr Ile Thr Thr Thr Arg Ser Leu Ser Val
1225 1230 1235
gtt caa atc acg g ga tcc att ctg gaa cag aat gaa gaa gcc act 4080
Val Gln Ile Thr Gly Ser Ile Leu Glu Gln Asn Glu Glu Ala Thr
1240 1245 1250
gca cct ttt gga ttg tat aca tgt att att gat aag ata tgt tga 4125
Ala Pro Phe Gly Leu Tyr Thr Cys Ile Ile Asp Lys Ile Cys
1255 1260 1265
gaa tcc cag cca agt ttt aaa ttg tga aag gag aag att tac aaa 4170
Glu Ser Gln Pro Ser Phe Lys Leu Lys Glu Lys Ile Tyr Lys
1270 1275
tct ctg cct gga tgc tgt ttg tgg tta cct tgt tga gct cca gtc 4215
Ser Leu Pro Gly Cys Cys Leu Trp Leu Pro Cys Ala Pro Val
1280 1285 1290
tat gag ctc gtc agt agc agt aca agc cat cac tgg gaa ttt taa 4260
Tyr Glu Leu Val Ser Ser Ser Thr Ser His His Trp Glu Phe
1295 1300 1305
atc tct tca agc taa att aga acg gct tca tta att act gtg ata 4305
Ile Ser Ser Ser Ile Arg Thr Ala Ser Leu Ile Thr Val Ile
1310 1315 1320
tac ttt cat ccg ttt tat gat ctg taa aat aaa aac tca gct ggg 4350
Tyr Phe His Pro Phe Tyr Asp Leu Asn Lys Asn Ser Ala Gly
1325 1330 1335
tcc ag 4355
Ser
SEQUENCE LISTING15
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_015589
<160>1
<170>PatentIn version 3.5
<210>1
<211>2356
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(194)
<220>
<221>exon
<222>(195)..(713)
<220>
<221>exon
<222>(714)..(977)
<220>
<221>exon
<222>(978)..(1087)
<220>
<221>exon
<222>(1088)..(1174)
<220>
<221>exon
<222>(1175)..(1508)
<220>
<221>exon
<222>(1509)..(1594)
<220>
<221>exon
<222>(1595)..(1713)
<220>
<221>exon
<222>(1714)..(1915)
<220>
<221>exon
<222>(1916)..(2042)
<220>
<221>exon
<222>(2043)..(2126)
<220>
<221>exon
<222>(2127)..(2338)
<400>1
gat gtt tcg cga cca ggt cgg ggt gct ggc ggg ctg gtt taa ggg ctg 48
Asp Val Ser Arg Pro Gly Arg Gly Ala Gly Gly Leu Val Gly Leu
1 5 10 15
gaa cga gtg cga gca gac tgt tgc gct gct gtc gct gct caa gcg cgt 96
Glu Arg Val Arg Ala Asp Cys Cys Ala Ala Val Ala Ala Gln Ala Arg
20 25 30
gag cca gac cca ggc ccg ctt cct cca gct ctg cct gga gca ctc gct 144
Glu Pro Asp Pro Gly Pro Leu Pro Pro Ala Leu Pro Gly Ala Leu Ala
35 40 45
ggc cga ctg cgc cga gct gca cgt cct cga acg cga ggc caa cag ccc 192
Gly Arg Leu Arg Arg Ala Ala Arg Pro Arg Thr Arg Gly Gln Gln Pro
50 55 60
cg g aat cat taa cca atg gca aca gga atc caa gga taa agt gat ttc 240
Arg Asn His Pro Met Ala Thr Gly Ile Gln Gly Ser Asp Phe
65 70 75
cct cct gtt aac tca tct gcc ttt gct gaa gcc agg aaa cct cga cgc 288
Pro Pro Val Asn Ser Ser Ala Phe Ala Glu Ala Arg Lys Pro Arg Arg
80 85 90
gaa agt aga ata tat gaa act gct gcc caa aat cct ggc tca ctc tat 336
Glu Ser Arg Ile Tyr Glu Thr Ala Ala Gln Asn Pro Gly Ser Leu Tyr
95 100 105
tga aca caa cca gca cat tga gga gag cag gca gct gct gtc cta tgc 384
Thr Gln Pro Ala His Gly Glu Gln Ala Ala Ala Val Leu Cys
110 115 120
ttt gat aca tcc agc cac ttc gtt aaa aga ccg tag tgc ttt agc cat 432
Phe Asp Thr Ser Ser His Phe Val Lys Arg Pro Cys Phe Ser His
125 130 135
gtg gct gaa tca ctt gga gga ccg cac gtc gac cag ctt tgg tgg cca 480
Val Ala Glu Ser Leu Gly Gly Pro His Val Asp Gln Leu Trp Trp Pro
140 145 150
gaa ccg agg ccg ctc aga ctc tgt gga tta tgg aca gac aca cta cta 528
Glu Pro Arg Pro Leu Arg Leu Cys Gly Leu Trp Thr Asp Thr Leu Leu
155 160 165 170
tca cca aag aca gaa ctc tga tga caa gct caa tgg gtg gca gaa ctc 576
Ser Pro Lys Thr Glu Leu Gln Ala Gln Trp Val Ala Glu Leu
175 180
tcg gga ttc tgg gat ttg cat caa tgc ctc caa ctg gca gga caa aag 624
Ser Gly Phe Trp Asp Leu His Gln Cys Leu Gln Leu Ala Gly Gln Lys
185 190 195 200
cat ggg gtg tga gaa tgg cca tgt gcc cct cta ctc ctc ctc atc tgt 672
His Gly Val Glu Trp Pro Cys Ala Pro Leu Leu Leu Leu Ile Cys
205 210 215
ccc cac cac aat caa tac gat tgg aac cag cac aag tac aa t tct ctc 720
Pro His His Asn Gln Tyr Asp Trp Asn Gln His Lys Tyr Asn Ser Leu
220 225 230
agg cca ggc aca cca cag ccc ttt gaa acg atc tgt gtc cct tac ccc 768
Arg Pro Gly Thr Pro Gln Pro Phe Glu Thr Ile Cys Val Pro Tyr Pro
235 240 245
acc cat gaa tgt gcc aaa cca gcc tct agg aca tgg atg gat gtc tca 816
Thr His Glu Cys Ala Lys Pro Ala Ser Arg Thr Trp Met Asp Val Ser
250 255 260
tga gga ctt acg agc tag agg acc cca gtg cct ccc atc cga tca tgc 864
Gly Leu Thr Ser Arg Thr Pro Val Pro Pro Ile Arg Ser Cys
265 270 275
ccc cct gtc tcc aca aag cag tgt agc ctc ttc agg aag tgg tgg gag 912
Pro Pro Val Ser Thr Lys Gln Cys Ser Leu Phe Arg Lys Trp Trp Glu
280 285 290
tga aca ctt aga aga tca gac cac tgc tcg taa cac att cca aga aga 960
Thr Leu Arg Arg Ser Asp His Cys Ser His Ile Pro Arg Arg
295 300 305
agg tag tgg gat gaa ag a tgt tcc agc ctg gct gaa aag cct ccg cct 1008
Arg Trp Asp Glu Arg Cys Ser Ser Leu Ala Glu Lys Pro Pro Pro
310 315 320
gca caa ata tgc cgc gct ttt ctc cca gat gac cta tga gga gat gat 1056
Ala Gln Ile Cys Arg Ala Phe Leu Pro Asp Asp Leu Gly Asp Asp
325 330 335
ggc cct cac cga gtg cca gct gga ggc gca g aa tgt tac caa agg tgc 1104
Gly Pro His Arg Val Pro Ala Gly Gly Ala Glu Cys Tyr Gln Arg Cys
340 345 350
aag aca caa aat tgt cat cag tat tca gaa gct caa aga aag aca aaa 1152
Lys Thr Gln Asn Cys His Gln Tyr Ser Glu Ala Gln Arg Lys Thr Lys
355 360 365
tct cct gaa gtc ttt gga aag g ga cat cat cga ggg ggg cag cct gcg 1200
Ser Pro Glu Val Phe Gly Lys Gly His His Arg Gly Gly Gln Pro Ala
370 375 380 385
cat ccc gct cca gga act gca cca gat gat cct gac tcc gat caa ggc 1248
His Pro Ala Pro Gly Thr Ala Pro Asp Asp Pro Asp Ser Asp Gln Gly
390 395 400
cta cag ctc ccc gag cac cac ccc cga ggc tcg ccg ccg gga gcc cca 1296
Leu Gln Leu Pro Glu His His Pro Arg Gly Ser Pro Pro Gly Ala Pro
405 410 415
ggc ccc gcg tca gcc ctc act gat ggg ccc cga gag cca gag ccc cga 1344
Gly Pro Ala Ser Ala Leu Thr Asp Gly Pro Arg Glu Pro Glu Pro Arg
420 425 430
ctg caa aga tgg ggc cgc agc cac tgg cgc cac ggc cac ccc ctc ggc 1392
Leu Gln Arg Trp Gly Arg Ser His Trp Arg His Gly His Pro Leu Gly
435 440 445
cgg ggc cag cgg ggg gct cca gcc gca cca gct gag cag ctg cga tgg 1440
Arg Gly Gln Arg Gly Ala Pro Ala Ala Pro Ala Glu Gln Leu Arg Trp
450 455 460 465
gga gct ggc cgt cgc ccc cct gcc aga ggg gga cct ccc cgg gca gtt 1488
Gly Ala Gly Arg Arg Pro Pro Ala Arg Gly Gly Pro Pro Arg Ala Val
470 475 480
cac acg cgt cat ggg gaa ag t gtg cac aca gct ctt ggt ctc cag acc 1536
His Thr Arg His Gly Glu Ser Val His Thr Ala Leu Gly Leu Gln Thr
485 490 495
tga tga gga aaa tat aag ttc cta ttt aca gct cat aga caa gtg tct 1584
Gly Lys Tyr Lys Phe Leu Phe Thr Ala His Arg Gln Val Ser
500 505 510
aat tca tga g gc att tac aga gac aca gaa aaa aag att gtt gtc atg 1632
Asn Ser Gly Ile Tyr Arg Asp Thr Glu Lys Lys Ile Val Val Met
515 520 525
gaa aca gca ggt gca gaa gct ctt tcg gtc ttt ccc tcg gaa aac cct 1680
Glu Thr Ala Gly Ala Glu Ala Leu Ser Val Phe Pro Ser Glu Asn Pro
530 535 540
tct aga cat atc agg ata tcg aca gca aag aaa tcg agg ctt tgg gca 1728
Ser Arg His Ile Arg Ile Ser Thr Ala Lys Lys Ser Arg Leu Trp Ala
545 550 555
atc caa ctc cct ccc gac ggc tgg ctc tgt ggg cgg tgg cat ggg cag 1776
Ile Gln Leu Pro Pro Asp Gly Trp Leu Cys Gly Arg Trp His Gly Gln
560 565 570
acg gaa ccc gcg cca gta cca gat ccc ctc tcg gaa cgt ccc ttc cgc 1824
Thr Glu Pro Ala Pro Val Pro Asp Pro Leu Ser Glu Arg Pro Phe Arg
575 580 585 590
ccg cct ggg cct ctt ggg cac cag tgg att cgt cag ctc caa cca gcg 1872
Pro Pro Gly Pro Leu Gly His Gln Trp Ile Arg Gln Leu Gln Pro Ala
595 600 605
caa cac cac agc tac ccc cac cat cat gaa aca agg aag aca g aa cct 1920
Gln His His Ser Tyr Pro His His His Glu Thr Arg Lys Thr Glu Pro
610 615 620
gtg gtt tgc caa ccc cgg ggg cag caa tag cat gcc aag ccg cac cca 1968
Val Val Cys Gln Pro Arg Gly Gln Gln His Ala Lys Pro His Pro
625 630 635
cag ctc agt cca gag gac ccg ctc gct gcc cgt gca cac ttc ccc aca 2016
Gln Leu Ser Pro Glu Asp Pro Leu Ala Ala Arg Ala His Phe Pro Thr
640 645 650
gaa cat gct gat gtt cca gca gcc ag a att cca gct tcc cgt gac cga 2064
Glu His Ala Asp Val Pro Ala Ala Arg Ile Pro Ala Ser Arg Asp Arg
655 660 665
acc tga cat caa caa cag gct gga gtc gtt gtg cct cag tat gac cga 2112
Thr His Gln Gln Gln Ala Gly Val Val Val Pro Gln Tyr Asp Arg
670 675 680
aca cgc cct ggg ag a cgg ggt tga ccg gac ctc cac cat cta gaa gct 2160
Thr Arg Pro Gly Arg Arg Gly Pro Asp Leu His His Leu Glu Ala
685 690 695
gaa gat gag agt gac cgc gct ggc cgt gaa atc gac tgc tgc ggg tcc 2208
Glu Asp Glu Ser Asp Arg Ala Gly Arg Glu Ile Asp Cys Cys Gly Ser
700 705 710 715
agt gtc cgc cat ctt cag ggt tgc aca gaa tcc tcc aag ata ctt tgc 2256
Ser Val Arg His Leu Gln Gly Cys Thr Glu Ser Ser Lys Ile Leu Cys
720 725 730
agc ctt ttt tcc ccc tgg tcc ctc tcc cgt ttt gat ttt gtg aga gcg 2304
Ser Leu Phe Ser Pro Trp Ser Leu Ser Arg Phe Asp Phe Val Arg Ala
735 740 745
tag gtc atc ctc gta aac ata tca gta gac ctg g aaaaaaaaaa aaaaaaaa 2356
Val Ile Leu Val Asn Ile Ser Val Asp Leu
750 755
SEQUENCE LISTING16
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_016002
<160>1
<170>PatentIn version 3.5
<210>1
<211>2482
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(537)
<220>
<221>exon
<222>(538)..(650)
<220>
<221>exon
<222>(651)..(731)
<220>
<221>exon
<222>(732)..(861)
<220>
<221>exon
<222>(862)..(911)
<220>
<221>exon
<222>(912)..(1042)
<220>
<221>exon
<222>(1043)..(1160)
<220>
<221>exon
<222>(1161)..(1280)
<220>
<221>exon
<222>(1281)..(1337)
<220>
<221>exon
<222>(1338)..(1449)
<220>
<221>exon
<222>(1450)..(1531)
<220>
<221>exon
<222>(1532)..(2474)
<220>
<221>STS
<222>(1577)..(1739)
<220>
<221>STS
<222>(1901)..(2027)
<220>
<221>STS
<222>(2019)..(2168)
<220>
<221>STS
<222>(2020)..(2144)
<220>
<221>STS
<222>(2020)..(2144)
<220>
<221>STS
<222>(2184)..(2428)
<220>
<221>STS
<222>(2247)..(2421)
<400>1
tgc gct gcc cgg ggc ggc cag agc cct gca gaa caa acc gcc gca cgg 48
Cys Ala Ala Arg Gly Gly Gln Ser Pro Ala Glu Gln Thr Ala Ala Arg
1 5 10 15
aat tag ggg ccg ccg tcc gcg cct gcc agg ctt gga agc gga ctc gcc 96
Asn Gly Pro Pro Ser Ala Pro Ala Arg Leu Gly Ser Gly Leu Ala
20 25 30
ccc agg gcc acc gcc cta gga aac ctc ccg tcg gaa gcc tcc caa gca 144
Pro Arg Ala Thr Ala Leu Gly Asn Leu Pro Ser Glu Ala Ser Gln Ala
35 40 45
agc cgc tca ccc gcg gct ccc gcg cga ggc ggc gtg ggc gtg ggc gcg 192
Ser Arg Ser Pro Ala Ala Pro Ala Arg Gly Gly Val Gly Val Gly Ala
50 55 60
gcc ctg gcg cgg cgg cgc gcg cgg ggt gaa ggg agc ccg gcg cgc tgg 240
Ala Leu Ala Arg Arg Arg Ala Arg Gly Glu Gly Ser Pro Ala Arg Trp
65 70 75
ctg cgg cga cgg cgg ccg ttg ctg cgc cgg gta ctg ggg tcg ctg cct 288
Leu Arg Arg Arg Arg Pro Leu Leu Arg Arg Val Leu Gly Ser Leu Pro
80 85 90 95
gag gcg cag gcg ccg tgg act cca ccc gcc ccg ggg cct ggg ctc gct 336
Glu Ala Gln Ala Pro Trp Thr Pro Pro Ala Pro Gly Pro Gly Leu Ala
100 105 110
gtg gac tcg tca tgg cga ccg agc aga ggc ctt tcc acc tgg tgg tgt 384
Val Asp Ser Ser Trp Arg Pro Ser Arg Gly Leu Ser Thr Trp Trp Cys
115 120 125
tcg gcg cgt ctg gct tca ccg gcc agt tcg tga ccg agg agg tgg ccc 432
Ser Ala Arg Leu Ala Ser Pro Ala Ser Ser Pro Arg Arg Trp Pro
130 135 140
ggg agc agg tgg acc cgg agc gga gct ccc gcc tgc cct ggg ccg tgg 480
Gly Ser Arg Trp Thr Arg Ser Gly Ala Pro Ala Cys Pro Gly Pro Trp
145 150 155
cgg gcc gct ccc ggg aga agc tgc agc ggg tgc tgg aga agg cgg ccc 528
Arg Ala Ala Pro Gly Arg Ser Cys Ser Gly Cys Trp Arg Arg Arg Pro
160 165 170
tga agc tgg gaa gac caa cac tgt cat ctg aag ttg gaa tca tca tct 576
Ser Trp Glu Asp Gln His Cys His Leu Lys Leu Glu Ser Ser Ser
175 180 185
gtg ata ttg cta atc cag cct cgc ttg atg aaa tgg cta aac agg caa 624
Val Ile Leu Leu Ile Gln Pro Arg Leu Met Lys Trp Leu Asn Arg Gln
190 195 200 205
cag ttg tcc tca att gcg tag gac ca t atc ggt ttt atg gag aac ctg 672
Gln Leu Ser Ser Ile Ala Asp His Ile Gly Phe Met Glu Asn Leu
210 215 220
taa taa aag cat gta ttg aaa atg gag cca gtt gta tcg aca tca gtg 720
Lys His Val Leu Lys Met Glu Pro Val Val Ser Thr Ser Val
225 230
gag aac ctc ag t ttc tgg aac taa tgc aac tga agt atc atg aga aag 768
Glu Asn Leu Ser Phe Trp Asn Cys Asn Ser Ile Met Arg Lys
235 240 245
ctg cag aca aag ggg ttt ata tca ttg gaa gca gcg gct ttg act cca 816
Leu Gln Thr Lys Gly Phe Ile Ser Leu Glu Ala Ala Ala Leu Thr Pro
250 255 260
ttc cag cag atc tgg gag taa tat ata cca gaa ata aaa tga atg gta 864
Phe Gln Gln Ile Trp Glu Tyr Ile Pro Glu Ile Lys Met Val
265 270 275
ctt tga ctg ctg tgg aaa gtt tcc tga cta tac att cag gac ctg ag g 912
Leu Leu Leu Trp Lys Val Ser Leu Tyr Ile Gln Asp Leu Arg
280 285 290
ggt tga gca ttc atg atg gta cct gga agt cag caa ttt atg gtt ttg 960
Gly Ala Phe Met Met Val Pro Gly Ser Gln Gln Phe Met Val Leu
295 300 305
gag atc aga gta att tga gaa aac taa gaa atg tat caa atc tga aac 1008
Glu Ile Arg Val Ile Glu Asn Glu Met Tyr Gln Ile Asn
310 315 320
ctg tcc cgc tca ttg gtc caa aat tga aga gaa g gt ggc caa ttt ctt 1056
Leu Ser Arg Ser Leu Val Gln Asn Arg Glu Gly Gly Gln Phe Leu
325 330 335
att gtc ggg aac tca aag gtt att cca ttc ctt tta tgg gat ctg atg 1104
Ile Val Gly Asn Ser Lys Val Ile Pro Phe Leu Leu Trp Asp Leu Met
340 345 350
tgt ctg ttg taa gga gga ctc aac gtt act tgt atg aaa att tag agg 1152
Cys Leu Leu Gly Gly Leu Asn Val Thr Cys Met Lys Ile Arg
355 360 365
aat cac ca g ttc agt atg ctg cgt atg taa ctg tgg gag gca tca cct 1200
Asn His Gln Phe Ser Met Leu Arg Met Leu Trp Glu Ala Ser Pro
370 375 380
ctg tta tta agc tga tgt ttg cag gac ttt tct ttt tgt tct ttg tga 1248
Leu Leu Leu Ser Cys Leu Gln Asp Phe Ser Phe Cys Ser Leu
385 390
ggt ttg gaa ttg gaa ggc aac ttc tca taa aa t tcc cat ggt tct tct 1296
Gly Leu Glu Leu Glu Gly Asn Phe Ser Asn Ser His Gly Ser Ser
395 400 405
cct ttg gct att ttt caa aac aag gcc caa cac aaa aac ag a ttg atg 1344
Pro Leu Ala Ile Phe Gln Asn Lys Ala Gln His Lys Asn Arg Leu Met
410 415 420 425
ctg cct cat tca cgc tga cat tct ttg gtc aag gat aca gcc aag gca 1392
Leu Pro His Ser Arg His Ser Leu Val Lys Asp Thr Ala Lys Ala
430 435 440
ctg gta cag ata aga aca aac caa ata tca aaa ttt gta ctc agg tga 1440
Leu Val Gln Ile Arg Thr Asn Gln Ile Ser Lys Phe Val Leu Arg
445 450 455
aag gac cag agg ctg gct atg tgg cta ccc cca tag cta tgg ttc agg 1488
Lys Asp Gln Arg Leu Ala Met Trp Leu Pro Pro Leu Trp Phe Arg
460 465 470
cag cca tga ctc ttc taa gtg atg ctt ctc atc tgc cta agg c gg gcg 1536
Gln Pro Leu Phe Val Met Leu Leu Ile Cys Leu Arg Arg Ala
475 480
ggg tct tca cac ctg gag cag ctt ttt cca aaa caa agt tga ttg aca 1584
Gly Ser Ser His Leu Glu Gln Leu Phe Pro Lys Gln Ser Leu Thr
485 490 495
gac tca aca aac acg gta ttg agt tta gtg tta tta gca gct ctg aag 1632
Asp Ser Thr Asn Thr Val Leu Ser Leu Val Leu Leu Ala Ala Leu Lys
500 505 510 515
tct aaa cac tgg aag aat taa ctg aag tca taa cgt gcg tga att aac 1680
Ser Lys His Trp Lys Asn Leu Lys Ser Arg Ala Ile Asn
520 525
agc ttc tct att tga tat ttg aaa ttc ttc tgt aag cct gtc tga gtg 1728
Ser Phe Ser Ile Tyr Leu Lys Phe Phe Cys Lys Pro Val Val
530 535 540
tat gtg gaa acg att gtc aaa tct aaa ata tct ata tat taa aaa gta 1776
Tyr Val Glu Thr Ile Val Lys Ser Lys Ile Ser Ile Tyr Lys Val
545 550 555
gga aat tgt cct agc tta ccc taa att tca aat ctg agt tga ttt tgt 1824
Gly Asn Cys Pro Ser Leu Pro Ile Ser Asn Leu Ser Phe Cys
560 565 570
gat ttt att gct tat aac aga gaa ctc ata ttt gac ata ttt ttt tca 1872
Asp Phe Ile Ala Tyr Asn Arg Glu Leu Ile Phe Asp Ile Phe Phe Ser
575 580 585
ttg atg tgt tcc tgg tag att ttc acg aat gag ctg gca ggt cta atg 1920
Leu Met Cys Ser Trp Ile Phe Thr Asn Glu Leu Ala Gly Leu Met
590 595 600
ggg gag gcg gcg tcc cag tct gtg ttg cag cag cat tct cat cgg ggg 1968
Gly Glu Ala Ala Ser Gln Ser Val Leu Gln Gln His Ser His Arg Gly
605 610 615
tgc gca cac cat cgt tac tgt cgg gca gta act gcc gct tgc ctt gcc 2016
Cys Ala His His Arg Tyr Cys Arg Ala Val Thr Ala Ala Cys Leu Ala
620 625 630
gca gta gga ggg aaa tct cac ctt cct tcc aca tac tgt ctt gag cct 2064
Ala Val Gly Gly Lys Ser His Leu Pro Ser Thr Tyr Cys Leu Glu Pro
635 640 645 650
ttg cta aat taa act gca ctt ttt gct att ttt gcc tag ttt ttc gcc 2112
Leu Leu Asn Thr Ala Leu Phe Ala Ile Phe Ala Phe Phe Ala
655 660
aat cta cac tga ttt tgg act gtt acc taa gtt gaa aaa taa aag gtt 2160
Asn Leu His Phe Trp Thr Val Thr Val Glu Lys Lys Val
665 670 675
gt c aat cga atg gtg gtt taa tgt ttg gac ctg ccg atg tat ttg tat 2208
Val Asn Arg Met Val Val Cys Leu Asp Leu Pro Met Tyr Leu Tyr
680 685 690
agt ggt aga aac atg ctg ctt aag tgg cct aac ctg ttt ctt gcc aat 2256
Ser Gly Arg Asn Met Leu Leu Lys Trp Pro Asn Leu Phe Leu Ala Asn
695 700 705
aag tag gct tat cat ttt atc ttt acg taa ttc tat atc tgt gac tag 2304
Lys Ala Tyr His Phe Ile Phe Thr Phe Tyr Ile Cys Asp
710 715 720
gtt ttt aag gat aca gct tat aag ttg cta tca att ttc act acc taa 2352
Val Phe Lys Asp Thr Ala Tyr Lys Leu Leu Ser Ile Phe Thr Thr
725 730 735
gca gaa ttt ttc tct aat tta ctt ttt gta ttt taa cta ggt ttt aca 2400
Ala Glu Phe Phe Ser Asn Leu Leu Phe Val Phe Leu Gly Phe Thr
740 745 750
tgg aag ccc taa aat aag gca aaa gac ttt ttc ttt tgt aat aag cat 2448
Trp Lys Pro Asn Lys Ala Lys Asp Phe Phe Phe Cys Asn Lys His
755 760 765
ata ata aac acg tat ata cat agc aa aaaaaaaa 2482
Ile Ile Asn Thr Tyr Ile His Ser
770
SEQUENCE LISTING 17
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_019073
<160>1
<170>PatentIn version 3.5
<210>1
<211>1739
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(216)
<220>
<221>exon
<222>(217)..(354)
<220>
<221>exon
<222>(355)..(403)
<220>
<221>exon
<222>(404)..(445)
<220>
<221>exon
<222>(446)..(570)
<220>
<221>exon
<222>(571)..(651)
<220>
<221>exon
<222>(652)..(945)
<220>
<221>exon
<222>(946)..(1033)
<220>
<221>exon
<222>(1034)..(1074)
<220>
<221>exon
<222>(1075)..(1259)
<220>
<221>exon
<222>(1260)..(1359)
<220>
<221>exon
<222>(1360)..(1451)
<220>
<221>exon
<222>(1452)..(1739)
<400>1
gct tct ccg gcg gaa ccc agg ctg gac cgc ggg ccc cgg cct ggg ggc 48
Ala Ser Pro Ala Glu Pro Arg Leu Asp Arg Gly Pro Arg Pro Gly Gly
1 5 10 15
cac tgc tgc cac cgc cgc cgc cac ctc gtc tcc tcc ccg tcc ccg ccc 96
His Cys Cys His Arg Arg Arg His Leu Val Ser Ser Pro Ser Pro Pro
20 25 30
agc ccc agg tct ccc cgc ctc act cgg gcc cgt ggc cgg ggt cac tcc 144
Ser Pro Arg Ser Pro Arg Leu Thr Arg Ala Arg Gly Arg Gly His Ser
35 40 45
ccg ccg ccc ctc ccc gca cgg atg ccg aag gtg aag gcg ctg cag tgc 192
Pro Pro Pro Leu Pro Ala Arg Met Pro Lys Val Lys Ala Leu Gln Cys
50 55 60
gcc ctg gcg ctg gag atc agc tca gta act tgc cca gga gtc gtg ctt 240
Ala Leu Ala Leu Glu Ile Ser Ser Val Thr Cys Pro Gly Val Val Leu
65 70 75 80
aaa gac aaa gag gac atc tat ctt agc atc tgt gtg ttt ggc caa tac 288
Lys Asp Lys Glu Asp Ile Tyr Leu Ser Ile Cys Val Phe Gly Gln Tyr
85 90 95
aaa aag aca caa tgt gtc cca gcc act ttt ccc ctg gtc ttc aat gcc 336
Lys Lys Thr Gln Cys Val Pro Ala Thr Phe Pro Leu Val Phe Asn Ala
100 105 110
aga atg gtg ttt gaa aag gtg ttc ccg gac gca gta gat cct gga gat 384
Arg Met Val Phe Glu Lys Val Phe Pro Asp Ala Val Asp Pro Gly Asp
115 120 125
gtg gtt aca cag ctt gaa t at gat aca gca gtg ttc gag ttg ata cag 432
Val Val Thr Gln Leu Glu Tyr Asp Thr Ala Val Phe Glu Leu Ile Gln
130 140
cta gtt cca cca g tg ggt gaa aca ctg tct acg tat gac gaa aat aca 480
Leu Val Pro Pro Val Gly Glu Thr Leu Ser Thr Tyr Asp Glu Asn Thr
145 150 155 160
cga gat ttc atg ttt ccg ggt cca aac caa atg tct gga cac cat gat 528
Arg Asp Phe Met Phe Pro Gly Pro Asn Gln Met Ser Gly His His Asp
165 170 175
tca aac cgc cag gtt acc atg agg agg att tct ggc ctt cga gga aat 576
Ser Asn Arg Gln Val Thr Met Arg Arg Ile Ser Gly Leu Arg Gly Asn
180 185 190
gct cca agg ctg gaa ttt tct acg act tca gtg att act gaa tgt ctg 624
Ala Pro Arg Leu Glu PheSer Thr Thr Ser Val Ile Thr Glu Cys Leu
195 200 205
ata agt tca agg aaa tgc cac act cag gat aaa ttt att tac cat ttg 672
Ile Ser Ser Arg Lys Cys His Thr Gln Asp Lys Phe Ile Tyr His Leu
210 215 220
gct cca gtt gaa aaa tca cat ggc aga ctg caa aac aga aca tca aga 720
Ala Pro Val Glu Lys Ser His Gly Arg Leu Gln Asn Arg Thr Ser Arg
225 230 235 240
tca caa aag aaa aaa tcc aag tca cct gag aga agt aaa tac tgt ata 768
Ser Gln Lys Lys Lys Ser Lys Ser Pro Glu Arg Ser Lys Tyr Cys Ile
245 250 255
aat gca aaa aac tac gaa cag cct aca att tct tca aaa tca cac tct 816
Asn Ala Lys Asn Tyr Glu Gln Pro Thr Ile Ser Ser Lys Ser His Ser
260 265 270
cca tct ccc tac aca aaa aga cgc atg tgt gag cta tct gaa gac acc 864
Pro Ser Pro Tyr Thr Lys Arg Arg Met Cys Glu Leu Ser Glu Asp Thr
275 280 285
agg cgg cgg ctg gcc cat tta aat ctg gga ccc tat gag ttc aaa aaa 912
Arg Arg Arg Leu Ala His Leu Asn Leu Gly Pro Tyr Glu Phe Lys Lys
290 295 300
gaa aca gat aaa cct cca ttt gtg att aga cat gtt gat ccc cca agt 960
Glu Thr Asp Lys Pro Pro Phe Val Ile Arg His Val Asp Pro Pro Ser
305 310 315 320
ccc agg gct gat act tta ttg gga tct tct gga aga gac tgt gaa aga 1008
Pro Arg Ala Asp Thr Leu Leu Gly Ser Ser Gly Arg Asp Cys Glu Arg
325 330 335
gat gga tgg tca agg gtg cac aat g at cat tct cat ctt ggc tgc tgc 1056
AspGly Trp Ser Arg Val His Asn Asp His Ser His Leu Gly Cys Cys
340 350
cga ccc aag gat tat aag gtt atc agg aca ccc cat ggg aga gac ttc 1104
Arg Pro Lys Asp Tyr Lys Val Ile Arg Thr Pro His Gly Arg Asp Phe
355 360 365
gat gac tct tta gaa aaa tgt gaa gag tat ttg agc cca agg tcg tgt 1152
Asp Asp Ser Leu Glu Lys Cys Glu Glu Tyr Leu Ser Pro Arg Ser Cys
370 375 380
agt aag ccc cgg cat tca gcg agg acc ttg cta gtc cat tca gca ccc 1200
Ser Lys Pro Arg His Ser Ala Arg Thr Leu Leu Val His Ser Ala Pro
385 390 395 400
tca aca atg cca aag cat tct cca agc cct gtg tta aat aga gct tct 1248
Ser Thr Met Pro Lys His Ser Pro Ser Pro Val Leu Asn Arg Ala Ser
405 410 415
ctc agg gaa ag a ttt cat tct gat tgg tgt tca cct tca aac tgc gat 1296
Leu Arg Glu Arg Phe His Ser Asp Trp Cys Ser Pro Ser Asn Cys Asp
425 430
gag atc cat gac cgg gta aaa aat gtc ttg aaa tca cat cag gct cat 1344
Glu Ile His Asp Arg Val Lys Asn Val Leu Lys Ser His Gln Ala His
435 440 445
caa aga cat tta tat gat gag aga gac cta gag aaa gat gat gaa ctg 1392
Gln Arg His Leu Tyr Asp Glu Arg Asp Leu Glu Lys Asp Asp Glu Leu
450 455 460
gaa ctg aaa aga agt ctt tta tgt aga gac tct gcc tat gac agt gac 1440
Glu Leu Lys Arg Ser Leu Leu Cys Arg Asp Ser Ala Tyr Asp Ser Asp
465 470 475 480
ccc gag tat ag c tca tgt cag cag cca cgt ggc act ttc cat ttg gat 1488
Pro Glu Tyr Ser Ser Cys Gln Gln Pro Arg Gly Thr Phe His Leu Asp
485 490 495
gac ggt gaa tac tgg tcc aac agg gca gcc tct tat aag gga aaa tcc 1536
Asp Gly Glu Tyr Trp Ser Asn Arg Ala Ala Ser Tyr Lys Gly Lys Ser
500 505 510
cac cga ccc atc ttt gag aac agc atg gac aag atg tac agg aac tta 1584
His Arg Pro Ile Phe Glu Asn Ser Met Asp Lys Met Tyr Arg Asn Leu
515 520 525
tac aaa aag gcc tgt agt tct gct tca cat aca cag gaa agc ttc tga 1632
Tyr Lys Lys Ala Cys Ser Ser Ala Ser His Thr Gln Glu Ser Phe
530 535 540
gac cat cca tga taa acc tca tta gtg tcc gtg tca att tct caa tga 1680
Asp His Pro Thr Ser Leu Val Ser Val Ser Ile Ser Gln
545 550 555
aaa tgt ttg atg tga tca ata tct gta ttc ctt ttt tta aaa aaa atg 1728
Lys Cys Leu Met Ser Ile Ser Val Phe Leu Phe Leu Lys Lys Met
560 565 570
gga tta taa ct 1739
Gly Leu
SEQUENCE LISTING18
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_003284
<160>1
<170>PatentIn version 3.5
<210>1
<211>415
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(164)
<220>
<221>exon
<222>(165)..(402)
<220>
<221>STS
<222>(213)..(393)
<400>1
gcc cct cat ttt ggc aga act tac cat gtc gac cag ccg caa att aaa 48
Ala Pro His Phe Gly Arg Thr Tyr His Val Asp Gln Pro Gln Ile Lys
1 5 10 15
gag tca tgg cat gag gag gag caa gag ccg atc tcc tca caa ggg agt 96
Glu Ser Trp His Glu Glu Glu Gln Glu Pro Ile Ser Ser Gln Gly Ser
20 25 30
caa gag agg tgg cag caa aag aaa ata ccg taa ggg caa cct gaa aag 144
Gln Glu Arg Trp Gln Gln Lys Lys Ile Pro Gly Gln Pro Glu Lys
35 40 45
tag gaa acg ggg cga tga cg c caa tcg caa tta ccg ctc cca ctt gtg 192
Glu Thr Gly Arg Arg Gln Ser Gln Leu Pro Leu Pro Leu Val
50 55 60
agc ccc cag cgg gct ctg ccc tgg tgc gct tca cac agc acc aag cag 240
Ser Pro Gln Arg Ala Leu Pro Trp Cys Ala Ser His Ser Thr Lys Gln
65 70 75
caa caa gaa cag cag aag ggg aac tgc caa gga gac ctg atg tta gat 288
Gln Gln Glu Gln Gln Lys Gly Asn Cys Gln Gly Asp Leu Met Leu Asp
80 85 90
caa agc cag aga gga gcc tat gga atg tgg atc aaa tgc cag ttg tga 336
Gln Ser Gln Arg Gly Ala Tyr Gly Met Trp Ile Lys Cys Gln Leu
95 100 105
cga aat gag gaa tgt ata tgt tgg ctg ttt ttc ccc aac atc tca ata 384
Arg Asn Glu Glu Cys Ile Cys Trp Leu Phe Phe Pro Asn Ile Ser Ile
110 115 120
aaa ctt tga aag cag aaa aaaaaaaaaa aaa 415
Lys Leu Lys Gln Lys
125
SEQUENCE LISTING19
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_021733
<160>1
<170>PatentIn version 3.5
<210>1
<211>1812
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(181)
<220>
<221>exon
<222>(182)..(410)
<220>
<221>exon
<222>(411)..(506)
<220>
<221>exon
<222>(507)..(590)
<220>
<221>exon
<222>(591)..(674)
<220>
<221>exon
<222>(675)..(1003)
<220>
<221>exon
<222>(1004)..(1198)
<220>
<221>exon
<222>(1199)..(1372)
<220>
<221>exon
<222>(1373)..(1508)
<220>
<221>exon
<222>(1509)..(1633)
<220>
<221>exon
<222>(1634)..(1812)
<220>
<221>polyA_signal
<222>(1786)..(1791)
<220>
<221>polyA_site
<222>(1812)..(1812)
<400>1
acc ccc aca cca tgg cga gcg tgg tgg tga aga cga tct ggc agt cca 48
Thr Pro Thr Pro Trp Arg Ala Trp Trp Arg Arg Ser Gly Ser Pro
1 5 10 15
aag aga tcc atg agg ccg ggg aca ccc cca cgg ggg tgg aga gct gct 96
Lys Arg Ser Met Arg Pro Gly Thr Pro Pro Arg Gly Trp Arg Ala Ala
20 25 30
ccc agc tag tcc cag agg ctc ccc gga ggg tga cca gcc ggg cca agg 144
Pro Ser Ser Gln Arg Leu Pro Gly Gly Pro Ala Gly Pro Arg
35 40 45
gga tcc cga aga aaa aga agg ccg tgt cgt tcc acg g gg tgg agc ccc 192
Gly Ser Arg Arg Lys Arg Arg Pro Cys Arg Ser Thr Gly Trp Ser Pro
50 55 60
aga tgt ccc atc agc cca tgc act ggt gcc tga acc tca aac ggt cct 240
Arg Cys Pro Ile Ser Pro Cys Thr Gly Ala Thr Ser Asn Gly Pro
65 70 75
cgg cct gca cca acg tgt cac tgc tca acc tgg ccg cca tgg agc cca 288
Arg Pro Ala Pro Thr Cys His Cys Ser Thr Trp Pro Pro Trp Ser Pro
80 85 90
ctg act cca cgg gga cag act cca cag tgg aag acc tca gcg gcc aac 336
Leu Thr Pro Arg Gly Gln Thr Pro Gln Trp Lys Thr Ser Ala Ala Asn
95 100 105
tca cac tgg ctg ggc ccc ctg cct ccc cta ccc tac cct ggg atc cgg 384
Ser His Trp Leu Gly Pro Leu Pro Pro Leu Pro Tyr Pro Gly Ile Arg
110 115 120
atg acg cag aca tca cgg aaa tcc tg a gtg ggg tca aca gtg gat tgg 432
Met Thr Gln Thr Ser Arg Lys Ser Val Gly Ser Thr Val Asp Trp
125 130 135 140
tcc gcg cca aag act cca tca cca gct tga agg aaa aga cca acc ggg 480
Ser Ala Pro Lys Thr Pro Ser Pro Ala Arg Lys Arg Pro Thr Gly
145 150 155
tta acc agc acg tgc agt ctc tgc ag a gcg agt gtt ctg tgc tga gcg 528
Leu Thr Ser Thr Cys Ser Leu Cys Arg Ala Ser Val Leu Cys Ala
160 165 170
aga atc tgg aga gaa ggc ggc aag agg cag aag agt tgg agg ggt act 576
Arg Ile Trp Arg Glu Gly Gly Lys Arg Gln Lys Ser Trp Arg Gly Thr
175 180 185
gca ttc aac tca ag g aga act gct gga agg tga ccc ggt ctg tgg aag 624
Ala Phe Asn Ser Arg Arg Thr Ala Gly Arg Pro Gly Leu Trp Lys
190 195 200
atg ctg aaa tca aaa cca acg tct tga agc aga att ctg ccc tgc tgg 672
Met Leu Lys Ser Lys Pro Thr Ser Ser Arg Ile Leu Pro Cys Trp
205 210 215
ag g aga agc tgc gct acc tcc agc agc agc tgc agg atg aga cgc cgc 720
Arg Arg Ser Cys Ala Thr Ser Ser Ser Ser Cys Arg Met Arg Arg Arg
220 225 230
gac ggc agg agg ccg agc tgc agg agc cgg agg aga agc agg agc cgg 768
Asp Gly Arg Arg Pro Ser Cys Arg Ser Arg Arg Arg Ser Arg Ser Arg
235 240 245
agg aga agc agg agc cgg agg aga agc aga agc cgg agg ctg gcc tct 816
Arg Arg Ser Arg Ser Arg Arg Arg Ser Arg Ser Arg Arg Leu Ala Ser
250 255 260
cct gga aca gcc tgg gcc ccg ccg cca cgt ccc agg gct gcc ccg gcc 864
Pro Gly Thr Ala Trp Ala Pro Pro Pro Arg Pro Arg Ala Ala Pro Ala
265 270 275 280
cgc cag gga gtc ccg aca aac cct cgc ggc cac acg gcc tgg tcc ccg 912
Arg Gln Gly Val Pro Thr Asn Pro Arg Gly His Thr Ala Trp Ser Pro
285 290 295
cag gct ggg gaa tgg ggc ctc ggg ctg gcg agg gcc cct acg tga gcg 960
Gln Ala Gly Glu Trp Gly Leu Gly Leu Ala Arg Ala Pro Thr Ala
300 305 310
agc agg aat tgc aga agc tgt tca ccg gca tcg aag agc tga g ga gag 1008
Ser Arg Asn Cys Arg Ser Cys Ser Pro Ala Ser Lys Ser Gly Glu
315 320
agg tgt cct cac tga ccg ccc ggt ggc atc agg agg agg ggg cgg tgc 1056
Arg Cys Pro His Pro Pro Gly Gly Ile Arg Arg Arg Gly Arg Cys
330 335 340
agg aag ccc tgc ggc tgc tcg ggg gcc tgg gcg gca ggg tcg acg gct 1104
Arg Lys Pro Cys Gly Cys Ser Gly Ala Trp Ala Ala Gly Ser Thr Ala
345 350 355
tcc tag gcc agt ggg agc ggg cac agc gcg aac agg cac aga cgg cgc 1152
Ser Ala Ser Gly Ser Gly His Ser Ala Asn Arg His Arg Arg Arg
360 365 370
ggg act tgc agg agc tgc gag gtc ggg cgg atg agc tgt gca cca t gg 1200
Gly Thr Cys Arg Ser Cys Glu Val Gly Arg Met Ser Cys Ala Pro Trp
375 380 385
tgg agc ggt cag cag tgt ctg tgg ctt cac tga gga gcg aac tgg agg 1248
Trp Ser Gly Gln Gln Cys Leu Trp Leu His Gly Ala Asn Trp Arg
390 395 400
ggc tgg gcc cac tga aac cca ttc tgg agg agt tcg ggc ggc aat ttc 1296
Gly Trp Ala His Asn Pro Phe Trp Arg Ser Ser Gly Gly Asn Phe
405 410 415
aga act ctc gaa gag ggc ctg acc tct cca tga acc tgg atc ggt ccc 1344
Arg Thr Leu Glu Glu Gly Leu Thr Ser Pro Thr Trp Ile Gly Pro
420 425 430
acc aag gca act gtg ccc gct gtg cca g cc agg ggt cgc agt tgt cta 1392
Thr Lys Ala Thr Val Pro Ala Val Pro Ala Arg Gly Arg Ser Cys Leu
435 440 445
cgg agt ccc tgc agc agc tgc tgg acc gag cac tga cct cac tag tgg 1440
Arg Ser Pro Cys Ser Ser Cys Trp Thr Glu His Pro His Trp
450 455 460
acg agg tga agc aga ggg gcc tga ctc ctg cct gtc cca gct gtc aga 1488
Thr Arg Ser Arg Gly Ala Leu Leu Pro Val Pro Ala Val Arg
465 470 475
ggc tac aca aga aga ttc tg g agc tgg agc gcc agg cct tag cca aac 1536
Gly Tyr Thr Arg Arg Phe Trp Ser Trp Ser Ala Arg Pro Pro Asn
480 485 490
acg tca ggg cag agg ccc tga gct cca ccc ttc ggc tgg ccc aag acg 1584
Thr Ser Gly Gln Arg Pro Ala Pro Pro Phe Gly Trp Pro Lys Thr
495 500 505
agg ccc tgc ggg cca aga acc tac tgc tga cag aca aga tga agc cag a 1633
Arg Pro Cys Gly Pro Arg Thr Tyr Cys Gln Thr Arg Ser Gln
510 515 520
gg aga aga tgg cca ctc tgg acc atc tac act tga aga tgt gct ccc 1680
Arg Arg Arg Trp Pro Leu Trp Thr Ile Tyr Thr Arg Cys Ala Pro
525 530 535
tcc acg atc atc tca gca acc tgc cac ttg agg ggt cca cgg gaa caa 1728
Ser Thr Ile Ile Ser Ala Thr Cys His Leu Arg Gly Pro Arg Glu Gln
540 545 550
tgg ggg gag gca gca gtg cag gaa ccc ccc caa aac agg ggg gct cag 1776
Trp Gly Glu Ala Ala Val Gln Glu Pro Pro Gln Asn Arg Gly Ala Gln
555 560 565
ccc ctg aac aat aaa tgg cct ctc atg cta gca tga 1812
Pro Leu Asn Asn Lys Trp Pro Leu Met Leu Ala
570 575
SEQUENCE LISTING20
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NM_017481
<160>1
<170>PatentIn version 3.5
<210>1
<211>2347
<212>DNA
<213>Homo sapiens
<220>
<221>exon
<222>(1)..(50)
<220>
<221>exon
<222>(51)..(2345)
<220>
<221>CDS
<222>(87)..(2054)
<220>
<221>STS
<222>(197)..(443)
<220>
<221>STS
<222>(257)..(1042)
<220>
<221>STS
<222>(422)..(665)
<220>
<221>STS
<222>(642)..(889)
<220>
<221>STS
<222>(783)..(1984)
<220>
<221>STS
<222>(860)..(1110)
<220>
<221>STS
<222>(1056)..(1303)
<220>
<221>STS
<222>(1131)..(1949)
<220>
<221>STS
<222>(1282)..(1549)
<220>
<221>STS
<222>(1520)..(1748)
<220>
<221>STS
<222>(1707)..(1947)
<220>
<221>STS
<222>(1919)..(2178)
<400>1
ggg agg ttt gga gcc ctg cat aaa gag aag gac ggg acc aca gct gac 48
Gly Arg Phe Gly Ala Leu His Lys Glu Lys Asp Gly Thr Thr Ala Asp
1 5 10 15
tg c tgt gtc ccc aca gat ctg ggc ctc ctg ctg cca cca tgg cca aag 96
Cys Cys Val Pro Thr Asp Leu Gly Leu Leu Leu Pro Pro Trp Pro Lys
20 25 30
gtg gag aag ccc tgc cac agg gca gcc cag cac cag tcc agg atc ccc 144
Val Glu Lys Pro Cys His Arg Ala Ala Gln His Gln Ser Arg Ile Pro
35 40 45
acc tca tca agg tga cag tga aga cgc cca aag aca agg agg att tct 192
Thr Ser Ser Arg Gln Arg Arg Pro Lys Thr Arg Arg Ile Ser
50 55 60
cag tta cag aca cat gca cta tcc agc agc tga agg aag aga tat ctc 240
Gln Leu Gln Thr His Ala Leu Ser Ser Ser Arg Lys Arg Tyr Leu
65 70 75
agc gct tta agg ccc acc ccg atc agc ttg ttc taa tct ttg ctg gca 288
Ser Ala Leu Arg Pro Thr Pro Ile Ser Leu Phe Ser Leu Leu Ala
80 85 90
aaa tcc tca agg atc ctg act cac tgg cac agt gtg gag tgc gag atg 336
Lys Ser Ser Arg Ile Leu Thr His Trp His Ser Val Glu Cys Glu Met
95 100 105
gcc tca ctg tcc acc tgg tca tca aga ggc agc acc gtg cca tgg gca 384
Ala Ser Leu Ser Thr Trp Ser Ser Arg Gly Ser Thr Val Pro Trp Ala
110 115 120
atg agt gcc cag ctg cct ctg tcc cta ccc agg gcc caa gtc ctg gat 432
Met Ser Ala Gln Leu Pro Leu Ser Leu Pro Arg Ala Gln Val Leu Asp
125 130 135 140
cac tcc ctc agc caa gct cca ttt acc cag cag atg ggc ccc ctg cct 480
His Ser Leu Ser Gln Ala Pro Phe Thr Gln Gln Met Gly Pro Leu Pro
145 150 155
tta gct tag gtc tcc tca cag gcc tca gta ggc tgg gct tgg cct atc 528
Leu Ala Val Ser Ser Gln Ala Ser Val Gly Trp Ala Trp Pro Ile
160 165 170
gtg gct tcc ctg acc agc caa gct ccc tga tgc ggc agc atg tgt ctg 576
Val Ala Ser Leu Thr Ser Gln Ala Pro Cys Gly Ser Met Cys Leu
175 180 185
tgc ctg agt ttg tga ctc agc tca ttg atg acc cct tca tcc cgg gtc 624
Cys Leu Ser Leu Leu Ser Ser Leu Met Thr Pro Ser Ser Arg Val
190 195 200
tgc tgt cca aca cag gcc tag tac gcc agc tgg ttc ttg aca acc ccc 672
Cys Cys Pro Thr Gln Ala Tyr Ala Ser Trp Phe Leu Thr Thr Pro
205 210 215
ata tgc agc agc tga tcc agc aca acc ctg aga ttg ggc ata ttc tta 720
Ile Cys Ser Ser Ser Ser Thr Thr Leu Arg Leu Gly Ile Phe Leu
220 225 230
aca acc cgg aaa tta tgc ggc aga cac tgg agt ttt tac gta acc ctg 768
Thr Thr Arg Lys Leu Cys Gly Arg His Trp Ser Phe Tyr Val Thr Leu
235 240 245
cca tga tgc agg aga tga tac gta gcc agg acc ggg tgc tca gta act 816
Pro Cys Arg Arg Tyr Val Ala Arg Thr Gly Cys Ser Val Thr
250 255 260
tgg aga gca ttc ctg gtg gct aca atg tgc ttt gca cta tgt aca cag 864
Trp Arg Ala Phe Leu Val Ala Thr Met Cys Phe Ala Leu Cys Thr Gln
265 270 275
ata tta tgg acc caa tgc tta acg cag tcc agg agc agt ttg gcg gca 912
Ile Leu Trp Thr Gln Cys Leu Thr Gln Ser Arg Ser Ser Leu Ala Ala
280 285 290
atc cct ttg cca ctg cca cta ctg ata atg cca cca cca cca cca gcc 960
Ile Pro Leu Pro Leu Pro Leu Leu Ile Met Pro Pro Pro Pro Pro Ala
295 300 305
aac ctt caa gga tgg aga att gtg acc ctc tcc cca acc cct gga ctt 1008
Asn Leu Gln Gly Trp Arg Ile Val Thr Leu Ser Pro Thr Pro Gly Leu
310 315 320 325
cca cac atg gag gct cag gta gca ggc aag gaa ggc agg atg ggg atc 1056
Pro His Met Glu Ala Gln Val Ala Gly Lys Glu Gly Arg Met Gly Ile
330 335 340
agg atg cac ctg aca tta gaa ata ggt ttc caa act ttc tgg gta tta 1104
Arg Met His Leu Thr Leu Glu Ile Gly Phe Gln Thr Phe Trp Val Leu
345 350 355
taa ggc tct atg act atc tcc agc aat tac acg aga acc ccc agt ccc 1152
Gly Ser Met Thr Ile Ser Ser Asn Tyr Thr Arg Thr Pro Ser Pro
360 365 370
tag gaa ctt atc tac agg gga ctg cat ctg ccc tca gcc aaa gcc agg 1200
Glu Leu Ile Tyr Arg Gly Leu His Leu Pro Ser Ala Lys Ala Arg
375 380 385
aac cac cac cat cag taa aca gag ttc ccc cat cgt cac cct cat ctc 1248
Asn His His His Gln Thr Glu Phe Pro His Arg His Pro His Leu
390 395 400
agg agc ctg ggt cag gcc agc ctc tcc ccg agg agt cag tag caa tca 1296
Arg Ser Leu Gly Gln Ala Ser Leu Ser Pro Arg Ser Gln Gln Ser
405 410 415
agg gaa ggt cct cct gcc cag ctt tcc tga gat acc cca cag aga aca 1344
Arg Glu Gly Pro Pro Ala Gln Leu Ser Asp Thr Pro Gln Arg Thr
420 425 430
gta ctg gac aag gtg gag acc aag atg gtg cag gga aaa gct cta ctg 1392
Val Leu Asp Lys Val Glu Thr Lys Met Val Gln Gly Lys Ala Leu Leu
435 440 445
gac ata gca caa act tgc ctg atc ttg tct cgg ggc tgg gag att ctg 1440
Asp Ile Ala Gln Thr Cys Leu Ile Leu Ser Arg Gly Trp Glu Ile Leu
450 455 460
cca aca ggg ttc cat ttg ctc cct tat ctt ttt ccc cca cgg cag cca 1488
Pro Thr Gly Phe His Leu Leu Pro Tyr Leu Phe Pro Pro Arg Gln Pro
465 470 475 480
ttc ctg gaa tcc ctg agc ctc cct ggc tgc cat ccc cgg ctt atc caa 1536
Phe Leu Glu Ser Leu Ser Leu Pro Gly Cys His Pro Arg Leu Ile Gln
485 490 495
gat ctc tga ggc cag atg gca tga atc cag ctc cac agt tac agg atg 1584
AspLeu Gly Gln Met Ala Ile Gln Leu His Ser Tyr Arg Met
500 505 510
aga tac aac cac agc tgc cac tgc tga tgc acc ttc agg cag cca tgg 1632
Arg Tyr Asn His Ser Cys His Cys Cys Thr Phe Arg Gln Pro Trp
515 520 525
caa acc ccc gtg ccc tgc aag ccc tgc ggc aga ttg agc agg gtc tac 1680
Gln Thr Pro Val Pro Cys Lys Pro Cys Gly Arg Leu Ser Arg Val Tyr
530 535 540
agg tcc tag cta ctg aag cac ctc gcc tcc tac tct ggt tca tgc ctt 1728
Arg Ser Leu Leu Lys His Leu Ala Ser Tyr Ser Gly Ser Cys Leu
545 550 555
gcc tag cag gga cgg gta gtg tgg cag gag gta tag agt cta gag aag 1776
Ala Gln Gly Arg Val Val Trp Gln Glu Val Ser Leu Glu Lys
560 565 570
atc ccc tta tgt ctg agg atc ctc tcc caa atc cac ctc ctg agg tgt 1824
lle Pro Leu Cys Leu Arg Ile Leu Ser Gln Ile His Leu Leu Arg Cys
575 580 585
tcc cag cac tgg act ctg cag agc tgg gct tcc ttt ccc ctc cct ttc 1872
Ser Gln His Trp Thr Leu Gln Ser Trp Ala Ser Phe Pro Leu Pro Phe
590 595 600
tcc ata tgc tgc aag att tag tta gta caa atc ccc agc agc tgc agc 1920
Ser Ile Cys Cys Lys Ile Leu Val Gln Ile Pro Ser Ser Cys Ser
605 610 615
ctg agg ctc act ttc agg tgc agc tgg agc aac tgc ggt cca tgg gct 1968
Leu Arg Leu Thr Phe Arg Cys Ser Trp Ser Asn Cys Gly Pro Trp Ala
620 625 630
ttc tga atc gtg aag cca atc ttc agg ccc tca ttg cta cgg ggg gcg 2016
Phe Ile Val Lys Pro Ile Phe Arg Pro Ser Leu Leu Arg Gly Ala
635 640 645
acg tgg atg ctg ctg tgg aga agc tga gac agt cgt agg agc ctt att 2064
Thr Trp Met Leu Leu Trp Arg Ser Asp Ser Arg Arg Ser Leu Ile
650 655 660
cat tca aac cat acg ttt tcc tct gtg cct ttt tcc cat atc cta gtt 2112
His Ser Asn His Thr Phe Ser Ser Val Pro Phe Ser His Ile Leu Val
665 670 675
ccc tag ctc tcc cat ttt tga ata cag ctg cat tat aaa cca aat tta 2160
Pro Leu Ser His Phe Ile Gln Leu His Tyr Lys Pro Asn Leu
680 685 690
cta tga agt cct ttg ctg tgg agg caatgt tgt tcc aga gtc aac gag 2208
Leu Ser Pro Leu Leu Trp Arg Gln Cys Cys Ser Arg Val Asn Glu
695 700 705
gaa gac taa tgg cca aaa cat agt gga ggt gct gtg tgt gag tca acc 2256
Glu Asp Trp Pro Lys His Ser Gly Gly Ala Val Cys Glu Ser Thr
710 715 720
act tgt acc act ata cca ctg ggg ggc ccc agt cta agc tct gct tat 2304
Thr Cys Thr Thr Ile Pro Leu Gly Gly Pro Ser Leu Ser Ser Ala Tyr
725 730 735
gcc tat ctt gag atg caa tta cac ccaatt tcc aat gtg aa aa 2347
Ala Tyr Leu Glu Met Gln Leu His Pro Ile Ser Asn Val
740 745 750
SEQUENCE LISTING21
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_001455
<160>1
<170>PatentIn version 3.5
<210>1
<211>735
<212>PRT
<213>Homo sapiens
<220>
<221>SITE
<222>(313)..(314)
<220>
<221>SITE
<222>(317)..(317)
<220>
<221>SITE
<222>(323)..(323)
<400>1
Met Trp Arg Val Leu Phe Leu Leu Ser Gly Leu Gly Gly Leu Arg Met
1 5 10 15
Asp Ser Asn Phe Asp Ser Leu Pro Val Gln Ile Thr Val Pro Glu Lys
20 25 30
Ile Arg Ser Ile Ile Lys Glu Gly Ile Glu Ser Gln Ala Ser Tyr Lys
35 40 45
Ile Val Ile Glu Gly Lys Pro Tyr Thr Val Asn Leu Met Gln Lys Asn
50 55 60
Phe Leu Pro His Asn Phe Arg Val Tyr Ser Tyr Ser Gly Thr Gly Ile
65 70 75 80
Met Lys Pro Leu Asp Gln Asp Phe Gln Asn Phe Cys His Tyr Gln Gly
85 90 95
Tyr Ile Glu Gly Tyr Pro Lys Ser Val Val Met Val Ser Thr Cys Thr
100 105 110
Gly Leu Arg Gly Val Leu Gln Phe Glu Asn Val Ser Tyr Gly Ile Glu
115 120 125
Pro Leu Glu Ser Ser Val Gly Phe Glu His Val Ile Tyr Gln Val Lys
130 135 140
His Lys Lys Ala Asp Val Ser Leu Tyr Asn Glu Lys Asp Ile Glu Ser
145 150 155 160
Arg Asp Leu Ser Phe Lys Leu Gln Ser Val Glu Pro Gln Gln Asp Phe
165 170 175
Ala Lys Tyr Ile Glu Met His Val Ile Val Glu Lys Gln Leu Tyr Asn
180 185 190
His Met Gly Ser Asp Thr Thr Val Val Ala Gln Lys Val Phe Gln Leu
195 200 205
Ile Gly Leu Thr Asn Ala Ile Phe Val Ser Phe Asn Ile Thr Ile Ile
210 215 220
Leu Ser Ser Leu Glu Leu Trp Ile Asp Glu Asn Lys Ile Ala Thr Thr
225 230 235 240
Gly Glu Ala Asn Glu Leu Leu His Thr Phe Leu Arg Trp Lys Thr Ser
245 250 255
Tyr Leu Val Leu Arg Pro His Asp Val Ala Phe Leu Leu Val Tyr Arg
260 265 270
Glu Lys Ser Asn Tyr Val Gly Ala Thr Phe Gln Gly Lys Met Cys Asp
275 280 285
Ala Asn Tyr Ala Gly Gly Val Val Leu His Pro Arg Thr Ile Ser Leu
290 295 300
Glu Ser Leu Ala Val Ile Leu Ala Gln Leu Leu Ser Leu Ser Met Gly
305 310 315 320
Ile Thr Tyr Asp Asp Ile Asn Lys Cys Gln Cys Ser Gly Ala Val Cys
325 330 335
Ile Met Asn Pro Glu Ala Ile His Phe Ser Gly Val Lys Ile Phe Ser
340 345 350
Asn Cys Ser Phe Glu Asp Phe Ala His Phe Ile Ser Lys Gln Lys Ser
355 360 365
Gln Cys Leu His Asn Gln Pro Arg Leu Asp Pro Phe Phe Lys Gln Gln
370 375 380
Ala Val Cys Gly Asn Ala Lys Leu Glu Ala Gly Glu Glu Cys Asp Cys
385 390 395 400
Gly Thr Glu Gln Asp Cys Ala Leu Ile Gly Glu Thr Cys Cys Asp Ile
405 410 415
Ala Thr Cys Arg Phe Lys Ala Gly Ser Asn Cys Ala Glu Gly Pro Cys
420 425 430
Cys Glu Asn Cys Leu Phe Met Ser Lys Glu Arg Met Cys Arg Pro Ser
435 440 445
Phe Glu Glu Cys Asp Leu Pro Glu Tyr Cys Asn Gly Ser Ser Ala Ser
450 455 460
Cys Pro Glu Asn His Tyr Val Gln Thr Gly His Pro Cys Gly Leu Asn
465 470 475 480
Gln Trp Ile Cys Ile Asp Gly Val Cys Met Ser Gly Asp Lys Gln Cys
485 490 495
Thr Asp Thr Phe Gly Lys Glu Val Glu Phe Gly Pro Ser Glu Cys Tyr
500 505 510
Ser His Leu Asn Ser Lys Thr Asp Val Ser Gly Asn Cys Gly Ile Ser
515 520 525
Asp Ser Gly Tyr Thr Gln Cys Glu Ala Asp Asn Leu Gln Cys Gly Lys
530 535 540
Leu Ile Cys Lys Tyr Val Gly Lys Phe Leu Leu Gln Ile Pro Arg Ala
545 550 555 560
Thr Ile Ile Tyr Ala Asn Ile Ser Gly His Leu Cys Ile Ala Val Glu
565 570 575
Phe Ala Ser Asp His Ala Asp Ser Gln Lys Met Trp Ile Lys Asp Gly
580 585 590
Thr Ser Cys Gly Ser Asn Lys Val Cys Arg Asn Gln Arg Cys Val Ser
595 600 605
Ser Ser Tyr Leu Gly Tyr Asp Cys Thr Thr Asp Lys Cys Asn Asp Arg
610 615 620
Gly Val Cys Asn Asn Lys Lys His Cys His Cys Ser Ala Ser Tyr Leu
625 630 635 640
Pro Pro Asp Cys Ser Val Gln Ser Asp Leu Trp Pro Gly Gly Ser Ile
645 650 655
Asp Ser Gly Asn Phe Pro Pro Val Ala Ile Pro Ala Arg Leu Pro Glu
660 665 670
Arg Arg Tyr Ile Glu Asn Ile Tyr His Ser Lys Pro Met Arg Trp Pro
675 680 685
Phe Phe Leu Phe Ile Pro Phe Phe Ile Ile Phe Cys Val Leu Ile Ala
690 695 700
Ile Met Val Lys Val Asn Phe Gln Arg Lys Lys Trp Arg Thr Glu Asp
705 710 715 720
Tyr Ser Ser Asp Glu Gln Pro Glu Ser Glu Ser Glu Pro Lys Gly
725 730 735
SEQUENCE LISTING22
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_076957
<160>1
<170>PatentIn version 3.5
<210>1
<211>300
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(300)
<400>1
Met Cys Ala Arg Gly Gln Val Gly Arg Gly Thr Gln Leu Arg Thr Gly
1 5 10 15
Arg Pro Cys Ser Gln Val Pro Gly Ser Arg Trp Arg Pro Glu Arg Leu
20 25 30
Leu Arg Arg Gln Arg Ala Gly Gly Arg Pro Ser Arg Pro His Pro Ala
35 40 45
Arg Ala Arg Pro Gly Leu Ser Leu Pro Ala Thr Leu Leu Gly Ser Arg
50 55 60
Ala Ala Ala Ala Val Pro Leu Pro Leu Pro Pro Ala Leu Ala Pro Gly
65 70 75 80
Asp Pro Ala Met Pro Val Arg Thr Glu Cys Pro Pro Pro Ala Gly Ala
85 90 95
Ser Ala Ala Ser Ala Ala Ser Leu Ile Pro Pro Pro Pro Ile Asn Thr
100 105 110
Gln Gln Pro Gly Val Ala Thr Ser Leu Leu Tyr Ser Gly Ser Lys Phe
115 120 125
Arg Gly His Gln Lys Ser Lys Gly Asn Ser Tyr Asp Val Glu Val Val
130 135 140
Leu Gln His Val Asp Thr Gly Asn Ser Tyr Leu Cys Gly Tyr Leu Lys
145 150 155 160
Ile Lys Gly Leu Thr Glu Glu Tyr Pro Thr Leu Thr Thr Phe Phe Glu
165 170 175
Gly Glu Ile Ile Ser Lys Lys His Pro Phe Leu Thr Arg Lys Trp Asp
180 185 190
Ala Asp Glu Asp Val Asp Arg Lys His Trp Gly Lys Phe Leu Ala Phe
195 200 205
Tyr Gln Tyr Ala Lys Ser Phe Asn Ser Asp Asp Phe Asp Tyr Glu Glu
210 215 220
Leu Lys Asn Gly Asp Tyr Val Phe Met Arg Trp Lys Glu Gln Phe Leu
225 230 235 240
Val Pro Asp His Thr Ile Lys Asp Ile Ser Gly Ala Ser Phe Ala Gly
245 250 255
Phe Tyr Tyr Ile Cys Phe Gln Lys Ser Ala Ala Ser Ile Glu Gly Tyr
260 265 270
Tyr Tyr His Arg Ser Ser Glu Trp Tyr Gln Ser Leu Asn Leu Thr His
275 280 285
Val Pro Glu His Ser Ala Pro Ile Tyr Glu Phe Arg
290 295 300
SEQUENCE LIST ING23
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_659473
<160>1
<170>PatentIn version 3.5
<210>1
<211>955
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(955)
<400>1
Met Glu Val Gly Ser Glu Glu Glu Lys Trp Glu Lys Leu Asp Ala Glu
1 5 10 15
Phe Asp His Phe Val Val Asp Met Lys Pro Phe Val Leu Lys Leu Pro
20 25 30
His Arg Thr Glu Arg Gln Arg Cys Ala Leu Trp Ile Arg Lys Leu Cys
35 40 45
Glu Pro Ser Gly Thr Gly Ala Gly Ile Met Gly Arg Lys Asn Arg Asn
50 55 60
Leu Tyr Ala Lys Leu Leu Leu His Met Leu Lys Arg Gly Ala Leu Glu
65 70 75 80
Gly Pro Phe Thr His Arg Pro Glu Pro Gly Thr Leu Lys Ile Leu Pro
85 90 95
Ser Tyr Met Ser Ile Tyr Phe Asp Glu Pro Asn Pro Ala Arg Ala Lys
100 105 110
Gly Ser Ser Pro Glu Gly Leu Pro Ala Trp Val Leu Gly Glu Leu Glu
115 120 125
Thr Ser Glu His Lys Leu Asn Glu Ser Trp Lys Leu Ser Ser Gly Glu
130 135 140
Asp Asn Thr Leu Val Gln Ser Pro Thr Asp Val Tyr Ser Arg Glu Gln
145 150 155 160
Tyr Thr Gly Lys Leu Arg Val Arg Ser His Ser Leu Ser Pro Thr His
165 170 175
Arg Glu Asp Gly Gln Asn Ile Thr Pro Lys Ile Cys Glu Val Tyr Ser
180 185 190
Lys Lys Ser Pro Val Ser Leu Asp Asp Ser Asp Ile Glu Ala Arg Leu
195 200 205
Asn Ser Trp Asn Leu Gly Ile Glu Asn Pro Arg Tyr Leu Arg Gln Lys
210 215 220
Pro Ile Pro Val Ser Leu Met Thr Pro Lys Phe Ser Leu Arg Lys Ser
225 230 235 240
Ser Ser Phe His Asp Asp His Phe Leu Ser Arg Ile Arg Glu Lys Glu
245 250 255
Leu Asp Met Lys Thr Lys Met Met Glu Ala Lys Phe His Glu Glu Lys
260 265 270
Leu Lys Leu Gln Gln Lys His Asp Ala Asp Val Gln Lys Ile Leu Glu
275 280 285
Arg Lys Asn Asn Glu Ile Glu Glu Leu Lys Thr Leu Tyr Arg Ser Lys
290 295 300
Gln His Glu Thr Glu Glu Thr Ile Arg Lys Leu Glu Lys Lys Val Gln
305 310 315 320
Thr Leu Ile Arg Asp Cys Gln Val Ile Arg Glu Thr Lys Glu Asp Gln
325 330 335
Ile Ala Glu Leu Lys Lys Ile Cys Glu Gln Ser Thr Glu Ser Leu Asn
340 345 350
Asn Asp Trp Glu Lys Lys Leu His Asn Ala Val Ala Glu Met Glu Gln
355 360 365
Glu Lys Phe Asp Leu Gln Lys Gln His Thr Glu Asn Ile Gln Glu Leu
370 375 380
Leu Glu Asp Thr Asn Val Arg Leu Asn Lys Met Glu Ser Glu Tyr Met
385 390 395 400
Ala Gln Thr Gln Ser Thr Asn His Met Ile Lys Glu Leu Glu Ala Arg
405 410 415
Val Gln Gln Leu Thr Gly Glu Ala Glu Asn Ser Asn Leu Gln Arg Gln
420 425 430
Lys Leu Ile Gln Glu Lys Ala Glu Leu Glu Arg Cys Tyr Gln Ile Thr
435 440 445
Cys Ser Glu Leu Gln Glu Val Lys Ala Arg Arg Asn Thr Leu His Lys
450 455 460
Glu Lys Asp His Leu Val Asn Asp Tyr Glu Gln Asn Met Lys Leu Leu
465 470 475 480
Gln Thr Lys Tyr Asp Ala Asp Ile Asn Leu Leu Lys Gln Glu His Ala
485 490 495
Leu Ser Ala Ser Lys Ala Ser Ser Met Ile Glu Glu Leu Glu Gln Asn
500 505 510
Val Cys Gln Leu Lys Gln Gln Leu Gln Glu Ser Glu Leu Gln Arg Lys
515 520 525
Gln Gln Leu Arg Asp Gln Glu Asn Lys Phe Gln Met Glu Lys Ser His
530 535 540
Leu Lys His Ile Tyr Glu Lys Lys Ala His Asp Leu Gln Ser Glu Leu
545 550 555 560
Asp Lys Gly Lys Glu Asp Thr Gln Lys Lys Ile His Lys Phe Glu Glu
565 570 575
Ala Leu Lys Glu Lys Glu Glu Gln Leu Thr Arg Val Thr Glu Val Gln
580 585 590
Arg Leu Gln Ala Gln Gln Ala Asp Ala Ala Leu Glu Glu Phe Lys Arg
595 600 605
Gln Val Glu Leu Asn Ser Glu Lys Val Tyr Ala Glu Met Lys Glu Gln
610 615 620
Met Glu Lys Val Glu Ala Asp Leu Thr Arg Ser Lys Ser Leu Arg Glu
625 630 635 640
Lys Gln Ser Lys Glu Phe Leu Trp Gln Leu Glu Asp Ile Arg Gln Arg
645 650 655
Tyr Glu Gln Gln Ile Val Glu Leu Lys Leu Glu His Glu Gln Glu Lys
660 665 670
Thr His Leu Leu Gln Gln His Asn Ala Glu Lys Asp Ser Leu Val Arg
675 680 685
Asp His Glu Arg Glu Ile Glu Asn Leu Glu Lys Gln Leu Arg Ala Ala
690 695 700
Asn Met Glu His Glu Asn Gln Ile Gln Glu Phe Lys Lys Arg Asp Ala
705 710 715 720
Gln Val Ile Ala Asp Met Glu Ala Gln Val His Lys Leu Arg Glu Glu
725 730 735
Leu Ile Asn Val Asn Ser Gln Arg Lys Gln Gln Leu Val Glu Leu Gly
740 745 750
Leu Leu Arg Glu Glu Glu Lys Gln Arg Ala Thr Arg Glu His Glu Ile
755 760 765
Val Val Asn Lys Leu Lys Ala Glu Ser Glu Lys Met Lys Ile Glu Leu
770 775 780
Lys Lys Thr His Ala Ala Glu Thr Glu Met Thr Leu Glu Lys Ala Asn
785 790 795 800
Ser Lys Leu Lys Gln Ile Glu Lys Glu Tyr Thr Gln Lys Leu Ala Lys
805 810 815
Ser Ser Gln Ile Ile Ala Glu Leu Gln Thr Thr Ile Ser Ser Leu Lys
820 825 830
Glu Glu Asn Ser Gln Gln Gln Leu Ala Ala Glu Arg Arg Leu Gln Asp
835 840 845
Val Arg Gln Lys Phe Glu Asp Glu Lys Lys Gln Leu Ile Arg Asp Asn
850 855 860
Asp Gln Ala Ile Lys Val Leu Gln Asp Glu Leu Glu Asn Arg Ser Asn
865 870 875 880
Gln Val Arg Cys Ala Glu Lys Lys Leu Gln His Lys Glu Leu Glu Ser
885 890 895
Gln Glu Gln Ile Thr Tyr Ile Arg Gln Glu Tyr Glu Thr Lys Leu Lys
900 905 910
Gly Leu Met Pro Ala Ser Leu Arg Gln Glu Leu Glu Asp Thr Ile Ser
915 920 925
Ser Leu Lys Ser Gln Val Asn Phe Leu Gln Lys Arg Ala Ser Ile Leu
930 935 940
Gln Glu Glu Leu Thr Thr Tyr Gln Gly Arg Arg
945 950 955
SEQUENCE LISTING24
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_001295
<160>1
<170>PatentIn version 3.5
<210>1
<211>1380
<212>PRT
<213>Homo sapiens
<220>
<221>SITE
<222>(172)..(172)
<220>
<221>SITE
<222>(811)..(811)
<220>
<221>SITE
<222>(955)..(955)
<400>1
Met Ala Ser Gly Arg Asp Glu Arg Pro Pro Trp Arg Leu Gly Arg Leu
1 5 10 15
Leu Leu Leu Met Cys Leu Leu Leu Leu Gly Ser Ser Ala Arg Ala Ala
20 25 30
His Ile Lys Lys Ala Glu Ala Thr Thr Thr Thr Thr Ser Ala Gly Ala
35 40 45
Glu Ala Ala Glu Gly Gln Phe Asp Arg Tyr Tyr His Glu Glu Glu Leu
50 55 60
Glu Ser Ala Leu Arg Glu Ala Ala Ala Ala Gly Leu Pro Gly Leu Ala
65 70 75 80
Arg Leu Phe Ser Ile Gly Arg Ser Val Glu Gly Arg Pro Leu Trp Val
85 90 95
Leu Arg Leu Thr Ala Gly Leu Gly Ser Leu Ile Pro Glu Gly Asp Ala
100 105 110
Gly Pro Asp Ala Ala Gly Pro Asp Ala Ala Gly Pro Leu Leu Pro Gly
115 120 125
Arg Pro Gln Val Lys Leu Val Gly Asn Met His Gly Asp Glu Thr Val
130 135 140
Ser Arg Gln Val Leu Ile Tyr Leu Ala Arg Glu Leu Ala Ala Gly Tyr
145 150 155 160
Arg Arg Gly Asp Pro Arg Leu Val Arg Leu Leu Asn Thr Thr Asp Val
165 170 175
Tyr Leu Leu Pro Ser Leu Asn Pro Asp Gly Phe Glu Arg Ala Arg Glu
180 185 190
Gly Asp Cys Gly Phe Gly Asp Gly Gly Pro Ser Gly Ala Ser Gly Arg
195 200 205
Asp Asn Ser Arg Gly Arg Asp Leu Asn Arg Ser Phe Pro Asp Gln Phe
210 215 220
Ser Thr Gly Glu Pro Pro Ala Leu Asp Glu Val Pro Glu Val Arg Ala
225 230 235 240
Leu Ile Glu Trp Ile Arg Arg Asn Lys Phe Val Leu Ser Gly Asn Leu
245 250 255
His Gly Gly Ser Val Val Ala Ser Tyr Pro Phe Asp Asp Ser Pro Glu
260 265 270
His Lys Ala Thr Gly Ile Tyr Ser Lys Thr Ser Asp Asp Glu Val Phe
275 280 285
Lys Tyr Leu Ala Lys Ala Tyr Ala Ser Asn His Pro Ile Met Lys Thr
290 295 300
Gly Glu Pro His Cys Pro Gly Asp Glu Asp Glu Thr Phe Lys Asp Gly
305 310 315 320
Ile Thr Asn Gly Ala His Trp Tyr Asp Val Glu Gly Gly Met Gln Asp
325 330 335
Tyr Asn Tyr Val Trp Ala Asn Cys Phe Glu Ile Thr Leu Glu Leu Ser
340 345 350
Cys Cys Lys Tyr Pro Pro Ala Ser Gln Leu Arg Gln Glu Trp Glu Asn
355 360 365
Asn Arg Glu Ser Leu Ile Thr Leu Ile Glu Lys Val His Ile Gly Val
370 375 380
Lys Gly Phe Val Lys Asp Ser Ile Thr Gly Ser Gly Leu Glu Asn Ala
385 390 395 400
Thr Ile Ser Val Ala Gly Ile Asn His Asn Ile Thr Thr Gly Arg Phe
405 410 415
Gly Asp Phe Tyr Arg Leu Leu Val Pro Gly Thr Tyr Asn Leu Thr Val
420 425 430
Val Leu Thr Gly Tyr Met Pro Leu Thr Val Thr Asn Val Val Val Lys
435 440 445
Glu Gly Pro Ala Thr Glu Val Asp Phe Ser Leu Arg Pro Thr Val Thr
450 455 460
Ser Val Ile Pro Asp Thr Thr Glu Ala Val Ser Thr Ala Ser Thr Val
465 470 475 480
Ala Ile Pro Asn Ile Leu Ser Gly Thr Ser Ser Ser Tyr Gln Pro Ile
485 490 495
Gln Pro Lys Asp Phe His His His His Phe Pro Asp Met Glu Ile Phe
500 505 510
Leu Arg Arg Phe Ala Asn Glu Tyr Pro Asn Ile Thr Arg Leu Tyr Ser
515 520 525
Leu Gly Lys Ser Val Glu Ser Arg Glu Leu Tyr Val Met Glu Ile Ser
530 535 540
Asp Asn Pro Gly Val His Glu Pro Gly Glu Pro Glu Phe Lys Tyr Ile
545 550 555 560
Gly Asn Met His Gly Asn Glu Val Val Gly Arg Glu Leu Leu Leu Asn
565 570 575
Le Ile Glu Tyr Leu Cys Lys Asn Phe Gly Thr Asp Pro Glu Val Thr
580 585 590
Asp Leu Val His Asn Thr Arg Ile His Leu Met Pro Ser Met Asn Pro
595 600 605
Asp Gly Tyr Glu Lys Ser Gln Glu Gly Asp Ser Ile Ser Val Ile Gly
610 615 620
Arg Asn Asn Ser Asn Asn Phe Asp Leu Asn Arg Asn Phe Pro Asp Gln
625 630 635 640
Phe Val Gln Ile Thr Asp Pro Thr Gln Pro Glu Thr Ile Ala Val Met
645 650 655
Ser Trp Met Lys Ser Tyr Pro Phe Val Leu Ser Ala Asn Leu His Gly
660 665 670
Gly Ser Leu Val Val Asn Tyr Pro Phe Asp Asp Asp Glu Gln Gly Leu
675 680 685
Ala Thr Tyr Ser Lys Ser Pro Asp Asp Ala Val Phe Gln Gln Ile Ala
690 695 700
Leu Ser Tyr Ser Lys Glu Asn Ser Gln Met Phe Gln Gly Arg Pro Cys
705 710 715 720
Lys Asn Met Tyr Pro Asn Glu Tyr Phe Pro His Gly Ile Thr Asn Gly
725 730 735
Ala Ser Trp Tyr Asn Val Pro Gly Gly Met Gln Asp Trp Asn Tyr Leu
740 745 750
Gln Thr Asn Cys Phe Glu Val Thr Ile Glu Leu Gly Cys Val Lys Tyr
755 760 765
Pro Leu Glu Lys Glu Leu Pro Asn Phe Trp Glu Gln Asn Arg Arg Ser
770 775 780
Leu Ile Gln Phe Met Lys Gln Val His Gln Gly Val Arg Gly Phe Val
785 790 795 800
Leu Asp Ala Thr Asp Gly Arg Gly Ile Leu Asn Ala Thr Ile Ser Val
805 810 815
Ala Glu Ile Asn His Pro Val Thr Thr Tyr Lys Thr Gly Asp Tyr Trp
820 825 830
Arg Leu Leu Val Pro Gly Thr Tyr LysIle Thr Ala Ser Ala Arg Gly
835 840 845
Tyr Asn Pro Val Thr Lys Asn Val Thr Val Lys Ser Glu Gly Ala Ile
850 855 860
Gln Val Asn Phe Thr Leu Val Arg Ser Ser Thr Asp Ser Asn Asn Glu
865 870 875 880
Ser Lys Lys Gly Lys Gly Ala Ser Ser Ser Thr Asn Asp Ala Ser Asp
885 890 895
Pro Thr Thr Lys Glu Phe Glu Thr Leu Ile Lys Asp Leu Ser Ala Glu
900 905 910
Asn Gly Leu Glu Ser Leu Met Leu Arg Ser Ser Ser Asn Leu Ala Leu
915 920 925
Ala Leu Tyr Arg Tyr His Ser Tyr Lys Asp Leu Ser Glu Phe Leu Arg
930 935 940
Gly Leu Val Met Asn Tyr Pro His Ile Thr Asn Leu Thr Asn Leu Gly
945 950 955 960
Gln Ser Thr Glu Tyr Arg His Ile Trp Ser Leu Glu Ile Ser Asn Lys
965 970 975
Pro Asn Val Ser Glu Pro Glu Glu Pro Lys Ile Arg Phe Val Ala Gly
980 985 990
Ile His Gly Asn Ala Pro Val Gly Thr Glu Leu Leu Leu Ala Leu Ala
995 1000 1005
Glu Phe Leu Cys Leu Asn Tyr Lys Lys Asn Pro Ala Val Thr Gln
1010 1015 1020
Leu Val Asp Arg Thr Arg Ile Val Ile Val Pro Ser Leu Asn Pro
1025 1030 1035
Asp Gly Arg Glu Arg Ala Gln Glu Lys Asp Cys Thr Ser Lys Ile
1040 1045 1050
Gly Gln Thr Asn Ala Arg Gly Lys Asp Leu Asp Thr Asp Phe Thr
1055 1060 1065
Asn Asn Ala Ser Gln Pro Glu Thr Lys Ala Ile Ile Glu Asn Leu
1070 1075 1080
Ile Gln Lys Gln Asp Phe Ser Leu Ser Val Ala Leu Asp Gly Gly
1085 1090 1095
Ser Met Leu Val Thr Tyr Pro Tyr Asp Lys Pro Val Gln Thr Val
1100 1105 1110
Glu Asn Lys Glu Thr Leu Lys His Leu Ala Ser Leu Tyr Ala Asn
1115 1120 1125
Asn His Pro Ser Met His Met Gly Gln Pro Ser Cys Pro Asn Lys
1130 1135 1140
Ser Asp Glu Asn Ile Pro Gly Gly Val Met Arg Gly Ala Glu Trp
1145 1150 1155
His Ser His Leu Gly Ser Met Lys Asp Tyr Ser Val Thr Tyr Gly
1160 1165 1170
His Cys Pro Glu Ile Thr Val Tyr Thr Ser Cys Cys Tyr Phe Pro
1175 1180 1185
Ser Ala Ala Arg Leu Pro Ser Leu Trp Ala Asp Asn Lys Arg Ser
1190 1195 1200
Leu Leu Ser Met Leu Val Glu Val His Lys Gly Val His Gly Phe
1205 1210 1215
Val Lys Asp Lys Thr Gly Lys Pro Ile Ser Lys Ala Val Ile Val
1220 1225 1230
Leu Asn Glu Gly Ile Lys Val Gln Thr Lys Glu Gly Gly Tyr Phe
1235 1240 1245
His Val Leu Leu Ala Pro Gly Val His Asn Ile Ile Ala Ile Ala
1250 1255 1260
Asp Gly Tyr Gln Gln Gln His Ser Gln Val Phe Val His His Asp
1265 1270 1275
Ala Ala Ser Ser Val Val Ile Val Phe Asp Thr Asp Asn Arg Ile
1280 1285 1290
Phe Gly Leu Pro Arg Glu Leu Val Val Thr Val Ser Gly Ala Thr
1295 1300 1305
Met Ser Ala Leu Ile Leu Thr Ala Cys Ile Ile Trp Cys Ile Cys
1310 1315 1320
Ser Ile Lys Ser Asn Arg His Lys Asp Gly Phe His Arg Leu Arg
1325 1330 1335
Gln His His Asp Glu Tyr Glu Asp Glu Ile Arg Met Met Ser Thr
1340 1345 1350
Gly Ser Lys Lys Ser Leu Leu Ser His Glu Phe Gln Asp Glu Thr
1355 1360 1365
Asp Thr Glu Glu Glu Thr Leu Tyr Ser Ser Lys His
1370 1375 1380
SEQUENCE LISTING25
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_000746
<160>1
<170>PatentIn version 3.5
<210>1
<211>626
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(626)
<400>1
Met Leu Ala Phe Ala Ala Arg Thr Val Val Lys Pro Leu Gly Phe Leu
1 5 10 15
Lys Pro Phe Ser Leu Met Lys Ala Ser Ser Arg Phe Lys Ala His Gln
20 25 30
Asp Ala Leu Pro Arg Leu Pro Val Pro Pro Leu Gln Gln Ser Leu Asp
35 40 45
His Tyr Leu Lys Ala Leu Gln Pro Ile Val Ser Glu Glu Glu Trp Ala
50 55 60
His Thr Lys Gln Leu Val Asp Glu Phe Gln Ala Ser Gly Gly Val Gly
65 70 75 80
Glu Arg Leu Gln Lys Gly Leu Glu Arg Arg Ala Arg Lys Thr Glu Asn
85 90 95
Trp Leu Ser Glu Trp Trp Leu Lys Thr Ala Tyr Leu Gln Tyr Arg Gln
100 105 110
Pro Val Val Ile Tyr Ser Ser Pro Gly Val Met Leu Pro Lys Gln Asp
115 120 125
Phe Val Asp Leu Gln Gly Gln Leu Arg Phe Ala Ala Lys Leu Ile Glu
130 135 140
Gly Val Leu Asp Phe Lys Val Met Ile Asp Asn Glu Thr Leu Pro Val
145 150 155 160
Glu Tyr Leu Gly Gly Lys Pro Leu Cys Met Asn Gln Tyr Tyr Gln Ile
165 170 175
Leu Ser Ser Cys Arg Val Pro Gly Pro Lys Gln Asp Thr Val Ser Asn
180 185 190
Phe Ser Lys Thr Lys Lys Pro Pro Thr His Ile Thr Val Val His Asn
195 200 205
Tyr Gln Phe Phe Glu Leu Asp Val Tyr His Ser Asp Gly Thr Pro Leu
210 215 220
Thr Ala Asp Gln Ile Phe Val Gln Leu Glu Lys Ile Trp Asn Ser Ser
225 230 235 240
Leu Gln Thr Asn Lys Glu Pro Val Gly Ile Leu Thr Ser Asn His Arg
245 250 255
Asn Ser Trp Ala Lys Ala Tyr Asn Thr Leu Ile Lys Asp Lys Val Asn
260 265 270
Arg Asp Ser Val Arg Ser Ile Gln Lys Ser Ile Phe Thr Val Cys Leu
275 280 285
Asp Ala Thr Met Pro Arg Val Ser Glu Asp Val Tyr Arg Ser His Val
290 295 300
Ala Gly Gln Met Leu His Gly Gly Gly Ser Arg Leu Asn Ser Gly Asn
305 310 315 320
Arg Trp Phe Asp Lys Thr Leu Gln Phe Ile Val Ala Glu Asp Gly Ser
325 330 335
Cys Gly Leu Val Tyr Glu His Ala Ala Ala Glu Gly Pro Pro Ile Val
340 345 350
Thr Leu Leu Asp Tyr Val Ile Glu Tyr Thr Lys Lys Pro Glu Leu Val
355 360 365
Arg Ser Pro Met Val Pro Leu Pro Met Pro Lys Lys Leu Arg Phe Asn
370 375 380
Ile Thr Pro Glu Ile Lys Ser Asp Ile Glu Lys Ala Lys Gln Asn Leu
385 390 395 400
Ser Ile Met Ile Gln Asp Leu Asp Ile Thr Val Met Val Phe His His
405 410 415
Phe Gly Lys Asp Phe Pro Lys Ser Glu Lys Leu Ser Pro Asp Ala Phe
420 425 430
Ile Gln Met Ala Leu Gln Leu Ala Tyr Tyr Arg Ile Tyr Gly Gln Ala
435 440 445
Cys Ala Thr Tyr Glu Ser Ala Ser Leu Arg Met Phe His Leu Gly Arg
450 455 460
Thr Asp Thr Ile Arg Ser Ala Ser Met Asp Ser Leu Thr Phe Val Lys
465 470 475 480
Ala Met Asp Asp Ser Ser Val Thr Glu His Gln Lys Val Glu Leu Leu
485 490 495
Arg Lys Ala Val Gln Ala His Arg Gly Tyr Thr Asp Arg Ala Ile Arg
500 505 510
Gly Glu Ala Phe Asp Arg His Leu Leu Gly Leu Lys Leu Gln Ala Ile
515 520 525
Glu Asp Leu Val Ser Met Pro Asp Ile Phe Met Asp Thr Ser Tyr Ala
530 535 540
Ile Ala Met His Phe His Leu Ser Thr Ser Gln Val Pro Ala Lys Thr
545 550 555 560
Asp Cys Val Met Phe Phe Gly Pro Val Val Pro Asp Gly Tyr Gly Val
565 570 575
Cys Tyr Asn Pro Met Glu Ala His Ile Asn Phe Ser Leu Ser Ala Tyr
580 585 590
Asn Ser Cys Ala Glu Thr Asn Ala Ala Arg Leu Ala His Tyr Leu Glu
595 600 605
Lys Ala Leu Leu Asp Met Arg Ala Leu Leu Gln Ser His Pro Arg Ala
610 615 620
Lys Leu
625
SEQUENCE LISTING26
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_001887
<160>1
<170>PatentIn version 3.5
<210>1
<211>350
<212>PRT
<213>Homo sapiens
<220>
<221>SITE
<222>(46)..(47)
<220>
<221>SITE
<222>(49)..(49)
<220>
<221>SITE
<222>(52)..(52)
<220>
<221>SITE
<222>(54)..(54)
<220>
<221>SITE
<222>(67)..(67)
<220>
<221>SITE
<222>(114)..(114)
<220>
<221>SITE
<222>(119)..(119)
<220>
<221>SITE
<222>(121)..(121)
<220>
<221>SITE
<222>(155)..(164)
<220>
<221>SITE
<222>(159)..(159)
<220>
<221>SITE
<222>(162)..(162)
<220>
<221>SITE
<222>(164)..(164)
<220>
<221>SITE
<222>(175)..(177)
<220>
<221>SITE
<222>(176)..(185)
<220>
<221>SITE
<222>(189)..(202)
<220>
<221>SITE
<222>(191)..(192)
<220>
<221>SITE
<222>(194)..(194)
<220>
<221>SITE
<222>(196)..(197)
<400>1
Met Pro Gly Pro Ala Ala Gly Ser Arg Ala Arg Val Tyr Ala Glu Val
1 5 10 15
Asn Ser Leu Arg Ser Arg Glu Tyr Trp Asp Tyr Glu Ala His Val Pro
20 25 30
Ser Trp Gly Asn Gln Asp Asp Tyr Gln Leu Val Arg Lys Leu Gly Arg
35 40 45
Gly Lys Tyr Ser Glu Val Phe Glu Ala Ile Asn Ile Thr Asn Asn Glu
50 55 60
Arg Val Val Val Lys Ile Leu Lys Pro Val Lys Lys Lys Lys Ile Lys
65 70 75 80
Arg Glu Val Lys Ile Leu Glu Asn Leu Arg Gly Gly Thr Asn Ile Ile
85 90 95
Lys Leu Ile Asp Thr Val Lys Asp Pro Val Ser Lys Thr Pro Ala Leu
100 105 110
Val Phe Glu Tyr Ile Asn Asn Thr Asp Phe Lys Gln Leu Tyr Gln Ile
115 120 125
Leu Thr Asp Phe Asp Ile Arg Phe Tyr Met Tyr Glu Leu Leu Lys Ala
130 135 140
Leu Asp Tyr Cys His Ser Lys Gly Ile Met His Arg Asp Val Lys Pro
145 150 155 160
His Asn Val Met Ile Asp His Gln Gln Lys Lys Leu Arg Leu Ile Asp
165 170 175
Trp Gly Leu Ala Glu Phe Tyr His Pro Ala Gln Glu Tyr Asn Val Arg
180 185 190
Val Ala Ser Arg Tyr Phe Lys Gly Pro Glu Leu Leu Val Asp Tyr Gln
195 200 205
Met Tyr Asp Tyr Ser Leu Asp Met Trp Ser Leu Gly Cys Met Leu Ala
210 215 220
Ser Met Ile Phe Arg Arg Glu Pro Phe Phe His Gly Gln Asp Asn Tyr
225 230 235 240
Asp Gln Leu Val Arg Ile Ala Lys Val Leu Gly Thr Glu Glu Leu Tyr
245 250 255
Gly Tyr Leu Lys Lys Tyr His Ile Asp Leu Asp Pro His Phe Asn Asp
260 265 270
Ile Leu Gly Gln His Ser Arg Lys Arg Trp Glu Asn Phe Ile His Ser
275 280 285
Glu Asn Arg His Leu Val Ser Pro Glu Ala Leu Asp Leu Leu Asp Lys
290 295 300
Leu Leu Arg Tyr Asp His Gln Gln Arg Leu Thr Ala Lys Glu Ala Met
305 310 315 320
Glu His Pro Tyr Phe Tyr Pro Val Val Lys Glu Gln Ser Gln Pro Cys
325 330 335
Ala Asp Asn Ala Val Leu Ser Ser Gly Leu Thr Ala Ala Arg
340 345 350
SEQUENCE LISTING27
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_003453
<160>1
<170>PatentIn version 3.5
<210>1
<211>280
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(280)
<400>1
Met Val Thr Ala Asn Lys Ala His Thr Gly Gln Gly Ser Cys Trp Val
1 5 10 15
Ala Thr Leu Ala Ser Ala Met Ile Pro Pro Ala Asp Ser Leu Leu Lys
20 25 30
Tyr Asp Thr Pro Val Leu Val Ser Arg Asn Thr Glu Lys Arg Ser Pro
35 40 45
Lys Ala Arg Leu Leu Lys Val Ser Pro Gln Gln Pro Gly Pro Ser Gly
50 55 60
Ser Ala Pro Gln Pro Pro Lys Thr Lys Leu Pro Ser Thr Pro Cys Val
65 70 75 80
Pro Asp Pro Thr Lys Gln Ala Glu Glu Ile Leu Asn Ala Ile Leu Pro
85 90 95
Pro Arg Glu Trp Val Glu Asp Thr Gln Leu Trp Ile Gln Gln Val Ser
100 105 110
Ser Thr Pro Ser Thr Arg Met Asp Val Val His Leu Gln Glu Gln Leu
115 120 125
Asp Leu Lys Leu Gln Gln Arg Gln Ala Arg Glu Thr Gly Ile Cys Pro
130 135 140
Val Arg Arg Glu Leu Tyr Ser Gln Cys Phe Asp Glu Leu Ile Arg Glu
145 150 155 160
Val Thr Ile Asn Cys Ala Glu Arg Gly Leu Leu Leu Leu Arg Val Arg
165 170 175
Asp Glu Ile Arg Met Thr Ile Ala Ala Tyr Gln Thr Leu Tyr Glu Ser
180 185 190
Ser Val Ala Phe Gly Met Arg Lys Ala Leu Gln Ala Glu Gln Gly Lys
195 200 205
Ser Asp Met Glu Arg Lys Ile Ala Glu Leu Glu Thr Glu Lys Arg Asp
210 215 220
Leu Glu Arg Gln Val Asn Glu Gln Lys Ala Lys Cys Glu Ala Thr Glu
225 230 235 240
Lys Arg Glu Ser Glu Arg Arg Gln Val Glu Glu Lys Lys His Asn Glu
245 250 255
Glu Ile Gln Phe Leu Lys Arg Thr Asn Gln Gln Leu Lys Ala Gln Leu
260 265 270
Glu Gly Ile Ile Ala Pro Lys Lys
275 280
SEQUENCE LISTING28
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_149991
<160>1
<170>PatentIn version 3.5
<210>1
<211>553
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(553)
<400>1
Met Ala Ala Pro Lys Thr Ala Ala Val Gly Pro Leu Val Gly Ala Val
1 5 10 15
Val Gln Gly Thr Asn Ser Thr Arg Phe Leu Val Phe Asn Ser Lys Thr
20 25 30
Ala Glu Leu Leu Ser His His Lys Val Glu Leu Thr Gln Glu Phe Pro
35 40 45
Lys Glu Gly Trp Val Glu Gln Asp Pro Lys Glu Ile Leu Gln Ser Val
50 55 60
Tyr Glu Cys Ile Ala Arg Thr Cys Glu Lys Leu Asp Glu Leu Asn Ile
65 70 75 80
Asp Ile Ser Asn Ile Lys Ala Val Gly Val Ser Asn Gln Arg Glu Thr
85 90 95
Thr Val Ile Trp Asp Lys Leu Thr Gly Glu Pro Leu Tyr Asn Ala Val
100 105 110
Val Trp Leu Asp Leu Arg Thr Gln Thr Thr Val Glu Asp Leu Ser Lys
115 120 125
Lys Ile Pro Gly Asn Ser Asn Phe Val Lys Ser Lys Thr Gly Leu Pro
130 135 140
Leu Ser Thr Tyr Phe Ser Ala Val Lys Leu Arg Trp Met Leu Asp Asn
145 150 155 160
Val Arg Asn Val Gln Lys Ala Val Glu Glu Gly Arg Ala Leu Phe Gly
165 170 175
Thr Ile Asp Ser Trp Leu Ile Trp Ser Leu Thr Gly Gly Val Asn Gly
180 185 190
Gly Val His Cys Thr Asp Val Thr Asn Ala Ser Arg Thr Met Leu Phe
195 200 205
Asn Ile His Ser Leu Glu Trp Asp Lys Glu Leu Cys Asp Phe Phe Glu
210 215 220
Ile Pro Met Asp Leu Leu Pro Asn Val Phe Ser Ser Ser Glu Ile Tyr
225 230 235 240
Gly Leu Ile Lys Thr Gly Ala Leu Glu Gly Val Pro Ile Ser Gly Cys
245 250 255
Leu Gly Asp Gln Cys Ala Ala Leu Val Gly Gln Met Cys Phe Gln Glu
260 265 270
Gly Gln Ala Lys Asn Thr Tyr Gly Thr Gly Cys Phe Leu Leu Cys Asn
275 280 285
Thr Gly Arg Lys Cys Val Phe Ser Glu His Gly Leu Leu Thr Thr Val
290 295 300
Ala Tyr Lys Leu Gly Arg Glu Lys Pro Ala Tyr Tyr Ala Leu Glu Gly
305 310 315 320
Ser Val Ala Ile Ala Gly Ala Val Ile Arg Trp Leu Arg Asp Asn Leu
325 330 335
Gly Ile Ile Glu Thr Ser Gly Asp Ile Glu Arg Leu Ala Lys Glu Val
340 345 350
Gly Thr Ser Tyr Gly Cys Tyr Phe Val Pro Ala Phe Ser Gly Leu Tyr
355 360 365
Ala Pro Tyr Trp Glu Pro Ser Ala Arg Gly Ile Leu Cys Gly Leu Thr
370 375 380
Gln Phe Thr Asn Lys Cys His Ile Ala Phe Ala Ala Leu Glu Ala Val
385 390 395 400
Cys Phe Gln Thr Arg Glu Ile Leu Glu Ala Met Asn Arg Asp Cys Gly
405 410 415
Ile Pro Leu Arg His Leu Gln Val Asp Gly Gly Met Thr Asn Asn Lys
420 425 430
Val Leu Met Gln Leu Gln Ala Asp Ile Leu His Ile Pro Val Ile Lys
435 440 445
Pro Phe Met Pro Glu Thr Thr Ala Leu Gly Ala Ala Met Ala Ala Gly
450 455 460
Ala Ala Glu Gly Val Ser Val Trp Ser Leu Glu Pro Gln Ala Leu Ser
465 470 475 480
Val Leu Arg Met Glu Arg Phe Glu Pro Gln Ile Gln Ala Thr Glu Ser
485 490 495
Glu Ile Arg Tyr Ala Thr Trp Lys Lys Ala Val Met Lys Ser Met Gly
500 505 510
Trp Val Thr Ser Gln Ser Pro Glu Gly Gly Asp Pro Ser Ile Phe Ser
515 520 525
Ser Leu Pro Leu Gly Phe Phe Ile Val Ser Ser Met Val Met Leu Ile
530 535 540
Gly Ala Arg Tyr Ile Ser Gly Val Pro
545 550
SEQUENCE LISTING29
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_722545
<160>1
<170>PatentIn version 3.5
<210>1
<211>326
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(326)
<400>1
Met Ala Lys Met Glu Leu Ser Lys Ala Phe Ser Gly Gln Arg Thr Leu
1 5 10 15
Leu Ser Ala Ile Leu Ser Met Leu Ser Leu Ser Phe Ser Thr Thr Ser
20 25 30
Leu Leu Ser Asn Tyr Trp Phe Val Gly Thr Gln Lys Val Pro Lys Pro
35 40 45
Leu Cys Glu Lys Gly Leu Ala Ala Lys Cys Phe Asp Met Pro Val Ser
50 55 60
Leu Asp Gly Asp Thr Asn Thr Ser Thr Gln Glu Val Val Gln Tyr Asn
65 70 75 80
Trp Glu Thr Gly Asp Asp Arg Phe Ser Phe Arg Ser Phe Arg Ser Gly
85 90 95
Met Trp Leu Ser Cys Glu Glu Thr Val Glu Glu Pro Gly Glu Arg Cys
100 105 110
Arg Ser Phe Ile Glu Leu Thr Pro Pro Ala Lys Arg Glu Ile Leu Trp
115 120 125
Leu Ser Leu Gly Thr Gln Ile Thr Tyr Ile Gly Leu Gln Phe Ile Ser
130 135 140
Phe Leu Leu Leu Leu Thr Asp Leu Leu Leu Thr Gly Asn Pro Ala Cys
145 150 155 160
Gly Leu Lys Leu Ser Ala Phe Ala Ala Val Ser Ser Val Leu Ser Gly
165 170 175
Leu Leu Gly Met Val Ala His Met Met Tyr Ser Gln Val Phe Gln Ala
180 185 190
Thr Val Asn Leu Gly Pro Glu Asp Trp Arg Pro His Val Trp Asn Tyr
195 200 205
Gly Trp Ala Phe Tyr Met Ala Trp Leu Ser Phe Thr Cys Cys Met Ala
210 215 220
Ser Ala Val Thr Thr Phe Asn Thr Tyr Thr Arg Met Val Leu Glu Phe
225 230 235 240
Lys Cys Lys His Ser Lys Ser Phe Lys Glu Asn Pro Asn Cys Leu Pro
245 250 255
His His His Gln Cys Phe Pro Arg Arg Leu Ser Ser Ala Ala Pro Thr
260 265 270
Val Gly Pro Leu Thr Ser Tyr His Gln Tyr His Asn Gln Pro Ile His
275 280 285
Ser Val Ser Glu Gly Val Asp Phe Tyr Ser Glu Leu Arg Asn Lys Gly
290 295 300
Phe Gln Arg Gly Ala Ser Gln Glu Leu Lys Glu Ala Val Arg Ser Ser
305 310 315 320
Val Glu Glu Glu Gln Cys
325
SEQUENCE LISTING30
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_000840
<160>1
<170>PatentIn version 3.5
<210>1
<211>225
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(225)
<400>1
Met Ser Cys Glu Ser Ser Met Val Leu Gly Tyr Trp Asp Ile Arg Gly
1 5 10 15
Leu Ala His Ala Ile Arg Leu Leu Leu Glu Phe Thr Asp Thr Ser Tyr
20 25 30
Glu Glu Lys Arg Tyr Thr Cys Gly Glu Ala Pro Asp Tyr Asp Arg Ser
35 40 45
Gln Trp Leu Asp Val Lys Phe Lys Leu Asp Leu Asp Phe Pro Asn Leu
50 55 60
Pro Tyr Leu Leu Asp Gly Lys Asn Lys Ile Thr Gln Ser Asn Ala Ile
65 70 75 80
Leu Arg Tyr Ile Ala Arg Lys His Asn Met Cys Gly Glu Thr Glu Glu
85 90 95
Glu Lys Ile Arg Val Asp Ile Ile Glu Asn Gln Val Met Asp Phe Arg
100 105 110
Thr Gln Leu Ile Arg Leu Cys Tyr Ser Ser Asp His Glu Lys Leu Lys
115 120 125
Pro Gln Tyr Leu Glu Glu Leu Pro Gly Gln Leu Lys Gln Phe Ser Met
130 135 140
Phe Leu Gly Lys Phe Ser Trp Phe Ala Gly Glu Lys Leu Thr Phe Val
145 150 155 160
Asp Phe Leu Thr Tyr Asp Ile Leu Asp Gln Asn Arg Ile Phe Asp Pro
165 170 175
Lys Cys Leu Asp Glu Phe Pro Asn Leu Lys Ala Phe Met Cys Arg Phe
180 185 190
Glu Ala Leu Glu Lys Ile Ala Ala Tyr Leu Gln Ser Asp Gln Phe Cys
195 200 205
Lys Met Pro Ile Asn Asn Lys Met Ala Gln Trp Gly Asn Lys Pro Val
210 215 220
Cys
225
SEQUENCE LISTING31
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_000631
<160>1
<170>PatentIn version 3.5
<210>1
<211>380
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(380)
<400>1
Met Ala Phe Val Cys Leu Ala Ile Gly Cys Leu Tyr Thr Phe Leu Ile
1 5 10 15
Ser Thr Thr Phe Gly Cys Thr Ser Ser Ser Asp Thr Glu Ile Lys Val
20 25 30
Asn Pro Pro Gln Asp Phe Glu Ile Val Asp Pro Gly Tyr Leu Gly Tyr
35 40 45
Leu Tyr Leu Gln Trp Gln Pro Pro Leu Ser Leu Asp His Phe Lys Glu
50 55 60
Cys Thr Val Glu Tyr Glu Leu Lys Tyr Arg Asn Ile Gly Ser Glu Thr
65 70 75 80
Trp Lys Thr Ile Ile Thr Lys Asn Leu His Tyr Lys Asp Gly Phe Asp
85 90 95
Leu Asn Lys Gly Ile Glu Ala Lys Ile His Thr Leu Leu Pro Trp Gln
100 105 110
Cys Thr Asn Gly Ser Glu Val Gln Ser Ser Trp Ala Glu Thr Thr Tyr
115 120 125
Trp Ile Ser Pro Gln Gly Ile Pro Glu Thr Lys Val Gln Asp Met Asp
130 135 140
Cys Val Tyr Tyr Asn Trp Gln Tyr Leu Leu Cys Ser Trp Lys Pro Gly
145 150 155 160
Ile Gly Val Leu Leu Asp Thr Asn Tyr Asn Leu Phe Tyr Trp Tyr Glu
165 170 175
Gly Leu Asp His Ala Leu Gln Cys Val Asp Tyr Ile Lys Ala Asp Gly
180 185 190
Gln Asn Ile Gly Cys Arg Phe Pro Tyr Leu Glu Ala Ser Asp Tyr Lys
195 200 205
Asp Phe Tyr Ile Cys Val Asn Gly Ser Ser Glu Asn Lys Pro Ile Arg
210 215 220
Ser Ser Tyr Phe Thr Phe Gln Leu Gln Asn Ile Val Lys Pro Leu Pro
225 230 235 240
Pro Val Tyr Leu Thr Phe Thr Arg Glu Ser Ser Cys Glu Ile Lys Leu
245 250 255
Lys Trp Ser Ile Pro Leu Gly Pro Ile Pro Ala Arg Cys Phe Asp Tyr
260 265 270
Glu Ile Glu Ile Arg Glu Asp Asp Thr Thr Leu Val Thr Ala Thr Val
275 280 285
Glu Asn Glu Thr Tyr Thr Leu Lys Thr Thr Asn Glu Thr Arg Gln Leu
290 295 300
Cys Phe Val Val Arg Ser Lys Val Asn Ile Tyr Cys Ser Asp Asp Gly
305 310 315 320
Ile Trp Ser Glu Trp Ser Asp Lys Gln Cys Trp Glu Gly Glu Asp Leu
325 330 335
Ser Lys Lys Thr Leu Leu Arg Phe Trp Leu Pro Phe Gly Phe Ile Leu
340 345 350
Ile Leu Val Ile Phe Val Thr Gly Leu Leu Leu Arg Lys Pro Asn Thr
355 360 365
Tyr Pro Lys Met Ile Pro Glu Phe Phe Cys Asp Thr
370 375 380
SEQUENCE LISTING32
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_057452
<160>1
<170>PatentIn version 3.5
<210>1
<211>558
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(558)
<400>1
Met Glu Ala Ala Ala Gln Phe Phe Val Glu Ser Pro Asp Val Val Tyr
1 5 10 15
Gly Pro Glu Ala Ile Glu Ala Gln Tyr Glu Tyr Arg Thr Thr Arg Val
20 25 30
Ser Arg Glu Gly Gly Val Leu Lys Val His Pro Thr Ser Thr Arg Phe
35 40 45
Thr Phe Arg Thr Ala Arg Gln Val Pro Arg Leu Gly Val Met Leu Val
50 55 60
Gly Trp Gly Gly Asn Asn Gly Ser Thr Leu Thr Ala Ala Val Leu Ala
65 70 75 80
Asn Arg Leu Arg Leu Ser Trp Pro Thr Arg Ser Gly Arg Lys Glu Ala
85 90 95
Asn Tyr Tyr Gly Ser Leu Thr Gln Ala Gly Thr Val Ser Leu Gly Leu
100 105 110
Asp Ala Glu Gly Gln Glu Val Phe Val Pro Phe Ser Ala Val Leu Pro
115 120 125
Met Val Ala Pro Asn Asp Leu Val Phe Asp Gly Trp Asp Ile Ser Ser
130 135 140
Leu Asn Leu Ala Glu Ala Met Arg Arg Ala Lys Val Leu Asp Trp Gly
145 150 155 160
Leu Gln Glu Gln Leu Trp Pro His Met Glu Ala Leu Arg Pro Arg Pro
165 170 175
Ser Val Tyr Ile Pro Glu Phe Ile Ala Ala Asn Gln Ser Ala Arg Ala
180 185 190
Asp Asn Leu Ile Pro Gly Ser Arg Ala Gln Gln Leu Glu Gln Ile Arg
195 200 205
Arg Asp Ile Arg Asp Phe Arg Ser Ser Ala Gly Leu Asp Lys Val Ile
210 215 220
Val Leu Trp Thr Ala Asn Thr Glu Arg Phe Cys Glu Val Ile Pro Gly
225 230 235 240
Leu Asn Asp Thr Ala Glu Asn Leu Leu Arg Thr Ile Glu Leu Gly Leu
245 250 255
Glu Val Ser Pro Ser Thr Leu Phe Ala Val Ala Ser Ile Leu Glu Gly
260 265 270
Cys Ala Phe Leu Asn Gly Ser Pro Gln Asn Thr Leu Val Pro Gly Ala
275 280 285
Leu Glu Leu Ala Trp Gln His Arg Val Phe Val Gly Gly Asp Asp Phe
290 295 300
Lys Ser Gly Gln Thr Lys Val Lys Ser Val Leu Val Asp Phe Leu Ile
305 310 315 320
Gly Ser Gly Leu Lys Thr Met Ser Ile Val Ser Tyr Asn His Leu Gly
325 330 335
Asn Asn Asp Gly Glu Asn Leu Ser Ala Pro Leu Gln Phe Arg Ser Lys
340 345 350
Glu Val Ser Lys Ser Asn Val Val Asp Asp Met Val Gln Ser Asn Pro
355 360 365
Val Leu Tyr Thr Pro Gly Glu Glu Pro Asp His Cys Val Val Ile Lys
370 375 380
Tyr Val Pro Tyr Val Gly Asp Ser Lys Arg Ala Leu Asp Glu Tyr Thr
385 390 395 400
Ser Glu Leu Met Leu Gly Gly Thr Asn Thr Leu Val Leu His Asn Thr
405 410 415
Cys Glu Asp Ser Leu Leu Ala Ala Pro Ile Met Leu Asp Leu Ala Leu
420 425 430
Leu Thr Glu Leu Cys Gln Arg Val Ser Phe Cys Thr Asp Met Asp Pro
435 440 445
Glu Pro Gln Thr Phe His Pro Val Leu Ser Leu Leu Ser Phe Leu Phe
450 455 460
Lys Ala Pro Leu Val Pro Pro Gly Ser Pro Val Val Asn Ala Leu Phe
465 470 475 480
Arg Gln Arg Ser Cys Ile Glu Asn Ile Leu Arg Ala Cys Val Gly Leu
485 490 495
Pro Pro Gln Asn His Met Leu Leu Glu His Lys Met Glu Arg Pro Gly
500 505 510
Pro Ser Leu Lys Arg Val Gly Pro Val Ala Ala Thr Tyr Pro Met Leu
515 520 525
Asn Lys Lys Gly Pro Val Pro Ala Ala Thr Asn Gly Cys Thr Gly Asp
530 535 540
Ala Asn Gly His Leu Gln Glu Glu Pro Pro Met Pro Thr Thr
545 550 555
SEQUENCE LISTING33
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_004914
<160>1
<170>PatentIn version 3.5
<210>1
<211>508
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(508)
<400>1
Met Glu Glu Gly Pro Leu Pro Gly Gly Leu Pro Ser Pro Glu Asp Ala
1 5 10 15
Met Val Thr Glu Leu Leu Ser Pro Glu Gly Pro Phe Ala Ser Glu Asn
20 25 30
Ile Gly Leu Lys Ala Pro Val Lys Tyr Glu Glu Asp Glu Phe His Val
35 40 45
Phe Lys Glu Ala Tyr Leu Gly Pro Ala Asp Pro Lys Glu Pro Val Leu
50 55 60
His Ala Phe Asn Pro Ala Leu Gly Ala Asp Cys Lys Gly Gln Val Lys
65 70 75 80
Ala Lys Leu Ala Gly Gly Asp Ser Asp Gly Gly Glu Leu Leu Gly Glu
85 90 95
Tyr Pro Gly Ile Pro Glu Leu Ser Ala Leu Glu Asp Val Ala Leu Leu
100 105 110
Gln Ala Pro Gln Pro Pro Ala Cys Asn Val His Phe Leu Ser Ser Leu
115 120 125
Leu Pro Ala His Arg Ser Pro Ala Val Leu Pro Leu Gly Ala Trp Val
130 135 140
Leu Glu Gly Ala Ser His Pro Gly Val Arg Met Ile Pro Val Glu Ile
145 150 155 160
Lys Glu Ala Gly Gly Thr Thr Thr Ser Asn Asn Pro Glu Glu Ala Thr
165 170 175
Leu Gln Asn Leu Leu Ala Gln Glu Ser Cys Cys Lys Phe Pro Ser Ser
180 185 190
Gln Glu Leu Glu Asp Ala Ser Cys Cys Ser Leu Lys Lys Asp Ser Asn
195 200 205
Pro Met Val Ile Cys Gln Leu Lys Gly Gly Thr Gln Met Leu Cys Ile
210 215 220
Asp Asn Ser Arg Thr Arg Glu Leu Lys Ala Leu His Leu Val Pro Gln
225 230 235 240
Tyr Gln Asp Gln Asn Asn Tyr Leu Gln Ser Asp Val Pro Lys Pro Met
245 250 255
Thr Ala Leu Val Gly Arg Phe Leu Pro Ala Ser Thr Lys Leu Asn Leu
260 265 270
Ile Thr Gln Gln Leu Glu Gly Ala Leu Pro Ser Val Val Asn Gly Ser
275 280 285
Ala Phe Pro Ser Gly Ser Thr Leu Pro Gly Pro Pro Lys Ile Thr Leu
290 295 300
Ala Gly Tyr Cys Asp Cys Phe Ala Ser Gly Asp Phe Cys Asn Asn Cys
305 310 315 320
Asn Cys Asn Asn Cys Cys Asn Asn Leu His His Asp Ile Glu Arg Phe
325 330 335
Lys Ala Ile Lys Ala Cys Leu Gly Arg Asn Pro Glu Ala Phe Gln Pro
340 345 350
Lys Ile Gly Lys Gly Gln Leu Gly Asn Val Lys Pro Gln His Asn Lys
355 360 365
Gly Cys Asn Cys Arg Arg Ser Gly Cys Leu Lys Asn Tyr Cys Glu Cys
370 375 380
Tyr Glu Ala Gln Ile Met Cys Ser Ser Ile Cys Lys Cys Ile Gly Cys
385 390 395 400
Lys Asn Tyr Glu Glu Ser Pro Glu Arg Lys Thr Leu Met Ser Met Pro
405 410 415
Asn Tyr Met Gln Thr Gly Gly Leu Glu Gly Ser His Tyr Leu Pro Pro
420 425 430
Thr Lys Phe Ser Gly Leu Pro Arg Phe Ser His Asp Arg Arg Pro Ser
435 440 445
Ser Cys Ile Ser Trp Glu Val Val Glu Ala Thr Cys Ala Cys Leu Leu
450 455 460
Ala Gln Gly Glu Glu Ala Glu Lys Glu His Cys Ser Lys Cys Leu Ala
465 470 475 480
Glu Gln Met Ile Leu Glu Glu Phe Gly Arg Cys Leu Ser Gln Ile Leu
485 490 495
His Thr Glu Phe Lys Ser Lys Gly Leu Lys Met Glu
500 505
SEQUENCE LISTING34
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_004289
<160>1
<170>PatentIn version 3.5
<210>1
<211>1332
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(1332)
<400>1
Met Ser Asp Met Asp Tyr Pro Leu Gln Gly Pro Gly Leu Leu Ser Val
1 5 10 15
Pro Asn Leu Pro Glu Ile Ser Ser Ile Arg Arg Val Pro Leu Pro Pro
20 25 30
Glu Leu Val Glu Gln Phe Gly His Met Gln Cys Asn Cys Met Met Gly
35 40 45
Val Phe Pro Pro Ile Ser Arg Ala Trp Leu Thr Ile Asp Ser Asp Ile
50 55 60
Phe Met Trp Asn Tyr Glu Asp Gly Gly Asp Leu Ala Tyr Phe Asp Gly
65 70 75 80
Leu Ser Glu Thr Ile Leu Ala Val Gly Leu Val Lys Pro Lys Ala Gly
85 90 95
Ile Phe Gln Pro His Val Arg His Leu Leu Val Leu Ala Thr Pro Val
100 105 110
Asp Ile Val Ile Leu Gly Leu Ser Tyr Ala Asn Leu Gln Thr Gly Ser
115 120 125
Gly Val Leu Asn Asp Ser Leu Ser Gly Gly Met Gln Leu Leu Pro Asp
130 135 140
Pro Leu Tyr Ser Leu Pro Thr Asp Asn Thr Tyr Leu Leu Thr Ile Thr
145 150 155 160
Ser Thr Asp Asn Gly Arg Ile Phe Leu Ala Gly Lys Asp Gly Cys Leu
165 170 175
Tyr Glu Val Ala Tyr Gln Ala Glu Ala Gly Trp Phe Ser Gln Arg Cys
180 185 190
Arg Lys Ile Asn His Ser Lys Ser Ser Leu Ser Phe Leu Val Pro Ser
195 200 205
Leu Leu Gln Phe Thr Phe Ser Glu Asp Asp Pro Ile Leu Gln Ile Ala
210 215 220
Ile Asp Asn Ser Arg Asn Ile Leu Tyr Thr Arg Ser Glu Lys Gly Val
225 230 235 240
Ile Gln Val Tyr Asp Leu Gly Gln Asp Gly Gln Gly Met Ser Arg Val
245 250 255
Ala Ser Val Ser Gln Asn Ala Ile Val Ser Ala Ala Gly Asn Ile Ala
260 265 270
Arg Thr Ile Asp Arg Ser Val Phe Lys Pro Ile Val Gln Ile Ala Val
275 280 285
Ile Glu Asn Ser Glu Ser Leu Asp Cys Gln Leu Leu Ala Val Thr His
290 295 300
Ala Gly Val Arg Leu Tyr Phe Ser Thr Cys Pro Phe Arg Gln Pro Leu
305 310 315 320
Ala Arg Pro Asn Thr Leu Thr Leu Val His Val Arg Leu Pro Pro Gly
325 330 335
Phe Ser Ala Ser Ser Thr Val Glu Lys Pro Ser Lys Val His Arg Ala
340 345 350
Leu Tyr Ser Lys Gly Ile Leu Leu Met Ala Ala Ser Glu Asn Glu Asp
355 360 365
Asn Asp Ile Leu Trp Cys Val Asn His Asp Thr Phe Pro Phe Gln Lys
370 375 380
Pro Met Met Glu Thr Gln Met Thr Ala Gly Val Asp Gly His Ser Trp
385 390 395 400
Ala Leu Ser Ala Ile Asp Glu Leu Lys Val Asp Lys Ile Ile Thr Pro
405 410 415
Leu Asn Lys Asp His Ile Pro Ile Thr Asp Ser Pro Val Val Val Gln
420 425 430
Gln His Met Leu Pro Pro Lys Lys Phe Val Leu Leu Ser Ala Gln Gly
435 440 445
Ser Leu Met Phe His Lys Leu Arg Pro Val Asp Gln Leu Arg His Leu
450 455 460
Leu Val Ser Asn Val Gly Gly Asp Gly Glu Glu Ile Glu Arg Phe Phe
465 470 475 480
Lys Leu His Gln Glu Asp Gln Ala Cys Ala Thr Cys Leu Ile Leu Ala
485 490 495
Cys Ser Thr Ala Ala Cys Asp Arg Glu Val Ser Ala Trp Ala Thr Arg
500 505 510
Ala Phe Phe Arg Tyr Gly Gly Glu Ala Gln Met Arg Phe Pro Thr Thr
515 520 525
Leu Pro Pro Pro Ser Asn Val Gly Pro Ile Leu Gly Ser Pro Val Tyr
530 535 540
Ser Ser Ser Pro Val Pro Ser Gly Ser Pro Tyr Pro Asn Pro Ser Phe
545 550 555 560
Leu Gly Thr Pro Ser His Gly Ile Gln Pro Pro Ala Met Ser Thr Pro
565 570 575
Val Cys Ala Leu Gly Asn Pro Ala Thr Gln Ala Thr Asn Met Ser Cys
580 585 590
Val Thr Gly Pro Glu Ile Val Tyr Ser Gly Lys His Asn Gly Ile Cys
595 600 605
Ile Tyr Phe Ser Arg Ile Met Gly Asn Ile Trp Asp Ala Ser Leu Val
610 615 620
Val Glu Arg Ile Phe Lys Ser Gly Asn Arg Glu Ile Thr Ala Ile Glu
625 630 635 640
Ser Ser Val Pro Cys Gln Leu Leu Glu Ser Val Leu Gln Glu Leu Lys
645 650 655
Gly Leu Gln Glu Phe Leu Asp Arg Asn Ser Gln Phe Ala Gly Gly Pro
660 665 670
Leu Gly Asn Pro Asn Thr Thr Ala Lys Val Gln Gln Arg Leu Ile Gly
675 680 685
Phe Met Arg Pro Glu Asn Gly Asn Pro Gln Gln Met Gln Gln Glu Leu
690 695 700
Gln Arg Lys Phe His Glu Ala Gln Leu Ser Glu Lys Ile Ser Leu Gln
705 710 715 720
Ala Ile Gln Gln Leu Val Arg Lys Ser Tyr Gln Ala Leu Ala Leu Trp
725 730 735
Lys Leu Leu Cys Glu His Gln Phe Thr Ile Ile Val Ala Glu Leu Gln
740 745 750
Lys Glu Leu Gln Glu Gln Leu Lys Ile Thr Thr Phe Lys Asp Leu Val
755 760 765
Ile Arg Asp Lys Glu Leu Thr Gly Ala Leu Ile Ala Ser Leu Ile Asn
770 775 780
Cys Tyr Ile Arg Asp Asn Ala Ala Val Asp Gly Ile Ser Leu His Leu
785 790 795 800
Gln Asp Ile Cys Pro Leu Leu Tyr Ser Thr Asp Asp Ala Ile Cys Ser
805 810 815
Lys Ala Asn Glu Leu Leu Gln Arg Ser Arg Gln Val Gln Asn Lys Thr
820 825 830
Glu Lys Glu Arg Met Leu Arg Glu Ser Leu Lys Glu Tyr Gln Lys Ile
835 840 845
Ser Asn Gln Val Asp Leu Ser Asn Val Cys Ala Gln Tyr Arg Gln Val
850 855 860
Arg Phe Tyr Glu Gly Val Val Glu Leu Ser Leu Thr Ala Ala Glu Lys
865 870 875 880
Lys Asp Pro Gln Gly Leu Gly Leu His Phe Tyr Lys His Gly Glu Pro
885 890 895
Glu Glu Asp Ile Val Gly Leu Gln Ala Phe Gln Glu Arg Leu Asn Ser
900 905 910
Tyr Lys Cys Ile Thr Asp Thr Leu Gln Glu Leu Val Asn Gln Ser Lys
915 920 925
Ala Ala Pro Gln Ser Pro Ser Val Pro Lys Lys Pro Gly Pro Pro Val
930 935 940
Leu Ser Ser Asp Pro Asn Met Leu Ser Asn Glu Glu Ala Gly His His
945 950 955 960
Phe Glu Gln Met Leu Lys Leu Ser Gln Arg Ser Lys Asp Glu Leu Phe
965 970 975
Ser Ile Ala Leu Tyr Asn Trp Leu Ile Gln Val Asp Leu Ala Asp Lys
980 985 990
Leu Leu Gln Val Ala Ser Pro Phe Leu Glu Pro His Leu Val Arg Met
995 1000 1005
Ala Lys Val Asp Gln Asn Arg Val Arg Tyr Met Asp Leu Leu Trp
1010 1015 1020
Arg Tyr Tyr Glu Lys Asn Arg Ser Phe Ser Asn Ala Ala Arg Val
1025 1030 1035
Leu Ser Arg Leu Ala Asp Met His Ser Thr Glu Ile Ser Leu Gln
1040 1045 1050
Gln Arg Leu Glu Tyr Ile Ala Arg Ala Ile Leu Ser Ala Lys Ser
1055 1060 1065
Ser Thr Ala Ile Ser Ser Ile Ala Ala Asp Gly Glu Phe Leu His
1070 1075 1080
Glu Leu Glu Glu Lys Met Glu Val Ala Arg Ile Gln Leu Gln Ile
1085 1090 1095
Gln Glu Thr Leu Gln Arg Gln Tyr Ser His His Ser Ser Val Gln
1100 1105 1110
Asp Ala Val Ser Gln Leu Asp Ser Glu Leu Met Asp Ile Thr Lys
1115 1120 1125
Leu Tyr Gly Glu Phe Ala Asp Pro Phe Lys Leu Ala Glu Cys Lys
1130 1135 1140
Leu Ala Ile Ile His Cys Ala Gly Tyr Ser Asp Pro Ile Leu Val
1145 1150 1155
Gln Thr Leu Trp Gln Asp Ile Ile Glu Lys Glu Leu Ser Asp Ser
1160 1165 1170
Val Thr Leu Ser Ser Ser Asp Arg Met His Ala Leu Ser Leu Lys
1175 1180 1185
Ile Val Leu Leu Gly Lys Ile Tyr Ala Gly Thr Pro Arg Phe Phe
1190 1195 1200
Pro Leu Asp Phe Ile Val Gln Phe Leu Glu Gln Gln Val Cys Thr
1205 1210 1215
Leu Asn Trp Asp Val Gly Phe Val Ile Gln Thr Met Asn Glu Ile
1220 1225 1230
Gly Val Pro Leu Pro Arg Leu Leu Glu Val Tyr Asp Gln Leu Phe
1235 1240 1245
Lys Ser Arg Asp Pro Phe Trp Asn Arg Met Lys Lys Pro Leu His
1250 1255 1260
Leu Leu Asp Cys Ile His Val Leu Leu Ile Arg Tyr Val Glu Asn
1265 1270 1275
Pro Ser Gln Val Leu Asn Cys Glu Arg Arg Arg Phe Thr Asn Leu
1280 1285 1290
Cys Leu Asp Ala Val Cys Gly Tyr Leu Val Glu Leu Gln Ser Met
1295 1300 1305
Ser Ser Ser Val Ala Val Gln Ala Ile Thr Gly Asn Phe Lys Ser
1310 1315 1320
Leu Gln Ala Lys Leu Glu Arg Leu His
1325 1330
SEQUENCE LISTING35
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_056404
<160>1
<170>PatentIn version 3.5
<210>1
<211>717
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(717)
<400>1
Met Phe Arg Asp Gln Val Gly Val Leu Ala Gly Trp Phe Lys Gly Trp
1 5 10 15
Ash Glu Cys Glu Gln Thr Val Ala Leu Leu Ser Leu Leu Lys Arg Val
20 25 30
Ser Gln Thr Gln Ala Arg Phe Leu Gln Leu Cys Leu Glu His Ser Leu
35 40 45
Ala Asp Cys Ala Glu Leu His Val Leu Glu Arg Glu Ala Asn Ser Pro
50 55 60
Gly Ile Ile Asn Gln Trp Gln Gln Glu Ser Lys Asp Lys Val Ile Ser
65 70 75 80
Leu Leu Leu Thr His Leu Pro Leu Leu Lys Pro Gly Asn Leu Asp Ala
85 90 95
Lys Val Glu Tyr Met Lys Leu Leu Pro Lys Ile Leu Ala His Ser Ile
100 105 110
Glu His Asn Gln His Ile Glu Glu Ser Arg Gln Leu Leu Ser Tyr Ala
115 120 125
Leu Ile His Pro Ala Thr Ser Leu Lys Asp Arg Ser Ala Leu Ala Met
130 135 140
Trp Leu Asn His Leu Glu Asp Arg Thr Ser Thr Ser Phe Gly Gly Gln
145 150 155 160
Asn Arg Gly Arg Ser Asp Ser Val Asp Tyr Gly Gln Thr His Tyr Tyr
165 170 175
His Gln Arg Gln Asn Ser Asp Asp Lys Leu Asn Gly Trp Gln Asn Ser
180 185 190
Arg Asp Ser Gly Ile Cys Ile Asn Ala Ser Asn Trp Gln Asp Lys Ser
195 200 205
Met Gly Cys Glu Asn Gly His Val Pro Leu Tyr Ser Ser Ser Ser Val
210 215 220
Pro Thr Thr Ile Asn Thr Ile Gly Thr Ser Thr Ser Thr Ile Leu Ser
225 230 235 240
Gly Gln Ala His His Ser Pro Leu Lys Arg Ser Val Ser Leu Thr Pro
245 250 255
Pro Met Asn Val Pro Asn Gln Pro Leu Gly His Gly Trp Met Ser His
260 265 270
Glu Asp Leu Arg Ala Arg Gly Pro Gln Cys Leu Pro Ser Asp His Ala
275 280 285
Pro Leu Ser Pro Gln Ser Ser Val Ala Ser Ser Gly Ser Gly Gly Ser
290 295 300
Glu His Leu Glu Asp Gln Thr Thr Ala Arg Asn Thr Phe Gln Glu Glu
305 310 315 320
Gly Ser Gly Met Lys Asp Val Pro Ala Trp Leu Lys Ser Leu Arg Leu
325 330 335
His Lys Tyr Ala Ala Leu Phe Ser Gln Met Thr Tyr Glu Glu Met Met
340 345 350
Ala Leu Thr Glu Cys Gln Leu Glu Ala Gln Asn Val Thr Lys Gly Ala
355 360 365
Arg His Lys Ile Val Ile Ser Ile Gln Lys Leu Lys Glu Arg Gln Asn
370 375 380
Leu Leu Lys Ser Leu Glu Arg Asp Ile Ile Glu Gly Gly Ser Leu Arg
385 390 395 400
Ile Pro Leu Gln Glu Leu His Gln Met Ile Leu Thr Pro Ile Lys Ala
405 410 415
Tyr Ser Ser Pro Ser Thr Thr Pro Glu Ala Arg Arg Arg Glu Pro Gln
420 425 430
Ala Pro Arg Gln Pro Ser Leu Met Gly Pro Glu Ser Gln Ser Pro Asp
435 440 445
Cys Lys Asp Gly Ala Ala Ala Thr Gly Ala Thr Ala Thr Pro Ser Ala
450 455 460
Gly Ala Ser Gly Gly Leu Gln Pro His Gln Leu Ser Ser Cys Asp Gly
465 470 475 480
Glu Leu Ala Val Ala Pro Leu Pro Glu Gly Asp Leu Pro Gly Gln Phe
485 490 495
Thr Arg Val Met Gly Lys Val Cys Thr Gln Leu Leu Val Ser Arg Pro
500 505 510
Asp Glu Glu Asn Ile Ser Ser Tyr Leu Gln Leu Ile Asp Lys Cys Leu
515 520 525
Ile His Glu Ala Phe Thr Glu Thr Gln Lys Lys Arg Leu Leu Ser Trp
530 535 540
Lys Gln Gln Val Gln Lys Leu Phe Arg Ser Phe Pro Arg Lys Thr Leu
545 550 555 560
Leu Asp Ile Ser Gly Tyr Arg Gln Gln Arg Asn Arg Gly Phe Gly Gln
565 570 575
Ser Asn Ser Leu Pro Thr Ala Gly Ser Val Gly Gly Gly Met Gly Arg
580 585 590
Arg Asn Pro Arg Gln Tyr Gln Ile Pro Ser Arg Asn Val Pro Ser Ala
595 600 605
Arg Leu Gly Leu Leu Gly Thr Ser Gly Phe Val Ser Ser Asn Gln Arg
610 615 620
Asn Thr Thr Ala Thr Pro Thr Ile Met Lys Gln Gly Arg Gln Asn Leu
625 630 635 640
Trp Phe Ala Asn Pro Gly Gly Ser Asn Ser Met Pro Ser Arg Thr His
645 650 655
Ser Ser Val Gln Arg Thr Arg Ser Leu Pro Val His Thr Ser Pro Gln
660 665 670
Asn Met Leu Met Phe Gln Gln Pro Glu Phe Gln Leu Pro Val Thr Glu
675 680 685
Pro Asp Ile Asn Asn Arg Leu Glu Ser Leu Cys Leu Ser Met Thr Glu
690 695 700
His Ala Leu Gly Asp Gly Val Asp Arg Thr Ser Thr Ile
705 710 715
SEQUENCE LISTING36
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_057086
<160>1
<170>PatentIn version 3.5
<210>1
<211>429
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(429)
<400>1
Met Ala Thr Glu Gln Arg Pro Phe His Leu Val Val Phe Gly Ala Ser
1 5 10 15
Gly Phe Thr Gly Gln Phe Val Thr Glu Glu Val Ala Arg Glu Gln Val
20 25 30
Asp Pro Glu Arg Ser Ser Arg Leu Pro Trp Ala Val Ala Gly Arg Ser
35 40 45
Arg Glu Lys Leu Gln Arg Val Leu Glu Lys Ala Ala Leu Lys Leu Gly
50 55 60
Arg Pro Thr Leu Ser Ser Glu Val Gly Ile Ile Ile Cys Asp Ile Ala
65 70 75 80
Asn Pro Ala Ser Leu Asp Glu Met Ala Lys Gln Ala Thr Val Val Leu
85 90 95
Asn Cys Val Gly Pro Tyr Arg Phe Tyr Gly Glu Pro Val Ile Lys Ala
100 105 110
Cys Ile Glu Asn Gly Ala Ser Cys Ile Asp Ile Ser Gly Glu Pro Gln
115 120 125
Phe Leu Glu Leu Met Gln Leu Lys Tyr His Glu Lys Ala Ala Asp Lys
130 135 140
Gly Val Tyr Ile Ile Gly Ser Ser Gly Phe Asp Ser Ile Pro Ala Asp
145 150 155 160
Leu Gly Val Ile Tyr Thr Arg Asn Lys Met Asn Gly Thr Leu Thr Ala
165 170 175
Val Glu Ser Phe Leu Thr Ile His Ser Gly Pro Glu Gly Leu Ser Ile
180 185 190
His Asp Gly Thr Trp Lys Ser Ala Ile Tyr Gly Phe Gly Asp Gln Ser
195 200 205
Asn Leu Arg Lys Leu Arg Asn Val Ser Asn Leu Lys Pro Val Pro Leu
210 215 220
Ile Gly Pro Lys Leu Lys Arg Arg Trp Pro Ile Ser Tyr Cys Arg Glu
225 230 235 240
Leu Lys Gly Tyr Ser Ile Pro Phe Met Gly Ser Asp Val Ser Val Val
245 250 255
Arg Arg Thr Gln Arg Tyr Leu Tyr Glu Asn Leu Glu Glu Ser Pro Val
260 265 270
Gln Tyr Ala Ala Tyr Val Thr Val Gly Gly Ile Thr Ser Val Ile Lys
275 280 285
Leu Met Phe Ala Gly Leu Phe Phe Leu Phe Phe Val Arg Phe Gly Ile
290 295 300
Gly Arg Gln Leu Leu Ile Lys Phe Pro Trp Phe Phe Ser Phe Gly Tyr
305 310 315 320
Phe Ser Lys Gln Gly Pro Thr Gln Lys Gln Ile Asp Ala Ala Ser Phe
325 330 335
Thr Leu Thr Phe Phe Gly Gln Gly Tyr Ser Gln Gly Thr Gly Thr Asp
340 345 350
Lys Asn Lys Pro Asn Ile Lys Ile Cys Thr Gln Val Lys Gly Pro Glu
355 360 365
Ala Gly Tyr Val Ala Thr Pro Ile Ala Met Val Gln Ala Ala Met Thr
370 375 380
Leu Leu Ser Asp Ala Ser His Leu Pro Lys Ala Gly Gly Val Phe Thr
385 390 395 400
Pro Gly Ala Ala Phe Ser Lys Thr Lys Leu Ile Asp Arg Leu Asn Lys
405 410 415
His Gly Ile Glu Phe Ser Val Ile Ser Ser Ser Glu Val
420 425
SEQUENCE LISTING37
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_061946
<160>1
<170>PatentIn version 3.5
<210>1
<211>488
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(488)
<400>1
Met Pro Lys Val Lys Ala Leu Gln Cys Ala Leu Ala Leu Glu Ile Ser
1 5 10 15
Ser Val Thr Cys Pro Gly Val Val Leu Lys Asp Lys Glu Asp Ile Tyr
20 25 30
Leu Ser Ile Cys Val Phe Gly Gln Tyr Lys Lys Thr Gln Cys Val Pro
35 40 45
Ala Thr Phe Pro Leu Val Phe Asn Ala Arg Met Val Phe Glu Lys Val
50 55 60
Phe Pro Asp Ala Val Asp Pro Gly Asp Val Val Thr Gln Leu Glu Tyr
65 70 75 80
Asp Thr Ala Val Phe Glu Leu Ile Gln Leu Val Pro Pro Val Gly Glu
85 90 95
Thr Leu Ser Thr Tyr Asp Glu Asn Thr Arg Asp Phe Met Phe Pro Gly
100 105 110
Pro Asn Gln Met Ser Gly His His Asp Ser Asn Arg Gln Val Thr Met
115 120 125
Arg Arg Ile Ser Gly Leu Arg Gly Asn Ala Pro Arg Leu Glu Phe Ser
130 135 140
Thr Thr Ser Val Ile Thr Glu Cys Leu Ile Ser Ser Arg Lys Cys His
145 150 155 160
Thr Gln Asp Lys Phe Ile Tyr His Leu Ala Pro Val Glu Lys Ser His
165 170 175
Gly Arg Leu Gln Asn Arg Thr Ser Arg Ser Gln Lys Lys Lys Ser Lys
180 185 190
Ser Pro Glu Arg Ser Lys Tyr Cys Ile Asn Ala Lys Asn Tyr Glu Gln
195 200 205
Pro Thr Ile Ser Ser Lys Ser His Ser Pro Ser Pro Tyr Thr Lys Arg
210 215 220
Arg Met Cys Glu Leu Ser Glu Asp Thr Arg Arg Arg Leu Ala His Leu
225 230 235 240
Asn Leu Gly Pro Tyr Glu Phe Lys Lys Glu Thr Asp Lys Pro Pro Phe
245 250 255
Val Ile Arg His Val Asp Pro Pro Ser Pro Arg Ala Asp Thr Leu Leu
260 265 270
Gly Ser Ser Gly Arg Asp Cys Glu Arg Asp Gly Trp Ser Arg Val His
275 280 285
Asn Asp His Ser His Leu Gly Cys Cys Arg Pro Lys Asp Tyr Lys Val
290 295 300
Ile Arg Thr Pro His Gly Arg Asp Phe Asp Asp Ser Leu Glu Lys Cys
305 310 315 320
Glu Glu Tyr Leu Ser Pro Arg Ser Cys Ser Lys Pro Arg His Ser Ala
325 330 335
Arg Thr Leu Leu Val His Ser Ala Pro Ser Thr Met Pro Lys His Ser
340 345 350
Pro Ser Pro Val Leu Asn Arg Ala Ser Leu Arg Glu Arg Phe His Ser
355 360 365
Asp Trp Cys Ser Pro Ser Asn Cys Asp Glu Ile His Asp Arg Val Lys
370 375 380
Asn Val Leu Lys Ser His Gln Ala His Gln Arg His Leu Tyr Asp Glu
385 390 395 400
Arg Asp Leu Glu Lys Asp Asp Glu Leu Glu Leu Lys Arg Ser Leu Leu
405 410 415
Cys Arg Asp Ser Ala Tyr Asp Ser Asp Pro Glu Tyr Ser Ser Cys Gln
420 425 430
Gln Pro Arg Gly Thr Phe His Leu Asp Asp Gly Glu Tyr Trp Ser Asn
435 440 445
Arg Ala Ala Ser Tyr Lys Gly Lys Ser His Arg Pro Ile Phe Glu Asn
450 455 460
Ser Met Asp Lys Met Tyr Arg Asn Leu Tyr Lys Lys Ala Cys Ser Ser
465 470 475 480
Ala Ser His Thr Gln Glu Ser Phe
485
SEQUENCE LISTING38
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_003275
<160>1
<170>PatentIn version 3.5
<210>1
<211>55
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(55)
<400>1
Met Ser Thr Ser Arg Lys Leu Lys Ser His Gly Met Arg Arg Ser Lys
1 5 10 15
Ser Arg Ser Pro His Lys Gly Val Lys Arg Gly Gly Ser Lys Arg Lys
20 25 30
Tyr Arg Lys Gly Asn Leu Lys Ser Arg Lys Arg Gly Asp Asp Ala Asn
35 40 45
Arg Asn Tyr Arg Ser His Leu
50 55
SEQUENCE LISTING39
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_068379
<160>1
<170>PatentIn version 3.5
<210>1
<211>592
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(592)
<400>1
Met Ala Ser Val Val Val Lys Thr Ile Trp Gln Ser Lys Glu Ile His
1 5 10 15
Glu Ala Gly Asp Thr Pro Thr Gly Val Glu Ser Cys Ser Gln Leu Val
20 25 30
Pro Glu Ala Pro Arg Arg Val Thr Ser Arg Ala Lys Gly Ile Pro Lys
35 40 45
Lys Lys Lys Ala Val Ser Phe His Gly Val Glu Pro Gln Met Ser His
50 55 60
Gln Pro Met His Trp Cys Leu Asn Leu Lys Arg Ser Ser Ala Cys Thr
65 70 75 80
Asn Val Ser Leu Leu Asn Leu Ala Ala Met Glu Pro Thr Asp Ser Thr
85 90 95
Gly Thr Asp Ser Thr Val Glu Asp Leu Ser Gly Gln Leu Thr Leu Ala
100 105 110
Gly Pro Pro Ala Ser Pro Thr Leu Pro Trp Asp Pro Asp Asp Ala Asp
115 120 125
Ile Thr Glu Ile Leu Ser Gly Val Asn Ser Gly Leu Val Arg Ala Lys
130 135 140
Asp Ser Ile Thr Ser Leu Lys Glu Lys Thr Asn Arg Val Asn Gln His
145 150 155 160
Val Gln Ser Leu Gln Ser Glu Cys Ser Val Leu Ser Glu Asn Leu Glu
165 170 175
Arg Arg Arg Gln Glu Ala Glu Glu Leu Glu Gly Tyr Cys Ile Gln Leu
180 185 190
Lys Glu Asn Cys Trp Lys Val Thr Arg Ser Val Glu Asp Ala Glu Ile
195 200 205
Lys Thr Asn Val Leu Lys Gln Asn Ser Ala Leu Leu Glu Glu Lys Leu
210 215 220
Arg Tyr Leu Gln Gln Gln Leu Gln Asp Glu Thr Pro Arg Arg Gln Glu
225 230 235 240
Ala Glu Leu Gln Glu Pro Glu Glu Lys Gln Glu Pro Glu Glu Lys Gln
245 250 255
Glu Pro Glu Glu Lys Gln Lys Pro Glu Ala Gly Leu Ser Trp Asn Ser
260 265 270
Leu Gly Pro Ala Ala Thr Ser Gln Gly Cys Pro Gly Pro Pro Gly Ser
275 280 285
Pro Asp Lys Pro Ser Arg Pro His Gly Leu Val Pro Ala Gly Trp Gly
290 295 300
Met Gly Pro Arg Ala Gly Glu Gly Pro Tyr Val Ser Glu Gln Glu Leu
305 310 315 320
Gln Lys Leu Phe Thr Gly Ile Glu Glu Leu Arg Arg Glu Val Ser Ser
325 330 335
Leu Thr Ala Arg Trp His Gln Glu Glu Gly Ala Val Gln Glu Ala Leu
340 345 350
Arg Leu Leu Gly Gly Leu Gly Gly Arg Val Asp Gly Phe Leu Gly Gln
355 360 365
Trp Glu Arg Ala Gln Arg Glu Gln Ala Gln Thr Ala Arg Asp Leu Gln
370 375 380
Glu Leu Arg Gly Arg Ala Asp Glu Leu Cys Thr Met Val Glu Arg Ser
385 390 395 400
Ala Val Ser Val Ala Ser Leu Arg Ser Glu Leu Glu Gly Leu Gly Pro
405 410 415
Leu Lys Pro Ile Leu Glu Glu Phe Gly Arg Gln Phe Gln Asn Ser Arg
420 425 430
Arg Gly Pro Asp Leu Ser Met Asn Leu Asp Arg Ser His Gln Gly Asn
435 440 445
Cys Ala Arg Cys Ala Ser Gln Gly Ser Gln Leu Ser Thr Glu Ser Leu
450 455 460
Gln Gln Leu Leu Asp Arg Ala Leu Thr Ser Leu Val Asp Glu Val Lys
465 470 475 480
Gln Arg Gly Leu Thr Pro Ala Cys Pro Ser Cys Gln Arg Leu His Lys
485 490 495
Lys Ile Leu Glu Leu Glu Arg Gln Ala Leu Ala Lys His Val Arg Ala
500 505 510
Glu Ala Leu Ser Ser Thr Leu Arg Leu Ala Gln Asp Glu Ala Leu Arg
515 520 525
Ala Lys Asn Leu Leu Leu Thr Asp Lys Met Lys Pro Glu Glu Lys Met
530 535 540
Ala Thr Leu Asp His Leu His Leu Lys Met Cys Ser Leu His Asp His
545 550 555 560
Leu Ser Asn Leu Pro Leu Glu Gly Ser Thr Gly Thr Met Gly Gly Gly
565 570 575
Ser Ser Ala Gly Thr Pro Pro Lys Gln Gly Gly Ser Ala Pro Glu Gln
580 585 590
SEQUENCE LISTING40
<110>北京思安创新生物技术有限公司
段,陵浔
<120>20种肿瘤特异相关的基因与产物的癌症的灵敏诊断与相关治疗
<130>NP_059509
<160>1
<170>PatentIn version 3.5
<210>1
<211>655
<212>PRT
<213>Homo sapiens
<220>
<221>DOMAIN
<222>(1)..(655)
<400>1
Met Ala Lys Gly Gly Glu Ala Leu Pro Gln Gly Ser Pro Ala Pro Val
1 5 10 15
Gln Asp Pro His Leu Ile Lys Val Thr Val Lys Thr Pro Lys Asp Lys
20 25 30
Glu Asp Phe Ser Val Thr Asp Thr Cys Thr Ile Gln Gln Leu Lys Glu
35 40 45
Glu Ile Ser Gln Arg Phe Lys Ala His Pro Asp Gln Leu Val Leu Ile
50 55 60
Phe Ala Gly Lys Ile Leu Lys Asp Pro Asp Ser Leu Ala Gln Cys Gly
65 70 75 80
Val Arg Asp Gly Leu Thr Val His Leu Val Ile Lys Arg Gln His Arg
85 90 95
Ala Met Gly Asn Glu Cys Pro Ala Ala Ser Val Pro Thr Gln Gly Pro
100 105 110
Ser Pro Gly Ser Leu Pro Gln Pro Ser Ser Ile Tyr Pro Ala Asp Gly
115 120 125
Pro Pro Ala Phe Ser Leu Gly Leu Leu Thr Gly Leu Ser Arg Leu Gly
130 135 140
Leu Ala Tyr Arg Gly Phe Pro Asp Gln Pro Ser Ser Leu Met Arg Gln
145 150 155 160
His Val Ser Val Pro Glu Phe Val Thr Gln Leu Ile Asp Asp Pro Phe
165 170 175
Ile Pro Gly Leu Leu Ser Asn Thr Gly Leu Val Arg Gln Leu Val Leu
180 185 190
Asp Asn Pro His Met Gln Gln Leu Ile Gln His Asn Pro Glu Ile Gly
195 200 205
His Ile Leu Asn Asn Pro Glu Ile Met Arg Gln Thr Leu Glu Phe Leu
210 215 220
Arg Asn Pro Ala Met Met Gln Glu Met Ile Arg Ser Gln Asp Arg Val
225 230 235 240
Leu Ser Asn Leu Glu Ser Ile Pro Gly Gly Tyr Asn Val Leu Cys Thr
245 250 255
Met Tyr Thr Asp Ile Met Asp Pro Met Leu Asn Ala Val Gln Glu Gln
260 265 270
Phe Gly Gly Asn Pro Phe Ala Thr Ala Thr Thr Asp Asn Ala Thr Thr
275 280 285
Thr Thr Ser Gln Pro Ser Arg Met Glu Asn Cys Asp Pro Leu Pro Asn
290 295 300
Pro Trp Thr Ser Thr His Gly Gly Ser Gly Ser Arg Gln Gly Arg Gln
305 310 315 320
Asp Gly Asp Gln Asp Ala Pro Asp Ile Arg Asn Arg Phe Pro Asn Phe
325 330 335
Leu Gly Ile Ile Arg Leu Tyr Asp Tyr Leu Gln Gln Leu His Glu Asn
340 345 350
Pro Gln Ser Leu Gly Thr Tyr Leu Gln Gly Thr Ala Ser Ala Leu Ser
355 360 365
Gln Ser Gln Glu Pro Pro Pro Ser Val Asn Arg Val Pro Pro Ser Ser
370 375 380
Pro Ser Ser Gln Glu Pro Gly Ser Gly Gln Pro Leu Pro Glu Glu Ser
385 390 395 400
Val Ala Ile Lys Gly Arg Ser Ser Cys Pro Ala Phe Leu Arg Tyr Pro
405 410 415
Thr Glu Asn Ser Thr Gly Gln Gly Gly Asp Gln Asp Gly Ala Gly Lys
420 425 430
Ser Ser Thr Gly His Ser Thr Asn Leu Pro Asp Leu Val Ser Gly Leu
435 440 445
Gly Asp Ser Ala Asn Arg Val Pro Phe Ala Pro Leu Ser Phe Ser Pro
450 455 460
Thr Ala Ala Ile Pro Gly Ile Pro Glu Pro Pro Trp Leu Pro Ser Pro
465 470 475 480
Ala Tyr Pro Arg Ser Leu Arg Pro Asp Gly Met Asn Pro Ala Pro Gln
485 490 495
Leu Gln Asp Glu Ile Gln Pro Gln Leu Pro Leu Leu Met His Leu Gln
500 505 510
Ala Ala Met Ala Asn Pro Arg Ala Leu Gln Ala Leu Arg Gln Ile Glu
515 520 525
Gln Gly Leu Gln Val Leu Ala Thr Glu Ala Pro Arg Leu Leu Leu Trp
530 535 540
Phe Met Pro Cys Leu Ala Gly Thr Gly Ser Val Ala Gly Gly Ile Glu
545 550 555 560
Ser Arg Glu Asp Pro Leu Met Ser Glu Asp Pro Leu Pro Asn Pro Pro
565 570 575
Pro Glu Val Phe Pro Ala Leu Asp Ser Ala Glu Leu Gly Phe Leu Ser
580 585 590
Pro Pro Phe Leu His Met Leu Gln Asp Leu Val Ser Thr Asn Pro Gln
595 600 605
Gln Leu Gln Pro Glu Ala His Phe Gln Val Gln Leu Glu Gln Leu Arg
610 615 620
Ser Met Gly Phe Leu Asn Arg Glu Ala Asn Leu Gln Ala Leu Ile Ala
625 630 635 640
Thr Gly Gly Asp Val Asp Ala Ala Val Glu Lys Leu Arg Gln Ser
645 650 655
机译: 用于诊断和治疗肿瘤和癌症尤其是神经胶质瘤,星形细胞瘤和少突胶质瘤的寡核苷酸,包括与肿瘤和癌症相关的基因的化学修饰基因组序列
机译: 用于诊断和治疗肿瘤和癌症尤其是神经胶质瘤,星形细胞瘤和少突胶质瘤的寡核苷酸,包括与肿瘤和癌症相关的基因的化学修饰基因组序列
机译: 造血干细胞,造血祖细胞,髓样/单核细胞受损的祖细胞,巨噬细胞或单核细胞,肿瘤相关抗原特异性t细胞,免疫检查点抑制剂,1-甲基色氨酸,免疫检查点抑制剂和特异抗体的组合肿瘤相关抗原的t细胞,治疗或预防癌症的方法以及造血干细胞,造血祖细胞,骨髓/单核细胞受损的祖细胞,巨噬细胞或单核细胞的群体。